2431 genotypes with 3515 annotations displayed
of selected term and subterms
|
Searched Term: abnormal muscle physiology
|
2310039L15RikTg(Prnp-SNCA*A53T)23Mkle/2310039L15Rik+
(involves: C3H/HeJ * C57BL/6J)
|
dystonia
|
J:77344
|
2310065F04Riktm1.1Boet/2310065F04Riktm1.1Boet
(involves: C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:306156
|
increased skeletal muscle satellite cell proliferation
|
J:306156
|
3425401B19Rikem1Liyu/3425401B19Rik+
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:350467
|
3425401B19Rikem1Liyu/3425401B19Rikem1Liyu
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:350467
|
dilated cardiomyopathy
|
J:350467
|
4933430I17Riktm1b(EUCOMM)Wtsi/4933430I17Riktm1b(EUCOMM)Wtsi
(C57BL/6N-4933430I17Riktm1b(EUCOMM)Wtsi/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S/Sv * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:164749
|
dilated cardiomyopathy
|
J:164749
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Ak2em1.1Dze/Ak2em1.1Dze
(involves: 129 * C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:305579
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Clk4em1Yihc/Clk4em1Yihc
(B6(FVB)-Clk4em1Yihc A1cfTg(Myh6-cre/Esr1*)1Jmk)
|
decreased heart ventricle muscle contractility
|
J:327369
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Dusp12em1Zhzy/Dusp12em1Zhzy
(involves: FVB/N)
|
cardiomyopathy
|
J:345360
|
decreased cardiac muscle contractility
|
J:345360
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Ppiftm1Jmol/Ppiftm1Jmol Slc8b1tm1c(EUCOMM)Wtsi/Slc8b1tm1c(EUCOMM)Wtsi
(involves: 129S4/SvJaeSor * C57BL/6N * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:325413
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Tg(CAG-cat,-Dusp14)4Lyg/0
(involves: C57BL/6J * FVB/N)
|
decreased cardiac muscle contractility
|
J:263251
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Tg(CAG-DMPK*)1323Coop/0
(involves: FVB)
|
abnormal cardiac muscle relaxation
|
J:127391
|
decreased cardiac muscle contractility
|
J:127391
|
dilated cardiomyopathy
|
J:127391
|
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Tg(Myh6-2A)#Know/0
(involves: BALB/c * C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:128060
|
dilated cardiomyopathy
|
J:128060
|
Aars1sti/Aars1tm1Slac
(involves: C57BL/6J)
|
decreased heart left ventricle muscle contractility
|
J:216802
|
Abca1tm1Wpfl/Abca1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
cardiomyopathy
|
J:64390
|
Abca1tm1Wpfl/Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J)
|
cardiomyopathy
|
J:64390
|
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrj * CBA/JNCrj)
|
dilated cardiomyopathy
|
J:99152
|
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)
|
dilated cardiomyopathy
|
J:99152
|
Abcb8tm1Hard/Abcb8tm1Hard A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: FVB)
|
abnormal cardiac muscle relaxation
|
J:182234
|
cardiomyopathy
|
J:182234
|
decreased cardiac muscle contractility
|
J:182234
|
Abcc9em1Nich/Abcc9+
(involves: C57BL/6J * CBA/J)
|
abnormal vascular smooth muscle physiology
|
J:281903
|
increased vasodilation
|
J:281903
|
Abcc9em1Nich/Abcc9em1Nich
(involves: C57BL/6J * CBA/J)
|
abnormal vascular smooth muscle physiology
|
J:281903
|
Abcc9em2Nich/Abcc9em2Nich
(involves: C57BL/6J * CBA/J)
|
decreased heart left ventricle muscle contractility
|
J:281630
|
increased muscle fatigability
|
J:281630
|
Abcc9tm1.1Mcn/Abcc9tm1.1Mcn Tg(Tagln-cre)1Her/0
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
cardiomyopathy
|
J:216539
|
decreased cardiac muscle contractility
|
J:216539
|
Abcc9tm1Cfb/Abcc9tm1Cfb
(involves: CD-1)
|
increased skeletal muscle cell glucose uptake
|
J:71840
|
Abcc9tm1Cfb/Abcc9tm1Cfb
(Not Specified)
|
abnormal vascular smooth muscle physiology
|
J:78066
|
Abcg5trac/Abcg5trac
(A/J-Abcg5trac)
|
cardiomyopathy
|
J:157223
|
Abcg8tm1b(KOMP)Wtsi/Abcg8tm1b(KOMP)Wtsi
(C57BL/6N-Abcg8tm1b(KOMP)Wtsi/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
Abhd5tm1Rze/Abhd5tm1Rze Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased heart left ventricle muscle contractility
|
J:197835
|
increased cardiac muscle cell glucose uptake
|
J:197835
|
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu)
|
increased skeletal muscle cell glucose uptake
|
J:234876
|
Abhd12tm1Crv/Abhd12tm1Crv
(involves: C57BL/6)
|
muscle weakness
|
J:193716
|
Abi3bptm1Tac/Abi3bptm1Tac
(involves: 129S5/SvEvBrd)
|
decreased heart left ventricle muscle contractility
|
J:251000
|
Abitramtm1b(EUCOMM)Wtsi/Abitramtm1b(EUCOMM)Wtsi
(C57BL/6N-Abitramtm1b(EUCOMM)Wtsi/Bay)
|
increased cardiac muscle contractility
|
J:211773
|
Abl1tm1Mlg/Abl1tm1Mlg
(B6.129-Abl1tm1Mlg)
|
increased fetal cardiomyocyte proliferation
|
J:156743
|
Acad9tm1c(KOMP)Wtsi/Acad9tm1c(KOMP)Wtsi Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * C57BL/6N * FVB/N * SJL)
|
muscle weakness
|
J:326969
|
Acad9tm1c(KOMP)Wtsi/Acad9tm1c(KOMP)Wtsi Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6N * FVB/N)
|
cardiomyopathy
|
J:326969
|
decreased cardiac muscle contractility
|
J:326969
|
Acadmtm1Uab/Acadmtm1Uab
(involves: 129P2/OlaHsd * C57BL/6)
|
cardiomyopathy
|
J:115759
|
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * C57BL/6)
|
cardiomyopathy
|
J:98627
|
Acadvltm1Zkhu/Acadvltm1Zkhu Tg(Myh6-cre)1Jmk/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCr)
|
decreased heart left ventricle muscle contractility
|
J:208711
|
dilated cardiomyopathy
|
J:208711
|
Acanb2b183Clo/Acanb2b183Clo
(C57BL/6J-Acanb2b183Clo)
|
cardiomyopathy
|
J:175213
|
Ace2tm1Hira/Y
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:135766
|
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cardiac muscle contractility
|
J:124548,
J:77232
|
dilated cardiomyopathy
|
J:124548
|
Ace2tm1Pngr/Y Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cardiac muscle contractility
|
J:124548
|
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cardiac muscle contractility
|
J:77232
|
Achetm1.1Pata/Achetm1.1Pata
(involves: 129X1/SvJ * C57BL/6)
|
muscle weakness
|
J:132775
|
Achetm2Pata/Achetm2Pata
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
muscle weakness
|
J:132775
|
Achetm4.1Pata/Achetm4.1Pata
(involves: 129X1/SvJ * Black Swiss * C57BL/6 * FVB * FVB/N)
|
muscle weakness
|
J:147855
|
Achetm4Pata/Achetm4Pata
(involves: 129X1/SvJ * Black Swiss * C57BL/6 * FVB)
|
muscle weakness
|
J:147855
|
Acot12em1(IMPC)Hmgu/Acot12em1(IMPC)Hmgu
(C57BL/6NCrl-Acot12em1(IMPC)Hmgu/Ieg)
|
decreased cardiac muscle contractility
|
J:211773
|
Acp1Gt(RRK222)Byg/Acp1Gt(RRK222)Byg
(C.129P2(B6)-Acp1Gt(RRK222)Byg)
|
decreased cardiomyocyte apoptosis
|
J:227733
|
Acta1tm1Jll/Acta1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal muscle physiology
|
J:78070
|
muscle weakness
|
J:78070
|
Acta2tm1Rjs/Acta2tm1Rjs
(involves: 129S7/SvEvBrd * C57)
|
decreased vasoconstriction
|
J:113261
|
Actbtm1(PyVT)Arge/Actb+ Waptm1(cre)Arge/Wap+
(involves: 129S1/Sv)
|
decreased cardiac muscle contractility
|
J:87544
|
Actc1tm1Jll/Actc1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss)
|
increased cardiomyocyte apoptosis
|
J:102007
|
Actc1tm1Jll/Actc1tm1Jll Tg(Myh6-Actg2)1Jll/0
(involves: 129P2/OlaHsd * Black Swiss * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:40165
|
decreased cardiac muscle contractility
|
J:107848,
J:40165
|
decreased heart ventricle muscle contractility
|
J:40165
|
Actg1tm1.2Erv/Actg1tm1.2Erv Tg(ACTA1-cre)79Jme/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
impaired skeletal muscle contractility
|
J:112808
|
Actg1tm1Erv/Actg1tm1Erv Tg(ACTA1-cre)79Jme/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
impaired skeletal muscle contractility
|
J:112808
|
Actmapem1Nki/Actmapem1Nki
(FVB/N-Actmapem1Nki)
|
impaired skeletal muscle contractility
|
J:331923
|
muscle weakness
|
J:331923
|
Actn2em1Kage/Actn2em1Kage
(C57BL/6-Actn2em1Kage)
|
decreased fetal cardiomyocyte proliferation
|
J:334092
|
Actn3tm1Knno/Actn3tm1Knno
(involves: 129 * 129S1/Sv * 129X1/SvJ)
|
abnormal muscle physiology
|
J:125639
|
Acvr1tm1Mak/Acvr1+ Olig2tm1.1(cre)Wdr/Olig2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle spasm
|
J:285841
|
Acvrl1tm1Dyl/Acvrl1tm1Dyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased vasodilation
|
J:85366
|
Acvrl1tm1Enl/Acvrl1+
(involves: C57BL/6)
|
telangiectasia
|
J:82115
|
Adatm1Mw/Adatm1Mw
(involves: 129S7/SvEvBrd)
|
increased vascular smooth muscle cell proliferation
|
J:231559
|
Adam7em1(IMPC)Ccpcz/Adam7em1(IMPC)Ccpcz
(C57BL/6NCrl-Adam7em1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
Adam17tm1.1Rain/Adam17tm1.2Rain Tg(Tek-cre)12Flv/0
(B6.Cg-Adam17tm1.1Rain Adam17tm1.2Rain Tg(Tek-cre)12Flv)
|
decreased cardiac muscle contractility
|
J:195050
|
Adam17tm1Imx/Adam17tm1Imx
(involves: 129 * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:85547
|
Adck2tm1(KOMP)Vlcg/Adck2+
(C57BL/6-Adck2tm1(KOMP)Vlcg)
|
abnormal muscle physiology
|
J:280282
|
Adcy6tm1Hkh/Adcy6tm1Hkh
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased heart left ventricle muscle contractility
|
J:143138
|
Adgrg6tm1Arte/Adgrg6tm1Arte Tg(Scx-GFP/cre)1Stzr/0
(involves: 129S5/SvEvBrd)
|
abnormal tendon physiology
|
J:313834
|
Adgrg7tm1Wfro/Adgrg7tm1Wfro
(129/Sv-Adgrg7tm1Wfro)
|
interstinal hyperperistalsis
|
J:243849
|
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal vasodilation
|
J:103106
|
decreased heart left ventricle muscle contractility
|
J:106599
|
Admtm1Hku/Adm+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:106173
|
Admtm1Unc/Admtm1Unc
(involves: 129S6/SvEvTac)
|
increased cardiomyocyte apoptosis
|
J:106927
|
Adra1atm1Pcs/Adra1atm1Pcs
(involves: 129X1/SvJ * FVB/N)
|
decreased vasoconstriction
|
J:77732
|
Adra1atm1Pcs/Adra1atm1Pcs Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal cardiac muscle contractility
|
J:102648
|
increased heart left ventricle muscle contractility
|
J:83876
|
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd)
|
decreased cardiac muscle contractility
|
J:103581,
J:43591
|
decreased vasoconstriction
|
J:103581
|
Adra1dtm1Gzt/Adra1dtm1Gzt
(involves: 129X1/SvJ * C57BL/6)
|
abnormal muscle tone
|
J:91151
|
Adra2btm1Gsb/Adra2btm1Gsb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal vasoconstriction
|
J:34819
|
Adrb1tm1Bkk/Adrb1tm1Bkk Adrb2tm1Bkk/Adrb2tm1Bkk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2 * FVB/N)
|
decreased cardiac muscle contractility
|
J:55553
|
Aebp2Gt(BC0681)Wtsi/Aebp2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal intestinal peristalsis
|
J:177673
|
Afg3l2Emv66/Afg3l2Emv66
(FVB.MEV2-Afg3l2Emv66/TyJ)
|
progressive muscle weakness
|
J:132285
|
Afg3l2par/Afg3l2par
(Not Specified)
|
muscle weakness
|
J:34237
|
progressive muscle weakness
|
J:13950,
J:132285
|
Agertm1.1Arnd/Agertm1.1Arnd
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:82620
|
decreased vascular smooth muscle cell proliferation
|
J:82620
|
Agltm1a(EUCOMM)Wtsi/Agltm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
muscle weakness
|
J:212003
|
Agrnnmf380/Agrnnmf380
(C57BL/6J-Agrnnmf380/J)
|
muscle spasm
|
J:87349
|
myopathy
|
J:87349
|
Agtr2tm1Gsb/Y
(FVB.129-Agtr2tm1Gsb)
|
abnormal vasoconstriction
|
J:103237
|
increased vasoconstriction
|
J:103376
|
Agxt2tm1Lex/Agxt2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased vasodilation
|
J:207876
|
Ahcyem1Cya/Ahcy+
(C57BL/6N-Ahcyem1Cya/Cya)
|
abnormal vasodilation
|
J:298071
|
Aifm1Hq/Y
(B6CBACa Aw-J/A-Aifm1Hq/J)
|
decreased cardiac muscle contractility
|
J:110278
|
increased cardiomyocyte apoptosis
|
J:110278
|
Aifm1Hq/Aifm1Hq
(B6CBACa Aw-J/A-Aifm1Hq/J)
|
decreased cardiac muscle contractility
|
J:110278
|
increased cardiomyocyte apoptosis
|
J:110278
|
Aifm1tm2Pngr/Y Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
decreased cardiac muscle contractility
|
J:113016
|
dilated cardiomyopathy
|
J:113016
|
Ak1tm1Bew/Ak1tm1Bew
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle physiology
|
J:66101
|
Ak1tm1Bew/Ak1tm1Bew Ckmtm1Bew/Ckmtm1Bew
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle contractility
|
J:109659
|
Akap6tm1.1Mskf/Akap6tm1.1Mskf A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: C57BL/6 * FVB/N * SJL)
|
increased cardiomyocyte apoptosis
|
J:214288
|
Akap12Gt(XE450)Byg/Akap12Gt(XE450)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased heart left ventricle muscle contractility
|
J:207542
|
Akap13Gt(CSJ306)Byg/Akap13Gt(CSJ306)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:231257
|
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle cell glucose uptake
|
J:71491
|
Albtm1(cre/ERT2)Mtz/Albtm1(cre/ERT2)Mtz Slc2a2tm2Thor/Slc2a2tm2Thor
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased skeletal muscle cell glucose uptake
|
J:197607
|
Aldh2tm1Dmro/Aldh2+
(B6.129-Aldh2tm1Dmro)
|
decreased cardiac muscle contractility
|
J:261952
|
Aldh5a1tm1Kmg/Aldh5a1tm1Kmg
(involves: 129/Sv * C57BL/6)
|
myoclonus
|
J:71949
|
Alpk3Gt(OST149512)Lex/Alpk3Gt(OST149512)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
cardiomyopathy
|
J:222361
|
decreased cardiac muscle contractility
|
J:222361
|
decreased heart left ventricle muscle contractility
|
J:222361
|
Alpk3tm1b(EUCOMM)Hmgu/Alpk3tm1b(EUCOMM)Hmgu
(C57BL/6N-Alpk3tm1b(EUCOMM)Hmgu/H)
|
decreased cardiac muscle contractility
|
J:211773
|
Ank1tm1Vso/Ank1tm1Vso
(B6J.129S4-Ank1tm1Vso)
|
abnormal muscle electrophysiology
|
J:223673
|
impaired skeletal muscle contractility
|
J:223673
|
myopathy
|
J:223673
|
Ank2em1Melr/Ank2em1Melr
(B6.Cg-Ank2em1Melr)
|
decreased cardiac muscle contractility
|
J:338515
|
Ank2tm3.1Bnt/Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J)
|
decreased skeletal muscle cell glucose uptake
|
J:222913
|
increased skeletal muscle cell glucose uptake
|
J:222913
|
Ankrd1tm1Krc/Ankrd1tm1Krc Ankrd2tm1Krc/Ankrd2tm1Krc Ankrd23tm1Krc/Ankrd23tm1Krc
(involves: 129 * Black Swiss)
|
abnormal muscle physiology
|
J:125819
|
Ano1tm1.1Cahb/Ano1tm1.1Cahb Tg(Myh11-icre/ERT2)1Soff/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased vasoconstriction
|
J:207993
|
Ano5tm1Lrk/Ano5tm1Lrk
(involves: C57BL/6)
|
delayed skeletal muscle regeneration
|
J:235810
|
impaired skeletal muscle regeneration
|
J:235810
|
increased muscle fatigability
|
J:235810
|
Anpepem1(IMPC)Hmgu/Anpepem1(IMPC)Hmgu
(C57BL/6N-Anpepem1(IMPC)Hmgu/Ieg)
|
increased cardiac muscle contractility
|
J:211773
|
Anxa6tm1Moss/Anxa6tm1Moss
(involves: 129P2/OlaHsd * C57BL/6)
|
increased heart ventricle muscle contractility
|
J:75832
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ieg)
|
increased cardiac muscle contractility
|
J:211773
|
Apex1tm1Cur/Apex1+
(involves: 129S1/Sv)
|
abnormal vascular smooth muscle physiology
|
J:119957
|
decreased vasoconstriction
|
J:102294
|
decreased vasodilation
|
J:102294
|
increased vasoconstriction
|
J:102294
|
Aplntm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:140286
|
Aplntm1Pngr/Aplntm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:140286
|
Aplntm1Tq/Y
(B6.129S6-Aplntm1Tq)
|
decreased cardiac muscle contractility
|
J:154303
|
Aplntm1Tq/Aplntm1Tq
(B6.129S6-Aplntm1Tq)
|
decreased cardiac muscle contractility
|
J:154303
|
Aplnrtm1.1Tq/Aplnrtm1.1Tq
(C57BL/6-Aplnrtm1.1Tq)
|
decreased cardiac muscle contractility
|
J:154303
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased cardiac muscle contractility
|
J:227165
|
Apobtm2Sgy/Apobtm2Sgy Ldlrtm1Her/Ldlrtm1Her Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
decreased cardiac muscle contractility
|
J:227165
|
Apobec2tm1Msn/Apobec2tm1Msn
(B6.129P2-Apobec2tm1Msn)
|
myopathy
|
J:221028
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
abnormal vascular smooth muscle physiology
|
J:338121
|
abnormal vasodilation
|
J:298071
|
decreased vasodilation
|
J:101576
|
impaired muscle relaxation
|
J:60364
|
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd)
|
decreased vasodilation
|
J:154332
|
Apoetm1Unc/Apoetm1Unc Cdkn1atm1Tyj/Cdkn1atm1Tyj
(B6.129-Apoetm1Unc Cdkn1atm1Tyj)
|
abnormal vascular smooth muscle physiology
|
J:125247
|
increased vascular smooth muscle cell proliferation
|
J:125247
|
Apoetm1Unc/Apoetm1Unc Il1r1tm1Imx/Il1r1tm1Imx
(B6.129-Il1r1tm1Imx Apoetm1Unc)
|
increased vasoconstriction
|
J:148173
|
increased vasodilation
|
J:148173
|
Apoetm1Unc/Apoetm1Unc Nos3tm1Plh/Nos3tm1Plh
(B6.129-Nos3tm1Plh Apoetm1Unc)
|
decreased cardiac muscle contractility
|
J:103306
|
Apoetm1Unc/Apoetm1Unc Sprr3tm1.1Ppy/Sprr3tm1.1Ppy
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J * SJL)
|
abnormal vascular smooth muscle physiology
|
J:230470
|
Apptm2.1Ldad/Apptm2.1Ldad
(involves: 129 * C57BL/6J)
|
myositis
|
J:166989
|
Appl1tm1Ymli/Appl1tm1Ymli
(involves: 129S1/Sv * C57BL/6J)
|
decreased vasodilation
|
J:189487
|
increased vasoconstriction
|
J:189487
|
Appl2tm1Smoc/Appl2tm1Smoc Tg(Ckmm-cre)5Khn/0
(involves: FVB)
|
increased skeletal muscle cell glucose uptake
|
J:230004
|
Artm1Ska/Y Tg(CMV-cre)1Ipc/?
(involves: C57BL/6 * CBA)
|
decreased heart left ventricle muscle contractility
|
J:101049
|
Artm4(AR)Dmr/Y
(involves: 129S1/Sv * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:114552
|
impaired muscle relaxation
|
J:114552
|
muscle weakness
|
J:114552
|
myopathy
|
J:114552
|
progressive muscle weakness
|
J:114552
|
Artm4(AR)Dmr/Ar+
(involves: 129S1/Sv * C57BL/6J)
|
muscle weakness
|
J:114552
|
Arfgef3tm1Hong/Arfgef3tm1Hong
(129.129P2(B6)-Arfgef3tm1Hong)
|
decreased skeletal muscle cell glucose uptake
|
J:216529
|
Arhgap26Gt(OST135790)Lex/Arhgap26Gt(OST135790)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
impaired skeletal muscle regeneration
|
J:215392
|
Arhgap42Gt(CE0477)Wtsi/Arhgap42Gt(CE0477)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased vasoconstriction
|
J:221301
|
Arhgef1tm1Rmt/Arhgef1tm1Rmt X/Tg(Myh11-icre/ERT2)1Soff
(involves: C57BL/6 * FVB/N)
|
decreased vasoconstriction
|
J:157074
|
Arhgef3em1Chej/Arhgef3em1Chej
(involves: C57BL/6N)
|
abnormal muscle contractility
|
J:304135
|
enhanced muscle regeneration
|
J:304135
|
Arhgef12tm1Soff/Arhgef12tm1Soff
(Not Specified)
|
decreased vasoconstriction
|
J:141641
|
Arid1bem1Hzhu/Arid1b+
(C57BL/6J-Arid1bem1Hzhu)
|
muscle weakness
|
J:256668
|
Arid2tm1a(EUCOMM)Wtsi/Arid2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:223458
|
Ark2nem1Wehi/Ark2nem1Wehi
(C57BL/6J-8030462N17Rikem1Wehi)
|
abnormal muscle physiology
|
J:330717
|
impaired skeletal muscle contractility
|
J:330717
|
Arrb1tm1Jse/Arrb1tm1Jse
(involves: 129X1/SvJ * Black Swiss)
|
increased heart left ventricle muscle contractility
|
J:44953
|
Arsbtm1Cptr/Arsbtm1Cptr
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased cardiac muscle contractility
|
J:102290
|
decreased heart left ventricle muscle contractility
|
J:102290
|
Arxtm1.1Ics/Y
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N)
|
muscle spasm
|
J:262482
|
Arxtm1.1Jno/Y
(involves: 129S7/SvEvBrd * C57BL/6J)
|
myoclonus
|
J:151082
|
Arxtm1.1Jno/Arxtm1.1Jno
(involves: 129S7/SvEvBrd * C57BL/6J)
|
myoclonus
|
J:151082
|
Arxtm4Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd)
|
myoclonus
|
J:260340
|
Arxtm5Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd)
|
myoclonus
|
J:260340
|
Asb7em1(IMPC)Ccpcz/Asb7em1(IMPC)Ccpcz
(C57BL/6N-Asb7em1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
Asic2tm1Wsh/Asic2+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased vasoconstriction
|
J:135644
|
Asic2tm1Wsh/Asic2tm1Wsh
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased vasoconstriction
|
J:135644
|
Asltm1Brle/Asltm1Brle
(involves: 129S7/SvEvBrd)
|
decreased vasodilation
|
J:180208
|
Asnsd1Gt(OST460318)Lex/Asnsd1Gt(OST460318)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
enhanced skeletal muscle regeneration
|
J:320329
|
muscle weakness
|
J:320329
|
myopathy
|
J:320329
|
Aspatm1a(EUCOMM)Wtsi/Aspatm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal muscle tone
|
J:172582
|
muscle hypertonia
|
J:172582
|
muscle weakness
|
J:172582
|
Asphtm1Egk/Asphtm1Egk
(Not Specified)
|
increased cardiac muscle contractility
|
J:130155
|
Aspscr1tm1.1Jsbo/Aspscr1tm1.1Jsbo Tg(Ckmm-cre)5Khn/0
(B6.Cg-Aspscr1tm1.1Jsbo Tg(Ckmm-cre)5Khn)
|
increased skeletal muscle cell glucose uptake
|
J:308358
|
Asxl3tm1.1(ASXL3*P723R)Clia/Asxl3tm2.1(ASXL3*P1817A)Clia
(Not Specified)
|
decreased cardiac muscle contractility
|
J:322485
|
Atcayji-hes/Atcayji-hes
(C3H/HeJ-Atcayji-hes)
|
dystonia
|
J:85793
|
Atcayji/Atcayji
(Not Specified)
|
dystonia
|
J:14903
|
muscle spasm
|
J:14903
|
Ate1tm1Akas/Ate1tm1Akas
(Not Specified)
|
decreased cardiac muscle contractility
|
J:144625
|
Atg5tm1Myok/Atg5tm1Myok A1cfTg(Myh6-cre/Esr1*)1Jmk/?
(involves: 129S/SvEv * FVB/N)
|
abnormal cardiac muscle contractility
|
J:121778
|
Atg5tm1Myok/Atg5tm1Myok Cnot3tm1.1Kjkb/Cnot3tm1.1Kjkb Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * FVB)
|
decreased cardiac muscle contractility
|
J:260012
|
Atg7tm1Tchi/Atg7tm1Tchi Cnot1tm1Tya/Cnot1tm1Tya Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6NCrlj * CBA/JNCrlj * FVB)
|
decreased cardiac muscle contractility
|
J:260012
|
Atg7tm1Tchi/Atg7tm1Tchi Cnot3tm1.1Kjkb/Cnot3tm1.1Kjkb A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj * FVB/N)
|
decreased cardiac muscle contractility
|
J:260012
|
Atg7tm1Tchi/Atg7tm1Tchi Cnot3tm1.1Kjkb/Cnot3tm1.1Kjkb A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cfTg(Myh6-cre/Esr1*)1Jmk
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj * FVB/N)
|
decreased cardiac muscle contractility
|
J:260012
|
Atictm1c(EUCOMM)Hmgu/Atictm1c(EUCOMM)Hmgu Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
decreased vascular smooth muscle cell proliferation
|
J:338121
|
Atictm1c(EUCOMM)Hmgu/Atictm1c(EUCOMM)Hmgu X/Tg(Myh11-icre/ERT2)1Soff
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N * FVB/N)
|
decreased vascular smooth muscle cell proliferation
|
J:338121
|
Atp1a1tm1Ling/Atp1a1+
(involves: 129P2/OlaHsd * C57BL/6 * Black Swiss)
|
decreased cardiac muscle contractility
|
J:55191
|
Atp1a1tm1Ling/Atp1a1+
(involves: 129P2/OlaHsd)
|
impaired muscle contractility
|
J:114415
|
Atp1a1tm2Ling/Atp1a1tm2Ling Atp1a2tm3Ling/Atp1a2tm3Ling
(involves: 129S6/SvEvTac * Black Swiss)
|
increased cardiac muscle contractility
|
J:95157
|
Atp1a2tm2Ling/Atp1a2+
(involves: 129P2/OlaHsd * C57BL/6 * Black Swiss)
|
decreased cardiac muscle contractility
|
J:55191
|
Atp1a2tm2Ling/Atp1a2+
(involves: 129P2/OlaHsd)
|
abnormal muscle contractility
|
J:114415
|
Atp1a2tm3Ling/Atp1a2tm3Ling
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal cardiac muscle contractility
|
J:87082
|
Atp1a3tm1.1Kwk/Atp1a3+
(B6JJcl.Cg-Atp1a3tm1.1Kwk/Kwk)
|
dystonia
|
J:210870
|
Atp1a3tm1Mika/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
dystonia
|
J:264408
|
Atp1a3tm1Ute/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
dystonia
|
J:262419
|
Atp1b1tm1.1Akra/Atp1b1tm1.1Akra Myl2tm1(cre)Krc/Myl2+
(involves: 129S/SvEv * 129S4/SvJae)
|
abnormal cardiac muscle contractility
|
J:152596
|
decreased heart ventricle muscle contractility
|
J:152596
|
Atp2a1tm1Dhm/Atp2a1tm1Dhm
(involves: CD-1)
|
abnormal muscle physiology
|
J:82947
|
impaired muscle relaxation
|
J:82947
|
impaired skeletal muscle contractility
|
J:82947
|
increased muscle fatigability
|
J:82947
|
Atp2a2tm1.1Iemr/Atp2a2tm1.1Iemr A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
decreased cardiac muscle contractility
|
J:157143
|
Atp2a2tm1Fwuy/Atp2a2tm1Fwuy
(involves: 129S1/Sv * 129X1/SvJ * Swiss)
|
abnormal cardiac muscle relaxation
|
J:111247
|
decreased cardiac muscle contractility
|
J:111247
|
Atp2a2tm1Fwuy/Atp2a2tm1Fwuy Plntm1Egk/Plntm1Egk
(involves: 129 * FVB/N * Swiss)
|
abnormal cardiac muscle relaxation
|
J:110974
|
Atp2a2tm1Ges/Atp2a2+
(involves: 129X1/SvJ * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:95608,
J:52186
|
decreased heart left ventricle muscle contractility
|
J:66006
|
decreased heart ventricle muscle contractility
|
J:95608,
J:52186
|
Atp2a3tm1Ges/Atp2a3tm1Ges
(involves: Black Swiss)
|
abnormal muscle relaxation
|
J:44333
|
Atp2b1Tg(Thy1-CHMP2B*)1Rene/Atp2b1+
(involves: C57BL/6 * DBA/2 * FVB/N)
|
abnormal muscle electrophysiology
|
J:237873
|
muscle fasciculation
|
J:237873
|
Atp2b1Tg(Thy1-CHMP2B*)1Rene/Atp2b1Tg(Thy1-CHMP2B*)1Rene
(involves: C57BL/6 * DBA/2 * FVB/N)
|
abnormal muscle electrophysiology
|
J:237873
|
muscle fasciculation
|
J:237873
|
Atp2b1tm1.1Hiraw/Atp2b1tm1.1Hiraw Tg(Tagln-cre)1Her/0
(B6J.Cg-Atp2b1tm1.1Hiraw Tg(Tagln-cre)1Her)
|
increased vasoconstriction
|
J:225010
|
Atp2b1tm1Ges/Atp2b1+ Atp2b4tm1Ges/Atp2b4tm1Ges
(Black Swiss)
|
decreased vasoconstriction
|
J:91844
|
Atp2b4tm1Ges/Atp2b4tm1Ges
(involves: 129X1/SvJ * Black Swiss)
|
decreased vasoconstriction
|
J:91844
|
Atp5if1tm1Ksuj/Atp5if1tm1Ksuj
(involves: C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:256558
|
Atp6ap2tm1.1Aich/Y Tg(Myh6-cre)2182Mds/?
(involves: C57BL/6 * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:165020
|
Atp6v0d1em1Nju/Atp6v0d1em1Nju Tg(Adipoq-cre)1Evdr/0
(involves: FVB/NJ)
|
decreased cardiac muscle contractility
|
J:346448
|
Atp7btx/Atp7btx
(DL-Atp7btx)
|
abnormal muscle physiology
|
J:7102
|
Atp7btx/Atp7btx
(involves: C57BL/6 * DL)
|
abnormal muscle physiology
|
J:7102
|
Atp11atm1c(KOMP)Wtsi/Atp11atm1c(KOMP)Wtsi Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * C57BL/6JJcl * C57BL/6N)
|
abnormal skeletal muscle regeneration
|
J:262981
|
Atrnmg-3J/Atrnmg-3J
(C3HeB/FeJ-Atrnmg-3J/J)
|
abnormal muscle physiology
|
J:80364
|
Atrnmg-3J/Atrnmg-3J Atrnl1tm1Gsb/Atrnl1tm1Gsb
(involves: 129S1/Sv * 129X1/SvJ * C3H * C3HeB/FeJ)
|
cardiomyopathy
|
J:130463
|
Atxn7tm1Hzo/Atxn7+
(involves: 129S7/SvEvBrd * C57BL/6)
|
myoclonus
|
J:82072
|
Avpi1tm1b(EUCOMM)Hmgu/Avpi1tm1b(EUCOMM)Hmgu
(C57BL/6N-Avpi1tm1b(EUCOMM)Hmgu/Cnrm)
|
increased cardiac muscle contractility
|
J:211773
|
Avpr1atm1Gzt/Avpr1atm1Gzt
(involves: 129 * C57BL/6J)
|
abnormal vasoconstriction
|
J:110099
|
Awat2tm1.2Golc/Y
(involves: 129 * C57BL/6 * C57BL/6J)
|
conjunctival telangiectasia
|
J:308387
|
Awat2tm1.2Golc/Awat2tm1.2Golc
(involves: 129 * C57BL/6 * C57BL/6J)
|
conjunctival telangiectasia
|
J:308387
|
b2b227Clo/b2b227Clo
(C57BL/6J-b2b227Clo)
|
cardiomyopathy
|
J:175213
|
b2b1247Clo/b2b1247Clo
(C57BL/6J-b2b1247Clo)
|
ventricular cardiomyopathy
|
J:175213
|
b2b1835Clo/b2b1835Clo
(C57BL/6J-b2b1835Clo)
|
ventricular cardiomyopathy
|
J:175213
|
Babam1em1(IMPC)Ccpcz/Babam1em1(IMPC)Ccpcz
(C57BL/6NCrl-Babam1em1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
Bace1tm1Cdi/Bace1tm1Cdi
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal muscle physiology
|
J:86936
|
Bach1tm1Igar/Bach1tm1Igar
(B6.129P2-Bach1tm1Igar)
|
decreased cardiomyocyte apoptosis
|
J:123370
|
Bag3Gt(OST16086)Lex/Bag3Gt(OST16086)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:112361
|
Bag3tm1c(EUCOMM)Hmgu/Bag3tm1.1Chen Tg(Myhca-cre)1Abel/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N * FVB/N)
|
decreased cardiac muscle contractility
|
J:246352
|
dilated cardiomyopathy
|
J:246352
|
Bag3tm1c(EUCOMM)Hmgu/Bag3tm1c(EUCOMM)Hmgu Tg(Myhca-cre)1Abel/0
(involves: C57BL/6N * FVB/N)
|
decreased cardiac muscle contractility
|
J:246352
|
dilated cardiomyopathy
|
J:246352
|
Bag5em1Asay/Bag5em1Asay
(C57BL/6JJcl-Bag5em1Asay)
|
decreased heart left ventricle muscle contractility
|
J:327046
|
Baiap2l2tm1a(EUCOMM)Hmgu/Baiap2l2tm1a(EUCOMM)Hmgu
(C57BL/6N-Baiap2l2tm1a(EUCOMM)Hmgu/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
Barx2tm1Rsd/Barx2tm1Rsd
(involves: 129/Sv * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:187799
|
Barx2tm1Rsd/Barx2tm1Rsd Dmdmdx/Y
(involves: 129 * C57BL/6 * C57BL/10ScSn)
|
impaired skeletal muscle regeneration
|
J:187799
|
progressive muscle weakness
|
J:187799
|
Barx2tm1Rsd/Barx2tm1Rsd Dmdmdx/Dmdmdx
(involves: 129 * C57BL/6 * C57BL/10ScSn)
|
impaired skeletal muscle regeneration
|
J:187799
|
progressive muscle weakness
|
J:187799
|
Baxtm1Sjk/Baxtm1Sjk Lama2tm1Eeng/Lama2tm1Eeng
(B6.129-Baxtm1Sjk Lama2tm1Eeng)
|
impaired skeletal muscle regeneration
|
J:94431
|
Bcar1tm1Hhi/Bcar1tm1Hhi
(involves: 129S/SvEv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:48967
|
increased vasodilation
|
J:48967
|
Bcl2tm1.1Sjk/Bcl2tm1.1Sjk Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6NCrj * SJL)
|
decreased skeletal muscle cell glucose uptake
|
J:181308
|
Bcl6tm1Gdba/Bcl6tm1Gdba Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ)
|
increased skeletal muscle cell glucose uptake
|
J:271078
|
Bcl9tm1.1Agt/Bcl9tm1.1Agt Bcl9ltm1.1Agt/Bcl9ltm1.1Agt Myf5tm1(cre)Mrc/Myf5+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
impaired skeletal muscle regeneration
|
J:154476
|
Bdh1tm1c(EUCOMM)Wtsi/Bdh1tm1c(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:274475
|
Best3tm1.1Zhoj/Best3tm1.1Zhoj Tg(Tagln-cre)1Her/0
(involves: C57BL/6 * SJL)
|
abnormal vascular smooth muscle physiology
|
J:338981
|
Bex1Gt(OST125186)Lex/Bex1Gt(OST125186)Lex
(involves: 129S5/SvEvBrd)
|
abnormal skeletal muscle regeneration
|
J:127357
|
Bgntm1Mfy/Y Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased tendon stiffness
|
J:76203
|
Bicraem3Hzhg/Bicraem3Hzhg H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: C57BL/6J * CBA/J)
|
decreased heart right ventricle muscle contractility
|
J:335098
|
Bidtm1Sjk/Bidtm1Sjk Cstbtm1Rm/Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myoclonus
|
J:115694
|
Bin1tm1Gcp/Bin1tm1Gcp
(involves: 129S6/SvEvTac * C57BL/6J)
|
ventricular cardiomyopathy
|
J:83753
|
Birc2tm1.1Rbr/Birc2tm1.1Rbr Birc3tm1.1Rbr/Birc3tm1.1Rbr
(involves: BALB/cJ * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:182515
|
Birc2tm1.1Rbr/Birc2tm1.1Rbr Xiaptm1Vdr/Xiaptm1Vdr
(involves: 129S1/Sv * BALB/cJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:182515
|
Bmal1tm1Bra/Bmal1tm1Bra
(B6.129-Bmal1tm1Bra)
|
abnormal vascular smooth muscle physiology
|
J:191844
|
decreased vasodilation
|
J:191844
|
increased vasoconstriction
|
J:191844
|
Bmp10tm1.1(Gdf2)Minh/Bmp10tm1.1(Gdf2)Minh
(C57BL/6N-Bmp10tm1.1(Gdf2)Minh)
|
decreased fetal cardiomyocyte proliferation
|
J:222016
|
Bmpr1atm1Bhr/Bmpr1atm2.1Bhr Tg(GATA6-cre)#Jbeb/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB)
|
decreased heart left ventricle muscle contractility
|
J:111392
|
Bmpr1atm2.1Bhr/Bmpr1atm2.2Bhr Isl1tm1(cre)Sev/Isl1+
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
abnormal cardiomyocyte apoptosis
|
J:107396
|
abnormal fetal cardiomyocyte proliferation
|
J:107396
|
Bmpr2tm1.1Enl/Bmpr2tm1.1Enl Tg(Acvrl1-cre)L1Spo/0
(involves: 129S4/SvJae * FVB)
|
increased vascular smooth muscle cell proliferation
|
J:158116
|
Bmpr2tm1Kmi/Bmpr2+
(involves: 129S4/SvJae * C57BL/6J)
|
increased vasoconstriction
|
J:117167
|
Bnip3tm1Gwd/Bnip3tm1Gwd
(Not Specified)
|
decreased cardiomyocyte apoptosis
|
J:127533
|
Bnip3ltm1.1Gwd/Bnip3ltm1.1Gwd Tg(Myh6-Gnaq)#Gwd/0
(involves: 129 * FVB/N)
|
decreased cardiac muscle contractility
|
J:145086
|
increased cardiomyocyte apoptosis
|
J:145086
|
Bnip3ltm1Gwd/Bnip3ltm1Gwd Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129 * 129S7/SvEvBrd)
|
decreased cardiomyocyte apoptosis
|
J:145086
|
increased cardiac muscle contractility
|
J:145086
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)
|
increased cardiac muscle contractility
|
J:170095
|
Bsntm1Gund/Bsntm1Gund
(Not Specified)
|
myoclonus
|
J:82241
|
Btctm1Dcl/Btctm1Dcl Hbegftm1Dcl/Hbegftm1Dcl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased heart ventricle muscle contractility
|
J:83820
|
Btdtm1Bwol/Btdtm1Bwol
(B6.Cg-Btdtm1Bwol)
|
hypotonia
|
J:168391
|
Bud23em2Asil/Bud23em2Asil Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
decreased cardiac muscle contractility
|
J:290738
|
dilated cardiomyopathy
|
J:290738
|
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg)
|
abnormal muscle physiology
|
J:212299
|
C2cd5Gt(IST12020E4)Tigm/C2cd5Gt(IST12020E4)Tigm
(C57BL/6N-C2cd5Gt(IST12020E4)Tigm)
|
decreased cardiac muscle cell glucose uptake
|
J:284780
|
decreased skeletal muscle cell glucose uptake
|
J:284780
|
C3tm1Crr/C3tm1Crr Dysftm1Kcam/Dysftm1Kcam
(B6.129-Dysftm1Kcam C3tm1Crr)
|
muscle weakness
|
J:171870
|
Cacna1atg-la/Cacna1aWb
(involves: AKR/J * C3H/HeJ * C57BL/6J)
|
dystonia
|
J:119639
|
Cacna1atg-rol/Cacna1atg-rol
(involves: C57BL/6 * SIII)
|
abnormal muscle electrophysiology
|
J:164115
|
muscle weakness
|
J:164115
|
Cacna1atg/Cacna1atg
(B6.D2-Cacna1atg/J)
|
abnormal muscle electrophysiology
|
J:233263
|
dystonia
|
J:233263
|
Cacna1atg/Cacna1atm2.1Maag
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J * FVB/N)
|
abnormal muscle electrophysiology
|
J:233263
|
dystonia
|
J:233263
|
Cacna1atg/Cacna1atm2.1Maag Tg(Pcp2-cre)2Mpin/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J * FVB/N)
|
dystonia
|
J:233263
|
Cacna1atm1(CACNA1A)Ttan/Cacna1atm1(CACNA1A)Ttan
(involves: 129S4/SvJae)
|
dystonia
|
J:123243
|
Cacna1atm1.1(CACNA1A)Ttan/Cacna1atm1.1(CACNA1A)Ttan
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL)
|
dystonia
|
J:123243
|
Cacna1atm1Hssh/Cacna1atm1Hssh
(involves: 129 * C57BL/6J)
|
muscle spasm
|
J:59076
|
Cacna1atm2.1(CACNA1A)Ttan/Cacna1atm2.1(CACNA1A)Ttan
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL)
|
dystonia
|
J:123243
|
Cacna1atm2.1Maag/Cacna1atm2.2Maag Tg(EIIa-cre)C5379Lmgd/0
(involves: 129P2/OlaHsd * FVB/N)
|
dystonia
|
J:117062
|
Cacna1aWb/Cacna1aWb
(either: C3.B6-Cacna1aWb or (involves: C3H/HeJ * C57BL/6J))
|
dystonia
|
J:119639
|
Cacna1ctm1.1Wac/Cacna1ctm1.1Wac
(involves: C57BL/6)
|
abnormal cardiac muscle contractility
|
J:203057
|
abnormal muscle electrophysiology
|
J:203057
|
decreased cardiac muscle contractility
|
J:203057
|
Cacna1ctm1Ggm/Cacna1ctm1Ggm A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased cardiac muscle contractility
|
J:189406
|
Cacna1ctm2.1Wac/Cacna1ctm2.1Wac
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:216746
|
Cacna1ctm3Hfm/Cacna1ctm4Hfm A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal muscle electrophysiology
|
J:175463
|
Cacna1htm1Kcam/Cacna1htm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased vasoconstriction
|
J:86616
|
Cacna1smdg/Cacna1smdg
(involves: STOCK T/t4)
|
abnormal muscle physiology
|
J:641
|
impaired skeletal muscle contractility
|
J:4724,
J:18533
|
Cacna1smdg/Cacna1smdg
(involves: 129P1/ReJ * STOCK T/t4)
|
impaired skeletal muscle contractility
|
J:5371
|
Cacna1smdg/Cacna1smdg
(involves: 129 * STOCK T/t4)
|
impaired muscle contractility
|
J:7390,
J:15029
|
Cacna1stm1.1Arte/Cacna1stm1.1Arte
(involves: C57BL/6N)
|
abnormal muscle electrophysiology
|
J:235534
|
abnormal muscle physiology
|
J:235534
|
impaired skeletal muscle contractility
|
J:235534
|
Cacna1stm1.1Cann/Cacna1s+
(involves: 129)
|
abnormal muscle contractility
|
J:193967
|
abnormal muscle physiology
|
J:193967
|
Cacna1stm1.1Cann/Cacna1stm1.1Cann
(involves: 129)
|
abnormal muscle contractility
|
J:193967
|
abnormal muscle physiology
|
J:193967
|
myopathy
|
J:193967
|
Cacna2d1tm1Aschw/Cacna2d1tm1Aschw
(involves: Black Swiss)
|
abnormal muscle electrophysiology
|
J:151101
|
decreased cardiac muscle contractility
|
J:151101
|
Cacna2d2du-3J/Cacna2d2du-3J
(involves: BALB/cByJ * C57BL/6J)
|
myoclonus
|
J:82238
|
Cacna2d2tm1Svi/Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J)
|
myoclonus
|
J:92396
|
Cacnb1tm1Rgg/Cacnb1tm1Rgg
(involves: 129S7/SvEvBrd)
|
abnormal muscle physiology
|
J:37052
|
impaired skeletal muscle contractility
|
J:37052
|
Cacnb3tm1Acv/Cacnb3tm1Acv
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:86381
|
Cacnb4lh/Cacnb4lh
(involves: BALB/cGn * C3H/HeSnJ * C57BL/6JEi)
|
facial muscle spasm
|
J:79139
|
Cacng1tm1Rgg/Cacng1+
(involves: 129S7/SvEvBrd)
|
abnormal muscle electrophysiology
|
J:146419
|
Cacng1tm1Rgg/Cacng1tm1Rgg
(involves: 129S7/SvEvBrd)
|
abnormal muscle electrophysiology
|
J:146419
|
Cacng1tm1Vfz/Cacng1tm1Vfz
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle electrophysiology
|
J:62133
|
Calb1em1(IMPC)Ccpcz/Calb1em1(IMPC)Ccpcz
(C57BL/6NCrl-Calb1em1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
Calcrltm1Kmca/Calcrltm1Kmca
(129S6/SvEvTac-Calcrltm1Kmca)
|
abnormal fetal cardiomyocyte proliferation
|
J:106927
|
increased cardiomyocyte apoptosis
|
J:106927
|
Calrtm1Star/Calrtm1Star
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL))
|
increased cardiomyocyte apoptosis
|
J:61550
|
ventricular cardiomyopathy
|
J:61550
|
Camkmttm1Rpav/Camkmttm1Rpav
(involves: 129S7/SvEvBrd * C57BL/6J)
|
myopathy
|
J:228818
|
Cap2tm1a(EUCOMM)Wtsi/Cap2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased heart left ventricle muscle contractility
|
J:234044
|
dilated cardiomyopathy
|
J:234044
|
Cap2tm1e(EUCOMM)Wtsi/Cap2tm1e(EUCOMM)Wtsi
(C57BL/6N-Cap2tm1e(EUCOMM)Wtsi)
|
dilated cardiomyopathy
|
J:226742
|
Capn3tm1Jsb/Capn3+ Ttntm1.1Isrd/Ttntm1.1Isrd
(involves: 129/Sv * 129S2/SvPas * C57BL/6)
|
dilated cardiomyopathy
|
J:165576
|
Capn6tm1Hiso/Capn6tm1Hiso
(B6.Cg-Capn6tm1Hiso)
|
enhanced skeletal muscle regeneration
|
J:200747
|
Capns1tm1.1Otsu/Capns1tm1.1Otsu Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * FVB/N)
|
decreased cardiac muscle contractility
|
J:176736
|
Car3tm1Gkim/Car3tm1Gkim
(involves: 129S/SvEv * 129S6/SvEvTac)
|
abnormal muscle contractility
|
J:94222
|
Casp3tm1Flv/Casp3tm1Flv
(B6N.129S1-Casp3tm1Flv/J)
|
increased cardiomyocyte apoptosis
|
J:189241
|
Casp8tm1Syon/Casp8tm1Syon
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:103506
|
Casp8tm1Syon/Casp8tm1Syon Tg(Myh7-BVp35-EGFP)#Ksa/?
(involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:102279
|
Casq1Gt(OST82566)Lex/Casq1Gt(OST82566)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal muscle electrophysiology
|
J:140828
|
abnormal muscle physiology
|
J:140828
|
impaired muscle relaxation
|
J:140828
|
impaired skeletal muscle contractility
|
J:140828
|
Casq2tm1Jse/Casq2tm1Jse
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:124211
|
Casq2tm2Jse/Casq2tm2Jse
(Not Specified)
|
decreased heart left ventricle muscle contractility
|
J:124211
|
Casz1Gt(CJ0565)Wtsi/Casz1Gt(CJ0565)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:242127
|
Casz1tm1.1Flc/Casz1tm1.1Flc Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
decreased fetal cardiomyocyte proliferation
|
J:221324
|
Cav1em2(IMPC)Ics/Cav1em2(IMPC)Ics
(C57BL/6N-Cav1em2(IMPC)Ics/Ics)
|
decreased cardiac muscle contractility
|
J:211773
|
Cav1tm1Krc/Cav1tm1Krc
(involves: 129S4/SvJae * Black Swiss)
|
decreased heart ventricle muscle contractility
|
J:78603
|
dilated cardiomyopathy
|
J:78603
|
increased heart right ventricle muscle contractility
|
J:78603
|
Cav1tm1Kur/Cav1tm1Kur
(involves: 129X1/SvJ * C57BL/6)
|
abnormal vasoconstriction
|
J:71760
|
increased vasodilation
|
J:71760
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal vasoconstriction
|
J:75193
|
abnormal vasodilation
|
J:75193
|
decreased cardiac muscle contractility
|
J:87282
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased vasoconstriction
|
J:120603
|
Cav1tm1Mls/Cav1tm1Mls
(STOCK Cav1tm1Mls/J)
|
decreased vasoconstriction
|
J:132392
|
increased vasodilation
|
J:132392
|
Cav1tm1Mls/Cav1tm1Mls Cav3tm1Mls/Cav3tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
cardiomyopathy
|
J:77372
|
decreased heart left ventricle muscle contractility
|
J:77372
|
Cav2tm1Mls/Cav2tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal muscle regeneration
|
J:117199
|
Cav3tm1Mls/Cav3tm1Mls
(involves: 129/Sv * C57BL/6J * SJL)
|
cardiomyopathy
|
J:79453
|
decreased heart ventricle muscle contractility
|
J:79453
|
myopathy
|
J:69965
|
Cavin1tm1Pfp/Cavin1tm1Pfp
(B6.129S6-Cavin1tm1Pfp/J)
|
impaired contractility of urinary bladder detrusor smooth muscle
|
J:217273
|
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6)
|
abnormal muscle physiology
|
J:94416
|
increased skeletal muscle cell glucose uptake
|
J:94416
|
Cbstm1Unc/Cbs+
(B6.129P2-Cbstm1Unc/J)
|
abnormal vasodilation
|
J:64885
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae)
|
increased vasodilation
|
J:155025
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol)
|
impaired skeletal muscle regeneration
|
J:118606
|
Ccm2ltm1Mlkn/Ccm2ltm1Mlkn Heg1tm1Mlkn/Heg1tm1Mlkn
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:187714
|
decreased heart left ventricle muscle contractility
|
J:187714
|
Ccn3tm1Cabo/Ccn3+
(involves: 129S/SvEv)
|
ventricular cardiomyopathy
|
J:135676
|
Ccn3tm1Cabo/Ccn3tm1Cabo
(involves: 129S/SvEv)
|
ventricular cardiomyopathy
|
J:135676
|
Ccn3tm1Hko/Ccn3tm1Hko
(B6.129-Ccn3tm1Hko)
|
increased vascular smooth muscle cell proliferation
|
J:172144
|
Ccr2em1(IMPC)H/Ccr2em1(IMPC)H
(C57BL/6N-Ccr2em1(IMPC)H/H)
|
increased cardiac muscle contractility
|
J:211773
|
Ccr10/Cntnap1tm1Bhat/Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle spasm
|
J:69621
|
Ccr10/Cntnap1tm1Bhat/Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle spasm
|
J:69621
|
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv * C57BL/6)
|
increased cardiac muscle cell glucose uptake
|
J:83611
|
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv)
|
abnormal muscle physiology
|
J:220343
|
decreased skeletal muscle cell glucose uptake
|
J:220343
|
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:101783
|
Cd55tm1Song/Cd55tm1Song Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd55tm1Song Cd59atm1Bpm)
|
myositis
|
J:113567
|
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
|
myositis
|
J:113567
|
Cd163tm1(KOMP)Vlcg/Cd163tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal skeletal muscle satellite cell proliferation
|
J:224919
|
enhanced skeletal muscle regeneration
|
J:224919
|
Cdc26tm1b(EUCOMM)Hmgu/Cdc26+
(C57BL/6N-Cdc26tm1b(EUCOMM)Hmgu/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
Cdc42tm1.1Yizh/Cdc42+
(Not Specified)
|
decreased heart ventricle muscle contractility
|
J:174208
|
Cdc42tm1.1Yizh/Cdc42+ Nkx2-5tm1Siz/Nkx2-5+
(involves: 129S4/SvJaeSor)
|
decreased heart ventricle muscle contractility
|
J:174208
|
Cdh2tm1Glr/Cdh2Gt(OST49160)Lex A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S5/SvEvBrd * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:98828
|
Cdh2tm1Glr/Cdh2tm1Hyn A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:98828
|
Cdk2tm1Kald/Cdk2tm1Kald Cdk4tm1Kiyo/Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:108720
|
Cdk2tm1Sgo/Cdk2tm1Sgo Cdk4tm2.1Bbd/Cdk4tm2.1Bbd
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6 * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:125217
|
Cdk5rap1tm1.2Tomik/Cdk5rap1tm1.2Tomik
(B6J.Cg-Cdk5rap1tm1.2Tomik)
|
decreased cardiac muscle contractility
|
J:220703
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj Rb1tm1Tyj/Rb1tm1Tyj Tg(Rb1)1Blg/0
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:65679
|
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL)
|
abnormal fetal cardiomyocyte proliferation
|
J:57380
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf Cdkn2dtm1Maro/Cdkn2dtm1Maro
(involves: 129X1/SvJ * C57BL/6)
|
muscle hypertonia
|
J:58522
|
Ceacam2tm1Snaj/Ceacam2tm1Snaj
(involves: 129S4/SvJae * C57BL/6)
|
decreased skeletal muscle cell glucose uptake
|
J:181979
|
Cebpatm6Nerl/Cebpatm6Nerl
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased skeletal muscle cell glucose uptake
|
J:120098
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
|
increased skeletal muscle cell glucose uptake
|
J:62132
|
Cebpbtm3Nerl/Cebpbtm3Nerl
(either: B6.129P2-Cebpbtm3Nerl or (involves: 129P2/OlaHsd * C57BL/6))
|
impaired skeletal muscle regeneration
|
J:153686
|
myositis
|
J:153686
|
Cenpftm1Dbdr/Cenpftm1Dbdr Tg(Tnnt2-cre)5Blh/0
(involves: C57BL/6 * DBA/2 * ICR)
|
decreased fetal cardiomyocyte proliferation
|
J:185133
|
dilated cardiomyopathy
|
J:185133
|
Cept1tm1.1Sem/Cept1tm1.1Sem Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * SJL)
|
muscle weakness
|
J:249456
|
Cert1Gt(RRF047)Byg/Cert1Gt(RRF047)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:146172
|
Cfhtm1.1Song/Cfhtm1.1Song
(involves: C57BL/6)
|
impaired muscle relaxation
|
J:240426
|
Cfl2tm1.1Itl/Cfl2tm1.1Itl
(involves: C57BL/6J * C57BL/6NTac)
|
muscle weakness
|
J:182571
|
Chat/Slc18a3tm1.1Vpra/Chat/Slc18a3tm1.1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
hypotonia
|
J:153908
|
Chat/Slc18a3tm1.1Vpra/Chat/Slc18a3tm1.1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
hypotonia
|
J:153908
|
Chattm1Mlt/Chattm1Mlt Tg(SLC18A3-cre)KMisa/0
(involves: 129 * C57BL/6)
|
muscle weakness
|
J:212048
|
Chchd10em3Dpn/Chchd10em3Dpn
(C57BL/6J-Chchd10em3Dpn)
|
myopathy
|
J:344465
|
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6)
|
cardiomyopathy
|
J:146743
|
Chd4em1Flc/Chd4em1Flc
(C57BL/6J-Chd4em1Flc)
|
decreased heart left ventricle muscle contractility
|
J:338019
|
increased fetal cardiomyocyte proliferation
|
J:338019
|
Chd7tm2a(EUCOMM)Wtsi/Chd7tm2a(EUCOMM)Wtsi
(involves: 129S6/SvEvTac * C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:207089
|
increased cardiomyocyte apoptosis
|
J:207089
|
Chkbrmd/Chkbrmd
(involves: BALB/cByJ * C57BL/6J)
|
abnormal muscle physiology
|
J:108320
|
Chn1Gt714Lex/Chn1Gt714Lex
(involves: 129S5/SvEvBrd)
|
abnormal muscle electrophysiology
|
J:128698
|
Chrdtm1Emdr/Chrdtm1Emdr
(either: B6SJL.129-Chrdtm1Emdr or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J))
|
increased vasodilation
|
J:83662
|
Chrm2tm1Jwe/Chrm2tm1Jwe
(involves: 129S4/SvJae * CF-1)
|
impaired smooth muscle contractility
|
J:60451,
J:125455
|
Chrm2tm1Minm/Chrm2tm1Minm Chrm3tm1Mmt/Chrm3tm1Mmt
(involves: 129X1/SvJ * C57BL/6)
|
impaired contractility of ileal smooth muscle
|
J:99247
|
impaired smooth muscle contractility
|
J:99247
|
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
decreased vasodilation
|
J:102321
|
impaired smooth muscle contractility
|
J:125455
|
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac)
|
impaired smooth muscle contractility
|
J:113518
|
Chrm3tm1Mmt/Chrm3tm1Mmt
(involves: 129X1/SvJ)
|
impaired contractility of ileal smooth muscle
|
J:99247
|
impaired smooth muscle contractility
|
J:99247
|
Chrm3tm1Mmt/Chrm3tm1Mmt
(involves: 129X1/SvJ * C57BL/6)
|
impaired contractility of ileal smooth muscle
|
J:64069
|
impaired contractility of urinary bladder detrusor smooth muscle
|
J:64069
|
Chrm4tm1Jwe/Chrm4tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
impaired smooth muscle contractility
|
J:125455
|
Chrm5tm1Jwe/Chrm5tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
abnormal vasodilation
|
J:72953
|
Chrnb2tm1Mdb/Chrnb2tm1Mdb Chrnb4tm1Mdb/Chrnb4tm1Mdb
(involves: 129S7/SvEvBrd * C57BL/6J)
|
intestinal hypoperistalsis
|
J:73590
|
Chrnetm1Vwi/Chrnetm1Vwi
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired skeletal muscle contractility
|
J:36557
|
Chrnetm2Vwi/Chrnetm2Vwi
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired skeletal muscle contractility
|
J:182046
|
Chrngtm1Mtak/Chrngtm1Mtak
(involves: 129X1/SvJ * C57BL/6)
|
abnormal muscle physiology
|
J:99894
|
Cirbilem1Cya/Cirbilem1Cya
(Not Specified)
|
decreased cardiac muscle contractility
|
J:301260
|
increased cardiomyocyte apoptosis
|
J:301260
|
Cisd2Gt(XS0445)Wtsi/Cisd2Gt(XS0445)Wtsi
(B6.129P2-Cisd2Gt(XS0445)Wtsi)
|
impaired skeletal muscle contractility
|
J:183788
|
Cittm1Fdc/Cittm1Fdc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
myoclonus
|
J:77297
|
Ckmtm1Bew/Ckmtm1Bew
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle physiology
|
J:76699
|
decreased cardiac muscle contractility
|
J:76204
|
impaired skeletal muscle contractility
|
J:76699,
J:20440
|
Ckmtm1Bew/Ckmtm1Bew Ckmt2tm1Bew/Ckmt2tm1Bew
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle physiology
|
J:106327
|
impaired skeletal muscle contractility
|
J:106327
|
Ckmtm1Bew/Ckmtm2Bew
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired skeletal muscle contractility
|
J:20440
|
Ckmtm2Bew/Ckmtm2Bew
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired skeletal muscle contractility
|
J:20440
|
Clcn1adr-mto2J/Clcn1adr-mto2J
(BALB/cByJ-Clcn1adr-mto2J)
|
impaired muscle relaxation
|
J:112061
|
Clcn1adr-mto7J/Clcn1adr-mto7J
(C57BL/6J-Clcn1adr-mto7J/J)
|
muscle spasm
|
J:82238
|
Clcn1adr-mto8J/Clcn1adr-mto8J
(B6;C3Fe-Clcn1adr-mto8J/CxJ)
|
muscle spasm
|
J:120858
|
Clcn1adr-mto9J/Clcn1adr-mto9J
(C57BL/6J-Clcn1adr-mto9J/J)
|
impaired muscle relaxation
|
J:134519
|
Clcn1adr-mto/Clcn1adr-mto
(SWR/J-Clcn1adr-mto/J)
|
abnormal muscle electrophysiology
|
J:6814,
J:14251
|
abnormal muscle physiology
|
J:6814
|
impaired muscle relaxation
|
J:14251
|
Clcn1adr/Clcn1adr
(A2G-Clcn1adr)
|
abnormal muscle electrophysiology
|
J:25830
|
abnormal muscle physiology
|
J:4480,
J:25830
|
impaired muscle relaxation
|
J:25830
|
impaired skeletal muscle contractility
|
J:25830
|
muscle twitch
|
J:7524
|
Clcn1m1Anu/Clcn1m1Anu
(involves: C57BL/6 * CBA/H)
|
muscle hypertonia
|
J:104190
|
Clcn3tm1.1Jrhm/Clcn3tm1.1Jrhm Tg(Myh6-tTA)6Smbf/0 Tg(tetO-cre)3Jig/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:222375
|
dilated cardiomyopathy
|
J:222375
|
Cldn12tm1.1(KOMP)Vlcg/Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg)
|
increased cardiac muscle contractility
|
J:279934
|
Clec9atm1b(KOMP)Wtsi/Clec9atm1b(KOMP)Wtsi
(C57BL/6N-Clec9atm1b(KOMP)Wtsi/Orl)
|
decreased cardiac muscle contractility
|
J:211773
|
Clip3tm1.1Ics/Clip3tm1.1Ics
(involves: C57BL/6)
|
impaired muscle contractility
|
J:194894
|
Clmptm1.1Fgr/Clmptm1.1Fgr
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal intestinal peristalsis
|
J:258315
|
abnormal muscle tone
|
J:258315
|
impaired ureteric peristalsis
|
J:258315
|
Clmptm1Fgr/Clmptm1Fgr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal intestinal peristalsis
|
J:258315
|
impaired ureteric peristalsis
|
J:258315
|
Clp1tm1.1Pngr/Clp1tm1.1Pngr
(CBA.Cg-Clp1tm1.1Pngr)
|
progressive muscle weakness
|
J:196364
|
Cltrntm1Thu/Y
(involves: 129S/SvEv * C57BL/6)
|
abnormal muscle physiology
|
J:148522
|
Clutm1Jakh/Clutm1Jakh
(involves: Black Swiss * FVB/N)
|
decreased cardiac muscle contractility
|
J:65660
|
Cmahtm1Avrk/Cmahtm1Avrk Dmdmdx/Dmdmdx
(involves: 129X1/SvJ * C57BL/10ScSn)
|
muscle weakness
|
J:164594
|
Cmn1CAST/Ei/? Ighmbp2nmd-2J/Ighmbp2nmd-2J MnmC/MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:102748
|
Cmn2CAST/Ei/? Ighmbp2nmd-2J/Ighmbp2nmd-2J MnmC/MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:102748
|
Cmn3C57BL/6J/? Ighmbp2nmd-2J/Ighmbp2nmd-2J MnmC/MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:102748
|
Cmn3CAST/Ei/? Ighmbp2nmd-2J/Ighmbp2nmd-2J MnmC/MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:102748
|
Cmtm3em1Wlh/Cmtm3em1Wlh
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:338327
|
increased cardiac muscle contractility
|
J:338327
|
cmy1/cmy1
(involves: C57BL/6J * DBA/2J)
|
decreased cardiac muscle contractility
|
J:149470
|
dilated cardiomyopathy
|
J:149470
|
cmy2/cmy2
(involves: C57BL/6J * DBA/2J)
|
decreased cardiac muscle contractility
|
J:149470
|
dilated cardiomyopathy
|
J:149470
|
Cmya5tm1Cap/Cmya5tm1Cap
(129-Cmya5tm1Cap)
|
decreased heart ventricle muscle contractility
|
J:322761
|
Cnot1tm1Tya/Cnot1tm1Tya Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
decreased cardiac muscle contractility
|
J:260012
|
Cnot3tm1.1Kjkb/Cnot3tm1.1Kjkb Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
cardiomyopathy
|
J:260012
|
decreased cardiac muscle contractility
|
J:260012
|
Cnot3tm1Pngr/Cnot3+
(B6.Cg-Cnot3tm1Pngr)
|
decreased cardiac muscle contractility
|
J:167954
|
decreased heart left ventricle muscle contractility
|
J:167954
|
Cnptm1(cre)Kan/Cnptm1(cre)Kan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
muscle weakness
|
J:91814
|
Cntftm1Mpin/Cntftm1Mpin
(involves: 129S2/SvPas)
|
muscle weakness
|
J:15313
|
Cntnap1em1Bhat/Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle weakness
|
J:342323
|
Cntnap1em2Bhat/Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle weakness
|
J:342323
|
Cntnap1tm1Bhat/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
muscle spasm
|
J:107653
|
Coasytm1.1Vtr/Coasytm1.1Vtr Tg(Syn1-cre)671Jxm/0
(involves: 129 * C57BL/6N * CBA)
|
dystonia
|
J:299154
|
Col1a1Aga2/Col1a1+
(C3HeB/FeJ-Col1a1Aga2)
|
decreased heart left ventricle muscle contractility
|
J:185988
|
Col1a1M1Jrt/Col1a1+
(involves: C3H/HeJ * C57BL/6J * FVB/NJ)
|
decreased tendon stiffness
|
J:216423
|
Col1a1tm2(CAG-IDH2*R172K)Kkw/Col1a1+ Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6)
|
decreased cardiac muscle contractility
|
J:209629
|
dilated cardiomyopathy
|
J:209629
|
increased cardiomyocyte apoptosis
|
J:209629
|
Col1a1tm3(CAG-IDH2*R140Q)Kkw/Col1a1+ Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6)
|
decreased cardiac muscle contractility
|
J:209629
|
dilated cardiomyopathy
|
J:209629
|
increased cardiomyocyte apoptosis
|
J:209629
|
Col1a2oim/Col1a2oim
(involves: C3H/HeJ * C57BL/6JLe)
|
decreased tendon stiffness
|
J:41509
|
Col3a1m1Lsmi/Col3a1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased vasoconstriction
|
J:180733
|
Col4a1deltaex40/Col4a1+
(involves: 129S/SvEv * C57BL/6J)
|
myopathy
|
J:172720
|
Col4a1deltaex40/Col4a1+
(involves: 129S/SvEv * C57BL/6J * CAST/EiJ)
|
myopathy
|
J:172720
|
Col5a3tm1Dgr/Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased skeletal muscle cell glucose uptake
|
J:171817
|
Col6a1tm1Gmb/Col6a1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myopathy
|
J:51410
|
Col6a1tm1Gmb/Col6a1tm1Gmb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired skeletal muscle contractility
|
J:86734
|
myopathy
|
J:51410
|
Col6a1tm1Sngi/Col6a1tm1Sngi
(B6.Cg-Col6a1tm1Sngi)
|
impaired skeletal muscle contractility
|
J:278926
|
muscle weakness
|
J:278926
|
Col6a3tm1Chu/Col6a3tm1Chu
(B6.129-Col6a3tm1Chu)
|
abnormal muscle physiology
|
J:198581
|
abnormal skeletal muscle regeneration
|
J:198581
|
myopathy
|
J:198581
|
Col6a3tm2.1Chu/Col6a3+
(B6.129(Cg)-Col6a3tm2.1Chu)
|
impaired skeletal muscle contractility
|
J:208903
|
myopathy
|
J:208903
|
Col6a3tm2.1Chu/Col6a3tm2.1Chu
(B6.129(Cg)-Col6a3tm2.1Chu)
|
myopathy
|
J:208903
|
Col12a1tm1Debi/Col12a1tm1Debi
(Not Specified)
|
abnormal muscle physiology
|
J:209074
|
Col13a1tm1Pih/Col13a1tm1Pih
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
myopathy
|
J:71939
|
myositis
|
J:71939
|
Col13a1tm3.1Pih/Col13a1tm3.1Pih
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle weakness
|
J:242846
|
Col14a1tm1Debi/Col14a1+
(involves: 129S4/SvJae * C57BL/6)
|
decreased tendon stiffness
|
J:148619
|
Col14a1tm1Debi/Col14a1tm1Debi
(involves: 129S4/SvJae * C57BL/6)
|
abnormal muscle physiology
|
J:148619
|
decreased tendon stiffness
|
J:148619
|
Col15a1tm1Pih/Col15a1tm1Pih
(involves: 129S1/Sv * 129X1/SvJ)
|
enhanced skeletal muscle regeneration
|
J:67212
|
myopathy
|
J:67212
|
Col19a1tm2Rmz/Col19a1tm2Rmz
(involves: 129T2/SvEmsJ)
|
impaired muscle relaxation
|
J:92510
|
Comptm1Mbri/Comptm1Mbri
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased tendon stiffness
|
J:154984
|
increased muscle fatigability
|
J:154984
|
myopathy
|
J:154984
|
Coq9tm1.1Lcl/Coq9tm1.1Lcl
(involves: C57BL/6 * C57BL/6NTac * SJL)
|
myopathy
|
J:193288
|
Corintm1Qwu/Corintm1Qwu
(involves: 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:96458
|
Cox7a1tm1Hutt/Cox7a1+
(B6.129-Cox7a1tm1Hutt)
|
decreased heart ventricle muscle contractility
|
J:192141
|
Cox7a1tm1Hutt/Cox7a1tm1Hutt
(B6.129-Cox7a1tm1Hutt)
|
decreased heart ventricle muscle contractility
|
J:192141
|
dilated cardiomyopathy
|
J:192141
|
Cox10tm1Ctm/Cox10tm1Ctm Myl1tm1(cre)Sjb/Myl1+
(involves: 129X1/SvJ * C57BL/6)
|
increased muscle fatigability
|
J:101747
|
myopathy
|
J:101747
|
Cox15tm1.1Zev/Cox15tm1.1Zev Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
myopathy
|
J:176080
|
Cpetm1Yplo/Cpetm1Yplo
(involves: 129S1/Sv * C57BL/6)
|
abnormal muscle physiology
|
J:95741
|
Cpt1ctm1Dhwu/Cpt1ctm1Dhwu
(involves: 129 * C57BL/6J)
|
decreased skeletal muscle cell glucose uptake
|
J:148205
|
Crattm1.1Pbrc/Crattm1.1Pbrc Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
abnormal muscle physiology
|
J:184778
|
Creb1tm1.1Berd/Creb1tm1.1Berd
(B6NHsd.129S4-Creb1tm1.1Berd)
|
enhanced skeletal muscle regeneration
|
J:177923
|
Creb1tm1.1Berd/Creb1tm1.1Berd Dmdmdx/Y
(B.Cg-Creb1tm1.1Berd Dmdmdx)
|
enhanced skeletal muscle regeneration
|
J:177923
|
Creg1tm1Yal/Creg1+
(involves: 129 * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:253911
|
increased cardiomyocyte apoptosis
|
J:253911
|
Cremtm1Gsc/Cremtm1Gsc
(involves: 129 * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:81241
|
Crim1em1(IMPC)Wtsi/Crim1em1(IMPC)Wtsi
(C57BL/6N-Crim1em1(IMPC)Wtsi/WtsiOrl)
|
telangiectasia
|
J:239583
|
Crim1Gt(KST264)Byg/Crim1Gt(KST264)Byg
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
impaired ureteric peristalsis
|
J:187026
|
Crktm1.1Cur/Crktm1.1Cur
(involves: 129S/SvEv * C57BL/6)
|
increased vasodilation
|
J:111399
|
Crtc3tm1Mmy/Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased muscle cell glucose uptake
|
J:167211
|
Cry1tm1Asn/Cry1tm1Asn Cry2tm1Hnos/Cry2tm1Hnos
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vasoconstriction
|
J:134129
|
Cryabem1Mtc/Cryabem1Mtc
(involves: C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:342762
|
Cryabtm1.1Ady/Cryab+
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J)
|
myopathy
|
J:171679
|
Cryabtm1.1Ady/Cryabtm1.1Ady
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J)
|
myopathy
|
J:171679
|
Csnk1g2tm1b(EUCOMM)Wtsi/Csnk1g2tm1b(EUCOMM)Wtsi
(C57BL/6N-Csnk1g2tm1b(EUCOMM)Wtsi/Ieg)
|
increased cardiac muscle contractility
|
J:211773
|
Csrp2tm1Sfy/Csrp2tm1Sfy
(B6.129S2-Csrp2tm1Sfy)
|
abnormal vascular smooth muscle physiology
|
J:117557
|
Csrp3tm1.1Kage/Csrp3tm1.1Kage
(involves: C57BL/6 * C57BL/6J * C57BL/6N * SJL)
|
abnormal cardiac muscle relaxation
|
J:307893
|
decreased heart left ventricle muscle contractility
|
J:307893
|
Csrp3tm1.1Rkn/Csrp3+
(either: (involves: Black Swiss) or (involves: C57BL/6N))
|
cardiomyopathy
|
J:170878
|
increased cardiac muscle contractility
|
J:170878
|
Csrp3tm1.1Rkn/Csrp3tm1.1Rkn
(either: (involves: Black Swiss) or (involves: C57BL/6N))
|
cardiomyopathy
|
J:170878
|
increased cardiac muscle contractility
|
J:170878
|
myopathy
|
J:170878
|
Csrp3tm1Crni/Csrp3tm1Crni
(Not Specified)
|
decreased cardiac muscle contractility
|
J:88510,
J:66250
|
decreased heart ventricle muscle contractility
|
J:38213
|
dilated cardiomyopathy
|
J:38213,
J:88510,
J:66250
|
Csrp3tm1Crni/Csrp3tm1Crni Plntm1Egk/Plntm1Egk
(involves: 129S2/SvPas * CF-1)
|
increased cardiac muscle contractility
|
J:58299
|
Csrp3tm1Crni/Csrp3tm1Crni Tg(Myh6-ADRBK1)27Wjk/0
(involves: C57BL/6 * SJL)
|
decreased heart ventricle muscle contractility
|
J:48062
|
Csrp3tm1Crni/Csrp3tm1Crni Tg(WTbeta2)4Wjk/0
(Not Specified)
|
decreased heart ventricle muscle contractility
|
J:48062
|
dilated cardiomyopathy
|
J:48062
|
Cstbtm1Rm/Cstbtm1Rm
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
facial muscle spasm
|
J:50587
|
myoclonus
|
J:50587
|
Cstbtm1Rm/Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myoclonus
|
J:115694
|
Cthtm1Liwu/Cthtm1Liwu
(involves: 129S/SvEvBrd * C57BL/6J)
|
decreased vasodilation
|
J:140705
|
Ctnna1tm1Efu/Ctnna1tm1Efu A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129X1/SvJ * FVB/N)
|
dilated cardiomyopathy
|
J:197814
|
Ctnna3tm1.1Fvr/Ctnna3tm1.1Fvr
(involves: 129S6/SvEvTac * BALB/cJ)
|
decreased cardiac muscle contractility
|
J:197814
|
dilated cardiomyopathy
|
J:197814
|
Ctsltm1Cptr/Ctsltm1Cptr
(involves: 129P2/OlaHsd)
|
decreased cardiac muscle contractility
|
J:76333
|
decreased heart left ventricle muscle contractility
|
J:76333
|
dilated cardiomyopathy
|
J:76333
|
Cul3tm1.1Arte/Cul3+
(involves: C57BL/6J * C57BL/6N)
|
increased vasoconstriction
|
J:229424
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
|
decreased vascular smooth muscle cell proliferation
|
J:124722
|
Cxadrtm1.1Mds/Cxadrtm1.1Mds
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:121400
|
Cxadrtm1Know/Cxadrtm1Know Tg(Myh6-cre)2182Mds/0
(involves: 129 * Black Swiss * FVB/N)
|
decreased cardiac muscle contractility
|
J:140870
|
Cxadrtm1Rwf/Cxadrtm1Rwf
(involves: 129S6/SvEvTac * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:99585
|
Cxcr4tm1Qma/Cxcr4tm1Qma
(B6.129X-Cxcr4tm1Qma/J)
|
abnormal muscle precursor cell migration
|
J:100909
|
Cxcr4tm1Qma/Cxcr4tm1Qma Gab1tm1Wbm/Gab1tm1Wbm
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
abnormal muscle precursor cell migration
|
J:100909
|
Cxcr4tm2Yzo/Cxcr4tm2Yzo Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
cardiomyopathy
|
J:289614
|
decreased heart left ventricle muscle contractility
|
J:289614
|
decreased heart ventricle muscle contractility
|
J:289614
|
Cyb5r3tm1c(KOMP)Wtsi/Cyb5r3tm1c(KOMP)Wtsi Tg(Myh11-icre/ERT2)1Soff/0
(B6.Cg-Cyb5r3tm1c(KOMP)Wtsi Tg(Myh11-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:280543
|
increased vasoconstriction
|
J:280543
|
increased vasodilation
|
J:280543
|
Cygbtm1Ppam/Cygbtm1Ppam Tg(Myog-cre)1Eno/0
(involves: 129 * C57BL/6)
|
abnormal muscle precursor cell physiology
|
J:206378
|
impaired muscle regeneration
|
J:206378
|
Cyp2j5tm1Dcz/Cyp2j5tm1Dcz
(129S/SvEv-Cyp2j5tm1Dcz)
|
increased vasoconstriction
|
J:146047
|
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6)
|
increased cardiac muscle contractility
|
J:105620
|
d-58H/d-58H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Daam1Gt(RRT390)Byg/Daam1Gt(RRT390)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal muscle physiology
|
J:167714
|
Dag1tm1.1Sabl/Dag1tm1.1Sabl
(involves: C57BL/6 * CD-1)
|
abnormal muscle physiology
|
J:350439
|
Dag1tm2Kcam/Dag1tm2Kcam Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal cardiac muscle contractility
|
J:169951
|
dilated cardiomyopathy
|
J:169951
|
Dcaf6tm1.1Ntuy/Dcaf6tm1.1Ntuy
(B6JNarl.Cg-Dcaf6tm1.1Ntuy)
|
abnormal muscle physiology
|
J:233771
|
delayed skeletal muscle regeneration
|
J:233771
|
impaired skeletal muscle regeneration
|
J:233771
|
Ddah1tm1Pval/Ddah1+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal vasodilation
|
J:121719
|
increased vasoconstriction
|
J:121719
|
Ddah1tm1Yjch/Ddah1tm1Yjch Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:168130
|
Ddr2tm1.1(cre/Esr1*)Rcow/Ddr2tm1.1(cre/Esr1*)Rcow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:214642
|
decreased cardiac muscle contractility
|
J:214642
|
Ddttm1Lhy/Ddttm1Lhy Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:213776
|
Degs1Gt(OST368559)Lex/Degs1+
(involves: 129S5/SvEvBrd)
|
increased muscle cell glucose uptake
|
J:203554
|
Del(1Aim2-Ifi205)1Stsn/+ Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
myositis
|
J:234263
|
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
myositis
|
J:234263
|
Del(4C4-C5)1Lap/Del(4C4-C5)1Lap
(involves: 129S6/SvEvTac)
|
abnormal vascular smooth muscle physiology
|
J:158126
|
increased vascular smooth muscle cell proliferation
|
J:158126
|
Del(4Cyp2j13-Cyp2j5)1Brs/Del(4Cyp2j13-Cyp2j5)1Brs
(involves: C57BL/6)
|
abnormal vasoconstriction
|
J:223128
|
Del(7Ube3a-Snrpn)1Alb/+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
hypotonia
|
J:56617
|
Del(9Hspb2-Cryab)1Wawr/Del(9Hspb2-Cryab)1Wawr
(involves: 129S4/SvJae)
|
progressive muscle weakness
|
J:72926
|
Del(16Hspa13-App)3Yah/+
(B6J.129P2-Del(16Hspa13-App)3Yah)
|
abnormal muscle physiology
|
J:223518
|
Del(18Pcdhg)1Xzw/Del(18Pcdhg)1Xzw
(Not Specified)
|
muscle hypertonia
|
J:188341
|
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6J * CBA)
|
myopathy
|
J:115155
|
Destm1.1Ccrs/Des+
(involves: 129 * C57BL/6J)
|
cardiomyopathy
|
J:219616
|
decreased cardiac muscle contractility
|
J:219616
|
dilated cardiomyopathy
|
J:219616
|
Destm1.1Ccrs/Destm1.1Ccrs
(involves: 129 * C57BL/6J)
|
cardiomyopathy
|
J:219616
|
decreased cardiac muscle contractility
|
J:219616
|
dilated cardiomyopathy
|
J:219616
|
impaired skeletal muscle contractility
|
J:219616
|
myopathy
|
J:219616
|
progressive muscle weakness
|
J:219616
|
Destm1Cap/Destm1Cap
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:59831
|
cardiomyopathy
|
J:35123
|
decreased heart ventricle muscle contractility
|
J:59831
|
Destm1Cap/Destm1Cap
(involves: 129S7/SvEvBrd)
|
decreased heart ventricle muscle contractility
|
J:88267
|
dilated cardiomyopathy
|
J:88267
|
Destm1Cba/Destm1Cba
(involves: 129S2/SvPas * C57BL/6J)
|
cardiomyopathy
|
J:130557
|
decreased cardiac muscle contractility
|
J:130557
|
Dgcr8tm1.1Blel/Dgcr8tm1.1Blel Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
decreased heart ventricle muscle contractility
|
J:161342
|
Dhcr7tm1Gst/Dhcr7tm1Gst Tg(APOE-DHCR7)2Hoyu/0
(involves: 129P2/OlaHsd * C57BL * C57BL/6J * FVB/N)
|
hypotonia
|
J:141730
|
Dhfrorana/Dhfr+
(involves: C57BL/6JAnu)
|
decreased vasodilation
|
J:236197
|
Dhtkd1tm1Zgwg/Dhtkd1tm1Zgwg
(involves: C57BL/6)
|
progressive muscle weakness
|
J:267178
|
Dicer1tm1Bdh/Dicer1tm1Bdh Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA)
|
impaired skeletal muscle regeneration
|
J:292144
|
Dicer1tm1Smr/Dicer1tm1Smr Tg(Myh6-cre)2182Mds/0
(involves: 129S7/SvEvBrd * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:131962
|
dilated cardiomyopathy
|
J:131962
|
increased cardiomyocyte apoptosis
|
J:131962
|
Dlg1tm1Jhm/Dlg1tm1Jhm
(involves: 129 * C57BL/6J)
|
impaired smooth muscle contractility
|
J:118250
|
impaired ureteric peristalsis
|
J:118250
|
Dlk1tm1.1Jvs/Dlk1+ Myf5tm3(cre)Sor/Myf5+
(involves: 129P2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
impaired skeletal muscle regeneration
|
J:167124
|
Dlx2tm1Jlr/Dlx2tm1Jlr
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * CD-1))
|
intestinal hypoperistalsis
|
J:29443
|
Dmdem1Eno/Y
(involves: C57BL/6J)
|
myositis
|
J:253191
|
Dmdem4Eno/Y
(C57BL/6-Dmdem4Eno)
|
muscle weakness
|
J:285447
|
myositis
|
J:285447
|
Dmdem4Eno/Dmdem4Eno
(C57BL/6-Dmdem4Eno)
|
muscle weakness
|
J:285447
|
myositis
|
J:285447
|
Dmdem#Tve/Y
(involves: C57BL/6 * CBA)
|
muscle weakness
|
J:275476
|
DmdGt(ROSABetageo)1Mpd/Y
(involves: 129S1/Sv)
|
abnormal muscle physiology
|
J:47968
|
DmdGt(ROSABetageo)1Mpd/DmdGt(ROSABetageo)1Mpd
(involves: 129S1/Sv)
|
abnormal muscle physiology
|
J:47968
|
Dmdmdx-2Cv/Y
(involves: C3H/HeHa * C57BL/6Ros * C57BL/10Sn * M. m. castaneus * M. m. musculus)
|
impaired muscle relaxation
|
J:9638
|
Dmdmdx-3Cv/Y
(involves: C3H/HeHa * C57BL/6Ros * C57BL/10Sn * M. m. castaneus * M. m. musculus)
|
impaired muscle relaxation
|
J:9638
|
Dmdmdx-3Cv/Y
(B6.Cg-Dmdmdx-3Cv/J)
|
abnormal muscle contractility
|
J:134272
|
Dmdmdx-4Cv/Y
(B6Ros.Cg-Dmdmdx-4Cv/J)
|
abnormal muscle contractility
|
J:134272
|
Dmdmdx-4Cv/Dmdmdx-4Cv Terctm1Rdp/Terctm1Rdp
(B6.Cg-Terctm1Rdp Dmdmdx-4Cv)
|
decreased heart ventricle muscle contractility
|
J:200365
|
dilated cardiomyopathy
|
J:200365
|
ventricular cardiomyopathy
|
J:200365
|
Dmdmdx-5Cv/Y
(B6Ros.Cg-Dmdmdx-5Cv)
|
impaired skeletal muscle contractility
|
J:177391
|
increased muscle fatigability
|
J:177391
|
Dmdmdx-5Cv/Dmdmdx-5Cv
(B6Ros.Cg-Dmdmdx-5Cv/J)
|
abnormal muscle contractility
|
J:164891
|
Dmdmdx-5Cv/Dmdmdx-5Cv Flt1tm1Jrt/Flt1+
(involves: C3HA * C57BL/6Ros)
|
abnormal muscle contractility
|
J:164891
|
Dmdmdx/Y
(C57BL/10ScSn-Dmdmdx/J)
|
abnormal muscle physiology
|
J:3666
|
myopathy
|
J:7361
|
Dmdmdx/Y
(C57BL/10ScSn-Dmdmdx)
|
abnormal muscle contractility
|
J:152525
|
impaired muscle relaxation
|
J:9638
|
impaired skeletal muscle contractility
|
J:177391
|
Dmdmdx/Y
(involves: C57BL/10ScSn)
|
abnormal muscle electrophysiology
|
J:142492
|
abnormal muscle tone
|
J:152749
|
diaphragmitis
|
J:140282
|
myositis
|
J:140282
|
Dmdmdx/Y Dtnatm1Jrs/Dtnatm1Jrs
(involves: 129X1/SvJ * C57BL/10ScSn)
|
cardiomyopathy
|
J:59675
|
Dmdmdx/Y Dtnatm1Jrs/Dtnatm1Jrs Utrntm1Jrs/Utrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn)
|
cardiomyopathy
|
J:59675
|
Dmdmdx/? Fgf2tm1Zllr/Fgf2tm1Zllr Fgf6tm1Thbr/Fgf6tm1Thbr
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * C57BL/10ScSn)
|
abnormal muscle physiology
|
J:85088
|
Dmdmdx/? Fgf6tm1Thbr/Fgf6tm1Thbr
(involves: 129S4/SvJae * C57BL/6 * C57BL/10ScSn)
|
myopathy
|
J:42574
|
Dmdmdx/? Myod1tm1Jae/Myod1tm1Jae
(involves: 129S4/SvJae * C57BL/10ScSn)
|
dilated cardiomyopathy
|
J:52248
|
Dmdmdx/Y Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)
|
abnormal muscle physiology
|
J:150572
|
Dmdmdx/Y Terctm1Rdp/Terc+
(involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL)
|
abnormal muscle physiology
|
J:167294
|
Dmdmdx/Y Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL)
|
abnormal muscle electrophysiology
|
J:167294
|
abnormal muscle physiology
|
J:167294
|
muscle weakness
|
J:167294
|
myositis
|
J:167294
|
Dmdmdx/Y Tg(DMD*)#Spc/0
(involves: 129P2/OlaHsd * C57BL/10ScSn * DBA/2)
|
myositis
|
J:280218
|
Dmdmdx/Y Utrntm1Jrs/Utrn+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn)
|
diaphragmitis
|
J:140282
|
myositis
|
J:140282
|
Dmdmdx/Dmdmdx
(involves: C57BL/10ScSn)
|
abnormal muscle contractility
|
J:152525
|
abnormal muscle electrophysiology
|
J:142492
|
abnormal muscle physiology
|
J:152750
|
abnormal muscle tone
|
J:152749
|
abnormal skeletal muscle satellite cell proliferation
|
J:152892
|
Dmdmdx/Dmdmdx
(C57BL/10ScSn-Dmdmdx/J)
|
abnormal muscle physiology
|
J:3666
|
abnormal skeletal muscle regeneration
|
J:226314
|
cardiomyopathy
|
J:226314
|
decreased cardiac muscle contractility
|
J:226314
|
impaired skeletal muscle contractility
|
J:226314
|
myopathy
|
J:7361
|
myositis
|
J:226314
|
Dmdmdx/Dmdmdx
(C57BL/10ScSn-Dmdmdx)
|
myopathy
|
J:7361
|
Dmdmdx/Dmdmdx
(involves: BALB/c * C57BL/10ScSn * C57BL/Ka)
|
impaired skeletal muscle contractility
|
J:125527
|
Dmdmdx/Dmdmdx
(D2.B10-Dmdmdx)
|
muscle weakness
|
J:160773
|
Dmdmdx/Dmdmdx
(D2.B10-Dmdmdx/J)
|
abnormal skeletal muscle regeneration
|
J:226314
|
cardiomyopathy
|
J:226314
|
decreased cardiac muscle contractility
|
J:226314
|
impaired skeletal muscle contractility
|
J:226314
|
myositis
|
J:226314
|
Dmdmdx/Dmdmdx Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6 * C57BL/10ScSn)
|
myositis
|
J:162340
|
Dmdmdx/Dmdmdx Mamstrtm1.2Eno/Mamstrtm1.2Eno
(involves: 129 * C57BL/6 * C57BL/10ScSn)
|
abnormal skeletal muscle satellite cell proliferation
|
J:179880
|
Dmdmdx/Dmdmdx Mmp9tm1Tvu/Mmp9+
(B10.Cg-Mmp9tm1Tvu Dmdmdx)
|
abnormal muscle physiology
|
J:150030
|
enhanced skeletal muscle regeneration
|
J:150030
|
Dmdmdx/Dmdmdx Mmp9tm1Tvu/Mmp9tm1Tvu
(B10.Cg-Mmp9tm1Tvu Dmdmdx)
|
enhanced skeletal muscle regeneration
|
J:150030
|
Dmdmdx/Dmdmdx Prkdcscid/Prkdcscid
(involves: BALB/c * C57BL/10ScSn * C57BL/Ka)
|
impaired skeletal muscle contractility
|
J:125527
|
Dmdmdx/Dmdmdx Snhg15tm1Nju/Snhg15tm1Nju
(involves: C57BL/6J * C57BL/10ScSn)
|
impaired skeletal muscle regeneration
|
J:291983
|
Dmdmdx/Dmdmdx Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)
|
abnormal muscle physiology
|
J:150572
|
Dmdmdx/Dmdmdx Utrntm1Jrs/Utrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn)
|
abnormal muscle physiology
|
J:42389
|
abnormal muscle relaxation
|
J:42389
|
cardiomyopathy
|
J:59675,
J:42389
|
muscle weakness
|
J:42389
|
Dmdmdx/Dmdmdx Utrntm1Ked/Utrntm1Ked
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10ScSn * DBA)
|
progressive muscle weakness
|
J:42388
|
Dmdtm1.1Know/Dmdtm1.1Know A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ Tg(Myh6-2A)#Know/0
(involves: BALB/c * C3H * C57BL/6 * FVB/N)
|
cardiomyopathy
|
J:207775
|
increased cardiac muscle contractility
|
J:207775
|
Dmdtm1Kmf/Y
(involves: C57BL/6)
|
myositis
|
J:233298
|
Dmpktm1Bew/Dmpktm1Bew
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle physiology
|
J:43052,
J:33711
|
Dmpktm1Rdd/Dmpk+
(involves: 129S2/SvPas * C57BL/6J)
|
enhanced skeletal muscle regeneration
|
J:33714
|
impaired skeletal muscle contractility
|
J:33714
|
myopathy
|
J:33714
|
Dmpktm1Rdd/Dmpktm1Rdd
(involves: 129S2/SvPas * C57BL/6J)
|
enhanced skeletal muscle regeneration
|
J:33714
|
impaired skeletal muscle contractility
|
J:33714
|
myopathy
|
J:33714
|
progressive muscle weakness
|
J:33714
|
Dnaja3tm1.1Jdl/Dnaja3tm1.1Jdl Tg(Myhca-cre)1Abel/0
(involves: 129X1/SvJ * C57BL/6J * FVB)
|
decreased heart ventricle muscle contractility
|
J:104462
|
dilated cardiomyopathy
|
J:104462
|
increased cardiomyocyte apoptosis
|
J:104462
|
Dnajb4em1Sngi/Dnajb4+
(involves: C57BL/6J)
|
impaired skeletal muscle contractility
|
J:333950
|
muscle weakness
|
J:333950
|
Dnajb4em2Sngi/Dnajb4em2Sngi
(involves: C57BL/6J)
|
impaired skeletal muscle contractility
|
J:333950
|
muscle weakness
|
J:333950
|
Dnajc5tm1Sud/Dnajc5tm1Sud
(involves: 129S6/SvEvTac)
|
progressive muscle weakness
|
J:91702
|
Dnajc11spc/Dnajc11spc
(B6.Cg-Dnajc11spc)
|
progressive muscle weakness
|
J:221543
|
Dnm1lPy/Dnm1l+
(involves: BALB/cAnNCrl * C3H/HeH)
|
abnormal cardiac muscle relaxation
|
J:161510
|
decreased heart ventricle muscle contractility
|
J:161510
|
Dnm2tm1.1Ics/Dnm2+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal muscle contractility
|
J:237196
|
muscle weakness
|
J:166364
|
Dnm2tm2.1Ics/Dnm2+
(involves: C57BL/6J)
|
abnormal muscle electrophysiology
|
J:288372
|
myopathy
|
J:288372
|
Dock1tm1Jfco/Dock1tm1Jfco
(involves: 129/Sv * C57BL/6)
|
abnormal muscle physiology
|
J:143342
|
Dok7tm2Yyam/Dok7tm2Yyam
(involves: 129P2/OlaHsd * C57BL/6J)
|
muscle weakness
|
J:213767
|
Dot1ltm1Tche/Dot1ltm1.1Tche Tg(Myhca-cre)1Abel/0
(Not Specified)
|
abnormal muscle physiology
|
J:168140
|
dilated cardiomyopathy
|
J:168140
|
increased cardiomyocyte apoptosis
|
J:168140
|
increased fetal cardiomyocyte proliferation
|
J:168140
|
Drd1tm2Jcd/Drd1+ Tg(Camk2a-cre)2Gsc/0
(involves: 129S4/SvJae * FVB/N)
|
dystonia
|
J:120070
|
Drd1tm2Jcd/Drd1+ Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S4/SvJae * BALB/c * CD-1 * FVB/N)
|
dystonia
|
J:120582
|
myoclonus
|
J:120582
|
Dsc2tm1.2Leu/Dsc2tm1.2Leu
(involves: C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:302593
|
Dscam3J/Dscam3J
(involves: BALB/c * C3H/HeSnSmn * C57BL/Ka)
|
muscle hypertonia
|
J:195831
|
Dsg2em1Spin/Dsg2em1Spin
(involves: C57BL/6J)
|
decreased heart ventricle muscle contractility
|
J:342765
|
Dsg2tm1a(EUCOMM)Wtsi/Dsg2tm1a(EUCOMM)Wtsi
(C57BL/6-Dsg2tm1a(EUCOMM)Wtsi)
|
cardiomyopathy
|
J:235770
|
Dsg2tm1b(EUCOMM)Wtsi/Dsg2tm1b(EUCOMM)Wtsi
(C57BL/6N-Dsg2tm1b(EUCOMM)Wtsi/Bay)
|
decreased cardiac muscle contractility
|
J:211773
|
Dsg2tm1d(EUCOMM)Wtsi/Dsg2tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
cardiomyopathy
|
J:235770
|
decreased cardiac muscle contractility
|
J:235770
|
increased cardiomyocyte apoptosis
|
J:235770
|
Dsg2tm1d(EUCOMM)Wtsi/Dsg2tm1d(EUCOMM)Wtsi Gsk3btm1Dral/Gsk3b+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
decreased cardiac muscle contractility
|
J:235770
|
Dsg2tm1d(EUCOMM)Wtsi/Dsg2tm1d(EUCOMM)Wtsi Gsk3btm1Dral/Gsk3btm1Dral
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
decreased cardiac muscle contractility
|
J:235770
|
Dsptm1Efu/Dsptm1Efu Myl2tm1(cre)Krc/Myl2+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:205990
|
ventricular cardiomyopathy
|
J:205990
|
Dstdt-23Rbrc/Dstdt-23Rbrc
(involves: C3H/HeN * C57BL/6)
|
abnormal muscle physiology
|
J:251779
|
dystonia
|
J:251779
|
Dstdt-30J/Dstdt-30J
(C57BL/6J-Dstdt-30J/J)
|
dystonia
|
J:155853
|
Dstdt-31J/Dstdt-31J
(involves: DBA/1LacJ)
|
dystonia
|
J:155854
|
Dstdt-37J/Dstdt-37J
(C57BL/6J-Dstdt-37J/J)
|
dystonia
|
J:82238
|
Dstdt-38J/Dstdt-38J
(involves: BALB/cByJ * C57BL/6J)
|
muscle spasm
|
J:82238
|
Dstdt-39J/Dstdt-39J
(involves: NOD)
|
dystonia
|
J:157224
|
Dstdt-alb/Dstdt-alb
(BALB/cByJ-Dstdt-alb)
|
dystonia
|
J:64441
|
Dstdt/Dstdt
(Q-Dstdt)
|
dystonia
|
J:64095
|
Dstdt/Dstdt
(involves: Q)
|
dystonia
|
J:5674
|
DstGt(E182H05)Wrst/DstGt(E182H05)Wrst
(B6NCrj.129P2-DstGt(E182H05)Wrst)
|
dystonia
|
J:228781,
J:251779
|
DstGt(E182H05)Wrst/DstGt(E182H05)Wrst
(involves: 129P2/OlaHsd * ICR)
|
abnormal muscle electrophysiology
|
J:228781,
J:251779
|
DstTg4/DstTg4
(involves: CD-1)
|
abnormal muscle physiology
|
J:55704
|
impaired skeletal muscle contractility
|
J:55704
|
muscle weakness
|
J:55704
|
Dsttm1Efu/Dsttm1Efu
(involves: C57BL/6)
|
dystonia
|
J:24974
|
Dtnatm1Jrs/Dtnatm1Jrs
(involves: 129X1/SvJ * C57BL/6)
|
cardiomyopathy
|
J:59675
|
Dtnatm1Jrs/Dtnatm1Jrs Utrntm1Jrs/Utrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ)
|
cardiomyopathy
|
J:59675
|
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
abnormal muscle regeneration
|
J:162340
|
Dusp6tm1Jmol/Dusp6tm1Jmol
(involves: 129 * C57BL/6)
|
abnormal muscle physiology
|
J:190460
|
Dusp8tm1Jmol/Dusp8tm1Jmol
(involves: 129/SvJ * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:233947
|
increased cardiac muscle contractility
|
J:233947
|
Dusp14em1Lyg/Dusp14em1Lyg
(Not Specified)
|
decreased cardiac muscle contractility
|
J:263251
|
Dync1h1Cra1/Dync1h1+
(C3HeB/FeJ-Dync1h1Cra1)
|
muscle spasm
|
J:83128
|
Dync1h1Cra1/Dync1h1+
(involves: C3HeB/FeJ * C57BL/6)
|
muscle spasm
|
J:83128
|
Dync1h1Loa/Dync1h1+
(C3H/HeH-Dync1h1Loa)
|
muscle spasm
|
J:83128
|
Dync1h1Loa/Dync1h1+
(involves: C3H/HeH * C57BL/6)
|
muscle spasm
|
J:83128
|
Dysfim/Dysf+ Large1myd/Large1myd
(involves: C57BL/6 * SJL/J)
|
myositis
|
J:221523
|
Dysfim/Dysfim
(involves: SJL)
|
progressive muscle weakness
|
J:57764
|
Dysfim/Dysfim Fktntm1Ttd/Fktntm2(FCMD)Ttd
(involves: 129S7/SvEvBrd * C57BL/6 * SJL/J)
|
myositis
|
J:221523
|
Dysfim/Dysfim Large1myd/Large1myd
(involves: C57BL/6 * SJL/J)
|
myositis
|
J:221523
|
Dysfprmd/Dysfprmd
(involves: 129 * A/J * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:331473
|
Dysftm1.1Mdcb/Dysftm1.1Mdcb
(B6.129P2(Cg)-Dysftm1.1Mdcb)
|
abnormal muscle physiology
|
J:302056
|
Dysftm1Kcam/Dysftm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:83126
|
myositis
|
J:171870
|
E2f1tm1Meg/E2f1tm1Meg Rb1tm1Tyj/Rb1tm1Tyj Tg(Rb1)1Blg/0
(involves: 129S2/SvPas * 129S4/SvJae)
|
abnormal muscle physiology
|
J:65679
|
Ece1tm1Reh/Ece1tm1Reh
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vasodilation
|
J:46640
|
Ecsitmpc178H/Ecsitmpc178H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
cardiomyopathy
|
J:234901
|
Ednrbtm1.1Nrd/Ednrb+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased heart ventricle muscle contractility
|
J:226561
|
Ednrbtm1.1Yko/Ednrbtm1.1Yko
(involves: 129P2/OlaHsd * Bkl:BKW * C57BL/6 * SJL)
|
decreased vasodilation
|
J:135711
|
Ednrbtm1Yko/Ednrbtm1Yko Tg(Tek-cre)1Ywa/0
(involves: 129P2/OlaHsd * Bkl:BKW * C57BL/6 * SJL)
|
decreased vasodilation
|
J:135711
|
Efemp2tm1.2Hiya/Efemp2tm1.2Hiya
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal vascular smooth muscle physiology
|
J:170883
|
increased vascular smooth muscle cell proliferation
|
J:170883
|
Efhc1tm1Kzy/Efhc1+
(B6.129P2-Efhc1tm1Kzy)
|
myoclonus
|
J:145858
|
Efhc1tm1Kzy/Efhc1tm1Kzy
(B6.129P2-Efhc1tm1Kzy)
|
myoclonus
|
J:145858
|
Efna1tm1Jinc/Efna1tm1Jinc
(involves: 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:166527
|
Eftud2tm1b(KOMP)Wtsi/Eftud2+
(C57BL/6N-Eftud2tm1b(KOMP)Wtsi/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
Egfrwa2/Egfrwa2
(involves: C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:241813
|
decreased heart right ventricle muscle contractility
|
J:241813
|
decreased heart ventricle muscle contractility
|
J:241813
|
Egfrwa2/Egfrwa2 Ptpn11tm1Paw/Ptpn11+
(involves: 129S1/Sv * 129X1/SvJ * B6EiC3Sn a/A-Egfrwa2 Wnt3avt * C57BL/6)
|
intestinal hypoperistalsis
|
J:75413
|
Egln1tm1.1Brei/Egln1tm1.1Brei Myl2tm1(cre)Krc/Myl2+
(B6.Cg-Myl2tm1(cre)Krc Egln1tm1.1Brei)
|
decreased cardiomyocyte apoptosis
|
J:170943
|
Egln1tm1Kael/Egln1tm1Kael Egln3tm1Vlcg/Egln3tm1Vlcg Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N)
|
cardiomyopathy
|
J:179490
|
decreased heart ventricle muscle contractility
|
J:179490
|
Egln1tm1Kael/Egln1tm1Kael Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
dilated cardiomyopathy
|
J:132718
|
Egln1tm1Kael/Egln1tm1Kael Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:179490
|
Egln2tm1Pec/Egln2tm1Pec
(involves: 129S/SvEv * Swiss)
|
abnormal muscle physiology
|
J:132630
|
Ehhadhtm1Jkr/Ehhadhtm1Jkr Hsd17b4tm1Baes/Hsd17b4tm1Baes
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
hypotonia
|
J:104835
|
Eif3ftm1(KOMP)Vlcg/Eif3f+
(B6J.B6N-Eif3ftm1(KOMP)Vlcg)
|
abnormal muscle physiology
|
J:294674
|
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
(involves: 129S4/SvJae * C57BL/6)
|
increased cardiac muscle contractility
|
J:163763
|
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso Mtortm1.1Gcon/Mtortm1.1Gcon A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased cardiomyocyte apoptosis
|
J:163763
|
Eif4hGt(Ex279)Byg/Eif4hGt(Ex279)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased muscle fatigability
|
J:181945
|
Elac2tm1c(EUCOMM)Wtsi/Elac2tm1c(EUCOMM)Wtsi Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB)
|
decreased cardiac muscle contractility
|
J:265839
|
dilated cardiomyopathy
|
J:265839
|
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon Tg(MYOD1-cre)M23Glh/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle contractility
|
J:279284
|
Elmo1tm1.2Ravi/Elmo1tm1.2Ravi Elmo2tm1.1Jfco/Elmo2tm1.1Jfco
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:331473
|
Elmo2tm2.1Jfco/Elmo2tm2.1Jfco
(involves: 129 * C57BL/6)
|
enhanced skeletal muscle regeneration
|
J:331473
|
Elp1tm1.1Gilas/Elp1tm1.1Gilas Tg(Dct-cre)1Apdn/0
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal intestinal peristalsis
|
J:237480
|
Elp2em2Bjw/Elp2em2Bjw
(involves: C57BL/6)
|
hypotonia
|
J:306113
|
Elp2em2Bjw/Elp2em2Bjw
(involves: C57BL/6 * DBA/2J)
|
hypotonia
|
J:306113
|
Elp2em2Bjw/Elp2em3Bjw
(involves: C57BL/6 * DBA/2J)
|
hypotonia
|
J:306113
|
Emdtm1.1Stw/Y
(involves: 129S1/Sv * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:218095
|
decreased heart right ventricle muscle contractility
|
J:218095
|
decreased heart ventricle muscle contractility
|
J:218095
|
Eml1heco/Eml1heco
(involves: NOR)
|
myoclonus
|
J:208031
|
En1tm2(cre)Wrst/En1+ Tor1atm1Wtd/Tor1atm3.1Wtd
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
dystonia
|
J:213785
|
En1tm2(cre)Wrst/En1+ Tor1atm2Wtd/Tor1atm3.1Wtd
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
dystonia
|
J:213785
|
Engtm1Mle/Eng+
(involves: 129P2/OlaHsd * C57BL/6)
|
ear telangiectasia
|
J:58502
|
neck telangiectasia
|
J:58502
|
tail telangiectasia
|
J:58502
|
Engtm1Mle/Eng+
(129P2/OlaHsd-Engtm1Mle)
|
ear telangiectasia
|
J:58502
|
tail telangiectasia
|
J:58502
|
Enhotm1.1Butl/Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl)
|
decreased skeletal muscle cell glucose uptake
|
J:225402
|
Entpd1tm1Djp/Entpd1tm1Djp
(B6.129-Entpd1tm1Djp)
|
abnormal muscle electrophysiology
|
J:143010
|
impaired smooth muscle contractility
|
J:143010
|
Ep300tm1Dli/Ep300tm1Dli
(either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6))
|
decreased cardiac muscle contractility
|
J:47301
|
epf/epf
(Not Specified)
|
emprosthotonos
|
J:6309
|
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased cardiac muscle cell glucose uptake
|
J:173769
|
muscle weakness
|
J:76688
|
myoclonus
|
J:76688
|
Erbb2tm1Cbm/Erbb2tm2Cbm Myl2tm1(cre)Krc/Myl2+
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
decreased heart left ventricle muscle contractility
|
J:77347
|
decreased heart ventricle muscle contractility
|
J:77347
|
dilated cardiomyopathy
|
J:77347
|
Erbb2tm1Klee/Erbb2tm1Klee Myl2tm1(cre)Krc/Myl2+
(involves: 129S4/SvJae)
|
abnormal cardiac muscle relaxation
|
J:76196
|
decreased heart ventricle muscle contractility
|
J:76196
|
dilated cardiomyopathy
|
J:76196
|
Erbb2tm1Klee/Erbb2tm1Klee Tg(Ckmm-cre)1Lrsn/0
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:76196
|
decreased heart left ventricle muscle contractility
|
J:76196
|
dilated cardiomyopathy
|
J:76196
|
Erbb2tm3(Erbb2)Mul/Erbb2tm3(Erbb2)Mul Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * FVB)
|
impaired skeletal muscle regeneration
|
J:81565
|
Erbb4tm1Htig/Erbb4tm1Htig Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:101252
|
dilated cardiomyopathy
|
J:101252
|
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
dystonia
|
J:117488
|
Ercc3tm2Jhjh/Ercc3tm2Jhjh Xpatm1Hvs/Xpatm1Hvs
(involves: 129P2/OlaHsd * C57BL/6)
|
muscle hypertonia
|
J:145759
|
Ercc6tm1Gvh/Ercc6tm1Gvh Xpatm1Hvs/Xpatm1Hvs
(B6.129P2-Xpatm1Hvs Ercc6tm1Gvh)
|
dystonia
|
J:122013
|
Ergic2tm1.1Bcgen/Ergic2tm1.1Bcgen
(Not Specified)
|
decreased cardiac muscle contractility
|
J:345070
|
decreased heart ventricle muscle contractility
|
J:345070
|
Ergic3tm1.1Bcgen/Ergic3tm1.1Bcgen
(Not Specified)
|
decreased cardiac muscle contractility
|
J:345070
|
decreased heart ventricle muscle contractility
|
J:345070
|
Esr1tm1.1Ics/Esr1tm1.1Ics
(involves: C57BL/6NTac)
|
abnormal vasodilation
|
J:206373
|
Esr1tm1.1Mma/Esr1tm1.1Mma
(involves: 129S2/SvPas)
|
abnormal vasodilation
|
J:206373
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:73898
|
abnormal vascular smooth muscle physiology
|
J:73898
|
increased vasoconstriction
|
J:73898
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd)
|
abnormal muscle contractility
|
J:95398
|
increased vasodilation
|
J:64165
|
Esrrbtm1.1Nat/Esrrbtm1.1Nat Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N * FVB/N)
|
decreased cardiac muscle contractility
|
J:241078
|
decreased heart ventricle muscle contractility
|
J:241078
|
dilated cardiomyopathy
|
J:241078
|
Etfdhtm1c(EUCOMM)Hmgu/Etfdhtm1c(EUCOMM)Hmgu Tg(ACTA1-rtTA,tetO-cre)102Monk/0
(involves: C3H * C57BL/6 * C57BL/6N)
|
abnormal muscle physiology
|
J:345923
|
myopathy
|
J:345923
|
F2tm1Jld/F2tm1Sjd Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
|
muscle hemorrhage
|
J:144572
|
F3tm1.1Dwr/F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)
|
abnormal vascular smooth muscle physiology
|
J:111390
|
increased vascular smooth muscle cell proliferation
|
J:111390
|
Faahtm1Crv/Faahtm1Crv Tg(SOD1*G93A)1Gur/0
(involves: 129X1/SvJ * ABH * C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:111498
|
Fabp3tm1Bin/Fabp3tm1Bin
(involves: 129P2/OlaHsd * BALB/c)
|
increased cardiac muscle cell glucose uptake
|
J:54614
|
Fabp4tm1Brsp/Fabp4tm1Brsp Fabp5tm1Hota/Fabp5tm1Hota Lepob/Lepob
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob)
|
increased muscle cell glucose uptake
|
J:111878
|
Fam120bem1Qqlg/Fam120bem1Qqlg
(C57BL/6-Fam120bem1Qqlg)
|
decreased fetal cardiomyocyte proliferation
|
J:318650
|
decreased heart ventricle muscle contractility
|
J:318650
|
Fat1Gt(KST249)Byg/Fat1Gt(KST249)Byg Tg(Myl1-lacZ)1Ibdml/0
(involves: 129P2/OlaHsd)
|
myositis
|
J:199157
|
Fat1tm1.2Fhel/Fat1tm1.2Fhel Tg(Myl1-lacZ)1Ibdml/0
(involves: 129S6/SvEvTac * BALB/cJ * C57BL/6J * SJL)
|
myositis
|
J:199157
|
Fbln5tm1Eno/Fbln5tm1Eno
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:96831
|
Fbn1Tsk Bloc1s6+/Fbn1+ Bloc1s6pa
(B6.Cg-Fbn1Tsk +/+ Bloc1s6pa/J)
|
abnormal vasodilation
|
J:81020
|
Fbn2fp/Fbn2fp
(C3Fe(B6)-Fbn2fp/J)
|
muscle weakness
|
J:157998
|
Fbn2fp/Fbn2mz
(involves: BALB/cAnNCrl * C3H/HeH * C3HeB/FeHu * C57BL/6J)
|
muscle weakness
|
J:157998
|
Fbn2mz/Fbn2mz
(involves: BALB/cAnNCrl * C3H/HeH)
|
abnormal muscle electrophysiology
|
J:157998
|
muscle weakness
|
J:157998
|
Fbxo10tm1b(KOMP)Wtsi/Fbxo10tm1b(KOMP)Wtsi
(C57BL/6N-Fbxo10tm1b(KOMP)Wtsi/Nju)
|
decreased cardiac muscle contractility
|
J:211773
|
Fbxw5em1Syli/Fbxw5em1Syli
(C57BL/6-Fbxw5em1Syli)
|
decreased cardiac muscle contractility
|
J:298305
|
Fdpstm1Jiy/Fdpstm1Jiy Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:317808
|
Fendrrtm1Bgh/Fendrrtm2Bgh
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:191565
|
Fgf2tm1Doe/Fgf2tm1Doe
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:119652
|
decreased cardiac muscle contractility
|
J:119652
|
decreased vasoconstriction
|
J:45775
|
increased cardiomyocyte apoptosis
|
J:119652
|
Fgf2tm1Zllr/Fgf2tm1Zllr Fgf6tm1Thbr/Fgf6tm1Thbr
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal myoblast migration
|
J:85088
|
Fgf2tm2Doe/Fgf2tm2Doe
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:119652
|
decreased cardiac muscle contractility
|
J:119652
|
increased cardiomyocyte apoptosis
|
J:119652
|
Fgf6tm1Thbr/Fgf6tm1Thbr
(either: (involves: 129S4/SvJae-Fgf6tm1Thbr) or (involves: 129S4/SvJae * C57BL/6))
|
impaired skeletal muscle regeneration
|
J:42574
|
Fgf9tm1Dor/Fgf9tm1Dor
(involves: C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:95803
|
Fgf16tm1Nit/Y
(C57BL/6-Fgf16tm1Nit)
|
abnormal fetal cardiomyocyte proliferation
|
J:139637
|
Fgfr1tm1Upir/Fgfr1tm1.1Upir
(involves: C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:95803
|
Fgfr2tm1Ewj/Fgfr2+ Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal vasodilation
|
J:101174
|
Fhl1tm1.1Mihi/Y
(involves: 129S/SvEv * C57BL/6J * C57BL/6NJ)
|
myopathy
|
J:218097
|
Fhod3tm1Hsum/Fhod3tm1Hsum
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased heart ventricle muscle contractility
|
J:187358
|
Fig4plt1/Fig4plt1
(involves: 129P2/OlaHsd * C3H * C57BL/6 * CAST/Ei * SJL)
|
muscle weakness
|
J:122737
|
Fkbp1atm1Slh/Fkbp1atm1Slh Tg(Ckmm-cre)5Khn/0
(involves: 129S7/SvEvBrd * FVB)
|
abnormal muscle contractility
|
J:176731
|
abnormal muscle physiology
|
J:176731
|
Fkbp1atm1Zuk/Fkbp1atm1Slh Tg(Ckmm-cre)5Khn/0
(involves: 129S7/SvEvBrd * FVB)
|
abnormal muscle contractility
|
J:94747
|
abnormal muscle physiology
|
J:94747
|
Fkbp1atm1Zuk/Fkbp1atm1Zuk
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))
|
abnormal muscle physiology
|
J:45536
|
decreased heart ventricle muscle contractility
|
J:45536
|
dilated cardiomyopathy
|
J:45536
|
Fkrptm1.1Pg/Fkrptm1.1Pg
(involves: 129P2/OlaHsd)
|
myopathy
|
J:285924
|
Fkrptm1Itl/Fkrptm1Itl
(involves: 129S6/SvEvTac * C57BL/6N)
|
muscle weakness
|
J:164448
|
Fkrptm1Scbr/Fkrptm1Scbr Sox1tm1(cre)Take/Sox1+
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
myositis
|
J:207119
|
Fkrptm1Scbr/Fkrptm1Scbr Sox1tm1(cre)Take/Sox1+ Tg(CAG-LARGE)126Fmu/0
(involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)
|
abnormal muscle physiology
|
J:207119
|
myositis
|
J:207119
|
Fktntm3.1Ttd/Fktntm3.1Ttd Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal muscle precursor cell physiology
|
J:198535
|
impaired skeletal muscle regeneration
|
J:198535
|
Fmodtm1Aol/Fmodtm1Aol
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased tendon stiffness
|
J:79115
|
Fmodtm1Aol/Fmodtm1Aol Lumtm1Chak/Lum+
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased tendon stiffness
|
J:83544
|
Fmodtm1Aol/Fmodtm1Aol Lumtm1Chak/Lumtm1Chak
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased tendon stiffness
|
J:83544
|
muscle weakness
|
J:79115
|
Fnip1em1(IMPC)Ccpcz/Fnip1em1(IMPC)Ccpcz
(C57BL/6NCrl-Fnip1em1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
Fnip1LPAB.1/Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1)
|
cardiomyopathy
|
J:187318
|
Fnip1tm1.1Baba/Fnip1tm1.1Baba Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
abnormal muscle physiology
|
J:220672
|
Foxe3tm1Mjam/Foxe3tm1Mjam
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:232427
|
Foxf1tm2Rhc/Foxf1+ Tg(Myh11-cre,-EGFP)2Mik/0
(involves: C57BL/6 * DBA/2)
|
impaired contractility of intestinal smooth muscle
|
J:203847
|
Foxj3Gt(XL913)Byg/Foxj3Gt(XL913)Byg
(either: 129P2/OlaHsd-Foxj3Gt(XL913)Byg or B6.129P2-Foxj3 |
abnormal muscle physiology
|
J:157260
|
abnormal skeletal muscle satellite cell proliferation
|
J:157260
|
impaired skeletal muscle contractility
|
J:157260
|
impaired skeletal muscle regeneration
|
J:157260
|
Foxk1tm1Djg/Foxk1tm1Djg
(involves: 129S4/SvJae)
|
impaired skeletal muscle regeneration
|
J:62225
|
Foxm1tm1.1Rhc/Foxm1tm1.1Rhc
(B6.129X1-Foxm1tm1.1Rhc)
|
decreased fetal cardiomyocyte proliferation
|
J:119481
|
Foxp1tm2.1Eem/Foxp1tm2.1Eem Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129 * C57BL/6 * SJL)
|
increased fetal cardiomyocyte proliferation
|
J:163662
|
Foxp1tm2.1Eem/Foxp1tm2.1Eem Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:163662
|
fsq/fsq
(KK(Cg)-fsq/J)
|
muscle hypertonia
|
J:137888
|
Fsttm1Zuk/Fst+
(B6.129S7-Fsttm1Zuk)
|
abnormal muscle physiology
|
J:182827
|
Fstl1tm1.1Mvdh/Fstl1tm1.1Mvdh Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:177416
|
Fxnem2Lutzy/Fxnem2.1Lutzy Tg(Ckmm-cre)5Khn/?
(B6.Cg-Fxnem2Lutzy Fxnem2.1Lutzy Tg(Ckmm-cre)5Khn/J)
|
cardiomyopathy
|
J:101977
|
decreased cardiac muscle contractility
|
J:101977
|
Fxntm2Mkn/Fxntm2.1Mkn Tg(Ckmm-cre)1Lrsn/0
(involves: 129 * C57BL/6J)
|
decreased heart ventricle muscle contractility
|
J:90401
|
dilated cardiomyopathy
|
J:75420,
J:90401
|
Fxntm2Mkn/Fxntm2.1Mkn Tg(Eno2-cre)39Jme/0
(involves: 129 * C57BL/6J)
|
dilated cardiomyopathy
|
J:75420
|
Fxyd1tm1Atck/Fxyd1tm1Atck
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased cardiac muscle contractility
|
J:97365
|
Fzd8em1(IMPC)Bay/Fzd8em1(IMPC)Bay
(C57BL/6N-Fzd8em1(IMPC)Bay/Bay)
|
increased cardiac muscle contractility
|
J:211773
|
Gaatm1.1Rabn/Gaatm1.1Rabn
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
myopathy
|
J:76435
|
progressive muscle weakness
|
J:76435
|
Gaatm1Rabn/Gaatm1Rabn
(involves: 129X1/SvJ * C57BL/6)
|
cardiomyopathy
|
J:76435,
J:48839
|
muscle weakness
|
J:48839
|
myopathy
|
J:76435
|
progressive muscle weakness
|
J:76435,
J:48839
|
Gaatm1Vdp/Gaatm1Vdp
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB))
|
cardiomyopathy
|
J:45386
|
Gaatm1Vdp/Gaatm1Vdp
(B6.129P2-Gaatm1Vdp)
|
abnormal muscle physiology
|
J:105167
|
progressive muscle weakness
|
J:105167
|
Gaatm2Rabn/Gaatm2Rabn
(involves: 129X1/SvJ * C57BL/6)
|
cardiomyopathy
|
J:76435
|
myopathy
|
J:76435
|
progressive muscle weakness
|
J:76435
|
Gab1tm1Nmoc/Gab1tm1Nmoc Gab2tm1Thir/Gab2tm1Thir Tg(Myh6-cre)2182Mds/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:124033
|
decreased cardiac muscle contractility
|
J:124033
|
Gab1tm1Wbm/Gab1tm1Wbm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle precursor cell migration
|
J:68751
|
Gab1tm1Wbm/Gab1tm1Wbm
(involves: 129P2/OlaHsd)
|
abnormal muscle precursor cell migration
|
J:100909
|
Gabra1tm1.1Geh/Gabra1+
(B6.129(Cg)-Gabra1tm1.1Geh)
|
myoclonus
|
J:227437
|
Gabra1tm1.1Mjga/Gabra1+
(B6J.Cg-Gabra1tm1.1Mjga)
|
myoclonus
|
J:227437
|
Gabrg2tm1.2Rmac/Gabrg2+
(involves: C57BL/6 * C57BL/6J * SJL)
|
myoclonus
|
J:306976
|
Gad2tm1Oba/Gad2tm1Oba
(involves: C57BL/6 * CBA)
|
myoclonus
|
J:62320
|
Galctwi/Galctwi
(B6.CE-Galctwi/J)
|
muscle twitch
|
J:170081
|
Galctwi/Galctwi
(involves: C57BL/6J * CE/J)
|
progressive muscle weakness
|
J:6390
|
Galnt1tm1.1Jxm/Galnt1tm1.1Jxm
(B6NHsd.Cg-Galnt1tm1.1Jxm)
|
decreased heart left ventricle muscle contractility
|
J:242253
|
Gantm1Yany/Gantm1Yany
(Not Specified)
|
muscle spasm
|
J:108239
|
progressive muscle weakness
|
J:108239
|
Gars1C201R/Gars1+
(involves: BALB/cAnN * C3H/HeH * C57BL/6J)
|
muscle weakness
|
J:149830
|
Gas2l3tm1c(EUCOMM)Hmgu/Gas2l3tm1c(EUCOMM)Hmgu Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
abnormal fetal cardiomyocyte proliferation
|
J:244087
|
Gas2l3tm1c(EUCOMM)Hmgu/Gas2l3tm1c(EUCOMM)Hmgu Nkx2-5tm2(cre)Rph/Nkx2-5+
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6N)
|
dilated cardiomyopathy
|
J:244087
|
Gas2l3tm1d(EUCOMM)Hmgu/Gas2l3tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N)
|
abnormal fetal cardiomyocyte proliferation
|
J:244087
|
decreased cardiac muscle contractility
|
J:244087
|
dilated cardiomyopathy
|
J:244087
|
Gas7tm1Slch/Gas7tm1Slch
(B6.129-Gas7tm1Slch)
|
progressive muscle weakness
|
J:227375
|
Gata4tm1.1Sad/Gata4tm1.1Sad Gata6tm2.1Sad/Gata6tm2.1Sad Tg(Wt1-cre)1Jbeb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased fetal cardiomyocyte proliferation
|
J:206877
|
Gata4tm1.1Sad/Gata4tm1.1Sad Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased cardiomyocyte apoptosis
|
J:121367
|
Gata4tm1.1Sad/Gata4tm1.1Sad Tg(Myh6-cre)1Jmk/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased cardiac muscle contractility
|
J:121367
|
Gata4tm1.1Sad/Gata4tm1.1Sad Tg(Myh7-cre)1Jmk/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased cardiac muscle contractility
|
J:121367
|
increased cardiomyocyte apoptosis
|
J:121367
|
Gata4tm1.1Sad/Gata4tm1.2Sad Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J)
|
abnormal muscle precursor cell physiology
|
J:231793
|
Gata4tm1.1Wtp/Gata4tm1.1Wtp Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S7/SvEvBrd)
|
abnormal fetal cardiomyocyte proliferation
|
J:99203
|
Gata4tm1.1Wtp/Gata4tm1.1Wtp Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
abnormal fetal cardiomyocyte proliferation
|
J:99203
|
Gata4tm1Eno/Gata4+ Gata6tm1Eno/Gata6+
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:111824
|
Gata4tm1Grg/Gata4+
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:185124
|
Gata4tm1Grg/Gata4tm1Grg
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:185124
|
Gata4tm1Jml/Gata4+ Gata5tm1Eem/Gata5tm1Eem
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:155855
|
Gata4tm1Wtp/Gata4tm1Wtp
(involves: 129 * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:94637
|
Gata5tm1.2Nemr/Gata5tm1.2Nemr
(involves: 129 * C57BL/6)
|
increased heart ventricle muscle contractility
|
J:175663
|
Gata5tm1.2Nemr/Gata5tm1.2Nemr
(Not Specified)
|
abnormal vasodilation
|
J:227997
|
Gatmtm1.1Isb/Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb)
|
hypotonia
|
J:191142
|
increased muscle cell glucose uptake
|
J:191142
|
Gbe1m1Yty/Gbe1m1Yty
(C3HeB/FeJ-Gbe1m1Yty)
|
abnormal fetal cardiomyocyte proliferation
|
J:167233
|
Gbe1tm1.1Hoa/Gbe1tm1.1Hoa
(involves: 129S7/SvEvBrd)
|
abnormal muscle physiology
|
J:176889
|
Gdnftm1Lmgd/Gdnf+
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * CD-1))
|
intestinal hypoperistalsis
|
J:73922
|
Gdnftm1Lmgd/Gdnftm1Lmgd
(either: (involves: 129S4/SvJae) or (involves: 129S1/Sv * 129X1/SvJ))
|
intestinal hypoperistalsis
|
J:33810
|
Gdnftm1Rosl/Gdnf+
(involves: 129S2/SvPas * C57BL/6)
|
intestinal hypoperistalsis
|
J:82456
|
Gdnftm1Rosl/Gdnf+ Nrtntm1Jmi/Nrtntm1Jmi
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
intestinal hypoperistalsis
|
J:82456
|
Gena26/Gena26+
(involves: BALB/c * C3H/HeH)
|
abnormal muscle tone
|
J:169366
|
Gena323/Gena323+
(involves: BALB/c * C3H/HeH)
|
abnormal muscle tone
|
J:169366
|
Gfaptm1Pkny/Gfaptm1Pkny Vimtm1Cba/Vimtm1Cba
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased vasodilation
|
J:124385
|
Gfpt1tm1c(EUCOMM)Wtsi/Gfpt1tm1c(EUCOMM)Wtsi Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * C57BL/6N * SJL/J)
|
abnormal muscle electrophysiology
|
J:265013
|
impaired skeletal muscle contractility
|
J:265013
|
increased muscle fatigability
|
J:265013
|
muscle weakness
|
J:265013
|
myopathy
|
J:265013
|
Gfra1tm1Jmi/Gfra1+
(involves: 129X1/SvJ * C57BL/6)
|
intestinal hypoperistalsis
|
J:82456
|
Gfra2tm1Msa/Gfra2tm1Msa
(either: B6.129-Gfra2tm1Msa or 129S2.129-Gfra2tm1Msa)
|
intestinal hypoperistalsis
|
J:93911
|
Gipc1Gt(OST93079)Lex/Gipc1Gt(OST93079)Lex
(B6.129S-Gipc1Gt(OST93079)Lex)
|
decreased heart ventricle muscle contractility
|
J:122652
|
Gja1M1Jrt/Gja1+
(involves: C3H/HeJ * C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:101733
|
decreased heart left ventricle muscle contractility
|
J:101733
|
decreased heart right ventricle muscle contractility
|
J:101733
|
Gja1tm1Kdr/Gja1tm1Kdr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:212895
|
Gja1tm1Kwi/Gja1tm1Kwi
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal muscle regeneration
|
J:94694
|
Gja1tm3.1Clo/Gja1tm3.1Clo
(B6.Cg-Gja1tm1.1Clo)
|
abnormal vascular smooth muscle cell proliferation
|
J:212895
|
Gja1tm5Gfi/Gja1tm5Gfi
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal cardiac muscle contractility
|
J:185692
|
Gja1tm6.1(Gjb3)Kwi/Gja1tm6.1(Gjb3)Kwi
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased cardiac muscle contractility
|
J:106509
|
Gja4tm1Paul/Gja4tm1Paul Gja5tm1Paul/Gja5tm1Paul
(involves: 129S4/SvJae * C57BL/6)
|
increased vasodilation
|
J:80178
|
Gja5tm1Paul/Gja5tm1Paul
(involves: 129S4/SvJae * C57BL/6)
|
dilated cardiomyopathy
|
J:109301
|
Gjc1tm1.1(Gjd2)Kwi/Gjc1tm1.1(Gjd2)Kwi Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
decreased cardiac muscle contractility
|
J:182927
|
Gjc1tm1.1Kni/Gjc1tm1.1Kni
(involves: 129S/SvEv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:63214
|
Gjc1tm1.2(Gjd2)Kwi/Gjc1tm1.2(Gjd2)Kwi
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:182927
|
Gjc1tm1Kni/Gjc1tm1Kni
(involves: 129S/SvEv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:63214
|
Gjd4tm1.1Malt/Gjd4tm1.1Malt
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
enhanced skeletal muscle regeneration
|
J:172698
|
Glatm1Kul/Y
(involves: 129S4/SvJae * C57BL/6)
|
cardiomyopathy
|
J:187258
|
Glra1m1Cpai/Glra1m1Cpai
(involves: 129 * C57BL/6)
|
muscle spasm
|
J:248717
|
Glra1spd-ot/Glra1spd-ot
(involves: C57BL/6J)
|
muscle spasm
|
J:107942
|
Glra1spd/Glra1spd
(B6C3Fe a/a-Glra1spd/J)
|
muscle hypertonia
|
J:20373
|
Glra1tm1Betz/Glra1tm1Betz
(B6.129P2-Glra1tm1Betz)
|
muscle hypertonia
|
J:117236
|
Glrbspa-Alb/Glrbspa-Alb
(C57BL/6Fla-H2-T18a)
|
muscle hypertonia
|
J:64454
|
Glrbspa/Glrbspa
(Not Specified)
|
muscle spasm
|
J:13079,
J:5196
|
Glrbspa/Glrbspa
(involves: C3HeB/FeLe * C57BL/6 * C57BL/6J * DBA/2)
|
muscle hypertonia
|
J:60037
|
Glrbspa/Glrbspa Tg(Eno2-Glrb)456Wha/0
(involves: C3HeB/FeLe * C57BL/6 * C57BL/6J * DBA/2)
|
muscle hypertonia
|
J:60037
|
Glrx3Gt(RRF094)Byg/Glrx3+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:143577
|
decreased cardiac muscle contractility
|
J:143577
|
Gmppatm1d(EUCOMM)Wtsi/Gmppatm1d(EUCOMM)Wtsi
(involves: C57BL/6N)
|
increased skeletal muscle cell apoptosis
|
J:305791
|
myopathy
|
J:305791
|
progressive muscle weakness
|
J:305791
|
Gna11tm1Soff/Gna11tm1Soff Gnaqtm2Soff/Gnaqtm2Soff X/Tg(Myh11-icre/ERT2)1Soff
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
decreased vasoconstriction
|
J:141641
|
Gna11tm1Soff/Gna11tm1Soff Gnaqtm2Soff/Gnaqtm2Soff Tg(Tek-icre/ERT2)1Soff/0
(B6N.Cg-Gna11tm1Soff Gnaqtm2Soff Tg(Tek-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:224523
|
Gna12tm1Citb/Gna12tm1Citb Gna13tm2.1Soff/Gna13tm2.1Soff X/Tg(Myh11-icre/ERT2)1Soff
(involves: 129S1/Sv * FVB/N)
|
decreased vasoconstriction
|
J:141641
|
Gnastm1Lsw/Gnas+
(involves: 129S4/SvJae * CD-1)
|
increased muscle cell glucose uptake
|
J:106729
|
Gnb5flr/Gnb5flr Myo5aflr/Myo5aflr
(involves: C57BL/6J * C57BL/10J * CBA/Ca)
|
opisthotonus
|
J:61324
|
Gnetm1Sngi/Gnetm1Sngi Tg(ACTB-GNE*D176V)9Sngi/0
(involves: C57BL/6)
|
abnormal muscle physiology
|
J:117854
|
muscle weakness
|
J:117854
|
Gng5tm1.1Rbs/Gng5tm1.1Rbs
(B6J.Cg-Gng5tm1.1Rbs)
|
decreased fetal cardiomyocyte proliferation
|
J:215128
|
Gnptabnym/Gnptabnym
(involves: BALB/cAnNHsd * C3H/HeNHsd)
|
progressive muscle weakness
|
J:218156
|
Gpcpd1tm1c(EUCOMM)Hmgu/Gpcpd1tm1c(EUCOMM)Hmgu Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * C57BL/6N * FVB)
|
increased cardiac muscle cell glucose uptake
|
J:345630
|
increased muscle cell glucose uptake
|
J:345630
|
Gpm6btm1KanPlp1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
muscle hypertonia
|
J:193310
|
muscle spasm
|
J:193310
|
Gpsm1tm1.1Lajb/Gpsm1tm1.1Lajb
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
increased vasodilation
|
J:138126
|
Grem2tm1Akh/Grem2tm1Akh
(involves: 129/Sv * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:250034
|
Grid2ho-8J/Grid2ho-8J
(B10.D2/nSnJ)
|
muscle spasm
|
J:155927
|
Grid2ho-16J/Grid2ho-16J
(C57BL/6J-Grid2ho-16J/J)
|
muscle spasm
|
J:87349
|
Grk2tm1Mca/Grk2tm1Mca
(involves: 129)
|
decreased heart left ventricle muscle contractility
|
J:36567
|
Grk5tm1Rjl/Grk5tm1Rjl
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal muscle contractility
|
J:96208
|
Grm1crv4/Grm1crv4
(BALB/cPas-Grm1crv4)
|
muscle spasm
|
J:112290
|
Grpel1tm1c(EUCOMM)Wtsi/Grpel1tm1c(EUCOMM)Wtsi Tg(ACTA1-cre/ERT2)97.16Mtz/0
(involves: C57BL/6N)
|
abnormal muscle physiology
|
J:330869
|
Gt(ROSA)26Sorem1(CAG-Zfas1)Cya/Gt(ROSA)26Sor+ Tg(Myh6-cre)#Cya/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:294533
|
increased cardiomyocyte apoptosis
|
J:294533
|
Gt(ROSA)26Sortm1(CAG-GCaMP5)Ryba/Gt(ROSA)26Sor+ Hnrnputm1.1Tman/Hnrnputm1.1Tman Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJaeSor * FVB)
|
decreased cardiac muscle contractility
|
J:223139
|
Gt(ROSA)26Sortm1(CAG-Nr2f2)Tsa/Gt(ROSA)26Sor+ A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased cardiac muscle contractility
|
J:227012
|
dilated cardiomyopathy
|
J:227012
|
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+ Kittm1(cre/ERT2)Dsa/Kit+
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6)
|
abnormal intestinal peristalsis
|
J:204737
|
Gt(ROSA)26Sortm1(DUX4)Sqh/Gt(ROSA)26Sor+ Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
muscle weakness
|
J:268959
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sortm1(EYFP)Cos Pax7tm1(cre/ERT2)Gaka/Pax7tm1(cre/ERT2)Gaka Paxbp1tm1.1Nju/Paxbp1tm1.1Nju
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCr)
|
impaired skeletal muscle regeneration
|
J:304562
|
Gt(ROSA)26Sortm1(H1/tetO-RNAi:Fxn)Dhg/Gt(ROSA)26Sor+
(B6.129-Gt(ROSA)26Sortm1(H1/tetO-RNAi:Fxn)Dhg)
|
cardiomyopathy
|
J:254962
|
Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas/Gt(ROSA)26Sor+ Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
muscle weakness
|
J:162008
|
Gt(ROSA)26Sortm1.1(CAG-Mirc20)Eem/Gt(ROSA)26Sor+ A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129 * C57BL/6 * FVB/N)
|
decreased cardiomyocyte apoptosis
|
J:233994
|
Gt(ROSA)26Sortm1.1(CAG-Mirc20)Eem/Gt(ROSA)26Sor+ Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cardiac muscle contractility
|
J:233994
|
increased cardiomyocyte apoptosis
|
J:233994
|
increased fetal cardiomyocyte proliferation
|
J:233994
|
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sor+ Tg(ACTA1-cre/Esr1*)2Kesr/0
(involves: C3H * C57BL/6)
|
myopathy
|
J:256652
|
Gt(ROSA)26Sortm1Lrsn/Gt(ROSA)26Sor+ Slc6a3tm1(cre)Lrsn/Slc6a3+ Tfamtm1Lrsn/Tfamtm1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle hypertonia
|
J:176022
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+ Pax7tm1.1Fan/Pax7tm2.1(cre/ERT2)Fan
(involves: 129 * C57BL/6 * SJL)
|
abnormal muscle regeneration
|
J:150962
|
Gt(ROSA)26Sortm2(ATF4)Myz/Gt(ROSA)26Sortm2(ATF4)Myz Tg(Myh11-icre/ERT2)1Soff/?
(either: D2.Cg-Atf4tm1.1Cmad Tg(Myh11-icre/ERT2)1Soff or B6.Cg-Atf4tm1.1Cmad Tg(Myh11-icre/ERT2)1Soff)
|
increased cardiomyocyte apoptosis
|
J:237331
|
Gt(ROSA)26Sortm2(SS18)Mrc/Gt(ROSA)26Sortm2(SS18)Mrc Myf6tm1(cre)Mrc/Myf6tm1(cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myopathy
|
J:120967
|
Gt(ROSA)26Sortm3(CAG-EYFP)Hze/Gt(ROSA)26Sor+ Hiratm1c(EUCOMM)Wtsi/Hiratm1d(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds/0
(B6.Cg-Gt(ROSA)26Sortm3(CAG-EYFP)Hze Hiratm1c(EUCOMM)Wtsi/Hiratm1d(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds)
|
abnormal cardiac muscle contractility
|
J:231593
|
Gt(ROSA)26Sortm3(SS18/EGFP)Mrc/Gt(ROSA)26Sortm3(SS18/EGFP)Mrc Myf6tm1(cre)Mrc/Myf6tm1(cre)Mrc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myopathy
|
J:120967
|
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+ Kdm6atm1.1Kaig/Y Pax7tm2.1(cre/ERT2)Fan/Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:232700
|
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/Gt(ROSA)26Sor+ Myf5tm1(cre)Mrc/Myf5+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
myopathy
|
J:194308
|
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/Gt(ROSA)26Sor+ Pax7tm1(cre/ERT2)Gaka/Pax7+
(involves: 129S6/SvEvTac * C57BL/6)
|
myopathy
|
J:194308
|
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/Gt(ROSA)26Sor+ Tg(Prrx1-cre/ERT2)1Mlgn/?
(involves: C57BL/6)
|
myopathy
|
J:194308
|
Gt(ROSA)26Sortm4(HIF2A*)Kael/Gt(ROSA)26Sor+ Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:179490
|
dilated cardiomyopathy
|
J:179490
|
Gt(ROSA)26Sortm37(H1/tetO-RNAi:Tafazzin)Arte/?
(Not Specified)
|
decreased heart left ventricle muscle contractility
|
J:176041
|
impaired skeletal muscle contractility
|
J:176041
|
Gt(ROSA)26Sortm37(H1/tetO-RNAi:Tafazzin)Arte/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased cardiac muscle contractility
|
J:167527
|
Gt(ROSA)26Sortm407(H1/tetO-RNAi:Large)Arte/Gt(ROSA)26Sor+
(B6.Cg-Gt(ROSA)26Sortm407(H1/tetO-RNAi:Large)Arte)
|
enhanced skeletal muscle regeneration
|
J:206057
|
Gucy1a1tm1.1Dko/Gucy1a1tm1.1Dko
(involves: C57BL/6)
|
abnormal vasodilation
|
J:110362
|
Gucy1b1tm1.1Frb/Gucy1b1tm1.1Frb
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal vasodilation
|
J:121321
|
intestinal hypoperistalsis
|
J:121321
|
Gucy1b1tm1.2Frb/Gucy1b1tm1.2Frb X/Tg(Myh11-icre/ERT2)1Soff
(B6.Cg-Gucy1b1tm1.2Frb Tg(Myh11-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:186053
|
Gyg1tm1a(KOMP)Wtsi/Gyg1tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal muscle electrophysiology
|
J:244440
|
Gys1Gt(OST33395)Lex/Gys1Gt(OST33395)Lex
(involves: 129S5/SvEvBrd * 129X1/SvJ * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:92245
|
Gys1tm1.1Arte/Gys1tm1.1Arte
(involves: C57BL/6J)
|
abnormal muscle cell glucose uptake
|
J:167911
|
Gys2tm1.1Pro/Gys2tm1.1Pro Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)
|
decreased cardiac muscle cell glucose uptake
|
J:162043
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)
|
decreased heart ventricle muscle contractility
|
J:86540
|
dilated cardiomyopathy
|
J:86540
|
myositis
|
J:86540
|
Hadhbm1Ytc/Hadhbm1Ytc
(C57BL/6J-Hadhbm1Yuan)
|
cardiomyopathy
|
J:117738
|
Hand1tm1(tTA)Prri/Hand1+ Tg(tetO-Hand1)1Prri/0
(involves: 129/Sv * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:116090
|
Hand2tm1Cse/Hand2+ H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * C57BL/6J * CBA/J)
|
abnormal fetal cardiomyocyte proliferation
|
J:155265
|
Hand2tm1Dsr/Hand2tm1Dsr
(involves: 129S7/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:40768
|
Hbegftm1.1Mek/Hbegftm1.1Mek
(involves: C57BL/6 * C57BL/6J * CBA)
|
decreased heart ventricle muscle contractility
|
J:82728
|
Hbegftm1Dcl/Hbegftm1Dcl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased heart ventricle muscle contractility
|
J:83820
|
Hbegftm2Mek/Hbegftm2Mek
(involves: 129/Sv * C57BL/6 * CBA)
|
decreased cardiac muscle contractility
|
J:86547
|
decreased heart left ventricle muscle contractility
|
J:86547
|
dilated cardiomyopathy
|
J:86547
|
Hccstm1Tcc/Y Nkx2-5tm2(cre)Rph/Nkx2-5+
(involves: 129S1/Sv)
|
decreased fetal cardiomyocyte proliferation
|
J:143285
|
Hccstm1Tcc/Hccs+ Nkx2-5tm2(cre)Rph/Nkx2-5+
(involves: 129S1/Sv)
|
dilated cardiomyopathy
|
J:143285
|
Hccstm1Tcc/Hccs+ Nkx2-5tm2(cre)Rph/Nkx2-5+ Tg(CAG-EGFP)D4Nagy/0 Tg(Hmgcr-lacZ)H253Sest/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal fetal cardiomyocyte proliferation
|
J:143285
|
Hcn4tm1Rsei/Hcn4tm1Rsei
(B6.Cg-Hcn4tm1Rsei)
|
decreased cardiac muscle contractility
|
J:131820
|
Hcrttm1Ywa/Hcrttm1Ywa
(involves: 129S6/SvEvTac)
|
abnormal muscle tone
|
J:170824
|
Hcrtr2tm1Tesc/Hcrtr2tm1Tesc
(B6.Cg-Hcrtr2tm1Tesc)
|
abnormal muscle tone
|
J:170824
|
Hdac1tm1.1Eno/Hdac1tm1.1Eno Hdac2tm1.1Eno/Hdac2tm1.1Eno Tg(Myh6-cre)2182Mds/?
(involves: 129S/SvEv * C57BL/6 * CD-1 * FVB/N)
|
increased cardiomyocyte apoptosis
|
J:123173
|
Hdac2Gt(W035F03)Joe/Hdac2Gt(W035F03)Joe
(Not Specified)
|
increased fetal cardiomyocyte proliferation
|
J:121697
|
Hdac2tm1.2Eno/Hdac2tm1.2Eno
(involves: 129S/SvEv * C57BL/6 * CD-1)
|
abnormal fetal cardiomyocyte proliferation
|
J:123173
|
increased cardiomyocyte apoptosis
|
J:123173
|
Hdac3tm1.1Eno/Hdac3tm1.1Eno Tg(Myh6-cre)2182Mds/?
(involves: 129S/SvEv * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:144604
|
Hdnrem1Bbr/Hdnrem1Bbr
(C57BL/6J-Hdnrem1Bbr)
|
increased cardiac muscle contractility
|
J:284183
|
Hectd3tm1(NCOM)Cmhd/Hectd3tm1(NCOM)Cmhd
(C57BL/6N-Hectd3tm1(NCOM)Cmhd/Nju)
|
increased cardiac muscle contractility
|
J:211773
|
Hexbtm1Grv/Hexbtm1Grv
(either: (involves: 129P2/Ola * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * C57L/6J))
|
muscle weakness
|
J:30899
|
Hexbtm1Rlp/Hexbtm1Rlp Tg(Hexb-tTA2S,tetO-Hexb)#Tjsa/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
muscle hypertonia
|
J:190450
|
Hexbtm1Rlp/Hexbtm1Rlp Tg(SYN1-tTA2S,tetO-Hexb)#Tjsa/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
muscle hypertonia
|
J:190450
|
Hexim1Gt(XB322)Byg/Hexim1Gt(XB322)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
dilated cardiomyopathy
|
J:141643
|
Hexim1tm1Maqs/Hexim1tm1Maqs
(involves: 129S/SvEv * Black Swiss)
|
increased fetal cardiomyocyte apoptosis
|
J:92209
|
Hey1tm1Kkb/Hey1tm1Kkb Heyltm1Kkb/Heyltm1Kkb
(B6.Cg-Hey1tm1Kkb Heyltm1Kkb)
|
abnormal skeletal muscle satellite cell proliferation
|
J:178310
|
impaired skeletal muscle regeneration
|
J:178310
|
Hey2tm1Eno/Hey2tm2Eno Tg(Nkx2-5-cre)9Eno/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:121577
|
Hey2tm1Eno/Hey2tm2Eno Tg(Tagln-cre)1Her/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:121577
|
Hey2tm1Kkb/Hey2tm1Kkb
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:97120,
J:216895
|
Hey2tm1Mtc/Hey2tm1Mtc
(involves: 129X1/SvJ * C57BL/6)
|
cardiomyopathy
|
J:80681
|
decreased cardiac muscle contractility
|
J:80681
|
Hey2tm2.1Mtc/Hey2tm2.1Mtc Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N * SJL)
|
decreased cardiac muscle contractility
|
J:186570
|
Hgstn/Hgstn
(B6.C3-Hgstn)
|
opisthotonus
|
J:5025
|
Hhipl1tm1a(KOMP)Wtsi/Hhipl1tm1a(KOMP)Wtsi
(B6J.B6N-Hhipl1tm1a(KOMP)Wtsi)
|
abnormal vascular smooth muscle physiology
|
J:280707
|
decreased vascular smooth muscle cell proliferation
|
J:280707
|
Hif1atm3Rsjo/Hif1atm3Rsjo Hprt1tm1(Pck1-cre)Vhh/Y Vhltm1Jae/Vhltm1Jae
(involves: 129 * BALB/c * C57BL/6)
|
abnormal vasodilation
|
J:97652
|
Hif1atm3Rsjo/Hif1atm3Rsjo Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:118455
|
decreased cardiac muscle contractility
|
J:118455
|
Hif1atm3Rsjo/Hif1atm3Rsjo Tg(Ckmm-cre)5Khn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal muscle physiology
|
J:97761
|
Hif1atm3Rsjo/Hif1atm3Rsjo Vhltm1Jae/Vhltm1Jae Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * BALB/c * C57BL/6 * DBA)
|
abnormal vasodilation
|
J:97652
|
Hilpdaem1(IMPC)Mhzh/Hilpdaem1(IMPC)Mhzh
(C57BL/6N-Hilpdaem1(IMPC)Mhzh/Mhzh)
|
decreased cardiac muscle contractility
|
J:211773
|
Hipk2tm1Ejh/Hipk2tm1Ejh
(involves: 129X1/SvJ * C57BL/6)
|
dystonia
|
J:117465
|
Hmox1tm1Mlee/Hmox1tm1Mlee
(involves: 129S2/SvPas * BALB/c)
|
increased cardiomyocyte apoptosis
|
J:54684
|
Hmox1tm1Mlee/Hmox1tm1Mlee
(B6.129S2-Hmox1tm1Mlee)
|
abnormal vascular smooth muscle physiology
|
J:106600
|
increased vascular smooth muscle cell proliferation
|
J:106600
|
Hmox1tm1Ysh/Hmox1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:95461
|
Hmox2tm1Poss/Hmox2tm1Poss
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:89581
|
abnormal muscle relaxation
|
J:89581
|
Hmox2tm1Poss/Hmox2tm1Poss Nos1tm1Plh/Nos1tm1Plh
(involves: 129S2/SvPas * 129S4/SvJae)
|
abnormal muscle physiology
|
J:89581
|
abnormal muscle relaxation
|
J:89581
|
Hmx3/Hmx2tm3Tlu/Hmx3/Hmx2tm3Tlu
(either: (involves: 129) or (involves: 129 * C57BL/6J))
|
muscle spasm
|
J:92940
|
Hmx3/Hmx2tm3Tlu/Hmx3/Hmx2tm3Tlu
(either: (involves: 129) or (involves: 129 * C57BL/6J))
|
muscle spasm
|
J:92940
|
Hnrnpa1tm1.1Cyf/Hnrnpa1tm1.1Cyf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl)
|
dilated cardiomyopathy
|
J:238260
|
Hnrnputm1.1Tman/Hnrnputm1.1Tman Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJaeSor * FVB)
|
decreased cardiac muscle relaxation
|
J:223139
|
decreased heart ventricle muscle contractility
|
J:223139
|
dilated cardiomyopathy
|
J:223139
|
increased cardiomyocyte apoptosis
|
J:223139
|
Hnrnputm1.1Tman/Hnrnputm1.1Tman Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJaeSor * FVB/N)
|
dilated cardiomyopathy
|
J:223139
|
Hopxtm1Eno/Hopxtm1Eno
(involves: 129S6/SvEvTac)
|
abnormal fetal cardiomyocyte proliferation
|
J:79152
|
abnormal muscle physiology
|
J:79152
|
decreased cardiac muscle contractility
|
J:79152
|
Hottiptm1Vlcg/Hottiptm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
muscle weakness
|
J:233815
|
Hoxa1tm1Ipc/Hoxa1tm1Ipc
(involves: 129S2/SvPas * C57BL/6)
|
muscle spasm
|
J:23837
|
Hoxc8tm1Phb/Hoxc8tm1Phb
(either: (involves: 129) or (involves: 129S2/SvPas * C57BL/6 * DBA/2))
|
muscle spasm
|
J:590
|
Hprt1tm1(Pck1-cre)Vhh/Y Vhltm1Jae/Vhltm1Jae
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal vasodilation
|
J:97652
|
Hprt1tm1Dhm/Y
(involves: 129P2/OlaHsd)
|
abnormal cardiac muscle relaxation
|
J:106044
|
decreased cardiac muscle contractility
|
J:106044
|
decreased heart ventricle muscle contractility
|
J:91410
|
Hprt1tm1Dhm/Y Plntm1Egk/Plntm1Egk
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal cardiac muscle relaxation
|
J:106044
|
increased cardiac muscle contractility
|
J:106044
|
Hprt1tm1Dhm/Hprt1tm1Dhm
(involves: 129P2/OlaHsd)
|
abnormal cardiac muscle relaxation
|
J:106044
|
decreased cardiac muscle contractility
|
J:106044
|
decreased heart ventricle muscle contractility
|
J:91410
|
Hprt1tm1Dhm/Hprt1tm1Dhm Plntm1Egk/Plntm1Egk
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal cardiac muscle relaxation
|
J:106044
|
increased cardiac muscle contractility
|
J:106044
|
Hprt1tm4(CAG-Tbx18*,-Venus)Akis/Y Tbx18tm4(cre)Akis/Tbx18+
(involves: 129S1/SvImJ * NMRI)
|
decreased fetal cardiomyocyte proliferation
|
J:210076
|
Hprt1tm4(Tek-IGF1R)Geno/Y
(B6.129P2-Hprt1tm4(Tek-IGF1R)Geno)
|
increased vasoconstriction
|
J:208523
|
Hrctm1.1Desa/Hrctm1.1Desa
(Not Specified)
|
decreased cardiac muscle contractility
|
J:243733
|
decreased cardiac muscle relaxation
|
J:243733
|
Hrtfm2DBA/2J/Hrtfm2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
dilated cardiomyopathy
|
J:100634
|
Hrtfm4AKR/J/Hrtfm4AKR/J Tg(Myh6-CASQ2)1Mord/0
(involves: AKR/J * DBA/2J)
|
dilated cardiomyopathy
|
J:86767
|
Hrtfm5AKR/J/? Tg(Myh6-CASQ2)1Mord/0
(involves: AKR/J * DBA/2J)
|
dilated cardiomyopathy
|
J:86767
|
Hrtfm6AKR/J/? Tg(Myh6-CASQ2)1Mord/0
(involves: AKR/J * DBA/2J)
|
dilated cardiomyopathy
|
J:86767
|
Hrtfm7AKR/J/Hrtfm7DBA/2J
(involves: C57BL/6J * DBA/2J)
|
dilated cardiomyopathy
|
J:100634
|
Hsd11b2tm1Yko/Hsd11b2tm1Yko
(involves: 129P2/OlaHsd * MF1)
|
abnormal fetal cardiomyocyte proliferation
|
J:53391
|
Hspb7tm1.1Yty/Hspb7tm1.1Yty Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6J * SJL)
|
myopathy
|
J:246267
|
Hspb7tm1.2Chen/Hspb7tm1.2Chen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased fetal cardiomyocyte proliferation
|
J:256653
|
Hspb8tm1.1Depr/Hspb8tm1.1Depr
(B.129-Hspb8tm1.1Depr)
|
decreased heart ventricle muscle contractility
|
J:186292
|
Hspb8tm1Vti/Hspb8tm1Vti
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
myopathy
|
J:284796
|
Hspd1tm1c(EUCOMM)Hmgu/Hspd1tm1c(EUCOMM)Hmgu A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: Black Swiss * C57BL/6 * C57BL/6N * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:283049
|
dilated cardiomyopathy
|
J:283049
|
Hspg2tm1.1Soni/Hspg2tm1.1Soni
(involves: 129S/SvEv * C57BL/6)
|
abnormal muscle electrophysiology
|
J:139975
|
Htr1btm1Rhn/Htr1btm1Rhn Slc6a4tm1Kpl/Slc6a4tm1Kpl
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:121505
|
dilated cardiomyopathy
|
J:121505
|
Htr2btm1Lum/Htr2btm1Lum
(129S2/SvPas-Htr2btm1Lum)
|
abnormal fetal cardiomyocyte proliferation
|
J:64067
|
Htr2ctm1.1Eme/Y
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
hypotonia
|
J:163043
|
Htra2mnd2/Htra2mnd2
(B6.Cg-Htra2mnd2)
|
dystonia
|
J:76481
|
muscle spasm
|
J:76481
|
Htra2tm1.1Hohj/Htra2tm1.1Hohj Tg(Nes-cre)1Kln/0
(involves: C57BL/6J)
|
muscle weakness
|
J:225666
|
Htra2tm1.2Hohj/Htra2tm1.2Hohj
(involves: C57BL/6 * C57BL/6J)
|
muscle weakness
|
J:225666
|
Hydinhy3/Hydinhy3
(involves: CBA)
|
muscle spasm
|
J:13103
|
Icam1tm1Jcgr/Icam1tm1Jcgr
(B6.129S4-Icam1tm1Jcgr/J)
|
abnormal cardiac muscle contractility
|
J:114093
|
Ido1tm1.1Mkks/Ido1tm1.1Mkks
(B6.Cg-Ido1tm1.1Mkks)
|
abnormal vasodilation
|
J:229059
|
Iduatm1Efn/Iduatm1Efn
(involves: C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:101932
|
decreased heart ventricle muscle contractility
|
J:101932
|
Ier3tm1Mxw/Ier3tm1Mxw
(involves: 129 * C57BL/6)
|
decreased vasodilation
|
J:157504
|
Ier3tm1Raku/Ier3tm1Raku
(involves: 129S6/SvEvTac)
|
decreased heart left ventricle muscle contractility
|
J:131099
|
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J)
|
impaired skeletal muscle regeneration
|
J:136628
|
Ifrd1tm1Lah/Ifrd1tm1Lah
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle regeneration
|
J:89917
|
Igf1tm2Ts/Igf1tm2Ts
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased heart left ventricle muscle contractility
|
J:37969
|
Igf1rtm1.1Mhz/Igf1r+ Insrtm1Khn/Insrtm1Khn Tg(Ckmm-cre)5Khn/0
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * FVB)
|
decreased heart left ventricle muscle contractility
|
J:118987
|
Igf1rtm1.1Mhz/Igf1rtm1.1Mhz Insrtm1Khn/Insrtm1Khn Tg(Ckmm-cre)5Khn/0
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * FVB)
|
decreased heart left ventricle muscle contractility
|
J:118987
|
dilated cardiomyopathy
|
J:118987
|
Igf2tm1Rob/Igf2+
(involves: 129S/SvEv * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:77413
|
Igh-Jtm1Aigl/Igh-J+ Mogtm1Dpd/Mogtm1Dpd Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
muscle hypertonia
|
J:151335
|
Igh-Jtm1Aigl/Igh-J+ Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
muscle hypertonia
|
J:151335
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J
(B6.BKS-Ighmbp2nmd-2J/J)
|
dilated cardiomyopathy
|
J:90418
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J MnmC/MnmC
(involves: C57BL/6J * C57BLKS/J * CAST/Ei * DBA/J)
|
dilated cardiomyopathy
|
J:90418
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J Tg(Eno2-Ighmbp2)17Cx/?
(involves: C57BL/6J * C57BLKS/J)
|
dilated cardiomyopathy
|
J:90418
|
Ighmbp2nmd-2J/Ighmbp2nmd-2J Tg(Eno2-Ighmbp2)90Cx/?
(involves: C57BL/6J * C57BLKS/J)
|
dilated cardiomyopathy
|
J:90418
|
Igs2em53(Myh6-cre/ERT2)Gpt/Igs2+ Stx17em1Gpt/Stx17em1Gpt
(involves: C57BL/6JGpt)
|
abnormal cardiac muscle contractility
|
J:345305
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myoblast migration
|
J:131016
|
abnormal skeletal muscle satellite cell proliferation
|
J:131016
|
decreased cardiac muscle contractility
|
J:150895
|
Il10tm1Cgn/Il10tm1Cgn
(B6.129P2-Il10tm1Cgn/J)
|
decreased vasoconstriction
|
J:59742
|
increased vasoconstriction
|
J:146372
|
Il10tm1Cgn/Il10tm1Cgn
(129S.Cg-Il10tm1Cgn)
|
decreased vasoconstriction
|
J:59742
|
Il18tm1Aki/Il18tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:118183
|
Ilktm1Star/Ilktm1Star Tg(Ckmm-cre)1Lrsn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased cardiac muscle contractility
|
J:112174
|
dilated cardiomyopathy
|
J:112174
|
Inpp4atm1Tsak/Inpp4atm1Tsak
(involves: 129P2/OlaHsd * C57BL/6)
|
dystonia
|
J:161963
|
Inpp5fGt(XL571)Byg/Inpp5fGt(XL571)Byg
(involves: 129P2/OlaHsd)
|
increased cardiomyocyte apoptosis
|
J:170072
|
Inpp5ktm1Brd/Inpp5k+
(B6.Cg-Inpp5ktm1Brd)
|
increased skeletal muscle cell glucose uptake
|
J:139745
|
Ins2Akita/?
(involves: C57BL/6NSlc)
|
abnormal cardiac muscle contractility
|
J:130021
|
decreased skeletal muscle cell glucose uptake
|
J:130021
|
Insrtm1Khn/Insrtm1Khn Tg(Myhca-cre)1Abel/0
(involves: 129S4/SvJae * FVB)
|
abnormal cardiac muscle cell glucose uptake
|
J:75348
|
decreased cardiac muscle cell glucose uptake
|
J:75348
|
decreased heart left ventricle muscle contractility
|
J:75348
|
increased cardiac muscle cell glucose uptake
|
J:75348
|
Irag1tm1Jens/Irag1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired smooth muscle contractility
|
J:94387
|
Irag1tm1Jens/Irag1tm1Jens
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired smooth muscle contractility
|
J:94387
|
Irag1tm2.1Jens/Irag1tm2.1Jens
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:175887
|
impaired muscle relaxation
|
J:175887
|
Irag1tm2.1Jens/Irag1tm2.1Jens Taglntm2(PRKG1*)Hfm/Taglntm2(PRKG1*)Hfm
(involves: 129S1/Sv * 129X1/SvJ)
|
impaired muscle relaxation
|
J:175887
|
Irs1tm1Tka/Irs1tm1Tka
(involves: C57BL/6 * CBA)
|
decreased vasodilation
|
J:99746
|
Irs2tm1Tka/Irs2tm1Tka
(involves: C57BL/6 * CBA)
|
decreased vasodilation
|
J:99746
|
Irx4tm1Jse/Irx4tm1Jse
(involves: 129X1/SvJ * Black Swiss)
|
cardiomyopathy
|
J:67359
|
decreased heart ventricle muscle contractility
|
J:67359
|
dilated cardiomyopathy
|
J:67359
|
Itga7tm1Burk/Itga7tm1Burk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
myopathy
|
J:100236
|
Itga7tm1Burk/Itga7tm1Burk
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle physiology
|
J:187752
|
myopathy
|
J:187752
|
Itga7tm1Burk/Itga7tm1Burk Sspntm1Kcam/Sspntm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle physiology
|
J:187752
|
enhanced skeletal muscle regeneration
|
J:187752
|
myopathy
|
J:187752
|
Itgavtm2Hyn/Itgavtm2.1Hyn Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB * SJL)
|
muscle hypertonia
|
J:94376
|
Itgb1tm1Lscd/Itgb1tm1Ref Tg(PLAT-cre)116Sdu/0
(Not Specified)
|
progressive muscle weakness
|
J:92060
|
Itgb1tm1Ross/Itgb1tm1Ross Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)
|
abnormal cardiac muscle cell glucose uptake
|
J:82534
|
abnormal cardiac muscle relaxation
|
J:82534
|
decreased heart left ventricle muscle contractility
|
J:82534
|
dilated cardiomyopathy
|
J:82534
|
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:119666
|
decreased cardiac muscle contractility
|
J:119666
|
myositis
|
J:119666
|
Itpr1opt/Itpr1opt
(involves: C57BLKS)
|
opisthotonus
|
J:13536
|
Itpr3tf/Itpr3tf Prkralear-5J/Prkralear-5J
(BTBR-Prkralear-5J Itpr3tf/GrsrJ)
|
dystonia
|
J:223062
|
Ivns1abptm1Htno/Ivns1abptm1Htno
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:162743
|
increased cardiomyocyte apoptosis
|
J:162743
|
Izumo2em1(IMPC)Bay/Izumo2em1(IMPC)Bay
(C57BL/6N-Izumo2em1(IMPC)Bay/BayMmucd)
|
increased cardiac muscle contractility
|
J:211773
|
Jarid2Gt(ROSA)1Gel/Jarid2Gt(ROSA)1Gel
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:100923
|
Jph1tm1Hta/Jph1tm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
impaired skeletal muscle contractility
|
J:77652
|
Jsrp1tm1Zor/Jsrp1tm1Zor
(involves: 129S4/SvJae * C57BL/6)
|
abnormal muscle physiology
|
J:128603
|
muscle weakness
|
J:128603
|
Jundtm1Mya/Jundtm1Mya Tg(H2-K-Fosl1)1Wag/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
dilated cardiomyopathy
|
J:95691
|
Juptm1.1Glr/Juptm1.1Glr A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
decreased heart left ventricle muscle contractility
|
J:170618
|
Juptm1.1Shou/Juptm1.1Shou Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6J)
|
cardiomyopathy
|
J:177567
|
decreased cardiac muscle contractility
|
J:177567
|
increased cardiomyocyte apoptosis
|
J:177567
|
Juptm1Ruiz/Jup+ Tg(Myh6-Jup*)1Ajm/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:192719
|
Juptm1Ruiz/Juptm1Ruiz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:64280
|
Kansl1em1.1Cya/Kansl1+
(B6(FVB)-Kansl1em1.1Cya)
|
decreased cardiac muscle contractility
|
J:327464
|
Kbtbd13em1Coeo/Kbtbd13em1Coeo
(involves: C57BL/6J)
|
impaired muscle relaxation
|
J:295442
|
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd)
|
myoclonus
|
J:164091
|
Kcna3tm1Gvd/Kcna3tm1Gvd
(involves: 129S1/Sv * C57BL/6)
|
increased skeletal muscle cell glucose uptake
|
J:88651
|
Kcna5tm1(Kcna1)Lndn/Kcna5tm1(Kcna1)Lndn
(involves: C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:70694
|
decreased vasoconstriction
|
J:70694
|
Kcnc1tm1Joho/Kcnc1tm1Joho Kcnc3tm1Echa/Kcnc3tm1Echa
(involves: 129/Sv * C57BL/6)
|
myoclonus
|
J:71179
|
Kcnc2tm1Rudy/Kcnc2tm1Rudy
(B6.129S1-Kcnc2tm1Rudy)
|
myoclonus
|
J:66730
|
Kcne4tm1Gwab/Kcne4tm1Gwab
(B6.129-Kcne4tm1Gwab)
|
increased cardiac muscle relaxation
|
J:227222
|
Kcng2em1(IMPC)Bay/Kcng2em1(IMPC)Bay
(C57BL/6N-Kcng2em1(IMPC)Bay/Bay)
|
decreased cardiac muscle contractility
|
J:211773
|
Kcnh2tm1.1Hjd/Kcnh2tm1.1Hjd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle electrophysiology
|
J:155273
|
Kcnj2tm1Swz/Kcnj2tm1Swz
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
abnormal vasodilation
|
J:78077
|
Kcnj6wv/Kcnj6wv
(involves: C57BL/6 * CBA/CaGnLe)
|
hypotonia
|
J:18348
|
Kcnj8em1Nich/Kcnj8+
(involves: C57BL/6J * CBA/J)
|
abnormal vascular smooth muscle physiology
|
J:281903
|
increased vasodilation
|
J:281903
|
Kcnj8tm1Sse/Kcnj8tm1Sse
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:202037
|
Kcnj11tm1Sse/Kcnj11tm1Sse
(involves: 129P2/OlaHsd)
|
abnormal muscle relaxation
|
J:105244
|
impaired skeletal muscle contractility
|
J:105244,
J:140833
|
increased muscle fatigability
|
J:140833
|
myoclonus
|
J:69832
|
Kcnk6tm1Tigm/Kcnk6tm1Tigm
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:194443
|
abnormal vasoconstriction
|
J:194443
|
Kcnma1tm1Ruth/Kcnma1tm1Ruth
(involves: 129/Sv * C57BL/6)
|
abnormal muscle contractility
|
J:148424
|
increased muscle relaxation
|
J:148424
|
Kcnma1tm1Ruth/Kcnma1tm2.1Ruth X/Tg(Myh11-icre/ERT2)1Soff
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal muscle contractility
|
J:148424
|
Kcnmb1tm1Ltor/Kcnmb1tm1Ltor
(Not Specified)
|
increased vasoconstriction
|
J:195657
|
Kcnmb1tm1Pong/Kcnmb1tm1Pong
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:82471
|
increased vasoconstriction
|
J:82471
|
Kcnmb1tm1Rwa/Kcnmb1tm1Rwa
(involves: 129X1/SvJ * C57BL/6)
|
abnormal muscle contractility
|
J:106302
|
abnormal vasoconstriction
|
J:65415
|
Kcnn4tm1Rklr/Kcnn4tm1Rklr
(involves: 129S/SvEv * C57BL/6)
|
decreased vasodilation
|
J:124858
|
Kcnq1m1Anu/?
(involves: BALB/c * C57BL/6 * DBA/2)
|
opisthotonus
|
J:196547
|
Kcnv1vibe/Kcnv1vibe
(C57BL/6JSfdAnu-Kcnv1vibe/Anu)
|
muscle spasm
|
J:104190
|
Kdm3atm1.1Yzha/Kdm3atm1.1Yzha
(B6.129P2-Kdm3atm1.1Yzha)
|
abnormal muscle physiology
|
J:147295
|
Kdm4atm1Zpl/Kdm4atm1Zpl Tg(Myh6-cre)1Jmk/0
(involves: 129S6/SvEv * C57BL/6)
|
increased cardiac muscle contractility
|
J:173908
|
Kdm6atm1.1Kaig/Y Pax7tm2.1(cre/ERT2)Fan/Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:232700
|
Kdm6atm1.1Kaig/Kdm6atm1.1Kaig Pax7tm2.1(cre/ERT2)Fan/Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:232700
|
Kdm6atm2.1Kaig/Y
(involves: 129 * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:232700
|
Kdm6atm2.1Kaig/Kdm6atm2.1Kaig
(involves: 129 * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:232700
|
Kif1btm1Noh/Kif1b+
(involves: 129S4/SvJae * C57BL/6J)
|
progressive muscle weakness
|
J:69772
|
Kif26atm1.1Noh/Kif26atm1.1Noh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
abnormal intestinal peristalsis
|
J:154859
|
Kittm1(cre/ERT2)Dsa/Kit+ Prkg1tm2Naw/Prkg1tm2Naw
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
abnormal intestinal peristalsis
|
J:204737
|
KitW/KitW-v
(involves: C57BL)
|
abnormal muscle physiology
|
J:70182
|
Klf3m1Cmhd/Klf3+
(involves: C3H/HeJ * C57BL/6J)
|
increased cardiac muscle contractility
|
J:206507
|
Klf5tm1Rng/Klf5+
(involves: 129/Sv * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:78275
|
Klf15tm1Jain/Klf15tm1Jain
(B6.129X1-Klf15tm1Jain)
|
cardiomyopathy
|
J:167880
|
decreased heart left ventricle muscle contractility
|
J:121109
|
Klhl29tm1b(EUCOMM)Hmgu/Klhl29tm1b(EUCOMM)Hmgu
(C57BL/6N-Klhl29tm1b(EUCOMM)Hmgu/Ics)
|
increased cardiac muscle contractility
|
J:211773
|
Klhl31em1Eno/Klhl31em1Eno
(involves: C57BL/6)
|
myopathy
|
J:247651
|
Klhl40tm1(KOMP)Vlcg/Klhl40tm1(KOMP)Vlcg
(C57BL/6-Klhl40tm1(KOMP)Vlcg)
|
abnormal muscle physiology
|
J:213780
|
impaired skeletal muscle contractility
|
J:213780
|
muscle weakness
|
J:213780
|
myopathy
|
J:213780
|
Klhl40tm1.1Itl/Klhl40tm1.1Itl
(involves: 129S6/SvEvTac * C57BL/6N)
|
increased skeletal muscle cell apoptosis
|
J:227534
|
Klhl41tm1a(KOMP)Wtsi/Klhl41tm1a(KOMP)Wtsi
(C57BL/6-Klhl41tm1a(KOMP)Wtsi)
|
myopathy
|
J:255305
|
Klk1tm1Pmtn/Klk1tm1Pmtn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:67868
|
decreased vasodilation
|
J:67868
|
Klk1tm1Pmtn/Klk1tm1Pmtn
(involves: 129/Sv * C57BL/6)
|
decreased vasodilation
|
J:103928
|
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig Tg(Tnnt2-cre)5Blh/0
(B6.Cg-Kmt2dtm1.1Kaig Tg(Tnnt2-cre)5Blh)
|
decreased fetal cardiomyocyte proliferation
|
J:229890
|
Krastm1(Hras)Rdl/Krastm1(Hras)Rdl
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased heart left ventricle muscle contractility
|
J:98940
|
dilated cardiomyopathy
|
J:98940
|
Krastm1Mok/Krastm1Mok
(involves: 129S/SvEv * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:42943
|
Krastm4.1Bbd/Krastm4.1Bbd
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J * FVB/N)
|
increased cardiac muscle contractility
|
J:223433
|
Krit1tm1Kwhi/Krit1tm1.1Kwhi Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA)
|
telangiectasia
|
J:215458
|
Kyky/Kyky
(Not Specified)
|
impaired skeletal muscle contractility
|
J:22972
|
Lama2dy-2J/Lama2dy-2J
(B6.WK-Lama2dy-2J/J)
|
enhanced skeletal muscle regeneration
|
J:134367
|
Lama2dy-2J/Lama2dy-2J
(involves: WK/ReJ)
|
opisthotonus
|
J:5151
|
Lama2dy-6J/Lama2dy-6J
(involves: C57BL/6JEi * DBA/2J)
|
progressive muscle weakness
|
J:56803
|
Lama2dy-7J/Lama2dy-7J
(C57BL/6J-Lama2dy-7J/J)
|
enhanced skeletal muscle regeneration
|
J:134367
|
muscle spasm
|
J:82238
|
myopathy
|
J:134367,
J:82238
|
Lama2dy-8J/Lama2dy-8J
(C57BL/6J-Lama2dy-8J/GrsrJ)
|
myopathy
|
J:149729
|
Lama2dy/Lama2dy
(involves: 129P1/Re * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:134367
|
myopathy
|
J:134367
|
Lama2dy/Lama2dy
(involves: 129P1/Re)
|
progressive muscle weakness
|
J:13125
|
Lama2dy/Lama2dy
(B6.129P1-Lama2dy/J)
|
muscle weakness
|
J:101670
|
Lama2dy/Lama2dy
(involves: 129P1/ReJ)
|
abnormal muscle physiology
|
J:102959
|
muscle weakness
|
J:102959
|
Lama2tm1Eeng/Lama2tm1Eeng
(involves: 129S1/Sv * Black Swiss)
|
impaired skeletal muscle regeneration
|
J:59089
|
Lama2tm1Eeng/Lama2tm1Eeng
(involves: 129S1/Sv)
|
muscle weakness
|
J:170192
|
myositis
|
J:170192
|
Lama2tm1Stk/Lama2tm1Stk
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * ICR)
|
muscle spasm
|
J:43145
|
myopathy
|
J:43145
|
Lama4tm1Ktry/Lama4tm1Ktry
(B6.129X1-Lama4tm1Ktry)
|
cardiomyopathy
|
J:105789
|
decreased heart ventricle muscle contractility
|
J:105789
|
Lamb1Lt/Lamb1+
(B6N.Cg-Lamb1Lt)
|
dystonia
|
J:247484
|
Lamp2tm1.2Ces/Y
(involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL)
|
cardiomyopathy
|
J:328713
|
decreased cardiac muscle contractility
|
J:328713
|
Lamp2tm1Psa/Lamp2tm1Psa
(either: (involves: 129P2/OlaHsd * 129/Sv * C57BL/6J) or (involves: 129P2/OlaHsd * 129/Sv))
|
decreased cardiac muscle contractility
|
J:64151
|
Large1myd-3J/Large1myd-3J
(STOCK Large1myd-3J/GrsrJ)
|
myopathy
|
J:160357
|
Large1myd/Large1myd
(MYD/Le-Os +/+ Largemyd/J)
|
abnormal muscle physiology
|
J:5670
|
myopathy
|
J:5670
|
myositis
|
J:5670
|
Large1myd/Large1myd
(B6.Cg-Large1myd/Pjn)
|
dilated cardiomyopathy
|
J:100214
|
Large1myd/Large1myd
(B6C3Fe a/a-Large1myd/J)
|
myositis
|
J:27793
|
Large1vls/Large1vls
(B6.CAST(Cg)-Large1vls/Pjn)
|
dilated cardiomyopathy
|
J:100214
|
Lbx1tm1.1Khan/Lbx1tm1.1Khan Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor * C57BL/6JJcl * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal muscle precursor cell migration
|
J:178868
|
Lbx1tm1Gld/Lbx1tm1Gld
(involves: 129S1/Sv * C57BL/6)
|
abnormal muscle precursor cell migration
|
J:56498
|
Lbx1tm1Thbr/Lbx1tm1Thbr
(involves: 129S4/SvJae)
|
abnormal muscle precursor cell migration
|
J:57891
|
Ldb3tm1Chen/Ldb3tm1Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
muscle weakness
|
J:72799
|
myopathy
|
J:72799
|
Ldb3tm2Chen/Ldb3tm2Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
myopathy
|
J:82141
|
Ldb3tm3Chen/Ldb3tm3Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
myopathy
|
J:82141
|
Ldb3tm4Chen/Ldb3tm4Chen A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * FVB/N)
|
dilated cardiomyopathy
|
J:144739
|
Ldb3tm4Chen/Ldb3tm4Chen Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)
|
dilated cardiomyopathy
|
J:144739
|
Ldb3tm6.2Chen/Ldb3tm6.2Chen
(involves: 129/Sv * Black Swiss * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:170494
|
dilated cardiomyopathy
|
J:170494
|
Ldlrtm1Her/Ldlrtm1Her Lrp1tm2Her/Lrp1tm2Her Tg(Tagln-cre)1Her/0
(involves: 129S7/SvEvBrd * C57BL/6J * SJL)
|
increased vascular smooth muscle cell proliferation
|
J:82871
|
Lemd2em1Eno/Lemd2em1Eno
(involves: C3H * C57BL/6 * C57BL/6N)
|
decreased cardiac muscle contractility
|
J:331716
|
dilated cardiomyopathy
|
J:331716
|
Lemd2em2Eno/Lemd2em2Eno Tg(Myh6-cre)2182Mds/0
(involves: C3H * C57BL/6 * C57BL/6N * FVB/N)
|
dilated cardiomyopathy
|
J:331716
|
Lemd2Gt(DD0639)Wtsi/Lemd2+
(B6.129P2-Lemd2Gt(DD0639)Wtsi)
|
delayed skeletal muscle regeneration
|
J:221495
|
Lepob/Lepob
(involves: C57BL/6J)
|
abnormal muscle contractility
|
J:106205
|
Lepob/Lepob
(B6.Cg-Lepob/J)
|
decreased cardiac muscle contractility
|
J:111488,
J:104171
|
Leprdb/Leprdb
(involves: C57BLKS/J)
|
decreased cardiac muscle contractility
|
J:106871
|
increased vasoconstriction
|
J:106597
|
Leprotl1tm1b(EUCOMM)Hmgu/Leprotl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Leprotl1tm1b(EUCOMM)Hmgu/H)
|
increased cardiac muscle contractility
|
J:211773
|
Lgals1tm1Rob/Lgals1tm1Rob Myf5tm2Pas/Myf5+
(involves: 129S/SvEv * 129S2/SvPas)
|
delayed skeletal muscle regeneration
|
J:119480
|
Lig3tm1.1Pmc/Lig3tm1.1Pmc Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
decreased cardiac muscle contractility
|
J:170077
|
Limch1em1Coop/Limch1em1Coop
(FVB-Limch1em1Coop)
|
impaired muscle relaxation
|
J:336773
|
impaired skeletal muscle contractility
|
J:336773
|
muscle weakness
|
J:336773
|
Lims1tm1.1Chen/Lims1tm1.1Chen Tg(Tnnt2-cre)5Blh/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:167114
|
Lims2tm1.1Chen/Lims2tm1.1Chen
(involves: 129S4/SvJae)
|
decreased cardiac muscle contractility
|
J:167114
|
Lipetm1Land/Lipetm1Land
(involves: 129 * C57BL/6J)
|
decreased skeletal muscle cell glucose uptake
|
J:85540
|
Lmbrd1tm1.1Ntum/Lmbrd1+
(B6.Cg-Lmbrd1tm1.1Ntum)
|
abnormal cardiac muscle cell glucose uptake
|
J:204994
|
increased cardiac muscle cell glucose uptake
|
J:204994
|
LmnaGt(S7-1F1)Sor/LmnaGt(S7-1F1)Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
muscle weakness
|
J:221850
|
Lmnatm1.1Bliu/Lmna+
(involves: C57BL/6 * FVB/N)
|
abnormal vasodilation
|
J:287256
|
Lmnatm1.1Bliu/Lmnatm1.1Bliu
(involves: C57BL/6 * FVB/N)
|
abnormal vasodilation
|
J:287256
|
Lmnatm1.1Otin/Lmna+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:211388
|
Lmnatm1.1Vde/Lmnatm1.1Vde
(B6.129(Cg)-Lmnatm1.1Vde)
|
abnormal muscle tone
|
J:322912
|
Lmnatm1Bliu/Lmnatm1Bliu Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal vasodilation
|
J:287256
|
decreased heart left ventricle muscle contractility
|
J:287256
|
dilated cardiomyopathy
|
J:287256
|
Lmnatm1Gbon/Lmnatm1Gbon
(involves: 129S2/SvPas * C57BL/6)
|
decreased cardiac muscle contractility
|
J:187399
|
decreased heart left ventricle muscle contractility
|
J:95528
|
dilated cardiomyopathy
|
J:187399
|
progressive muscle weakness
|
J:95528
|
Lmnatm1Stw/Lmna+ Mliptm1.1(cre)Dzw/Mliptm1.1(cre)Dzw
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:227485
|
dilated cardiomyopathy
|
J:227485
|
Lmnatm1Stw/Lmnatm1Stw
(involves: 129S1/Sv * C57BL/6)
|
muscle weakness
|
J:95274
|
Lmnatm1Stw/Lmnatm1Stw Mliptm1.1(cre)Dzw/Mliptm1.1(cre)Dzw
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:227485
|
Lmnatm1Stw/Lmnatm1Stw Zmpste24tm1Sgy/Zmpste24+
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
muscle weakness
|
J:95274
|
Lmnatm1Stw/Lmnatm1Stw Zmpste24tm1Sgy/Zmpste24tm1Sgy
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
muscle weakness
|
J:95274
|
Lmnatm2.1Gbon/Lmna+
(involves: 129 * C57BL/6)
|
decreased cardiac muscle contractility
|
J:198526
|
dilated cardiomyopathy
|
J:198526
|
Lmnatm3Stw/Lmnatm3Stw
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL)
|
decreased heart left ventricle muscle contractility
|
J:100393
|
dilated cardiomyopathy
|
J:100393
|
Lmnatm5Lgf/Lmnatm5Lgf
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:160705
|
dilated cardiomyopathy
|
J:160705
|
Lmnatm8Lgf/Lmnatm8Lgf
(involves: 129P2/OlaHsd)
|
decreased heart ventricle muscle contractility
|
J:167229
|
Lmnatm10Lgf/Lmnatm10Lgf Zmpste24tm1Sgy/Zmpste24tm1Sgy
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
esophageal achalasia
|
J:220988
|
Lmnatm11Lgf/Lmna+
(involves: 129P2/OlaHsd * C57BL/6)
|
esophageal achalasia
|
J:220988
|
Lmod2tm1(KOMP)Vlcg/Lmod2tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
decreased cardiac muscle contractility
|
J:227272
|
dilated cardiomyopathy
|
J:227272
|
Lmod2Tn(pb-Act-RFP)1.1Zhu/Lmod2Tn(pb-Act-RFP)1.1Zhu
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:233669
|
dilated cardiomyopathy
|
J:233669
|
Lmod3em1Eno/Lmod3em1Eno
(involves: C3H * C57BL/6)
|
decreased cardiac muscle contractility
|
J:222174
|
Lmod3Tn(pb-Act-RFP)1.1Zhu/Lmod3Tn(pb-Act-RFP)1.1Zhu
(involves: C57BL/6J)
|
muscle weakness
|
J:223382
|
Lncpinttm1Vlcg/Lncpinttm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
progressive muscle weakness
|
J:233815
|
Lnhrttm1.1Koho/Lnhrttm1.1Koho
(involves: C57BL/6 * DBA/2)
|
decreased heart ventricle muscle contractility
|
J:293789
|
Lpltm1Bres/Lpl+ Tg(Myh6-LPL*)357Ijg/0
(involves: 129S4/SvJae)
|
cardiomyopathy
|
J:134550
|
decreased heart left ventricle muscle contractility
|
J:134550
|
Lpltm1Ijg/Lpltm1Ijg Tg(Myh6-cre)2182Mds/?
(involves: C57BL/6)
|
increased cardiac muscle cell glucose uptake
|
J:90737
|
Lpltm1Ijg/Lpltm1Ijg Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:110484
|
increased cardiac muscle cell glucose uptake
|
J:110484
|
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL)
|
dilated cardiomyopathy
|
J:307289
|
myositis
|
J:307289
|
Lrp1tm2Her/Lrp1tm2Her Tg(Fabp4-cre)1Rev/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased skeletal muscle cell glucose uptake
|
J:127398
|
Lrp1tm2Her/Lrp1tm2Her Tg(Tagln-cre)1Her/0
(B6.Cg-Lrp1tm2Her Tg(Tagln-cre)1Her)
|
abnormal vascular smooth muscle physiology
|
J:167799
|
decreased vasoconstriction
|
J:167799
|
Lrp1tm2Her/Lrp1tm2Her Tg(Tagln-cre)1Her/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:209752
|
dilated cardiomyopathy
|
J:209752
|
Lrrc10tm1Sgt/Lrrc10tm1Sgt
(B6.129P2-Lrrc10tm1Sgt)
|
decreased cardiac muscle contractility
|
J:195548
|
dilated cardiomyopathy
|
J:195548
|
Lrrc25em1Cya/Lrrc25em1Cya
(C57BL/6J-Lrrc25em1Cya/Cya)
|
decreased heart left ventricle muscle contractility
|
J:270157
|
Ltbp4dmod1-129T2/SvEmsJ/Ltbp4dmod1-129T2/SvEmsJ Sgcgtm1Mcn/Sgcgtm1Mcn
(129T2.Cg-Ltbp4dmod1-129T2/SvEmsJ Sgcgtm1Mcn)
|
abnormal muscle physiology
|
J:155107
|
Ltbp4dmod1-DBA/2J/Ltbp4dmod1-DBA/2J Sgcgtm1Mcn/Sgcgtm1Mcn
(D2.Cg-Ltbp4dmod1-DBA/2J Sgcgtm1Mcn)
|
abnormal muscle physiology
|
J:155107
|
Ltbp4Gt(U3Cre)1Vmel/Ltbp4Gt(U3Cre)1Vmel
(involves: 129S2/SvPas * C57BL/6)
|
cardiomyopathy
|
J:85162
|
Ltbp4Gt(U3Cre)1Vmel/Ltbp4Gt(U3Cre)1Vmel
(B6.129S2-Ltbp4Gt(U3Cre)1Vmel)
|
ventricular cardiomyopathy
|
J:78819
|
Ltn1lister/Ltn1lister
(C57BL/6-Ltn1lister)
|
abnormal muscle regeneration
|
J:146493
|
Ly6etm1Zmt/Ly6etm1Zmt
(involves: 129S1/Sv)
|
dilated cardiomyopathy
|
J:73972
|
Lztr1tm1a(EUCOMM)Wtsi/Lztr1+
(involves: C57BL/6N)
|
decreased cardiac muscle contractility
|
J:268690
|
Mafgtm1Jeng/Mafgtm1Jeng Mafktm1Jeng/Mafk+
(involves: 129S1/Sv * 129X1/SvJ)
|
myoclonus
|
J:81813
|
Mamstrtm1.1Eno/Mamstrtm1.1Eno Pax7tm2.1(cre/ERT2)Fan/Pax7+
(involves: 129 * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:179880
|
Mamstrtm1.2Eno/Mamstrtm1.2Eno
(involves: 129 * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:179880
|
Mamstrtm1.2Eno/Mamstrtm1.2Eno Mrtfatm1Eno/Mrtfatm1Eno
(involves: 129 * C57BL/6)
|
abnormal muscle physiology
|
J:179880
|
abnormal skeletal muscle satellite cell proliferation
|
J:179880
|
impaired skeletal muscle regeneration
|
J:179880
|
Map3k1tm1Glj/Map3k1tm1Glj
(involves: 129S/SvEv)
|
abnormal vascular smooth muscle physiology
|
J:108989
|
decreased heart ventricle muscle contractility
|
J:78068
|
increased cardiomyocyte apoptosis
|
J:78068
|
Mapk1tm1Melo/Mapk1+
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:127872
|
increased cardiomyocyte apoptosis
|
J:127872
|
Mapk1tm1Melo/Mapk1+
(involves: 129S2/SvPas)
|
decreased cardiac muscle contractility
|
J:124903
|
Mapk8tm1Flv/Mapk8tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiomyocyte apoptosis
|
J:102152
|
Mapk8tm1Flv/Mapk8tm1Flv
(involves: 129S1/Sv)
|
decreased cardiac muscle contractility
|
J:108253
|
increased cardiomyocyte apoptosis
|
J:108253
|
Mapk9tm1Mka/Mapk9tm1Mka
(involves: 129/Sv * C57BL/6)
|
decreased cardiomyocyte apoptosis
|
J:102152
|
Mapk11tm1Jsca/Mapk11tm1Jsca
(involves: 129P2/OlaHsd)
|
increased fetal cardiomyocyte proliferation
|
J:176023
|
Mapk11tm1Jsca/Mapk11tm1Jsca Mapk14tm2Nbr/Mapk14tm2Nbr Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal fetal cardiomyocyte proliferation
|
J:176023
|
Mapk14tm1.2Otsu/Mapk14tm1.2Otsu Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:95116
|
decreased heart left ventricle muscle contractility
|
J:95116
|
increased cardiomyocyte apoptosis
|
J:95116
|
Mapk14tm1Lex/Mapk14tm1Lex Myl7tm1(cre)Krc/Myl7+
(involves: 129S1/Sv * 129S5/SvEvBrd * 129X1/SvJ * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:98514
|
Mapk14tm1Nbr/Mapk14tm1Nbr
(either: (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1))
|
decreased cardiac muscle contractility
|
J:63877
|
Mapkapk2tm1Mgl/Mapkapk2tm1Mgl
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased cardiomyocyte apoptosis
|
J:101888
|
Mavstm1Itl/Mavstm1Itl Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6)
|
myositis
|
J:181257
|
Mbtm1Wlm/Mbtm1Wlm
(Not Specified)
|
increased muscle fatigability
|
J:72560
|
Mbtm1Wlm/Mbtm1Wlm
(B6.Cg-Mbtm1Wlm)
|
decreased heart ventricle muscle contractility
|
J:86546
|
Mbnl1tm1Sws/Mbnl1tm1Sws
(involves: 129S1/Sv * C57BL/6J)
|
abnormal muscle physiology
|
J:86903
|
Mbnl1tm1Sws/Mbnl1tm1Sws Mbnl2tm1.1Sws/Mbnl2+
(involves: 129S1/Sv * 129S1/SvImJ * C57BL)
|
impaired muscle relaxation
|
J:218011
|
progressive muscle weakness
|
J:218011
|
Mbnl2Gt(RRK149)Byg/Mbnl2Gt(RRK149)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
impaired muscle relaxation
|
J:130160
|
Mbnl3tm1.1Sws/Y
(involves: BALB/c * C57BL/6 * C57BL/6J)
|
impaired skeletal muscle regeneration
|
J:199127
|
Mbnl3tm1.1Sws/Mbnl3tm1.1Sws
(involves: BALB/c * C57BL/6 * C57BL/6J)
|
impaired skeletal muscle regeneration
|
J:199127
|
Mcattm1.1Ssmi/Mcattm1.1Ssmi Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
|
abnormal muscle physiology
|
J:192213
|
Mcm2tm1(cre/ERT2)Scpr/Mcm2tm1(cre/ERT2)Scpr
(involves: 129S6/SvEvTac)
|
muscle weakness
|
J:141493
|
Mcoln1tm1Sasl/Mcoln1tm1Sasl
(involves: 129S6/SvEvTac * C57BL/6)
|
dilated cardiomyopathy
|
J:135368
|
Mcutm1.1Jmol/Mcutm1.1Jmol A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
decreased cardiomyocyte apoptosis
|
J:224853
|
decreased heart ventricle muscle contractility
|
J:224853
|
Mdga2Tg(Prnp-PFN1*G118V)838Kiaei/Mdga2+
(involves: C57BL/6N)
|
progressive muscle weakness
|
J:241428
|
Mdm2tm1Glo/Mdm2tm2.1Glo Tg(Myh6-cre)2182Mds/0
(involves: 129S7/SvEvBrd * FVB/N)
|
increased cardiomyocyte apoptosis
|
J:104114
|
Mdm4tm2Glo/Mdm4tm2.1Glo Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J * FVB/N)
|
dilated cardiomyopathy
|
J:137114
|
increased cardiomyocyte apoptosis
|
J:137114
|
Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * CD-1)
|
increased muscle fatigability
|
J:268051
|
Mecp2tm1Nlnd/Y
(involves: 129 * CD-1)
|
increased muscle fatigability
|
J:268051
|
Med1tm2Jkr/Med1tm2Jkr A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129P2/OlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:243730
|
dilated cardiomyopathy
|
J:243730
|
increased cardiomyocyte apoptosis
|
J:243730
|
Med1tm2Jkr/Med1tm2Jkr Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:243730
|
dilated cardiomyopathy
|
J:243730
|
increased cardiomyocyte apoptosis
|
J:243730
|
Med30m1Btlr/Med30m1Btlr
(involves: C57BL/6J)
|
cardiomyopathy
|
J:180728
|
decreased cardiac muscle contractility
|
J:180728
|
Mef2ctm1Eno/Mef2ctm1Eno
(involves: 129S7/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:40724
|
decreased heart ventricle muscle contractility
|
J:40724
|
Mef2dtm3Eno/Mef2dtm3Eno Meox2tm1(cre)Sor/Meox2+
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:130825
|
Meox2tm1(cre)Sor/Meox2+ Ptrh2tm1Eruo/Ptrh2tm1.1Eruo
(B6.Cg-Ptrh2tm1Eruo Ptrh2tm1.1Eruo Meox2tm1(cre)Sor)
|
muscle weakness
|
J:220518
|
Mettm1Cbm/Mettm1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle precursor cell migration
|
J:28570
|
Mettm1Cbm/Mettm1Cbm
(involves: ICR)
|
abnormal muscle precursor cell migration
|
J:80685
|
Mettm1Kln/Mettm1Kln
(involves: 129/Sv * C57BL/6 * CD-1)
|
abnormal myoblast migration
|
J:94030
|
Mettm2Kln/Mettm2Kln
(involves: 129/Sv * C57BL/6 * CD-1)
|
abnormal myoblast migration
|
J:94030
|
Mettl21ctm1.1Krug/Mettl21ctm1.1Krug
(involves: 129 * C57BL/6)
|
abnormal muscle physiology
|
J:270838
|
muscle weakness
|
J:270838
|
Mfn2tm1.1Mzhe/Mfn2tm1.1Mzhe Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
decreased heart ventricle muscle contractility
|
J:188865
|
increased fetal cardiomyocyte apoptosis
|
J:188865
|
Mgrn1md-nc/Mgrn1md-nc
(involves: 101/H * C3H/HeH)
|
muscle weakness
|
J:81466
|
Mib1em1Jlp/Mib1tm2Kong Tg(Tnnt2-cre)5Blh/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:338889
|
Micu1em#Fink/Micu1em#Fink
(C57BL/6N-Micu1em#Fink)
|
abnormal muscle physiology
|
J:238984
|
Micu2Gt(OST409343)Lex/Micu2Gt(OST409343)Lex
(B6.129S5-Micu2Gt(OST409343)Lex)
|
decreased cardiac muscle contractility
|
J:249367
|
decreased cardiac muscle relaxation
|
J:249367
|
Mir1a-1tm1Dsr/Mir1a-1tm1Dsr Mir1a-2tm1Dsr/Mir1a-2tm1Dsr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased cardiac muscle contractility
|
J:207845
|
Mir21atm1.1Zqy/Mir21atm1.1Zqy Tg(Tek-cre)12Flv/0
(involves: 129S/SvEv * C3H * C57BL/6 * SJL)
|
decreased vasodilation
|
J:199907
|
Mir22tm1.1Arod/Mir22tm1.1Arod
(involves: 129S1/SvImJ * 129S7/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:183005
|
Mir133a-1tm1.1Eno/Mir133a-1tm1.1Eno Mir133a-2tm1.1Eno/Mir133a-2tm1.1Eno
(involves: 129S/SvEv * C57BL/6 * SJL)
|
decreased cardiac muscle contractility
|
J:142220
|
decreased heart ventricle muscle contractility
|
J:142220
|
dilated cardiomyopathy
|
J:142220
|
increased cardiomyocyte apoptosis
|
J:142220
|
Mir133a-1tm1Eno/Mir133a-1tm1Eno Mir133a-2tm1Eno/Mir133a-2tm1Eno
(involves: 129S/SvEv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:142220
|
decreased heart left ventricle muscle contractility
|
J:142220
|
dilated cardiomyopathy
|
J:142220
|
increased cardiomyocyte apoptosis
|
J:142220
|
Mir208atm1.1Eno/Mir208atm1.1Eno
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:120908
|
Mir214tm1.1Eno/Mir214tm1.1Eno
(involves: C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:184550
|
Mirc32tm1Gcon/Mirc32tm1Gcon
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:159593
|
Mirc32tm1Thbr/Mirc32tm1Thbr
(involves: 129/Sv * C57BL/6)
|
decreased vasoconstriction
|
J:152702
|
Mliptm1.1(cre)Dzw/Mliptm1.1(cre)Dzw
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:227485
|
Mliptm1.1(cre)Dzw/Mliptm1.1(cre)Dzw Tg(Myh6-Ppp3ca)37Eno/0
(involves: C57BL/6 * FVB)
|
decreased cardiac muscle contractility
|
J:227485
|
Mlxtm1.2Rne/Mlxtm1.2Rne
(Not Specified)
|
impaired skeletal muscle regeneration
|
J:227117
|
Mlxiptm1.2Lchan/Mlxiptm1.2Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal muscle physiology
|
J:217834
|
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:101783
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac)
|
abnormal vascular smooth muscle physiology
|
J:109006
|
decreased cardiac muscle contractility
|
J:148442
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:101783
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(FVB.129S6-Mmp9tm1Tvu)
|
increased heart ventricle muscle contractility
|
J:104786
|
Mnx1tm4(cre)Tmj/Mnx1+ Tardbptm1.1Ckjs/Tardbptm1.2Cjks
(involves: 129S1/Sv * C57BL/6J)
|
muscle weakness
|
J:190254
|
Mocs2tm1(KOMP)Vlcg/Mocs2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
muscle weakness
|
J:242197
|
Mogtm1Dpd/Mogtm1Dpd Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * C57BL/6)
|
muscle hypertonia
|
J:151335
|
Mpp3tm1b(EUCOMM)Wtsi/Mpp3tm1b(EUCOMM)Wtsi
(C57BL/6N-Mpp3tm1b(EUCOMM)Wtsi/BayMmucd)
|
increased cardiac muscle contractility
|
J:211773
|
Mpzl3tm1Tacz/Mpzl3tm1Tacz
(B6.129P2-Mpzl3tm1Tacz)
|
abnormal muscle contractility
|
J:199257
|
abnormal muscle physiology
|
J:199257
|
Mregdsu/Mregdsu Myo5ad-l20J/Myo5ad-l20J
(involves: C57BL/6J)
|
opisthotonus
|
J:20299
|
Mrgprdtm5Mjz/Mrgprdtm5Mjz
(B6.129S1-Mrgprdtm5Mjz/Mmnc)
|
decreased cardiac muscle contractility
|
J:269603
|
dilated cardiomyopathy
|
J:269603
|
increased vasodilation
|
J:269603
|
Mrlnem1Eno/Mrlnem1Eno
(involves: C3H * C57BL/6)
|
abnormal muscle physiology
|
J:217579
|
Mrlntm1.1Nju/Mrlntm1.1Nju
(involves: C57BL/6)
|
impaired skeletal muscle regeneration
|
J:243999
|
Mrps12em2.2Afi/Mrps12em2.2Afi
(B6N(Cg)-Mrps12em2.2Afi)
|
decreased cardiac muscle contractility
|
J:284101
|
dilated cardiomyopathy
|
J:284101
|
Mrps34m1Anu/Mrps34m1Anu
(C57BL/6J-Mrps34m1Anu)
|
increased cardiac muscle contractility
|
J:222643
|
MstnCmpt/MstnCmpt
(BEH)
|
impaired skeletal muscle contractility
|
J:119757
|
Mstntm1.1Mgs/Mstntm1.1Mgs
(involves: 129S1/Sv * 129X1/SvJ * C57BL * FVB/N)
|
abnormal muscle physiology
|
J:184622
|
Mstntm1.1Swel/Mstntm1.1Swel
(involves: 129S7/SvEvBrd-Hprt1 * C57BL/6J * FVB/N)
|
abnormal muscle physiology
|
J:106054
|
mt-Co1m1Jiha
(involves: C57BL/6J * M. m. domesticus)
|
cardiomyopathy
|
J:132659
|
myopathy
|
J:132659
|
mt-Nd6m1Jbst mt-Tam1Jbst
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)
|
cardiomyopathy
|
J:238994
|
mt-Rnr2m1Dwa
(C3H/An-mt-Rnr2m1Dwa)
|
dilated cardiomyopathy
|
J:133576
|
myopathy
|
J:133576
|
mt-Tkm1
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
muscle weakness
|
J:206827
|
Mterf2Gt(OST453159)Lex/Mterf2Gt(OST453159)Lex
(B6.129S5-Mterf2Gt(OST453159)Lex)
|
muscle weakness
|
J:149828
|
Mterf3tm1.1Lrsn/Mterf3tm1.1Lrsn Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB * SJL)
|
cardiomyopathy
|
J:145125
|
Mterf4tm1.1Lrsn/Mterf4tm1.1Lrsn Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)
|
cardiomyopathy
|
J:175816
|
Mtfp1tm1.2Wait/Mtfp1tm1.2Wait Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6N * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:330965
|
dilated cardiomyopathy
|
J:330965
|
increased cardiomyocyte apoptosis
|
J:330965
|
Mtg1em1Ywxu/Mtg1em1Ywxu
(Not Specified)
|
increased cardiac muscle contractility
|
J:271147
|
Mtif3tm1c(EUCOMM)Wtsi/Mtif3tm1c(EUCOMM)Wtsi Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N)
|
cardiomyopathy
|
J:287609
|
decreased cardiac muscle contractility
|
J:287609
|
Mtm1Gt(OST290577)Lex/Y
(involves: 129S5/SvEvBrd * C57BL/6)
|
myopathy
|
J:192845
|
Mtm1tm1.1Jman/Y
(involves: 129T1/Sv * C57BL/6)
|
abnormal muscle physiology
|
J:81791
|
myopathy
|
J:81791
|
progressive muscle weakness
|
J:81791,
J:179741
|
Mtm1tm1.2Jman/Y Tg(ACTA1-cre)79Jme/?
(involves: 129T1/Sv * C57BL/6 * SJL)
|
myopathy
|
J:81791
|
Mtm1tm1Itl/Y
(B6.Cg-Mtm1tm1Itl)
|
progressive muscle weakness
|
J:179741
|
Mtmr14tm1Ckq/Mtmr14tm1Ckq
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:155068
|
abnormal muscle contractility
|
J:155068
|
abnormal muscle physiology
|
J:155068
|
abnormal muscle relaxation
|
J:155068
|
impaired skeletal muscle contractility
|
J:155068
|
impaired smooth muscle contractility
|
J:267733
|
increased muscle fatigability
|
J:155068
|
Mto1Gt(G019A03)Wrst/Mto1Gt(G019A03)Wrst
(involves: 129S2/SvPas * C57BL/6J)
|
cardiomyopathy
|
J:223246
|
Mtortm1.1Clyn/Mtor+
(involves: BALB/c * C57BL/6J)
|
abnormal muscle physiology
|
J:162945
|
Mtortm1.1Gcon/Mtortm1.1Gcon A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:163763
|
decreased heart ventricle muscle contractility
|
J:163763
|
dilated cardiomyopathy
|
J:163763
|
increased cardiomyocyte apoptosis
|
J:163763
|
Mtortm1.2Koz/Mtortm1.2Koz Tg(ACTA1-cre)79Jme/?
(involves: 129S4/SvJae * C57BL/6J * SJL)
|
abnormal muscle contractility
|
J:162918
|
abnormal muscle physiology
|
J:162918
|
abnormal muscle relaxation
|
J:162918
|
increased muscle fatigability
|
J:162918
|
Musktm1.1Vwi/Musktm2Vwi
(Not Specified)
|
abnormal muscle electrophysiology
|
J:141024
|
muscle weakness
|
J:141024
|
Musktm1.2Ics/Musktm1.2Ics
(involves: BALB/cN * C57BL/6NTac)
|
increased muscle fatigability
|
J:221340
|
progressive muscle weakness
|
J:221340
|
Musktm1Vwi/Musktm1.1Vwi Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
muscle weakness
|
J:106867
|
Musktm1Vwi/Musktm1Vwi Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
muscle weakness
|
J:106867
|
Mybpc2tm1Ssad/Mybpc2tm1Ssad
(involves: C57BL/6 * FVB/N)
|
abnormal muscle contractility
|
J:309473
|
abnormal muscle physiology
|
J:309473
|
hypotonia
|
J:309473
|
impaired muscle relaxation
|
J:309473
|
impaired skeletal muscle contractility
|
J:309473
|
muscle weakness
|
J:309473
|
Mybpc3tm1.1Jse/Mybpc3tm1.1Jse
(Not Specified)
|
decreased heart ventricle muscle contractility
|
J:58295
|
dilated cardiomyopathy
|
J:58295
|
Mybpc3tm1Jse/Mybpc3tm1Jse
(Not Specified)
|
decreased heart left ventricle muscle contractility
|
J:58295
|
dilated cardiomyopathy
|
J:58295
|
Mybpc3tm1Jse/Mybpc3tm1Jse
(involves: 129S/SvEv)
|
abnormal cardiac muscle contractility
|
J:98868
|
abnormal cardiac muscle relaxation
|
J:98868
|
dilated cardiomyopathy
|
J:98868
|
increased cardiac muscle contractility
|
J:98868
|
Mybpc3tm1Lcrr/Mybpc3tm1Lcrr
(involves: 129S4/SvJae * Black Swiss)
|
abnormal cardiac muscle contractility
|
J:105732
|
decreased cardiac muscle contractility
|
J:101903
|
impaired muscle relaxation
|
J:101903
|
Mybpc3tm1Rmos/Mybpc3tm1Rmos
(either: (involves: 129) or (involves: 129 * C57BL/6))
|
cardiomyopathy
|
J:95725
|
decreased cardiac muscle contractility
|
J:95725
|
decreased heart left ventricle muscle contractility
|
J:95725
|
Mybpc3tm1Rmos/Mybpc3tm1Rmos
(involves: 129)
|
decreased heart ventricle muscle contractility
|
J:202199
|
Mybpc3tm2.1Lcrr/Mybpc3+
(involves: 129S2/SvPasCrl * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:185726
|
Mybpc3tm2.1Lcrr/Mybpc3tm2.1Lcrr
(involves: 129S2/SvPasCrl * Black Swiss * C57BL/6 * CD-1 * DBA/2)
|
decreased cardiac muscle contractility
|
J:164934
|
Mybpc3tm2.1Lcrr/Mybpc3tm2.1Lcrr
(involves: 129S2/SvPasCrl * Black Swiss)
|
abnormal cardiac muscle relaxation
|
J:185726
|
decreased cardiac muscle contractility
|
J:185726
|
Mybpc3tm2.1Rmos/Mybpc3tm2.1Rmos A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129 * C57BL/6 * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:202199
|
Mycntm1Jrt/Mycntm1Par
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:15281
|
Myf5tm1Pas/Myf5tm1Pas
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal muscle precursor cell migration
|
J:92799
|
Myf5tm1Tajb/Myf5tm1Tajb
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal muscle precursor cell migration
|
J:92799
|
Myf5tm2Pas/Myf5tm2Tajb
(involves: 129S2/SvPas)
|
abnormal muscle regeneration
|
J:128921
|
Myf5tm2Tajb/Myf5tm2Tajb
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal muscle precursor cell migration
|
J:92799
|
Myf5tm2Tajb/Myf5tm2Tajb
(involves: 129S2/SvPas)
|
abnormal muscle regeneration
|
J:128921
|
abnormal skeletal muscle satellite cell proliferation
|
J:128921
|
Myf5tm3(cre)Sor/Myf5+ Sik1tm1.1Berd/Sik1tm1.1Berd
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J * SJL)
|
increased skeletal muscle cell glucose uptake
|
J:236223
|
Myh1tm1Lnwd/Myh1tm1Lnwd
(involves: 129/Ola * 129P2/OlaHsd * C57BL/6)
|
impaired skeletal muscle contractility
|
J:44448
|
muscle weakness
|
J:44448
|
Myh4arl/Myh4arl
(involves: C3H/HeH * C57BL/6J)
|
myositis
|
J:181892
|
Myh4tm1Lnwd/Myh4tm1Lnwd
(involves: 129/Ola * 129P2/OlaHsd * C57BL/6)
|
impaired skeletal muscle contractility
|
J:44448
|
muscle weakness
|
J:44448
|
Myh6tm1.1Jpsc/Myh6tm2Jse
(involves: 129)
|
abnormal cardiac muscle relaxation
|
J:247162
|
decreased heart ventricle muscle contractility
|
J:247162
|
Myh6tm1Ces/Myh6+
(involves: 129S/SvEv * 129X1/SvJ)
|
abnormal cardiac muscle relaxation
|
J:114549
|
decreased cardiac muscle contractility
|
J:114549
|
dilated cardiomyopathy
|
J:114549
|
Myh6tm1Ces/Myh6tm1Ces
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased cardiac muscle contractility
|
J:114549
|
dilated cardiomyopathy
|
J:114549
|
Myh6tm1Jse/Myh6+
(129S.129X1-Myh6tm1Jse)
|
increased heart left ventricle muscle contractility
|
J:104363
|
Myh6tm1Jse/Myh6+ Tg(Myh6-TNNI3*G203S)1Chs/0
(involves: 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:153302
|
dilated cardiomyopathy
|
J:153302
|
Myh6tm1Jse/Myh6+ Tg(Myh6/tetO-Tnnc1*I61Q)1Jmol/0 Tg(Myh6-tTA)55Rbns/0
(involves: 129X1/SvJ * FVB)
|
abnormal cardiac muscle contractility
|
J:234490
|
Myh6tm1Jse/Myh6tm1Jse
(involves: 129X1/SvJ * Black Swiss)
|
decreased heart ventricle muscle contractility
|
J:51939
|
dilated cardiomyopathy
|
J:51939
|
Myh6tm1Rbns/Myh6+
(involves: 129P2/OlaHsd)
|
decreased cardiac muscle contractility
|
J:36089
|
Myh6tm2Ces/Myh6+
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased cardiac muscle contractility
|
J:114549
|
dilated cardiomyopathy
|
J:114549
|
Myh6tm2Ces/Myh6tm2Ces
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased cardiac muscle contractility
|
J:114549
|
dilated cardiomyopathy
|
J:114549
|
Myh6tm2Jse/Myh6+
(involves: 129)
|
increased cardiac muscle contractility
|
J:247162
|
Myh6tm2Jse/Myh6tm2Jse
(involves: 129)
|
increased cardiomyocyte apoptosis
|
J:247162
|
Myh6tm3.1Jse/Myh6+
(involves: 129X1/SvJ)
|
cardiomyopathy
|
J:165269
|
Myh6tm3.1Jse/Myh6+
(involves: 129)
|
increased cardiac muscle contractility
|
J:247162
|
Myh6tm3.1Jse/Myh6tm3.1Jse
(involves: 129)
|
increased cardiomyocyte apoptosis
|
J:247162
|
Myh10tm2Rsad/Myh10tm2Rsad
(involves: 129S4/SvJae)
|
decreased fetal cardiomyocyte proliferation
|
J:92230
|
increased cardiomyocyte apoptosis
|
J:248868
|
Myh10tm2Rsad/Myh10tm2Rsad Myh14tm1Rsad/Myh14tm1Rsad
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
cardiomyopathy
|
J:168304
|
Myh10tm3.1Rsad/Myh10tm3.1Rsad
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
decreased cardiac muscle contractility
|
J:245570
|
Myh10tm4Rsad/Myh10tm4Rsad Myh14tm1Rsad/Myh14tm1Rsad
(involves: 129S6/SvEvTac * C57BL/6)
|
cardiomyopathy
|
J:168304
|
Myh10tm6(Myh9/GFP)Rsad/Myh10tm6(Myh9/GFP)Rsad
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased cardiac muscle contractility
|
J:124610
|
dilated cardiomyopathy
|
J:124610
|
Myh10tm7Rsad/Myh10tm7Rsad Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
cardiomyopathy
|
J:170148
|
decreased cardiac muscle contractility
|
J:170148
|
increased cardiomyocyte apoptosis
|
J:170148
|
Myh11tm1.1Dmmz/Myh11tm1.1Dmmz
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:212664
|
decreased vasoconstriction
|
J:212664
|
increased vascular smooth muscle cell proliferation
|
J:212664
|
Myh11tm1Bdr/Myh11tm1Bdr
(Not Specified)
|
dilated cardiomyopathy
|
J:82859
|
impaired contractility of urinary bladder detrusor smooth muscle
|
J:82859
|
intestinal hypoperistalsis
|
J:82859
|
Myh11tm1Peri/Myh11+
(involves: 129 * C57BL/6)
|
impaired smooth muscle contractility
|
J:97927
|
Myh11tm1Peri/Myh11tm1Peri
(involves: 129 * C57BL/6)
|
impaired smooth muscle contractility
|
J:97927
|
Myh11tm2Peri/Myh11tm2Peri
(involves: 129 * C57BL/6)
|
abnormal muscle contractility
|
J:142230
|
Myhastm1Bcgen/Myhastm1Bcgen Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB)
|
muscle weakness
|
J:240240
|
Myl1tm1(cre)Sjb/Myl1+ Smarcd3tm1Jddl/Smarcd3tm1Jddl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal muscle physiology
|
J:256788
|
Myl1tm1(cre)Sjb/Myl1+ Tfamtm1Lrsn/Tfamtm1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired skeletal muscle contractility
|
J:81561
|
Myl2tm1(cre)Krc/Myl2+ Nkx2-5tm1Krc/Nkx2-5tm1Krc
(either: (involves: 129/Sv * Black Swiss) or (involves: 129/Sv * C57BL/6))
|
dilated cardiomyopathy
|
J:89404
|
Myl2tm1(cre)Krc/Myl2+ Slc8a1tm1Kdp/Slc8a1tm1Kdp
(involves: 129S4/SvJae)
|
decreased cardiac muscle contractility
|
J:101484
|
Myl2tm1(cre)Krc/Myl2+ Srsf1tm1Xdfu/Srsf1tm1Xdfu
(involves: 129S4/SvJae)
|
abnormal cardiac muscle contractility
|
J:96039
|
dilated cardiomyopathy
|
J:96039
|
Myl2tm1(cre)Krc/Myl2+ Srsf2tm1Xdfu/Srsf2tm1Xdfu
(involves: 129S4/SvJae)
|
decreased heart left ventricle muscle contractility
|
J:88432
|
decreased heart ventricle muscle contractility
|
J:88432
|
dilated cardiomyopathy
|
J:88432
|
Myl2tm1(cre)Krc/Myl2+ Tsc1tm1Djk/Tsc1tm1Djk
(involves: 129S4/SvJae)
|
decreased cardiac muscle contractility
|
J:96138
|
dilated cardiomyopathy
|
J:96138
|
Myl2tm1(cre)Krc/Myl2+ Vcltm1Ross/Vcltm1Ross
(involves: 129S4/SvJae * Black Swiss * C57BL/6 * SJL)
|
abnormal cardiac muscle relaxation
|
J:129075
|
decreased cardiac muscle contractility
|
J:129075
|
dilated cardiomyopathy
|
J:129075
|
Myl2tm2.1Chen/Myl2tm2.1Chen
(B6.129-Myl2tm2.1Chen)
|
decreased heart ventricle muscle contractility
|
J:184548
|
dilated cardiomyopathy
|
J:184548
|
Myl7tm1(cre)Krc/Myl7+ Prkg1tm2Naw/Prkg1tm2Naw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal cardiac muscle contractility
|
J:84611
|
Myl9tm1Mzhu/Myl9tm1Mzhu Tg(Acta2-cre)#Xya/0
(involves: C57BL/6 * CBA)
|
abnormal intestinal peristalsis
|
J:308237
|
abnormal vascular smooth muscle physiology
|
J:308237
|
impaired contractility of jejunal smooth muscle
|
J:308237
|
impaired smooth muscle contractility
|
J:308237
|
Mylk2tm1Jtst/Mylk2tm1Jtst
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired skeletal muscle contractility
|
J:104384
|
Mylk3tm1.1Hkas/Mylk3tm1.1Hkas
(involves: 129 * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:210147
|
Mylk3tm1Jtst/Mylk3+
(involves: 129S/SvEv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:167590
|
Mylk3tm1Jtst/Mylk3tm1Jtst
(involves: 129S/SvEv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:167590
|
Mylk4em1Yima/Mylk4em1Yima
(Not Specified)
|
abnormal muscle physiology
|
J:316008
|
Mylk4em2Yima/Mylk4em2Yima
(Not Specified)
|
abnormal muscle physiology
|
J:316008
|
Mylktm1.1Bph/Mylktm1.1Bph Tg(Myh11-cre,-EGFP)2Mik/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
impaired smooth muscle contractility
|
J:204964
|
Mylktm1.1Bph/Mylktm1.2Bph Tg(Myh11-cre,-EGFP)2Mik/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
impaired smooth muscle contractility
|
J:204964
|
Mylktm1Avs/Mylktm1Avs
(B6.129-Mylktm1Avs)
|
abnormal muscle contractility
|
J:106058
|
abnormal muscle relaxation
|
J:106058
|
Mylktm1Mzhu/Mylktm1Mzhu Taglntm1(cre/ERT2)Feil/?
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
abnormal intestinal peristalsis
|
J:141907
|
Mymxem1Shcs/Mymxem1Shcs
(involves: C57BL/6J)
|
muscle weakness
|
J:241564
|
Myo5ad-15H/Myo5ad-15H
(Not Specified)
|
opisthotonus
|
J:13409
|
Myo5ad-50H/Myo5ad-50H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-51H/Myo5ad-51H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-53H/Myo5ad-53H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-80H/Myo5ad-80H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-82H/Myo5ad-82H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-83H/Myo5ad-83H
(involves: C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-84H/Myo5ad-84H
(involves: 101/H)
|
opisthotonus
|
J:178968
|
Myo5ad-85H/Myo5ad-85H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:169366
|
Myo5ad-86H/Myo5ad-86H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-86H/Myo5ad-97H
(involves: 101/H * C3H/HeH)
|
opisthotonus
|
J:178968
|
Myo5ad-90H/Myo5ad-l
(involves: 101/H * C3H/HeH * C57BL/Gr)
|
opisthotonus
|
J:179353
|
Myo5ad-93H/Myo5ad-l
(involves: 101/H * C3H/HeH * C57BL/Gr)
|
opisthotonus
|
J:179353
|
Myo5ad-l20J/Myo5ad-l20J
(involves: C57BL/6J * DBA/2J)
|
opisthotonus
|
J:20299
|
Myo5ad-l32J/Myo5ad-l32J
(B6.Cg-Myo5ad-l32J/GrsrJ)
|
opisthotonus
|
J:169210
|
Myo5ad-l34J/Myo5ad-l34J
(BALB/cJ-Myo5ad-l34J/GrsrJ)
|
opisthotonus
|
J:216055
|
Myo5ad-l/d-100H
(involves: C3H/HeH * C57BL/Gr)
|
opisthotonus
|
J:181531
|
Myo5ad-l/Myo5ad-l
(involves: C57BL)
|
opisthotonus
|
J:12978
|
Myo5ad-n2Btlr/Myo5ad-n2Btlr
(C57BL/6J-Myo5ad-n2Btlr)
|
myoclonus
|
J:133120
|
opisthotonus
|
J:133120
|
Myo5ad-n3Btlr/Myo5ad-n3Btlr
(C57BL/6J-Myo5ad-n3Btlr)
|
opisthotonus
|
J:201726
|
Myo5ad-nBtlr/Myo5ad-nBtlr
(C57BL/6J-Myo5ad-nBtlr)
|
myoclonus
|
J:133119
|
opisthotonus
|
J:133119
|
Myo6chl/Myo6chl
(involves: C57BL/6JAnu)
|
cardiomyopathy
|
J:196601
|
Myocdtm1Msp/Myocdtm1Msp
(involves: 129)
|
increased cardiomyocyte apoptosis
|
J:154666
|
Myocdtm1Msp/Myocdtm1Msp A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129/Sv * C57BL/6J * FVB/N)
|
decreased cardiac muscle contractility
|
J:154666
|
dilated cardiomyopathy
|
J:154666
|
increased cardiomyocyte apoptosis
|
J:154666
|
Myocdtm1Msp/Myocdtm1Msp Tg(Myh6-cre)2182Mds/0
(involves: 129/Sv * FVB/N)
|
decreased cardiac muscle contractility
|
J:154666
|
dilated cardiomyopathy
|
J:154666
|
Myod1tm1Ahb/Myod1tm1Ahb
(Not Specified)
|
abnormal muscle physiology
|
J:116060
|
delayed skeletal muscle regeneration
|
J:116060
|
myol/myol
(C3.Cg-myol/GrsrJ)
|
impaired muscle relaxation
|
J:234691
|
Myoz1tm1Eno/Myoz1tm1Eno
(involves: 129 * C57BL/6J)
|
abnormal muscle physiology
|
J:144597
|
abnormal muscle tone
|
J:144597
|
enhanced skeletal muscle regeneration
|
J:144597
|
Myoz2tm1Eno/Myoz2tm1Eno
(involves: 129 * C57BL/6J)
|
cardiomyopathy
|
J:94665
|
decreased cardiac muscle contractility
|
J:94665
|
Mypntm1.1Epu/Mypn+
(either: (involves: 129S6/SvEv) or (involves: 129S6/SvEv * C57BL/6NCrl))
|
abnormal cardiac muscle relaxation
|
J:243710
|
Mypntm1.1Epu/Mypntm1.1Epu
(involves: 129S6/SvEvTac)
|
myopathy
|
J:248575
|
Myzaptm1Norf/Myzaptm1Norf
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:231032
|
Nacatm1Dsr/Nacatm1Dsr
(129S6/SvEvTac-Nacatm1Dsr)
|
abnormal fetal cardiomyocyte proliferation
|
J:167169
|
abnormal muscle physiology
|
J:167169
|
impaired skeletal muscle regeneration
|
J:167169
|
Nae1tm1c(EUCOMM)Wtsi/Nae1tm1c(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * FVB/N * SJL)
|
decreased fetal cardiomyocyte proliferation
|
J:261328
|
decreased heart ventricle muscle contractility
|
J:261328
|
NbeaTg(GH1)240BNec/NbeaTg(GH1)240BNec
(involves: C57BL/6 * SJL)
|
impaired muscle contractility
|
J:128767
|
Ncam2tm1b(EUCOMM)Hmgu/Ncam2tm1b(EUCOMM)Hmgu
(C57BL/6N-Ncam2tm1b(EUCOMM)Hmgu/Orl)
|
decreased cardiac muscle contractility
|
J:211773
|
Ncf1tm1Shl/Ncf1tm1Shl
(involves: 129S2/SvPas * C57BL/6J)
|
decreased vasoconstriction
|
J:120187
|
Ncf1tm1Shl/Ncf1tm1Shl
(B6.129S2-Ncf1tm1Shl)
|
abnormal cardiac muscle contractility
|
J:133916
|
abnormal vascular smooth muscle physiology
|
J:111142
|
Ncoa6tm1.1Jkr/Ncoa6tm1.1Jkr
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal fetal cardiomyocyte proliferation
|
J:81217
|
Ncoa6tm1Jkr/Ncoa6+ Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:269856
|
dilated cardiomyopathy
|
J:269856
|
Ncoa6tm1Jkr/Ncoa6tm1Jkr Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:269856
|
dilated cardiomyopathy
|
J:269856
|
Ncoa6tm1Jxu/Ncoa6tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:80175
|
Ncor1tm1.1Ics/Ncor1tm1.1Ics Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle physiology
|
J:178827
|
nd/nd
(129/Sv-nd)
|
muscle hypertonia
|
J:24834
|
Ndntm1Stw/Ndn+
(involves: 129S1/Sv * C57BL/6)
|
hypotonia
|
J:57890
|
Ndntm2Stw/Ndn+
(involves: 129S1/Sv * C57BL/6)
|
hypotonia
|
J:57890
|
Ndrg4tm1b(KOMP)Wtsi/Ndrg4tm1b(KOMP)Wtsi
(C57BL/6N-Ndrg4tm1b(KOMP)Wtsi/H)
|
decreased cardiac muscle contractility
|
J:211773
|
Ndufs4tm1.1Rpa/Ndufs4tm1.1Rpa
(involves: 129S4/SvJaeSor)
|
abnormal muscle tone
|
J:161393
|
Ndufs4tm1.1Rpa/Ndufs4tm1.1Rpa
(B6.129S4-Ndufs4tm1.1Rpa)
|
hypotonia
|
J:190475
|
Ndufs4tm1Rpa/Ndufs4tm1Rpa Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL)
|
abnormal muscle tone
|
J:161393
|
Ndufs4tm1Rpa/Ndufs4tm1Rpa Tg(Nes-cre)1Kln/0
(B6.Cg-Tg(Nes-cre)1Kln Ndufs4tm1Rpa)
|
hypotonia
|
J:190475
|
Ndufs6Gt(AR0138)Wtsi/Ndufs6Gt(AR0138)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:183619
|
decreased heart ventricle muscle contractility
|
J:183619
|
Nebm1Anu/Nebm2Anu
(C57BL/6J-Nebm1Anu Nebm2Anu)
|
abnormal muscle physiology
|
J:285564
|
impaired skeletal muscle contractility
|
J:285564
|
Nebtm1.1Hgra/Nebtm1.1Hgra
(involves: C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle physiology
|
J:206854
|
muscle weakness
|
J:206854
|
Nebtm1Slbt/Nebtm1Slbt
(involves: 129P2/OlaHsd)
|
abnormal muscle contractility
|
J:119578
|
progressive muscle weakness
|
J:119578
|
Nebtm2.1Chen/Nebtm2.1Chen
(involves: 129 * Black Swiss)
|
abnormal muscle electrophysiology
|
J:211217
|
Nebtm2Hgra/Nebtm2Hgra Tg(Ckmm-cre)5Khn/0
(involves: 129S6/SvEvTac * FVB)
|
impaired skeletal muscle contractility
|
J:225840
|
Nebltm1.1Epu/Nebltm1.1Epu
(involves: 129S/SvEv * C57BL/6)
|
decreased cardiac muscle relaxation
|
J:304786
|
Nedd4ltm1.2Blyg/Nedd4ltm1.2Blyg
(involves: 129X1/SvJ * C57BL/6J)
|
decreased cardiac muscle contractility
|
J:148641
|
Nek6tm1Dgen/Nek6tm1Dgen
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased heart left ventricle muscle contractility
|
J:215160
|
Neu1tm1Adz/Neu1tm1Adz
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI))
|
myoclonus
|
J:76937
|
Neu2em1Kyp/Neu2em1Kyp
(C57BL/6J-Neu2em1Kyp)
|
increased muscle free fatty acids level
|
J:321653
|
Nexnem1Chen/Nexnem1Chen
(C57BL/6J-Nexnem1Chen)
|
decreased cardiac muscle contractility
|
J:301807
|
dilated cardiomyopathy
|
J:301807
|
Nexntm1.1Chen/Nexntm1.1Chen
(Not Specified)
|
decreased cardiac muscle contractility
|
J:290931
|
dilated cardiomyopathy
|
J:290931
|
Nexntm1.1Zhh/Nexn+
(involves: C57BL/6NTac)
|
dilated cardiomyopathy
|
J:228046
|
Nexntm1.1Zhh/Nexntm1.1Zhh
(involves: C57BL/6NTac)
|
decreased cardiac muscle contractility
|
J:228046
|
dilated cardiomyopathy
|
J:228046
|
Nexntm1Chen/Nexntm1Chen Tg(myl7.L-cre)1118Tmhn/0
(involves: MF1)
|
dilated cardiomyopathy
|
J:290931
|
Nexntm1Chen/Nexntm1Chen Tg(Tnnt2-cre)5Blh/0
(involves: C57BL/6 * DBA/2)
|
dilated cardiomyopathy
|
J:290931
|
Nf1tm1Par/Nf1tm1Par Tg(Prrx1-cre)1Cjt/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J)
|
abnormal muscle physiology
|
J:173779
|
Nfat5tm1Skc/Nfat5tm1Skc
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:175527
|
Nfatc1tm1(cre)Bz/Nfatc1+ Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
cardiomyopathy
|
J:226941
|
Nfatc2tm1Glm/Nfatc2tm1Glm Nfatc3tm1Glm/Nfatc3tm1Glm Nfatc4tm1Grc/Nfatc4tm1Grc
(involves: 129S2/SvPas)
|
hypotonia
|
J:109139
|
Nfatc2tm1Glm/Nfatc2tm1Glm Nfatc4tm1Grc/Nfatc4tm1Grc
(involves: 129S2/SvPas)
|
hypotonia
|
J:109139
|
Nfatc3tm1Glm/Nfatc3tm1Glm
(involves: 129S2/SvPas)
|
muscle weakness
|
J:68675
|
Ngftm1.1Blhe/Ngf+
(B6.Cg-Ngftm1.1Blhe)
|
decreased cardiac muscle contractility
|
J:190893
|
dilated cardiomyopathy
|
J:190893
|
Ngftm1.1Blhe/Ngf+ Sort1tm1Tew/Sort1tm1Tew
(B6.Cg-Ngftm1.1Blhe Sort1tm1Tew)
|
dilated cardiomyopathy
|
J:190893
|
Ngfrtm1Jae/Ngfrtm1Jae Ntf3tm1Jae/Ntf3+
(involves: 129S4/SvJae * BALB/c)
|
dystonia
|
J:53825
|
muscle spasm
|
J:53825
|
Nhlrc1tm1.2Geno/Nhlrc1tm1.2Geno
(involves: 129S2/SvPas * C57BL/6J)
|
myoclonus
|
J:181559
|
Nid1tm1Dong/Nid1tm1Dong
(involves: 129P2/OlaHsd)
|
abnormal muscle physiology
|
J:80843
|
Nkx2-3tm1Rph/Nkx2-3tm1Rph
(involves: 129S1/Sv * C57BL/6)
|
abnormal intestinal peristalsis
|
J:64018
|
Nkx2-5tm1.1Hkas/Nkx2-5+
(129S2.Cg-Nkx2-5tm1.1Hkas)
|
cardiomyopathy
|
J:273096
|
Nkx2-5tm1Siz/Nkx2-5+
(involves: 129S4/SvJaeSor)
|
decreased heart ventricle muscle contractility
|
J:174208
|
Nkx2-5tm2.1Mwc/Nkx2-5+
(B6J.Cg-Nkx2-5tm2.1Mwc/Mwc)
|
decreased heart left ventricle muscle contractility
|
J:239808
|
decreased heart right ventricle muscle contractility
|
J:239808
|
decreased heart ventricle muscle contractility
|
J:239808
|
Nkx2-5tm3.1Mwc/Nkx2-5+
(B6J.Cg-Nkx2-5tm3.1Mwc/Mwc)
|
decreased heart right ventricle muscle contractility
|
J:239808
|
Nkx2-5tm4Rph/Nkx2-5+
(involves: 129S1/Sv)
|
decreased heart left ventricle muscle contractility
|
J:98489
|
Nkx2-5tm4Rph/Nkx2-5+ Tbx20tm1.1Rph/Tbx20+
(involves: 129S1/Sv * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:98489
|
dilated cardiomyopathy
|
J:98489
|
Nkx2-5tm6Rph/Nkx2-5+ Tg(DMPK/tetO-EGFP/DMPK)5-313Masm/0
(involves: 129S1/Sv * FVB/N)
|
impaired muscle relaxation
|
J:131302
|
Nkx2-5tm6Rph/Nkx2-5+ Tg(DMPK/tetO-EGFP/DMPK)5-313Masm/Tg(DMPK/tetO-EGFP/DMPK)5-313Masm
(involves: 129S1/Sv * FVB/N)
|
impaired muscle relaxation
|
J:131302
|
Nmf31/Nmf31
(BALB/cByJ-Nmf31/J)
|
myoclonus
|
J:87349
|
nmf67/nmf67
(C57BL/6J-nmf67/J)
|
muscle weakness
|
J:82238
|
nmf161/nmf161
(C57BL/6J-nmf161/J)
|
muscle spasm
|
J:82238
|
nmf242/nmf242
(C57BL/6J-nmf242/J)
|
muscle spasm
|
J:82238
|
nmf347/nmf347
(C57BL/6J-nmf347/J)
|
muscle spasm
|
J:87349
|
nmf356/nmf356
(C57BL/6J-nmf356/J)
|
muscle spasm
|
J:87349
|
muscle weakness
|
J:87349
|
nmf391/nmf391
(C57BL/6J-nmf391/J)
|
muscle weakness
|
J:87349
|
myoclonus
|
J:87349
|
nmf418/nmf418
(B6;CByJ-nmf418/J)
|
muscle spasm
|
J:87349
|
muscle weakness
|
J:87349
|
Nol3tm1Rvh/Nol3tm1Rvh
(involves: C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:121501
|
increased cardiomyocyte apoptosis
|
J:121501
|
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:103346
|
abnormal muscle physiology
|
J:104916
|
decreased cardiac muscle contractility
|
J:75645
|
increased heart ventricle muscle contractility
|
J:103346
|
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae)
|
abnormal gastroesophageal sphincter physiology
|
J:70182,
J:56948
|
abnormal muscle physiology
|
J:89581
|
abnormal muscle relaxation
|
J:56948,
J:89581
|
Nos1tm1Plh/Nos1tm1Plh
(B6.129S4-Nos1tm1Plh/J)
|
impaired skeletal muscle contractility
|
J:144588
|
increased muscle fatigability
|
J:144588
|
Nos1tm1Plh/Nos1tm1Plh Nos3tm1Plh/Nos3tm1Plh
(B6.129S4-Nos3tm1Plh Nos1tm1Plh)
|
abnormal cardiac muscle relaxation
|
J:129064
|
increased cardiac muscle contractility
|
J:129064
|
Nos1tm1Plh/Nos1tm1Plh Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:75645
|
decreased cardiac muscle contractility
|
J:75645
|
increased cardiac muscle contractility
|
J:75645
|
Nos1aptm1Tsso/Nos1aptm1Tsso
(involves: C57BL/6JJcl)
|
decreased cardiac muscle contractility
|
J:268528
|
Nos2tm1Mrl/Nos2tm1Mrl Tg(Myh6-Tnf)1.6Amf/?
(involves: 129S7/SvEvBrd * C57BL/6 * FVB)
|
abnormal cardiac muscle contractility
|
J:109732
|
decreased cardiac muscle contractility
|
J:109732
|
Nos3tm1Gdk/Nos3tm1Gdk
(involves: 129P2/OlaHsd * C57BL/6)
|
increased vasoconstriction
|
J:46061
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae)
|
abnormal vasodilation
|
J:112419
|
decreased vasodilation
|
J:28778
|
increased vasoconstriction
|
J:57624
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
decreased cardiac muscle contractility
|
J:75645
|
increased cardiac muscle contractility
|
J:75645
|
Nos3tm1Unc/Nos3+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased vasodilation
|
J:54772
|
Nos3tm1Unc/Nos3tm1Unc
(B6.129P2-Nos3tm1Unc/J)
|
decreased cardiac muscle contractility
|
J:103270
|
increased fetal cardiomyocyte apoptosis
|
J:103270
|
increased heart ventricle muscle contractility
|
J:98094
|
Nos3tm1Unc/Nos3tm1Unc
(involves: 129P2/OlaHsd)
|
decreased cardiac muscle contractility
|
J:102136
|
decreased vasodilation
|
J:103153
|
Nos3tm1Unc/Nos3tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vasodilation
|
J:54772
|
increased vasoconstriction
|
J:54772
|
Nos3tm1Weo/Nos3tm1Weo
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:51563
|
Nos3tm2.1Plh/Nos3tm2.1Plh
(involves: 129S4/SvJae * C57BL/6)
|
decreased vasodilation
|
J:198075
|
Notch3hpbk/Notch3hpbk
(C57BL/6J-Notch3hpbk/GrsrJ)
|
myopathy
|
J:157222
|
Nox1tm1Cyn/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vasodilation
|
J:116837
|
Nox4tm1.1Jusa/Nox4tm1.1Jusa Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB)
|
decreased cardiomyocyte apoptosis
|
J:163751
|
decreased heart left ventricle muscle contractility
|
J:163751
|
decreased heart ventricle muscle contractility
|
J:163751
|
Npas4tm1Ooe/Npas4tm1Ooe
(involves: 129/Sv * C57BL/6)
|
myoclonus
|
J:145569
|
Nplem1Avps/Nplem1Avps
(C57BL/6-Nplem1Avps)
|
muscle weakness
|
J:342764
|
Nplem2Avps/Nplem2Avps
(C57BL/6-Nplem2Avps)
|
muscle weakness
|
J:342764
|
Npr1tm1Gar/Npr1tm1Gar
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal vasodilation
|
J:42893
|
Npr1tm1Kuhn/Npr1tm1Kuhn Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:83298
|
Npr1tm1Kuhn/Npr1tm1Kuhn Tg(Tagln-cre)1Her/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal vasodilation
|
J:76460
|
Npr2slw/Npr2slw
(involves: C57BL/6 * DDY)
|
impaired muscle relaxation
|
J:163374
|
Npy1rtm1Tped/Npy1rtm1Tped
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal vasoconstriction
|
J:47972
|
Nr1h2tm1.1Nph/Nr1h2tm1.1Nph
(B6.129-Nr1h2tm1.1Nph)
|
increased muscle cell glucose uptake
|
J:169945
|
Nr1h2tm1Djm/Nr1h2tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired smooth muscle contractility
|
J:120923
|
Nr1h2tm1Djm/Nr1h2tm1Djm Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired smooth muscle contractility
|
J:120923
|
Nr2f1tm1Mjts/Nr2f1+
(involves: 129S7/SvEvBrd)
|
hypotonia
|
J:286647
|
Nr3c1tm1.1Jaci/Nr3c1tm1.1Jaci Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:201995
|
Nr3c2tm1.1Ics/Nr3c2tm1.1Ics Tg(Acta2-cre/ERT2)#Pcn/0
(involves: 129S2/SvPas * FVB/N)
|
abnormal muscle tone
|
J:193438
|
abnormal vasoconstriction
|
J:193438
|
abnormal vasodilation
|
J:193438
|
decreased vasoconstriction
|
J:193438
|
increased vasoconstriction
|
J:193438
|
increased vasodilation
|
J:193438
|
Nrg1tm1Cbm/Nrg1+
(involves: 129P2/OlaHsd)
|
decreased heart left ventricle muscle contractility
|
J:100313
|
Nrg1tm1Leth/Nrg1tm1Leth
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:33038
|
Nrp2tm1.2Mom/Nrp2+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)
|
myoclonus
|
J:166116
|
Nrp2tm1.2Mom/Nrp2tm1.2Mom
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)
|
myoclonus
|
J:166116
|
Nrtntm1Jmi/Nrtntm1Jmi
(involves: 129X1/SvJ * C57BL/6)
|
impaired smooth muscle contractility
|
J:53261
|
intestinal hypoperistalsis
|
J:82456
|
Nsun3tm1.1Tomik/Nsun3tm1.1Tomik Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * C57BL/6J * FVB/N)
|
increased cardiac muscle contractility
|
J:336777
|
Ntsr1tm2Dgen/Ntsr1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
intestinal hypoperistalsis
|
J:126020
|
Ntsr1tm2Dgen/Ntsr1tm2Dgen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
intestinal hypoperistalsis
|
J:126020
|
Nuak1tm1Esu/Nuak1tm1Esu Tg(Ckmm-cre)5Khn/0
(B6.Cg-Nuak1tm1Esu Tg(Ckmm-cre)5Khn)
|
abnormal skeletal muscle cell glucose uptake
|
J:185463
|
nur15/nur15
(Not Specified)
|
opisthotonus
|
J:85113
|
nur16/nur16
(Not Specified)
|
opisthotonus
|
J:85113
|
nur33/nur33
(Not Specified)
|
muscle weakness
|
J:89098
|
myoclonus
|
J:89098
|
Nxntm1a(EUCOMM)Wtsi/Nxn+
(C57BL/6N-Nxntm1a(EUCOMM)Wtsi/Bay)
|
decreased cardiac muscle contractility
|
J:211773
|
Obscntm1.1Geno/Obscntm1.1Geno
(B6.129-Obscntm1.1Geno)
|
increased heart left ventricle muscle contractility
|
J:243723
|
Obscntm1Chen/Obscntm1Chen
(involves: 129S1/Sv * 129X1/SvJ)
|
myopathy
|
J:153150
|
Obscntm1Chen/Obscntm1Chen
(involves: 129 * Black Swiss * C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:283623
|
Obscntm1Chen/Obscntm1Chen Obsl1tm1.1Slan/Obsl1tm1.1Slan Tg(Myog-cre)1Eno/0
(involves: 129 * Black Swiss * C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:283623
|
Odad2b2b227.1Clo/Odad2b2b227.1Clo
(C57BL/6J-Odad2b2b227.1Clo)
|
cardiomyopathy
|
J:175213
|
Olig2tm1(cre)Tmj/Olig2+ Smn1tm1Jme/Smn1tm1Msd Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
(involves: 129 * 129P2/OlaHsd * FVB/N)
|
muscle weakness
|
J:164292
|
Olig2tm1(cre/Esr1*)Htak/Olig2tm1(cre/Esr1*)Htak
(involves: BALB/c * C57BL/6 * C57BL/6NCrj * CBA)
|
hypotonia
|
J:77821
|
Olr1tm1Meht/Olr1tm1Meht
(B6.129X1-Olr1tm1Meht/Meht)
|
increased muscle relaxation
|
J:130794
|
Opa3m1Votr/Opa3m1Votr
(involves: C3H * C57BL/6JCrl)
|
dilated cardiomyopathy
|
J:181670
|
Or51e1tm1Jplu/Or51e1tm1Jplu
(C57BL/6N-Or51e1tm1Jplu/J)
|
abnormal vascular smooth muscle physiology
|
J:346436
|
decreased vasoconstriction
|
J:346436
|
increased vasoconstriction
|
J:346436
|
increased vasodilation
|
J:346436
|
Orm1tm1Smoc/Orm1tm1Smoc
(involves: C57BL/6J)
|
abnormal muscle electrophysiology
|
J:264446
|
Oxct1tm1a(KOMP)Wtsi/Oxct1tm1a(KOMP)Wtsi
(C57BL/6-Oxct1tm1a(KOMP)Wtsi)
|
abnormal muscle physiology
|
J:170537
|
P2rx4tm1Ando/P2rx4tm1Ando
(Not Specified)
|
abnormal vasodilation
|
J:104459
|
P2ry2tm1c(EUCOMM)Hmgu/P2ry2tm1c(EUCOMM)Hmgu Tg(Tek-icre/ERT2)1Soff/0
(B6N.Cg-P2ry2tm1c(EUCOMM)Hmgu Tg(Tek-icre/ERT2)1Soff)
|
decreased vasodilation
|
J:224523
|
P2ry6tm1.1Brob/P2ry6tm1.1Brob
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased vasoconstriction
|
J:169742
|
decreased vasodilation
|
J:169742
|
P2ry14tm1Gbtm/P2ry14tm1Gbtm
(B6.129P2-P2ry14tm1Gbtm)
|
abnormal muscle physiology
|
J:149708
|
Pabir1em1.1Yhua/Pabir1em1.1Yhua Myh6em2(cre)Smoc/Myh6+
(involves: C57BL/6 * C57BL/6J)
|
decreased cardiac muscle contractility
|
J:337007
|
Pak1tm1.1Xwg/Pak1tm1.1Xwg Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased cardiac muscle contractility
|
J:193804
|
increased cardiomyocyte apoptosis
|
J:193804
|
Pank1tm1.1Suja/Pank1tm1.1Suja Pank2tm1.1Suja/Pank2tm1.1Suja
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
dystonia
|
J:189609
|
Pard3btm1b(EUCOMM)Wtsi/Pard3btm1b(EUCOMM)Wtsi
(C57BL/6N-Pard3btm1b(EUCOMM)Wtsi/Ieg)
|
increased cardiac muscle contractility
|
J:211773
|
Pasktm1Weng/Pasktm1Weng
(B6.129S6-Pasktm1Weng)
|
abnormal muscle physiology
|
J:125307
|
Pax3Sp-2H/Pax3Sp-2H
(involves: C57BL/6)
|
abnormal muscle precursor cell migration
|
J:32016
|
Pax3Sp-2H/Pax3Sp-2H
(involves: 101 * C3H/He * CBA/Ca)
|
decreased heart left ventricle muscle contractility
|
J:46341
|
Pax3Sp-2H/Pax3Sp-2H
(involves: 101 * C3H/He)
|
decreased heart left ventricle muscle contractility
|
J:46341
|
Pax3Sp/Pax3Sp
(involves: C57BL)
|
abnormal muscle precursor cell migration
|
J:32016
|
Pax3tm1Buck/Pax3tm1Buck
(involves: 129P2/OlaHsd)
|
abnormal muscle precursor cell migration
|
J:176192
|
Pax3tm3.1(Pax7)Buck/Pax3tm3.1(Pax7)Buck
(involves: 129S2/SvPas)
|
abnormal muscle precursor cell migration
|
J:90568
|
Pax3tm6.1(Pax8)Buck/Pax3tm6.1(Pax8)Buck
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal muscle precursor cell migration
|
J:176192
|
Pax7tm1(cre/ERT2)Gaka/0 Snhg15tm1.1Nju/Snhg15tm1.1Nju
(involves: C57BL/6J * SJL/J)
|
delayed skeletal muscle regeneration
|
J:291983
|
Pax7tm1(cre/ERT2)Gaka/Pax7+ Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:174914
|
Pax7tm1(cre/ERT2)Gaka/Pax7tm1(cre/ERT2)Gaka Styxl2tm1Nju/Styxl2tm1Nju
(involves: 129S * C57BL/6)
|
impaired skeletal muscle contractility
|
J:351096
|
impaired skeletal muscle regeneration
|
J:351096
|
Pax7tm1.1(HBEGF,-EYFP)Mal/Pax7+
(involves: C57BL/6)
|
impaired skeletal muscle regeneration
|
J:180899
|
myositis
|
J:180899
|
Pax7tm1.1(HBEGF,-EYFP)Mal/Pax7+ Tg(Pax7-EGFP)15Tajb/0
(involves: C57BL/6 * SJL/J)
|
abnormal muscle regeneration
|
J:180899
|
Pax7tm1.1Thbr/Pax7tm1.1Thbr
(Not Specified)
|
abnormal skeletal muscle satellite cell proliferation
|
J:202693
|
Pax7tm1.1Thbr/Pax7tm1.1Thbr Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJaeSor)
|
impaired skeletal muscle regeneration
|
J:202693
|
Pax7tm1.1Thbr/Pax7tm2.1(cre/ERT2)Fan
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle regeneration
|
J:202693
|
abnormal skeletal muscle satellite cell proliferation
|
J:202693
|
Pax7tm1.2Fan/Pax7tm1.2Fan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
impaired skeletal muscle regeneration
|
J:150962
|
Pax7tm1Pgr/Pax7tm1Pgr
(involves: 129S2/SvPas)
|
abnormal muscle regeneration
|
J:64793
|
muscle weakness
|
J:64793
|
Pax7tm2Pgr/Pax7tm2Pgr
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal muscle regeneration
|
J:92280
|
Pccatm1Tmiy/Pccatm1Tmiy Tg(CAG-PCCA*A138T,-EGFP)#Miab/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:282292
|
Pcdh15m2Btlr/Pcdh15m2Btlr
(involves: C57BL/6J)
|
dystonia
|
J:198553
|
Pcdhgtm1.1Tman/Pcdhgtm1.1Tman
(involves: 129S4/SvJae * C57BL/6)
|
muscle hypertonia
|
J:188341
|
Pcmt1tm1Shs/Pcmt1tm1Shs
(involves: 129P2/OlaHsd * C57BL/6)
|
myoclonus
|
J:46228
|
Pdctm1Luhe/Pdctm1Luhe
(B6.129P2-Pdctm1Luhe)
|
decreased vasodilation
|
J:155373
|
increased heart ventricle muscle contractility
|
J:155373
|
increased vasoconstriction
|
J:155373
|
Pdcd1tm1Hon/Pdcd1tm1Hon
(C.129S2(B6)-Pdcd1tm1Hon)
|
abnormal cardiac muscle contractility
|
J:66979
|
Pde1aem1Cjwa/Pde1aem1Cjwa
(C57BL/6J-Pde1aem1Cjwa)
|
increased heart left ventricle muscle contractility
|
J:246596
|
Pde1aem2Cjwa/Pde1aem2Cjwa
(C57BL/6J-Pde1aem2Cjwa)
|
increased heart left ventricle muscle contractility
|
J:246596
|
Pde4dtm1Mct/Pde4dtm1Mct
(involves: 129P2/OlaHsd)
|
increased cardiac muscle contractility
|
J:96125
|
Pdgfrbtm14(Pdgfrb)Sor/Pdgfrb+ Tg(Tagln-cre)1Her/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL)
|
increased vascular smooth muscle cell proliferation
|
J:173602
|
Pdha1tm1Ptl/Y Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
decreased cardiac muscle contractility
|
J:141289
|
Pdha1tm1Ptl/Pdha1+ Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
decreased cardiac muscle contractility
|
J:141289
|
Pdk2tm1Rhar/Pdk2tm1Rhar
(B6.129-Pdk2tm1Rhar)
|
impaired skeletal muscle contractility
|
J:172411
|
Pdlim3tm1Krc/Pdlim3tm1Krc
(either: (involves: 129S) or (involves: C57BL/6) or (involves: Black Swiss))
|
decreased heart right ventricle muscle contractility
|
J:69097
|
dilated cardiomyopathy
|
J:69097
|
Pdlim5tm1.1Chen/Pdlim5tm1.1Chen
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal cardiac muscle contractility
|
J:175042
|
dilated cardiomyopathy
|
J:175042
|
Pdlim5tm1Chen/Pdlim5tm1Chen Tg(Tnnt2-cre)5Blh/?
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * DBA/2)
|
decreased heart left ventricle muscle contractility
|
J:175042
|
dilated cardiomyopathy
|
J:175042
|
Pdpk1tm1.1Mlw/Pdpk1tm1.1Mlw Tg(Ckmm-cre)5Khn/?
(involves: BALB/c)
|
decreased cardiac muscle contractility
|
J:85498
|
dilated cardiomyopathy
|
J:85498
|
Pdss2kd/Pdss2kd
(CBA/H-Pdss2kd)
|
myopathy
|
J:197578
|
Pdxptm1.2Ango/Pdxptm1.2Ango
(involves: C57BL/6J)
|
muscle weakness
|
J:270551
|
Pecam1Gt(OST16303)Lex/Pecam1Gt(OST16303)Lex
(B6.129S5-Pecam1Gt(OST16303)Lex)
|
decreased vasodilation
|
J:104082
|
Pecam1Gt(OST16303)Lex/Pecam1Gt(OST16303)Lex
(B6.129S-Pecam1Gt(OST16303)Lex/J)
|
abnormal vasodilation
|
J:114343
|
decreased vasodilation
|
J:114343
|
Perm1em1Jswn/Perm1em1Jswn
(C57BL/6-Perm1em1Jswn)
|
decreased cardiac muscle contractility
|
J:334191
|
Pex5tm1Baes/Pex5tm1Baes
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle weakness
|
J:42719
|
Pex7tm1Rjaw/Pex7tm1Rjaw
(Swiss)
|
dystonia
|
J:92346
|
Pex13tm1.1Crne/Pex13tm1.1Crne
(involves: 129T2/SvEms * C57BL/6J)
|
hypotonia
|
J:84795
|
Pfkmtm1Fbos/Pfkmtm1Fbos
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal muscle physiology
|
J:152153
|
enhanced skeletal muscle regeneration
|
J:152153
|
Pik3c3tm1c(EUCOMM)Wtsi/Pik3c3tm1c(EUCOMM)Wtsi Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB/N)
|
decreased cardiac muscle contractility
|
J:182628
|
Pik3catm1.1Rzl/Pik3catm1.1Rzl A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:166421
|
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd)
|
abnormal cardiac muscle relaxation
|
J:79151
|
increased cardiac muscle contractility
|
J:79151
|
Pik3cgtm1Pngr/Pik3cgtm1Pngr Ptentm2Mak/Ptentm2Mak Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
increased cardiac muscle contractility
|
J:79151
|
Pik3cgtm1Wym/Pik3cgtm1Wym
(involves: 129S1/Sv * 129X1/SvJ)
|
increased cardiac muscle contractility
|
J:79151
|
Pik3r1tm1Tka/Pik3r1tm1Tka
(involves: C57BL/6 * CBA)
|
increased skeletal muscle cell glucose uptake
|
J:52576
|
Pik3r4tm1.1Mpnd/Pik3r4tm1.1Mpnd Tg(ACTA1-cre)79Jme/0
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL)
|
muscle weakness
|
J:198770
|
myopathy
|
J:198770
|
myositis
|
J:198770
|
Pikfyvetm1.1Ashi/Pikfyvetm1.1Ashi Tg(Ckm-cre)28Arte/0
(involves: C57BL/6)
|
decreased muscle cell glucose uptake
|
J:199213
|
Pkn1tm1Ajmc/Pkn1tm1Ajmc
(B6.129P2-Pkn1tm1Ajmc)
|
decreased cardiac muscle contractility
|
J:258572
|
decreased cardiac muscle relaxation
|
J:258572
|
pl/pl
(involves: PERU-COPPOCK)
|
abnormal muscle tone
|
J:14122
|
Pla2g5tm1.1Kiku/Pla2g5tm1.1Kiku
(involves: 129 * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:186024
|
abnormal cardiomyocyte apoptosis
|
J:186024
|
Pla2g10tm1Kiku/Pla2g10tm1Kiku
(B6.129P2-Pla2g10tm1Kiku)
|
abnormal cardiac muscle contractility
|
J:155082
|
Plattm1Mlg/Plattm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:95236
|
Platr4em#Dlsp/Platr4em#Dlsp
(B6.Cg-Platr4em#Dlsp)
|
decreased cardiac muscle contractility
|
J:331476
|
Plautm1Mlg/Plautm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
increased heart left ventricle muscle contractility
|
J:95236
|
Plautm1Mlg/Plautm1Mlg
(B6.Cg-Plautm1Mlg)
|
impaired skeletal muscle regeneration
|
J:68083
|
myopathy
|
J:73613
|
Plaurtm1Mlg/Plaurtm1Mlg
(B6.Cg-Plaurtm1Mlg)
|
myoclonus
|
J:81735
|
Plce1tm1Avsm/Plce1tm1Avsm
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:117556
|
Plce1tm1Tkat/Plce1tm1Tkat
(involves: 129/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:97661
|
decreased heart ventricle muscle contractility
|
J:97661
|
Plectm1Gwi/Plectm1Gwi
(involves: 129S1/Sv * 129X1/SvJ)
|
myopathy
|
J:59000
|
Plectm2Gwi/Plectm2Gwi
(involves: 129S1/Sv * 129X1/SvJ)
|
myopathy
|
J:59000
|
Plekha1tm1.1Arte/Plekha1tm1.1Arte Plekha2tm1.1Arte/Plekha2tm1.1Arte
(C57BL/6J-Plekha1tm1.1Arte Plekha2tm1.1Arte)
|
increased cardiac muscle cell glucose uptake
|
J:169475
|
increased skeletal muscle cell glucose uptake
|
J:169475
|
Plekhg5tm1Jbar/Plekhg5tm1Jbar Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
decreased heart ventricle muscle contractility
|
J:195233
|
Plin5tm1Macl/Plin5tm1Macl
(involves: 129S6/SvEvTac * C57BL/6JBomTac)
|
decreased cardiac muscle contractility
|
J:286482
|
increased cardiac muscle cell glucose uptake
|
J:286482
|
Plin5tm1Tosu/Plin5tm1Tosu
(involves: C57BL/6JJcl)
|
decreased cardiac muscle contractility
|
J:188390
|
Plntm1Egk/Plntm1Egk
(involves: 129S2/SvPas * CF-1)
|
increased cardiac muscle contractility
|
J:39745,
J:59967
|
Plntm1Egk/Plntm1Egk
(involves: 129S2/SvPas)
|
abnormal cardiac muscle relaxation
|
J:106044
|
increased cardiac muscle contractility
|
J:106044
|
Plntm1Egk/Plntm1Egk Tg(Myh6-Pln)11Egk/?
(involves: 129S2/SvPas)
|
abnormal cardiac muscle contractility
|
J:66084
|
Plntm1Egk/Plntm1Egk Tnnt2tm2.1Feah/Tnnt2+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N)
|
decreased cardiac muscle contractility
|
J:243725
|
dilated cardiomyopathy
|
J:243725
|
Plod1tm1Soin/Plod1tm1Soin
(involves: 129S6/SvEvTac * C57BL/6)
|
hypotonia
|
J:120891
|
Plod3tm1Rmyl/Plod3tm1Rmyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased vasodilation
|
J:106510
|
Plod3tm2Rmyl/Plod3tm2Rmyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased vasodilation
|
J:106510
|
Plpp7em1Eno/Plpp7em1Eno
(involves: C3H * C57BL/6 * C57BL/6N)
|
abnormal muscle physiology
|
J:302139
|
muscle weakness
|
J:302139
|
Plrg1tm2Jcbr/Plrg1tm2Jcbr Tg(Ckmm-cre)5Khn/0
(involves: FVB)
|
decreased heart ventricle muscle contractility
|
J:149153
|
dilated cardiomyopathy
|
J:149153
|
increased cardiomyocyte apoptosis
|
J:149153
|
pma/pma
(involves: CF-1)
|
myopathy
|
J:8195
|
Pmm2tm1.1Jins/Pmm2tm2.1Jins
(involves: 129S6/SvEvTac * C57BL/6J)
|
hypotonia
|
J:236704
|
Pmp22tm1Lnot/Pmp22tm1Lnot
(Not Specified)
|
muscle weakness
|
J:104989
|
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cardiomyocyte apoptosis
|
J:108546
|
decreased heart left ventricle muscle contractility
|
J:108546
|
Pnpla2tm1Rze/Pnpla2tm1Rze
(involves: 129P2/OlaHsd)
|
decreased heart ventricle muscle contractility
|
J:176252
|
Pold1tm1Loeb/Pold1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cardiomyopathy
|
J:129046
|
Poldip2Gt(IST12080D9)Tigm/Poldip2+
(involves: C57BL/6N)
|
abnormal vasoconstriction
|
J:211022
|
abnormal vasodilation
|
J:211022
|
Polrmttm1.1Arte/Polrmttm1.1Arte Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB)
|
dilated cardiomyopathy
|
J:258184
|
Pomgnt1tm1Stk/Pomgnt1tm1Stk
(involves: 129S/SvEv)
|
abnormal muscle physiology
|
J:144928
|
abnormal muscle regeneration
|
J:144928
|
abnormal skeletal muscle satellite cell proliferation
|
J:144928
|
Pomt1Gt(OST194127)Lex/Pomt1+
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased vasodilation
|
J:103485
|
Popdc1tm1Tbd/Popdc1tm1Tbd
(involves: 129S4/SvJae)
|
delayed skeletal muscle regeneration
|
J:74656
|
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
|
cardiomyopathy
|
J:81834
|
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae)
|
cardiomyopathy
|
J:63801
|
Pparatm1Gonz/Pparatm1Gonz
(involves: 129S4/SvJae * C57BL/6J)
|
increased muscle cell glucose uptake
|
J:129848
|
Ppardtm1Dsvg/Ppardtm1Dsvg
(involves: 129S2/SvPas * C57BL/6)
|
muscle weakness
|
J:219677
|
Ppargtm1Lja/Pparg+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased skeletal muscle cell glucose uptake
|
J:98786
|
Ppargtm2Rev/Ppargtm2Rev Tg(Tek-cre)12Flv/?
(B6.Cg-Ppargtm2Rev Tg(Tek-cre)12Flv)
|
abnormal vasodilation
|
J:154216
|
impaired muscle relaxation
|
J:154216
|
Ppargc1atm1Brsp/Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N)
|
dystonia
|
J:93896
|
myoclonus
|
J:93896
|
Ppargc1atm1Dpk/Ppargc1atm1Dpk
(involves: 129X1/SvJ * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:96306
|
increased muscle fatigability
|
J:96306
|
Ppargc1btm1.1Dpk/Ppargc1btm1.1Dpk
(involves: 129X1/SvJ * FVB/N)
|
abnormal muscle physiology
|
J:137598
|
Ppp1r3atm1Ptwc/Ppp1r3atm1Ptwc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased skeletal muscle cell glucose uptake
|
J:82422
|
Ppp1r3ctm1Adpr/Ppp1r3ctm1Adpr
(B6.Cg-Ppp1r3ctm1Adpr)
|
increased muscle cell glucose uptake
|
J:242758
|
Ppp1r3ctm1Ars/Ppp1r3c+
(B6.129-Ppp1r3ctm1Ars)
|
decreased skeletal muscle cell glucose uptake
|
J:83297
|
Ppp1r12atm1Mzhu/Ppp1r12atm1Mzhu Tg(Acta2-cre)#Xya/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal muscle contractility
|
J:207752
|
abnormal muscle electrophysiology
|
J:207752
|
intestinal hypoperistalsis
|
J:207752
|
Ppp1r12bem1(IMPC)J/Ppp1r12bem1(IMPC)J
(C57BL/6NJ-Ppp1r12bem1(IMPC)J/Mmjax)
|
increased cardiac muscle contractility
|
J:335272
|
Ppp1r13ltm1.1Xlu/Ppp1r13ltm1.1Xlu
(involves: 129 * C57BL/6J)
|
decreased heart ventricle muscle contractility
|
J:220162
|
ventricular cardiomyopathy
|
J:220162
|
Ppp1r13lwa3-J/Ppp1r13lwa3-J
(BALB/cJ-Ppp1r13lwa3-J/J)
|
cardiomyopathy
|
J:146206
|
dilated cardiomyopathy
|
J:264272
|
Ppp1r13lwa3/Ppp1r13lwa3
(either: C57BL/6-Ppp1r13lwa3 or (involves: C57BL/6 * DBA/2J))
|
decreased cardiac muscle contractility
|
J:96392
|
dilated cardiomyopathy
|
J:96392
|
Ppp1r14aem1Gpt/Ppp1r14a+
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:290992
|
Ppp1r14aem1Gpt/Ppp1r14aem1Gpt
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:290992
|
Ppp2r5cGt(XP0444)Wtsi/Ppp2r5cGt(XP0444)Wtsi
(B6.129P2-Ppp2r5cGt(XP0444)Wtsi)
|
increased fetal cardiomyocyte apoptosis
|
J:210365
|
Ppp3cbtm1Jmk/Ppp3cbtm1Jmk Tg(Myh6/tetO-Tnnc1*I61Q)1Jmol/0 Tg(Myh6-tTA)55Rbns/0
(involves: 129S6/SvEvTac * FVB)
|
decreased cardiac muscle contractility
|
J:234490
|
Ppp3r1tm1.1Jhon/Ppp3r1tm1.1Jhon
(involves: C57BL/6 * C57BL/6NTac)
|
decreased heart left ventricle muscle contractility
|
J:298603
|
dilated cardiomyopathy
|
J:298603
|
increased cardiomyocyte apoptosis
|
J:298603
|
Ppp3r1tm2Grc/Ppp3r1tm2.1Grc Tg(Pax3-cre)1Joe/0
(involves: 129S6/SvEvTac)
|
impaired ureteric peristalsis
|
J:89217
|
Ppp3r1tm2Grc/Ppp3r1tm2Grc Tg(Pax3-cre)1Joe/0
(involves: 129S6/SvEvTac)
|
impaired ureteric peristalsis
|
J:89217
|
Ppt1tm1Aj/Ppt1tm1Aj
(involves: 129S4/SvJae * C57BL/6)
|
myoclonus
|
J:95522
|
Ppt1tm1Hof/Ppt1tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J)
|
myoclonus
|
J:72931
|
Ppt2tm1Hof/Ppt2tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J)
|
muscle spasm
|
J:86202
|
Prdm4tm1b(EUCOMM)Hmgu/Prdm4tm1b(EUCOMM)Hmgu
(C57BL/6N-Prdm4tm1b(EUCOMM)Hmgu/H)
|
increased cardiac muscle contractility
|
J:211773
|
Prdm16tm1.1Brsp/Prdm16tm1.1Brsp Tg(myl7.L-cre)1118Tmhn/0
(involves: 129 * C57BL/6J * MF1)
|
cardiomyopathy
|
J:326525
|
decreased cardiac muscle contractility
|
J:326525
|
decreased fetal cardiomyocyte proliferation
|
J:326525
|
Prepltm1.2Sagh/Prepltm1.2Sagh
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * Swiss Webster)
|
hypotonia
|
J:213429
|
Prkaa1tm1Sbj/Prkaa1tm1Sbj
(involves: 129S2/SvPas * C57BL/6J)
|
decreased skeletal muscle cell glucose uptake
|
J:87719
|
Prkaa2tm1.1Vio/Prkaa2tm1.1Vio
(involves: 129S2/SvPas)
|
decreased skeletal muscle cell glucose uptake
|
J:87719
|
increased skeletal muscle cell glucose uptake
|
J:87719
|
Prkab1tm1Grst/Prkab1tm1Grst Prkab2tm1Grst/Prkab2tm1Grst Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6 * FVB)
|
decreased muscle cell glucose uptake
|
J:176578
|
increased muscle fatigability
|
J:176578
|
Prkab2Gt(AL0483)Wtsi/Prkab2Gt(AL0483)Wtsi
(B6.129P2-Prkab2Gt(AL0483)Wtsi)
|
decreased muscle cell glucose uptake
|
J:186658
|
Prkab2tm1.1Grst/Prkab2tm1.1Grst
(involves: C57BL/6)
|
decreased skeletal muscle cell glucose uptake
|
J:167339
|
increased muscle cell glucose uptake
|
J:167339
|
muscle weakness
|
J:167339
|
Prkag2tm1.1Geno/Prkag2tm1.1Geno
(B6J.129S(Cg)-Prkag2tm1.1Geno)
|
decreased cardiac muscle contractility
|
J:256296
|
Prkar1atm2Gsm/Prkar1atm2Gsm Tlx2tm1.1(cre)Rpk/Tlx2+
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6 * C57BL/6N * DBA/2)
|
intestinal hypoperistalsis
|
J:148464
|
Prkcatm1Far/Prkcatm1Far
(involves: 129/Sv * 129P2/OlaHsd)
|
increased skeletal muscle cell glucose uptake
|
J:85923
|
Prkcatm1Jmk/Prkcatm1Jmk
(involves: 129)
|
abnormal cardiac muscle contractility
|
J:132098
|
Prkcitm1Rfar/Prkci+ Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased cardiac muscle cell glucose uptake
|
J:123964
|
decreased muscle cell glucose uptake
|
J:123964
|
decreased skeletal muscle cell glucose uptake
|
J:123964
|
Prkcitm1Rfar/Prkcitm1Rfar Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased cardiac muscle cell glucose uptake
|
J:123964
|
decreased skeletal muscle cell glucose uptake
|
J:123964
|
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle cell glucose uptake
|
J:92834
|
Prkd1tm1Eno/Prkd1tm1Eno Tg(Myh6-cre)2182Mds/?
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
increased cardiac muscle contractility
|
J:132803
|
Prkg1tm1.1Arte/Prkg1tm1.1Arte
(C57BL/6-Prkg1tm1.1Arte)
|
decreased vasodilation
|
J:181180
|
Prkg1tm1Hfm/Prkg1tm1Hfm
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:48058
|
abnormal intestinal peristalsis
|
J:48058
|
abnormal vascular smooth muscle physiology
|
J:48058
|
impaired muscle relaxation
|
J:60928,
J:48058
|
impaired smooth muscle contractility
|
J:94387
|
Prkg1tm1Meme/Prkg1tm1Meme
(involves: 129S/SvEv)
|
decreased vasodilation
|
J:134634
|
Prkg1tm1Naw/Prkg1tm1Naw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal cardiac muscle contractility
|
J:84611
|
Prkg1tm2.1Naw/Prkg1tm2.1Naw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:134928
|
Prmt7tm1.1Rchd/Prmt7tm1.1Rchd Pax7tm1(cre/ERT2)Gaka/Pax7+
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal muscle physiology
|
J:271361
|
impaired skeletal muscle regeneration
|
J:271361
|
Prmt7tm1.2Rchd/Prmt7tm1.2Rchd
(involves: 129S4/SvJaeSor * FVB/N)
|
abnormal muscle physiology
|
J:271361
|
impaired skeletal muscle regeneration
|
J:271361
|
Prnptm1Cwe/Prnptm1Cwe Tg(Prnp*)#Rgab/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
myoclonus
|
J:183170
|
Prnptm2.1Cwe/Prnptm2.1Cwe
(involves: 129P2/OlaHsd)
|
abnormal muscle physiology
|
J:67593
|
Prorptm1.1Afi/Prorptm1.1Afi Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6N * FVB)
|
cardiomyopathy
|
J:238964
|
Prox1tm2Gco/Prox1tm2Gco Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
decreased heart ventricle muscle contractility
|
J:212185
|
dilated cardiomyopathy
|
J:212185
|
Prrt2tm1d(KOMP)Wtsi/Prrt2+
(B6(Cg)-Prrt2tm1d(KOMP)Wtsi)
|
dystonia
|
J:299667
|
Prrt2tm1d(KOMP)Wtsi/Prrt2tm1d(KOMP)Wtsi
(B6(Cg)-Prrt2tm1d(KOMP)Wtsi)
|
dystonia
|
J:299667
|
Psaptm1Suz/Psaptm1Suz
(involves: 129P2/OlaHsd)
|
progressive muscle weakness
|
J:33477
|
Psaptm2Suz/Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J)
|
abnormal intestinal peristalsis
|
J:78223
|
muscle weakness
|
J:78223
|
Psen1tm1Hko/Psen1tm1Hko
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased vasodilation
|
J:84418
|
Psmf1tm1c(EUCOMM)Hmgu/Psmf1tm1c(EUCOMM)Hmgu Tg(CDX2-cre)101Erf/0
(involves: C57BL/6J * C57BL/6N * SJL/J)
|
abnormal muscle tone
|
J:282431
|
Ptcd1tm1(KOMP)Vlcg/Ptcd1+
(C57BL/6N-Ptcd1tm1(KOMP)Vlcg)
|
increased cardiac muscle contractility
|
J:256004
|
Ptch1tm1Mps/Ptch1+ Ptch2tm1Pmc/Ptch2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
telangiectasia
|
J:112118
|
Ptchd1tm2.2Gfng/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
hypotonia
|
J:232709
|
Ptentm1Hwu/Ptentm1Hwu Tg(Ckmm-cre)5Khn/?
(involves: 129S4/SvJae * FVB)
|
enhanced skeletal muscle regeneration
|
J:169364
|
Ptentm2Mak/Ptentm2Mak Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB)
|
decreased cardiac muscle contractility
|
J:79151
|
Ptentm2Mak/Ptentm2Mak Tg(Ckmm-cre)5Khn/0 Tg(Myh6-Pik3ca)1Siz/0
(involves: 129P2/OlaHsd * FVB)
|
decreased cardiac muscle contractility
|
J:79151
|
Ptgdrtm1Dgen/Ptgdr+
(B6.129P2-Ptgdrtm1Dgen)
|
decreased vasodilation
|
J:109107
|
increased vasodilation
|
J:109107
|
Ptgdrtm1Dgen/Ptgdrtm1Dgen
(B6.129P2-Ptgdrtm1Dgen)
|
decreased vasodilation
|
J:109107
|
Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal vasodilation
|
J:53646
|
Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac)
|
abnormal vasodilation
|
J:78902
|
increased vasoconstriction
|
J:78902
|
Ptger3tm1Cof/Ptger3tm1Cof
(involves: 129P2/OlaHsd)
|
increased vasodilation
|
J:77409
|
Ptger4tm1.1Matb/Ptger4tm1.1Matb Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * FVB/N)
|
decreased cardiac muscle contractility
|
J:158439
|
dilated cardiomyopathy
|
J:158439
|
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
hypotonia
|
J:146321
|
Ptgs2tm1Gaf/Ptgs2tm1Gaf A1cfTg(Myh6-cre/Esr1*)1Jmk/?
(involves: 129/Sv * C57BL/6 * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:148331
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6;129P2-Ptgs2tm1Unc/Tac)
|
impaired skeletal muscle regeneration
|
J:107751
|
Ptk2btm1Okig/Ptk2btm1Okig
(involves: C57BL/6)
|
decreased vasodilation
|
J:139849
|
Ptpn11tm1.1Ics/Ptpn11+
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:216593
|
dilated cardiomyopathy
|
J:216593
|
Ptpn11tm1Bgn/Ptpn11+
(involves: 129S4/SvJae * C57BL/6J)
|
decreased cardiomyocyte apoptosis
|
J:91609
|
Ptpn11tm1Bgn/Ptpn11tm1Bgn
(involves: 129S4/SvJae * C57BL/6J)
|
decreased cardiomyocyte apoptosis
|
J:91609
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Tg(Ckmm-cre)5Khn/0
(involves: 129S1/Sv * 129X1/SvJ * FVB)
|
decreased cardiac muscle cell glucose uptake
|
J:144767
|
decreased heart left ventricle muscle contractility
|
J:144767
|
decreased skeletal muscle cell glucose uptake
|
J:144767
|
dilated cardiomyopathy
|
J:144767
|
Ptpn11tm4.2Bgn/Ptpn11+
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:172033
|
dilated cardiomyopathy
|
J:172033
|
Ptprmtm1Mfbg/Ptprmtm1Mfbg
(FVB.129P2-Ptprmtm1Mfbg)
|
decreased vasodilation
|
J:97057
|
Ptprvtm1Kry/Ptprvtm1Kry Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
increased muscle cell glucose uptake
|
J:126780
|
Ptrh2tm1.1Eruo/Ptrh2tm1.1Eruo
(C57BL/6-Ptrh2tm1.1Eruo)
|
myopathy
|
J:241883
|
progressive muscle weakness
|
J:241883,
J:131853
|
Ptstm1Ich/Ptstm1Ich Tg(DBH-PTS)6Csic/0
(involves: 129X1/SvJ * C57BL/6J)
|
dystonia
|
J:138968
|
Ptstm1Thny/Ptstm1Thny
(involves: 129/Sv * C57BL/6)
|
dystonia
|
J:84533
|
Pus1tm1.1Mdf/Pus1tm1.1Mdf
(B6.129S7(C)-Pus1tm1.1Mdf)
|
abnormal muscle physiology
|
J:237107
|
Pvalbtm1Swal/Pvalbtm1Swal
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle contractility
|
J:53121
|
R3hdmltm1Mita/R3hdmltm1Mita
(B6.Cg-R3hdmltm1Mita)
|
abnormal skeletal muscle satellite cell proliferation
|
J:282737
|
impaired skeletal muscle regeneration
|
J:282737
|
Rac1tm1Djk/Rac1tm1Djk Tg(Nkx2-5-cre)9Eno/0
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:321017
|
Raf1tm1.1Bgn/Raf1+
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
decreased cardiac muscle contractility
|
J:172034
|
dilated cardiomyopathy
|
J:172034
|
increased cardiac muscle contractility
|
J:189143,
J:172034
|
Raf1tm2.1Ara/Raf1tm2.1Ara
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
increased cardiac muscle contractility
|
J:189143
|
Raf1tm2Bacc/Raf1tm2Bacc Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:93418
|
decreased heart left ventricle muscle contractility
|
J:93418
|
increased cardiomyocyte apoptosis
|
J:93418
|
Ralgapa1tm1.1Schen/Ralgapa1tm1.1Schen
(involves: C57BL/6J)
|
abnormal muscle physiology
|
J:287672
|
decreased muscle cell glucose uptake
|
J:287672
|
Ralgapa1tm2c(KOMP)Wtsi/Ralgapa1tm2c(KOMP)Wtsi Myl1tm1(cre)Sjb/Myl1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N)
|
increased muscle cell glucose uptake
|
J:287672
|
Ramp1tm1.1Tsuj/Ramp1tm1.1Tsuj
(involves: 129S2/SvPas * C57BL/6)
|
decreased vasodilation
|
J:125974
|
Rangrftm1.1Tke/Rangrftm1.1Tke
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:325055
|
Rap1gds1tm1Ytk/Rap1gds1tm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
increased cardiomyocyte apoptosis
|
J:62244
|
Rapsntm1Jrs/Rapsntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ)
|
muscle weakness
|
J:28777
|
Rarres2tm1Yktk/Rarres2tm1Yktk
(B6.Cg-Rarres2tm1Yktk)
|
increased muscle cell glucose uptake
|
J:206120
|
Rasa1tm1Wid/Rasa1tm1Wid
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6N)
|
increased cardiomyocyte apoptosis
|
J:189241
|
Rb1tm1Tyj/Rb1tm1Tyj Tg(Rb1)1Blg/0 Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:65679
|
Rb1tm2Brn/Rb1tm2Brn Rbl2tm1Tyj/Rbl2tm1Tyj Tg(Myh6-cre)2182Mds/Tg(Myh6-cre)2182Mds
(involves: 129 * 129S2/SvPas * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:97589
|
Rbkstm1d(EUCOMM)Wtsi/Rbkstm1d(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
interstinal hyperperistalsis
|
J:236053
|
Rbl1tm1Mru/Rbl1tm1Mru
(involves: 129S4/SvJae * BALB/cJ)
|
abnormal muscle physiology
|
J:51060
|
Rbm20em1Hide/Rbm20+
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:297234
|
Rbm20em1Hide/Rbm20em1Hide
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:297234
|
dilated cardiomyopathy
|
J:297234
|
Rbm20em2Wguo/Rbm20em2Wguo
(C57BL/6J-Rbm20em2Wguo)
|
dilated cardiomyopathy
|
J:324125
|
Rbm20em3Hide/Rbm20em3Hide
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:297234
|
Rbm20em3Wguo/Rbm20+
(C57BL/6-Rbm20em3Wguo)
|
decreased heart left ventricle muscle contractility
|
J:324088
|
dilated cardiomyopathy
|
J:324088
|
Rbm20em3Wguo/Rbm20em3Wguo
(C57BL/6-Rbm20em3Wguo)
|
decreased heart left ventricle muscle contractility
|
J:324088
|
dilated cardiomyopathy
|
J:324088
|
Rbm20tm1Hgra/Rbm20tm1Hgra
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:208676
|
Rbm24tm1.1Xixu/Rbm24tm1.1Xixu Tg(Myh6-cre)1Xya/0
(involves: C57BL/6NTac)
|
decreased heart left ventricle muscle contractility
|
J:302917
|
dilated cardiomyopathy
|
J:302917
|
Rbp4tm1Gott/Rbp4tm1Gott
(involves: 129/Sv * C57BL/6 * CD-1)
|
abnormal fetal cardiomyocyte proliferation
|
J:82903
|
Rbpjtm1Kyo/Rbpj+
(involves: 129S2/SvPas * CD-1)
|
decreased cardiac muscle contractility
|
J:187551
|
Rbpjtm1Kyo/Rbpjtm1Kyo
(involves: 129S2/SvPas)
|
abnormal fetal cardiomyocyte proliferation
|
J:119151
|
Rbpmsem1Eno/Rbpmsem1Eno
(involves: C3H * C57BL/6)
|
cardiomyopathy
|
J:324468
|
decreased cardiac muscle contractility
|
J:324468
|
Rce1tm2Kim/Rce1tm2.1Kim Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6)
|
dilated cardiomyopathy
|
J:87958
|
Relatm2.1Gho/Relatm2.1Gho
(involves: 129S6/SvEvTac * C57BL/6)
|
myositis
|
J:163663
|
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
myositis
|
J:22675
|
Relnrl-6J/Relnrl-6J
(C57BL/6J-Relnrl-6J/J)
|
muscle spasm
|
J:87349
|
Ren1tm1.2Sig/Ren1tm1.2Sig
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:169129
|
Rettm1Cos/Ret+
(involves: 129S/SvEv * C57BL/6)
|
intestinal hypoperistalsis
|
J:82456
|
Rettm1Cos/Rettm1Cos
(involves: 129S/SvEv * MF1)
|
intestinal hypoperistalsis
|
J:23852,
J:30389
|
Rettm2Cos/Rettm2Cos
(involves: 129S1/Sv)
|
abnormal intestinal peristalsis
|
J:60659
|
Rettm3(RET)Vpa/Rettm3(RET)Vpa
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal intestinal peristalsis
|
J:102170
|
Rfx3b2b1213Clo/Rfx3b2b1213Clo
(C57BL/6J-Rfx3b2b1213Clo)
|
cardiomyopathy
|
J:175213
|
Rgs2tm1.1Kjb/Rgs2tm1.1Kjb Tg(Tek-cre/ERT2)1Arnd/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased vasodilation
|
J:184284
|
Rgs2tm1Pngr/Rgs2tm1Pngr
(B6.129P2-Rgs2tm1Pngr)
|
decreased vasodilation
|
J:184284
|
increased vasoconstriction
|
J:184284
|
Rhebtm1.1Otsu/Rhebtm1.1Otsu Tg(Myh6-cre)2182Mds/0
(involves: 129 * C57BL/6J * FVB/N)
|
cardiomyopathy
|
J:197831
|
decreased cardiac muscle contractility
|
J:197831
|
Rictortm1Rueg/Rictortm1Rueg Rptortm1Rueg/Rptortm1Rueg Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:143748
|
Rnf5tm1Zron/Rnf5tm1Zron
(involves: 129S/SvEv * C57BL/6)
|
abnormal muscle regeneration
|
J:132185
|
Rnf170Gt(OST104375)Lex/Rnf170Gt(OST104375)Lex
(B6.129S-Rnf170Gt(OST104375)Lex)
|
abnormal muscle physiology
|
J:226836
|
Rnu2-8nmf291/Rnu2-8nmf291
(B6;129-Rnu2-8nmf291/J)
|
progressive muscle weakness
|
J:87349
|
Robo4tm1Kzh/Robo4tm1Kzh
(Not Specified)
|
increased vasodilation
|
J:294754
|
Rock2tm1.1Itl/Rock2+ Tg(Tagln-cre)1Her/0
(B6.Cg-Rock2tm1.1Itl Tg(Tagln-cre)1Her)
|
abnormal vascular smooth muscle physiology
|
J:222206
|
decreased vascular smooth muscle cell proliferation
|
J:222206
|
Rorasg/Rorasg
(involves: C57BL/6)
|
abnormal vasoconstriction
|
J:109735
|
abnormal vasodilation
|
J:109735
|
RpgrRd9/Y
(C57BL/6-RpgrRd9)
|
telangiectasia
|
J:237833
|
RpgrRd9/RpgrRd9
(C57BL/6-RpgrRd9)
|
telangiectasia
|
J:237833
|
Rpl3lem1Kei/Rpl3lem1Kei
(C57BL/6J-Rpl3em1Kei)
|
abnormal cardiac muscle contractility
|
J:335523
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho Rps6kb2tm1Gtho/Rps6kb2tm1Gtho
(involves: 129P2/OlaHsd)
|
abnormal muscle physiology
|
J:129852
|
Rps6kb1tm1Nte/Rps6kb1tm1Nte
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle regeneration
|
J:155912
|
Rptortm1Rueg/Rptortm1Rueg Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal muscle cell glucose uptake
|
J:143748
|
abnormal muscle physiology
|
J:143748
|
Rr28tm1Tilg/Rr28+ Igf2tm1Rob/Igf2+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J)
|
abnormal fetal cardiomyocyte proliferation
|
J:77413
|
Rr34tm1.1Lap/Rr34tm1.1Lap
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased cardiac muscle contractility
|
J:252154
|
Rr35tm1.1Lap/Rr35tm1.1Lap
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased cardiac muscle contractility
|
J:252154
|
Rradtm1Yec/Rradtm1Yec
(B6.129X1-Rradtm1Yec)
|
abnormal cardiac muscle contractility
|
J:143140
|
Rreb1em1Rtpl/Rreb1+
(C57BL/6J-Rreb1em1Rtpl)
|
cardiomyopathy
|
J:296982
|
decreased cardiac muscle contractility
|
J:296982
|
Rsph9em1Jwji/Rsph9em1Jwji
(B6.Cg-Rsph9em1Jwji)
|
muscle weakness
|
J:294184
|
Rtf1tm1c(KOMP)Wtsi/Rtf1tm1c(KOMP)Wtsi A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: C57BL/6N * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:338311
|
decreased heart ventricle muscle contractility
|
J:338311
|
dilated cardiomyopathy
|
J:338311
|
Rtn2tm1Lex/Rtn2+
(involves: 129S/SvEvBrd)
|
decreased skeletal muscle cell glucose uptake
|
J:158249
|
Rtn2tm1Lex/Rtn2tm1Lex
(involves: 129S/SvEvBrd)
|
decreased skeletal muscle cell glucose uptake
|
J:158249
|
Runx3tm1Yg/Runx3tm1Yg
(either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
abnormal muscle tone
|
J:77764
|
Runx3tm1Yg/Runx3tm1Yg
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle tone
|
J:77764
|
Rxratm1Rev/Rxratm1Rev
(involves: 129S4/SvJae * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:65904
|
Rxrgtm1Ysa/Rxrgtm1Ysa
(B6.129S2-Rxrgtm1Ysa)
|
increased muscle relaxation
|
J:77613
|
Ryr1em1Tmur/Ryr1+
(Not Specified)
|
abnormal muscle physiology
|
J:322211
|
Ryr1em1Zor/Ryr1+
(C57BL/6J-Ryr1em1Zor)
|
muscle weakness
|
J:275501
|
Ryr1em1Zor/Ryr1em2Zor
(C57BL/6J-Ryr1em1Zor Ryr1em2Zor)
|
muscle weakness
|
J:292405
|
Ryr1m1Nisw/Ryr1+
(129S1.B6-Ryr1m1Nisw)
|
muscle weakness
|
J:219285
|
myopathy
|
J:219285
|
Ryr1tm1.1Dhm/Ryr1+
(involves: 129S2/SvPasCrl * 129S6/SvEvTac)
|
impaired muscle contractility
|
J:155825
|
muscle weakness
|
J:155825
|
myopathy
|
J:155825
|
Ryr1tm1.1Dhm/Ryr1tm1.1Dhm
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal muscle physiology
|
J:127629
|
impaired skeletal muscle contractility
|
J:127629
|
Ryr1tm1.1Inp/Ryr1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle physiology
|
J:181523
|
Ryr1tm1.1Inp/Ryr1tm1.1Inp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle physiology
|
J:181523
|
impaired muscle relaxation
|
J:181523
|
Ryr1tm1.1Itl/?
(B6.Cg-Ryr1tm1.1Itl)
|
abnormal muscle contractility
|
J:176731
|
abnormal muscle physiology
|
J:176731
|
Ryr1tm1.1Msnr/Ryr1tm1.1Msnr
(129S.129P2-Ryr1tm1.1Msnr)
|
abnormal muscle contractility
|
J:195542
|
abnormal muscle electrophysiology
|
J:195542
|
muscle tetany
|
J:195542
|
muscle twitch
|
J:195542
|
Ryr1tm1Slh/Ryr1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle contractility
|
J:105738
|
abnormal muscle physiology
|
J:105738
|
Ryr1tm1Slh/Ryr1tm1Slh
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal muscle physiology
|
J:105738
|
Ryr1tm1Tno/Ryr1tm1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
impaired skeletal muscle contractility
|
J:18895
|
Ryr1tm2.1Itl/?
(B6.Cg-Ryr1tm2.1Itl)
|
abnormal muscle physiology
|
J:205099
|
Ryr1tm3.1Alle/Ryr1+
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle physiology
|
J:303297
|
Ryr1tm3.1Alle/Ryr1tm3.1Alle
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle physiology
|
J:303297
|
Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs/Ryr2tm1(CAG-KRAS*G12V,-lacZ)Nobs Trp53tm1Sia/Trp53tm1Sia
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
myositis
|
J:117828
|
Ryr2tm1.1Msnr/Ryr2tm1.1Msnr
(involves: 129S6/SvEvTac * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:122033
|
decreased heart ventricle muscle contractility
|
J:122033
|
Ryr2tm1Krbr/Ryr2tm1Krbr A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
cardiomyopathy
|
J:210083
|
Ryr2tm1Slh/Ryr2+
(involves: 129S7/SvEvBrd * C57BL/6)
|
cardiomyopathy
|
J:111780
|
decreased cardiac muscle contractility
|
J:111780
|
decreased heart right ventricle muscle contractility
|
J:111780
|
Ryr2tm2.1Swch/Ryr2+
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal cardiac muscle contractility
|
J:214434
|
Ryr2tm2.1Wex/Ryr2tm2.1Wex
(B6.129S7-Ryr2tm2.1Wex)
|
decreased cardiac muscle contractility
|
J:179475
|
Ryr3tm1Vso/Ryr3tm1Vso
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle contractility
|
J:45244
|
impaired muscle contractility
|
J:45244
|
Ryr3tm1Vso/Ryr3tm1Vso
(involves: 129P2/OlaHsd)
|
abnormal muscle contractility
|
J:106292
|
S100a1tm1Jhh/S100a1+
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:75781
|
S100a1tm1Jhh/S100a1tm1Jhh
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:75781
|
decreased vasodilation
|
J:230300
|
S100a1tm1Mfs/S100a1tm1Mfs
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal muscle physiology
|
J:132177
|
Sacstm2Bebr/Sacstm2Bebr
(involves: C57BL/6)
|
muscle weakness
|
J:217753
|
Samd4m1Btlr/Samd4m1Btlr
(C57BL/6J-Samd4m1Btlr)
|
myopathy
|
J:208616
|
Scamp5tm1Smoc/Scamp5tm1Smoc
(involves: C57BL/6J)
|
abnormal muscle electrophysiology
|
J:288324
|
Scn3btm1a(KOMP)Wtsi/Scn3btm1a(KOMP)Wtsi
(C57BL/6N-Scn3btm1a(KOMP)Wtsi/Wtsi)
|
myositis
|
J:232539
|
Scn4am1Aaa/Scn4a+
(involves: BALB/c * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:217522
|
abnormal muscle physiology
|
J:217522
|
impaired muscle relaxation
|
J:217522
|
impaired skeletal muscle contractility
|
J:217522
|
increased muscle fatigability
|
J:217522
|
muscle twitch
|
J:217522
|
Scn4atm1.1Cann/Scn4a+
(involves: 129)
|
muscle weakness
|
J:178228
|
Scn4atm1.1Cann/Scn4atm1.1Cann
(involves: 129)
|
abnormal muscle contractility
|
J:178228
|
muscle weakness
|
J:178228
|
Scn4atm1.1Ljh/Scn4a+
(B6.129S4-Scn4atm1.1Ljh)
|
abnormal muscle physiology
|
J:135831
|
impaired muscle relaxation
|
J:135831
|
impaired skeletal muscle contractility
|
J:135831
|
increased muscle fatigability
|
J:135831
|
increased muscle relaxation
|
J:135831
|
muscle weakness
|
J:135831
|
myopathy
|
J:135831
|
Scn4atm1.1Ljh/Scn4atm1.1Ljh
(B6.129S4-Scn4atm1.1Ljh)
|
muscle weakness
|
J:135831
|
myopathy
|
J:135831
|
Scn4atm1Ljh/Scn4a+
(B6.129S4-Scn4atm1Ljh)
|
abnormal muscle physiology
|
J:135831
|
impaired muscle relaxation
|
J:135831
|
impaired skeletal muscle contractility
|
J:135831
|
increased muscle fatigability
|
J:135831
|
increased muscle relaxation
|
J:135831
|
muscle weakness
|
J:135831
|
myopathy
|
J:135831
|
Scn4atm1Ljh/Scn4atm1Ljh
(B6.129S4-Scn4atm1Ljh)
|
muscle weakness
|
J:135831
|
myopathy
|
J:135831
|
Scn5atm1(SCN5A)Rdn/Scn5atm3(SCN5A*)Rdn
(involves: 129S6/SvEvTac)
|
decreased cardiac muscle contractility
|
J:189389
|
dilated cardiomyopathy
|
J:189389
|
Scn5atm1Agrc/Scn5atm1Agrc
(involves: 129 * C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:76331
|
Scn5atm3(SCN5A*)Rdn/Scn5atm3(SCN5A*)Rdn
(involves: 129S6/SvEvTac)
|
decreased cardiac muscle contractility
|
J:189389
|
dilated cardiomyopathy
|
J:189389
|
Scn8a7J/Scn8a7J
(involves: BALB/cByJ * C57BL/6J)
|
myoclonus
|
J:87349
|
myopathy
|
J:87349
|
Scn8a9J/Scn8a9J
(B6J.C-Scn8a9J/Mm)
|
dystonia
|
J:230867
|
muscle weakness
|
J:230867
|
Scn8am11J/Scn8am11J
(B6.Cg-Scn8am11J/GrsrJ)
|
impaired muscle relaxation
|
J:231578
|
Scn8amed-J/Scn8amed-J
(involves: STOCK Krt71Ca)
|
dystonia
|
J:141236
|
Scn8amed-J/Scn8amed-J Scnm1s/Scnm1s
(involves: C57BL/6J)
|
dystonia
|
J:79617
|
Scn8amed-J/Scn8amed-J Scnm1s/Scnm1s
(involves: C57BL/6J * STOCK Krt71Ca)
|
muscle weakness
|
J:141236
|
Scn8amed/Scn8amed
(PCT)
|
abnormal muscle physiology
|
J:5192
|
abnormal muscle tone
|
J:28679
|
progressive muscle weakness
|
J:28678,
J:5153
|
Sco2tm1.1Easc/Sco2tm2.1Easc
(129X1/SvJ-Sco2tm1.1Easc/Sco2tm2.1Easc)
|
muscle weakness
|
J:155116
|
Sco2tm2.1Easc/Sco2tm2.1Easc
(129X1/SvJ-Sco2tm2.1Easc)
|
muscle weakness
|
J:155116
|
Scxtm1.1Stzr/Scxtm1.1Stzr
(Not Specified)
|
abnormal tendon stiffness
|
J:122742
|
Scyl1mdf/Scyl1mdf
(B6C3Fe a/a-Scyl1mdf/J)
|
abnormal muscle electrophysiology
|
J:30384
|
abnormal muscle regeneration
|
J:30384
|
Sdhaf4em1Bcgen/Sdhaf4em1Bcgen Tg(Ckmm-cre)5Khn/0
(B6.Cg-Sdhaf4em1Bcgen Tg(Ckmm-cre)5Khn)
|
abnormal cardiac muscle contractility
|
J:345348
|
decreased heart left ventricle muscle contractility
|
J:345348
|
dilated cardiomyopathy
|
J:345348
|
Sdhctm1c(EUCOMM)Wtsi/Sdhctm1c(EUCOMM)Wtsi Gt(ROSA)26Sortm1.1(rtTA,tetO-cre)Bkmn/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal muscle physiology
|
J:284745
|
Sectm1aem1Gcfa/Sectm1aem1Gcfa
(C57BL/6-Sectm1aem1Gcfa)
|
decreased cardiac muscle contractility
|
J:317204
|
Selenontm1.2Mred/Selenontm1.2Mred
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:168699
|
abnormal muscle regeneration
|
J:168699
|
Selenontm1.2Mred/Selenontm1.2Mred
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle physiology
|
J:176499
|
Selenostm1.1Sfa/Selenos+
(involves: C57BL/6)
|
muscle weakness
|
J:264254
|
Selenostm1.1Sfa/Selenostm1.1Sfa
(involves: C57BL/6)
|
muscle weakness
|
J:264254
|
Serac1em1Bcgen/Serac1em1Bcgen
(C57BL/6N-Serac1em1Bcgen)
|
cardiomyopathy
|
J:326672
|
muscle weakness
|
J:326672
|
Sfrp2tm1Sato/Sfrp2tm1Sato
(Not Specified)
|
increased cardiac muscle contractility
|
J:146963
|
Sgcatm1Eeng/Sgcatm1Eeng
(involves: 129S/SvEv * 129X1/SvJ)
|
impaired skeletal muscle contractility
|
J:83034
|
Sgcatm1Kcam/Sgcatm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle contractility
|
J:49992
|
cardiomyopathy
|
J:177563
|
Sgcatm1Kcam/Sgcatm1Kcam Sgcetm1Vinni/Sgcetm1Vinni
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
cardiomyopathy
|
J:177563
|
decreased cardiac muscle contractility
|
J:177563
|
Sgcatm1Kcam/Sgcatm1Kcam Tg(Ckm-SGCE)1Kcam/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
cardiomyopathy
|
J:177563
|
Sgcatm2Kcam/Sgcatm2Kcam
(either: (129S6/SvEvTac-Sgcatm2Kcam) or (involves: 129S6/SvEvTac * C57BL/6J))
|
abnormal muscle contractility
|
J:130252
|
Sgcatm2Kcam/Sgcatm2Kcam
(B6.129S6-Sgcatm2Kcam/J)
|
abnormal muscle physiology
|
J:250485
|
Sgcbtm1Kcam/Sgcbtm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
cardiomyopathy
|
J:60154
|
Sgcbtm1Oza/Sgcbtm1Oza
(involves: 129S4/SvJae * C57BL/6J)
|
myositis
|
J:57590
|
Sgcdtm1Kcam/Sgcdtm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
cardiomyopathy
|
J:57107
|
dilated cardiomyopathy
|
J:57107
|
Sgcdtm1Mcn/Sgcdtm1Mcn
(involves: 129S1/Sv * 129T2/SvEmsJ * 129X1/SvJ)
|
abnormal muscle contractility
|
J:76730
|
abnormal muscle physiology
|
J:76730
|
cardiomyopathy
|
J:76730
|
Sgcdtm1Mcn/Sgcdtm1Mcn
(B6.129-Sgcdtm1Mcn/J)
|
abnormal muscle physiology
|
J:250485
|
decreased cardiac muscle contractility
|
J:234761
|
dilated cardiomyopathy
|
J:234761
|
Sgcdtm1Ojml/Sgcd+
(B6.129-Sgcdtm1Ojml)
|
dilated cardiomyopathy
|
J:234761
|
Sgcetm1Ygl/Sgce+
(involves: 129S2/SvPas)
|
myoclonus
|
J:180682
|
Sgcetm1Ygl/Sgcetm1Ygl
(involves: 129S2/SvPas * 129S4/SvJaeSor * BALB/c * C57BL/6)
|
myoclonus
|
J:101332
|
Sgcgtm1Oza/Sgcgtm1Oza
(involves: 129S4/SvJae * C57BL/6)
|
abnormal muscle regeneration
|
J:102780
|
progressive muscle weakness
|
J:102780
|
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
myositis
|
J:117880
|
Sh3tc1tm1b(EUCOMM)Hmgu/Sh3tc1tm1b(EUCOMM)Hmgu
(C57BL/6N-Sh3tc1tm1b(EUCOMM)Hmgu/Orl)
|
decreased cardiac muscle contractility
|
J:211773
|
Shc1tm1Paw/Shc1tm1Paw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))
|
decreased cardiac muscle contractility
|
J:62182
|
Shc1tm1Pgp/Shc1tm1Pgp
(involves: 129)
|
increased vasodilation
|
J:81977
|
Shroom3Gt(ROSA53)Sor/Shroom3Gt(ROSA53)Sor
(B6.129S4-Shroom3Gt(ROSA53)Sor/J)
|
increased fetal cardiomyocyte proliferation
|
J:293794
|
Sik2tm1Lex/Sik2tm1Lex
(involves: 129S/SvEvBrd)
|
decreased muscle cell glucose uptake
|
J:229999
|
Sirt7tm1Evbo/Sirt7tm1Evbo
(involves: 129/Sv * C57BL/6)
|
cardiomyopathy
|
J:147652
|
increased cardiomyocyte apoptosis
|
J:147652
|
Six1tm1Mair/Six1tm1Mair Six4tm1Mair/Six4tm1Mair
(either: 129/Sv-Six1tm1Mair Six4tm1Mair or B6N.129-Six1tm1Mair Six4tm1Mair)
|
abnormal muscle precursor cell migration
|
J:98519
|
Six1tm1Rsd/Six1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle precursor cell migration
|
J:86619
|
Six1tm2.1Mair/Six1tm2.1Mair Pax7tm1(cre/ERT2)Gaka/Pax7+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6Cr * C57BL/6NTac)
|
abnormal muscle physiology
|
J:190460
|
abnormal muscle regeneration
|
J:190460
|
skimp/skimp
(involves: C3H/HeH)
|
opisthotonus
|
J:77535
|
Slc2a4tm1Abel/Slc2a4+ Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * FVB)
|
decreased muscle cell glucose uptake
|
J:110773
|
Slc2a4tm1Abel/Slc2a4tm1Abel Tg(Ckmm-cre)5Khn/?
(involves: 129/Sv * C57BL/6)
|
abnormal muscle physiology
|
J:75418
|
decreased skeletal muscle cell glucose uptake
|
J:75418
|
Slc2a4tm1Abel/Slc2a4tm1Abel Tg(Ckmm-cre)5Khn/0
(involves: 129S4/SvJae * FVB)
|
decreased skeletal muscle cell glucose uptake
|
J:110773
|
Slc2a4tm1Abel/Slc2a4tm1Abel Tg(Myhca-cre)1Abel/?
(involves: 129S4/SvJae * FVB)
|
decreased cardiac muscle cell glucose uptake
|
J:59054
|
Slc2a4tm1Abel/Slc2a4tm1Abel Tg(Myhca-cre)1Abel/?
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
decreased cardiac muscle cell glucose uptake
|
J:108830
|
increased cardiac muscle cell glucose uptake
|
J:108830
|
Slc2a4tm1Jdz/Slc2a4tm1Jdz
(involves: 129S1/Sv * C57BL/6)
|
decreased skeletal muscle cell glucose uptake
|
J:123335
|
Slc2a4tm1Jdz/Slc2a4tm1Jdz Tg(ACTA1-cre)1Jdz/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased skeletal muscle cell glucose uptake
|
J:123335
|
increased cardiac muscle cell glucose uptake
|
J:123335
|
increased skeletal muscle cell glucose uptake
|
J:123335
|
Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * C57BL/6J * CD-1 * SJL)
|
decreased muscle cell glucose uptake
|
J:43935
|
decreased skeletal muscle cell glucose uptake
|
J:43650
|
Slc2a4tm1Mch/Slc2a4tm1Mch
(involves: 129/Sv * C57BL/6 * C57BL/6J * CD-1 * SJL)
|
abnormal muscle physiology
|
J:49328
|
Slc2a4tm1Mch/Slc2a4tm1Mch
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)
|
impaired skeletal muscle contractility
|
J:75600
|
increased muscle fatigability
|
J:75600
|
Slc3a1tm1Jat/Slc3a1tm1Jat
(involves: 129 * C57BL/6)
|
impaired contractility of urinary bladder detrusor smooth muscle
|
J:254981
|
Slc4a1tm1Llp/Slc4a1tm1Llp
(B6;129S4-Slc4a1tm1Llp/J)
|
decreased heart ventricle muscle contractility
|
J:120610
|
Slc4a3tm1Ges/Slc4a3tm1Ges Tg(Myh6-Tpm1*E180G)57Dfw/0
(involves: 129X1/SvJ * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:171021
|
decreased cardiac muscle contractility
|
J:171021
|
Slc4a7Gt(40G1)Cmhd/Slc4a7Gt(40G1)Cmhd
(B6.129-Slc4a7Gt(40G1)Cmhd)
|
abnormal vascular smooth muscle physiology
|
J:189470
|
abnormal vasoconstriction
|
J:189470
|
decreased vasodilation
|
J:189470
|
Slc6a3tm1(cre)Lrsn/Slc6a3+ Tfamtm1Lrsn/Tfamtm1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
muscle spasm
|
J:119515
|
Slc6a4tm1Kpl/Slc6a4tm1Kpl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal intestinal peristalsis
|
J:237081
|
decreased cardiac muscle contractility
|
J:121505
|
dilated cardiomyopathy
|
J:121505
|
Slc6a4tm2.1Rbl/Slc6a4tm2.1Rbl
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
intestinal hypoperistalsis
|
J:237081
|
Slc6a5m1J/Slc6a5m1J
(involves: 129S2/SvPas * NOD)
|
muscle hypertonia
|
J:184306
|
muscle spasm
|
J:184306
|
Slc6a5tm1Betz/Slc6a5tm1Betz
(involves: 129P2/OlaHsd)
|
muscle hypertonia
|
J:86625
|
Slc6a6tm1Jaz/Slc6a6tm1Jaz
(involves: 129S2/SvPas * C57BL/6)
|
decreased cardiac muscle contractility
|
J:135159
|
dilated cardiomyopathy
|
J:135159
|
Slc6a8tm1e(KOMP)Wtsi/Y
(involves: C57BL/6J * C57BL/6N)
|
abnormal muscle physiology
|
J:264220
|
hypotonia
|
J:264220
|
muscle weakness
|
J:264220
|
Slc6a9tm1Betz/Slc6a9tm1Betz
(involves: 129P2/OlaHsd * C57BL/6)
|
hypotonia
|
J:86624
|
Slc6a9tm1Veul/Slc6a9tm1Veul Tg(EIIa-cre)C5379Lmgd/?
(involves: 129P2/OlaHsd * FVB/N)
|
hypotonia
|
J:161993
|
Slc6a9tm1Veul/Slc6a9tm1Veul Tg(Gfap-cre)2Brn/?
(involves: 129P2/OlaHsd * FVB/N)
|
hypotonia
|
J:161993
|
Slc7a7Gt(OST41878)Lex/Slc7a7Gt(OST41878)Lex
(B6.129S-Slc7a7Gt(OST41878)Lex)
|
hypotonia
|
J:125847
|
Slc7a10tm1Dgen/Slc7a10tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
myoclonus
|
J:100127
|
Slc8a1tm1Yin/Slc8a1+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal cardiac muscle relaxation
|
J:75050
|
impaired smooth muscle contractility
|
J:65985
|
increased heart left ventricle muscle contractility
|
J:75050
|
Slc8a1tm1Yin/Slc8a1tm1Yin
(involves: 129X1/SvJ * C57BL/6J)
|
increased cardiomyocyte apoptosis
|
J:65985
|
Slc8b1tm1c(EUCOMM)Wtsi/Slc8b1tm1c(EUCOMM)Wtsi A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S4/SvJaeSor * C57BL/6N * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:325413
|
Slc12a6tm1Tjj/Slc12a6tm1Tjj
(involves: 129/Sv * C57BL/6)
|
muscle hypertonia
|
J:86183
|
Slc13a5tm1.2Helf/Slc13a5tm1.2Helf
(B6.Cg-Slc13a5tm1.2Helf)
|
abnormal muscle physiology
|
J:176732
|
increased skeletal muscle cell glucose uptake
|
J:176732
|
Slc25a3tm1.1Jmol/Slc25a3tm1.1Jmol A1cfTg(Myh6-cre/Esr1*)1Jmk/?
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
cardiomyopathy
|
J:229795
|
decreased heart left ventricle muscle contractility
|
J:229795
|
Slc25a4tm2Dwa/Slc25a4tm2Dwa
(involves: 129S4/SvJae * C57BL/6J)
|
myopathy
|
J:41256
|
Slc26a4em1Jgao/Slc26a4em1Jgao
(involves: CBA/CaJ)
|
torticollis
|
J:291230
|
Slc27a1tm1Jkk/Slc27a1tm1Jkk
(involves: 129S/SvEv * C57BL/6J)
|
abnormal skeletal muscle cell glucose uptake
|
J:88657
|
Slc32a1tm1Bros/Slc32a1tm1Bros
(involves: 129P2/OlaHsd)
|
muscle hypertonia
|
J:122318
|
Slc34a1tm1Hten/Slc34a1tm1Hten
(involves: 129S2/SvPas * C57BL/6J)
|
muscle weakness
|
J:47637
|
Slc39a8tm1.2Mrl/Slc39a8tm1.2Mrl
(B6(Cg)-Slc39a8tm1.2Mrl)
|
increased fetal cardiomyocyte proliferation
|
J:258360
|
Slc39a14tm1Thir/Slc39a14tm1Thir
(involves: 129 * C57BL/6)
|
torticollis
|
J:171670
|
Slntm1Peri/Slntm1Peri
(involves: Black Swiss * C57BL/6)
|
increased cardiac muscle contractility
|
J:127150
|
Smad5tm1Huy/Smad5tm1.1Huy Tg(Tagln-cre)1Her/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL)
|
decreased cardiac muscle contractility
|
J:121072
|
Smad6tm1Glvn/Smad6tm1Glvn
(involves: 129S6/SvEvTac * BALB/cByJ)
|
decreased vasodilation
|
J:60214
|
Smad7Gt(YHC053)Byg/Smad7+ Tbx1tm1Bld/Tbx1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
increased vascular smooth muscle cell proliferation
|
J:212881
|
Smad7tm1.1Shou/Smad7tm1.1Shou
(involves: C57BL/6 * FVB)
|
decreased cardiac muscle contractility
|
J:145777
|
Smad7tm1Shou/Smad7tm1Shou Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6)
|
decreased cardiac muscle contractility
|
J:145777
|
Smarca2tm1Mya/Smarca2tm1Mya
(involves: 129S2/SvPas)
|
abnormal muscle physiology
|
J:172661
|
Smarca2tm1Mya/Smarca2tm1Mya Smarca4tm1.1Pcn/Smarca4+
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal muscle physiology
|
J:172661
|
Smarca2tm1Mya/Smarca2tm1Mya Smarca4tm1.2Pcn/Smarca4tm1.1Pcn Tg(Myh11-cre,-EGFP)2Mik/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal muscle physiology
|
J:172661
|
impaired smooth muscle contractility
|
J:172661
|
Smarca4tm1.2Pcn/Smarca4tm1.1Pcn Tg(Myh11-cre,-EGFP)2Mik/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal muscle physiology
|
J:172661
|
impaired smooth muscle contractility
|
J:172661
|
Smarcb1tm2Sho/Smarcb1tm2Sho Trp53tm1Brn/Trp53tm1Brn Tg(GFAP-cre)#Gtm/0
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA)
|
dystonia
|
J:226786
|
Smarcd3tm1.1Bbr/Smarcd3tm1.1Bbr Tg(Myh6-cre)2182Mds/0
(either: (involves: 129 * C57BL/6 * FVB/N * SJL) or (involves: 129 * C57BL/6 * FVB/N * ICR * SJL))
|
decreased cardiac muscle contractility
|
J:257963
|
increased cardiomyocyte apoptosis
|
J:257963
|
Smarcd3tm1.2Bbr/Smarcd3tm1.2Bbr
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * ICR * SJL))
|
abnormal cardiac muscle relaxation
|
J:257963
|
decreased fetal cardiomyocyte proliferation
|
J:257963
|
decreased heart left ventricle muscle contractility
|
J:257963
|
Smn1tm1Jme/Smn1tm1.1Jme Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6J * SJL)
|
abnormal muscle physiology
|
J:67884
|
Smn1tm1Jme/Smn1tm1.1Jme Tg(Eno2-cre)39Jme/0
(involves: 129 * C57BL/6J * SJL)
|
hypotonia
|
J:61396
|
Smn1tm1Msd/Smn1tm1Msd Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb Tg(SMN2*delta7)4299Ahmb/Tg(SMN2*delta7)4299Ahmb
(FVB.Cg-Grm7Tg(SMN2)89Ahmb Smn1tm1Msd Tg(SMN2*delta7)4299Ahmb/J)
|
dilated cardiomyopathy
|
J:164446
|
Smn1tm1Msd/Smn1tm1Msd Tg(SMN1*A2G)2023Ahmb/0 Grm7Tg(SMN2)89Ahmb/Grm7+
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal muscle electrophysiology
|
J:81238
|
Smn1tm1Msd/Smn1tm1Msd Tg(SMN2)11Tro/0 Tg(SMN2)46Tro/0
(B6.Cg-Tg(SMN2)11Tro Tg(SMN2)46Tro Smn1tm1Msd/J)
|
abnormal muscle electrophysiology
|
J:159930
|
progressive muscle weakness
|
J:159930
|
Smstm1a(EUCOMM)Wtsi/Y
(involves: C57BL/6N)
|
muscle weakness
|
J:200082
|
Smtntm1Gve/Smtntm1Gve
(involves: 129/Sv * C57BL/6)
|
decreased vasoconstriction
|
J:158046
|
impaired contractility of jejunal smooth muscle
|
J:104648
|
intestinal hypoperistalsis
|
J:104648
|
Smtntm2Gve/Smtntm2Gve
(B6.129-Smtntm2Gve)
|
decreased vasoconstriction
|
J:158046
|
Smtnl1tm1Tajh/Smtnl1tm1Tajh
(129S6.129P2-Smtnl1tm1Tajh)
|
decreased vasoconstriction
|
J:136573
|
increased vasodilation
|
J:136573
|
Smyd3em1Yzzh/Smyd3em1Yzzh
(C57BL/6-Smyd3em1Yzzh)
|
abnormal vasodilation
|
J:296379
|
Snap25tm2Mcw/Snap25tm2Mcw
(involves: C57BL/6J)
|
myoclonus
|
J:94005
|
Snhg15tm1Nju/Snhg15tm1Nju
(involves: C57BL/6J)
|
delayed skeletal muscle regeneration
|
J:291983
|
Snrktm2Rra/Snrktm2Rra Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:218247
|
Socs1tm2Wehi/Socs1tm2Wehi
(C57BL/6-Socs1tm2Wehi)
|
myositis
|
J:72528
|
Sod1m1H/Sod1m1H
(involves: C3H/HeH * C57BL/6J)
|
progressive muscle weakness
|
J:219360
|
Sod1tm1Dkd/Sod1tm1Dkd
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased cardiac muscle contractility
|
J:60470
|
Sod1tm1Svb/Sod1tm1Svb Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * SJL)
|
abnormal muscle physiology
|
J:201098
|
abnormal muscle regeneration
|
J:201098
|
muscle weakness
|
J:201098
|
Sod2tm1(tetO-Sod2)Evbo/Sod2+
(involves: 129S4/SvJae * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:162190
|
increased cardiomyocyte apoptosis
|
J:162190
|
Sod2tm1(tetO-Sod2)Evbo/Sod2tm1(tetO-Sod2)Evbo
(involves: 129S4/SvJae * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:162190
|
Sod2tm1.1Kskk/Sod2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:98289
|
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * CD-1)
|
dilated cardiomyopathy
|
J:29899
|
hypotonia
|
J:29899
|
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J)
|
dilated cardiomyopathy
|
J:45913
|
Sod2tm1Cje/Sod2tm1Cje
(B6.Cg-Sod2tm1Cje/Mmmh)
|
dilated cardiomyopathy
|
J:73998
|
Sod2tm1Leb/Sod2tm1Leb
(B6.129S7-Sod2tm1Leb/J)
|
dilated cardiomyopathy
|
J:36148
|
Sod2tm1Shs/Sod2tm1Shs Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6CrSlc * FVB)
|
decreased cardiac muscle contractility
|
J:117386
|
dilated cardiomyopathy
|
J:117386
|
Sod2tm1Shs/Sod2tm1Shs Tg(Ckmm-cre)5Khn/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:171017
|
Sod2tm1Shs/Sod2tm1Shs Tg(TNNI2-icre)1Vrmn/0
(involves: C57BL/6)
|
abnormal muscle contractility
|
J:155917
|
abnormal muscle physiology
|
J:155917
|
increased muscle cell glucose uptake
|
J:155917
|
increased muscle fatigability
|
J:155917
|
Sorl1tm1Bujo/Sorl1tm1Bujo
(involves: 129/Sv * C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:140878
|
Sos1tm1.2Rak/Sos1+
(involves: 129S/Sv * C57BL/6 * FVB/N * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:171873
|
increased cardiomyocyte apoptosis
|
J:171873
|
Sos1tm1.2Rak/Sos1tm1.2Rak
(involves: 129S/Sv * C57BL/6 * FVB/N * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:171873
|
Sox2tm2Skn/Sox2tm3Skn
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J)
|
dystonia
|
J:92063
|
Sox9tm1Gsr/Sox9tm1Gsr Tg(Pax3-cre)1Joe/0
(involves: 129P2/OlaHsd * C57BL/6 * NMRI * SJL)
|
impaired ureteric peristalsis
|
J:166547
|
Sox15tm1Imad/Sox15tm1Imad
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
impaired skeletal muscle regeneration
|
J:93031
|
Spaarem1Ppp/Spaarem1Ppp
(C57BL/6J-Spaarem1Ppp)
|
abnormal muscle physiology
|
J:238474
|
enhanced muscle regeneration
|
J:238474
|
Spegtm1Mkap/Spegtm1Mkap
(either: B6.129S2-Spegtm1Mkap or (involves: 129S2/SvPas * C57BL/6))
|
decreased heart left ventricle muscle contractility
|
J:163968
|
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal vasodilation
|
J:103050
|
Spp1tm1Rit/Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cardiac muscle contractility
|
J:95591
|
Sptbn1tm1a(EUCOMM)Wtsi/Sptbn1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:219548
|
increased fetal cardiomyocyte apoptosis
|
J:219548
|
Sptbn1tm1c(EUCOMM)Wtsi/Sptbn1tm1c(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased fetal cardiomyocyte proliferation
|
J:219548
|
increased fetal cardiomyocyte apoptosis
|
J:219548
|
Sptbn4Gt(ROSABetageo)62Sor/Sptbn4Gt(ROSABetageo)62Sor
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal muscle contractility
|
J:120916,
J:77228
|
Sptbn4Gt(ROSABetageo)62Sor/Sptbn4Gt(ROSABetageo)62Sor
(129S4/SvJaeSor-Spnb4Gt(ROSABetageo)62Sor)
|
abnormal muscle contractility
|
J:77228
|
Sptbn4Gt(ROSABetageo)62Sor/Sptbn4Gt(ROSABetageo)62Sor
(B6.129S4-Sptbn4Gt(ROSABetageo)62Sor/Mmucd)
|
abnormal muscle contractility
|
J:77228
|
Srftm1Rjs/Srftm2.1Nor Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
increased cardiomyocyte apoptosis
|
J:101311
|
Srftm1Zli/Srftm1Zli A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129 * C57BL/6J * FVB/N)
|
abnormal cardiac muscle relaxation
|
J:135043
|
decreased heart left ventricle muscle contractility
|
J:135043
|
dilated cardiomyopathy
|
J:135043
|
Srltm1Hta/Srltm1Hta
(B6.129S4-Srltm1Hta)
|
abnormal muscle physiology
|
J:101569
|
Srltm1Hta/Srltm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal cardiac muscle relaxation
|
J:96983
|
abnormal muscle contractility
|
J:96983
|
decreased cardiac muscle contractility
|
J:96983
|
impaired skeletal muscle contractility
|
J:96983
|
Srsf5em1Nju/Srsf5em1Nju
(C57BL/6JGpt-Srsf5em1Nju)
|
decreased cardiac muscle contractility
|
J:311867
|
decreased fetal cardiomyocyte proliferation
|
J:311867
|
Sspntm1Kcam/Sspntm1Kcam
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle physiology
|
J:187752
|
Stab1tm1.1Cger/Stab1tm1.1Cger Stab2tm1.1Cger/Stab2tm1.1Cger
(C.129S2-Stab2tm1.1Cger Stab1tm1.1Cger)
|
dilated cardiomyopathy
|
J:171818
|
Stac3tm1a(KOMP)Wtsi/Stac3tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal muscle electrophysiology
|
J:222015
|
impaired skeletal muscle contractility
|
J:222015
|
Stat1tm1Rds/Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac)
|
increased cardiomyocyte apoptosis
|
J:120449
|
Stat3tm1Vpo/Stat3+ Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
cardiomyopathy
|
J:141591
|
Stat3tm1Vpo/Stat3tm1Vpo Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N)
|
cardiomyopathy
|
J:141591
|
decreased cardiac muscle contractility
|
J:141591
|
increased cardiomyocyte apoptosis
|
J:141591
|
Stat3tm1Xyfu/Stat3tm1.1Xyfu Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * FVB/N)
|
decreased cardiac muscle contractility
|
J:86400
|
increased cardiomyocyte apoptosis
|
J:86400
|
Steap4tm1Dgen/Steap4tm1Dgen
(involves: 129P2/OlaHsd)
|
decreased muscle cell glucose uptake
|
J:187736
|
Stim1tm1.1Pg/Stim1+
(involves: C57BL/6)
|
abnormal muscle physiology
|
J:285187
|
myopathy
|
J:285187
|
Stim1tm3Ics/Stim1+
(involves: C57BL/6N)
|
abnormal muscle physiology
|
J:277842,
J:327797
|
decreased muscle fatigability
|
J:277842
|
enhanced skeletal muscle regeneration
|
J:327797
|
impaired muscle relaxation
|
J:277842
|
increased skeletal muscle cell apoptosis
|
J:327797
|
muscle weakness
|
J:277842
|
myositis
|
J:277842
|
Stk11tm1.1Arte/Stk11tm1.1Arte
(involves: C57BL/6J)
|
abnormal muscle physiology
|
J:208379
|
Stk11tm1Keis/Stk11tm1Keis Tg(Ckmm-cre)5Khn/0
(involves: FVB)
|
decreased muscle cell glucose uptake
|
J:98513
|
Stk39tm2.1Arte/Stk39tm2.1Arte
(involves: C57BL/6J)
|
decreased vasoconstriction
|
J:224087
|
Stmn1tm1Wed/Stmn1tm1Wed
(involves: 129P2/OlaHsd * C57BL/6)
|
myopathy
|
J:74496
|
Stradaem1Pbcr/Stradaem1Pbcr
(C57BL/6N-Stradaem1Pbcr)
|
hypotonia
|
J:308972
|
Strip2tm1.2Tac/Strip2tm1.2Tac
(Not Specified)
|
decreased cardiac muscle contractility
|
J:306481
|
Strit1em1Eno/Strit1em1Eno
(involves: C57BL/6)
|
impaired muscle relaxation
|
J:229305
|
Sulf1tm1.1Cpe/Sulf1tm1.1Cpe Sulf2tm1.1Cpe/Sulf2tm1.1Cpe
(involves: 129S/SvEv * C57BL/6)
|
impaired smooth muscle contractility
|
J:124898
|
Syislem1Bzuo/Syislem1Bzuo
(involves: C57BL/6)
|
enhanced muscle regeneration
|
J:266240
|
Synctm1.1Ked/Synctm1.1Ked
(involves: 129/Sv * C57BL/6)
|
impaired skeletal muscle contractility
|
J:138552
|
Synctm1Chen/Synctm1Chen
(involves: 129X1/SvJ * Black Swiss)
|
abnormal muscle physiology
|
J:136645
|
Syne1tm1.1Chen/Syne1tm1.1Chen
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)
|
abnormal muscle physiology
|
J:155342
|
Syne1tm1Chen/Syne1tm1Chen Syne2tm1.1Chen/Syne2tm1.1Chen Tg(Nkx2-5-cre)9Eno/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss)
|
decreased cardiac muscle contractility
|
J:211007
|
increased cardiomyocyte apoptosis
|
J:211007
|
Synmtm1.1(KOMP)Vlcg/Synmtm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal muscle physiology
|
J:224030
|
cardiomyopathy
|
J:257039
|
decreased heart left ventricle muscle contractility
|
J:257039
|
increased muscle fatigability
|
J:224030
|
muscle twitch
|
J:224030
|
Synmtm1.1Ics/Synmtm1.1Ics
(involves: 129S2/SvPas * C57BL/6 * FVB/N * SJL)
|
abnormal muscle electrophysiology
|
J:268425
|
abnormal skeletal muscle regeneration
|
J:268425
|
myopathy
|
J:268425
|
Sypl2tm1Hta/Sypl2tm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
impaired skeletal muscle contractility
|
J:59188
|
Syt7tm1Nan/Syt7tm1Nan
(involves: 129S1/Sv * C57BL/6)
|
myositis
|
J:85201
|
Taf7ltm1.1Jw/Y
(B6J.Cg-Taf7ltm1.1Jw)
|
abnormal muscle physiology
|
J:228546
|
Tafazzinem1Xfa/Y Tg(myl7.L-cre)1118Tmhn/0
(involves: C57BL/6NCrl * MF1)
|
decreased heart left ventricle muscle contractility
|
J:339058
|
dilated cardiomyopathy
|
J:339058
|
Tafazzinem1Xfa/Tafazzinem1Xfa Tg(myl7.L-cre)1118Tmhn/0
(involves: C57BL/6NCrl * MF1)
|
decreased heart left ventricle muscle contractility
|
J:339058
|
dilated cardiomyopathy
|
J:339058
|
Taok1em1Bcgen/Taok1+
(C57BL/6N-Taok1em1Bcgen)
|
hypotonia
|
J:341142
|
Tarbp2tm1.1Dzw/Tarbp2tm1.1Dzw Tg(Tnnt2-cre)5Blh/0
(involves: 129 * C57BL/6 * DBA/2J)
|
decreased heart left ventricle muscle contractility
|
J:222613
|
dilated cardiomyopathy
|
J:222613
|
Tardbpm1H/Tardbp+
(involves: C3H/HeH * C57BL/6J)
|
abnormal muscle tone
|
J:211620
|
impaired muscle relaxation
|
J:211620
|
Tardbpm1H/Tardbp+ Tg(SOD1*G93A)dl1Gur/0
(involves: C3H/HeH * C57BL/6 * C57BL/6J * SJL)
|
abnormal muscle tone
|
J:211620
|
impaired muscle relaxation
|
J:211620
|
Tbc1d1Gt(E140H06)Wrst/Tbc1d1Gt(E140H06)Wrst
(B6.129P2-Tbc1d1Gt(E140H06)Wrst)
|
abnormal muscle cell glucose uptake
|
J:203285
|
Tbc1d4tm1.1Arte/Tbc1d4tm1.1Arte
(involves: C57BL/6)
|
decreased muscle cell glucose uptake
|
J:169477
|
increased muscle cell glucose uptake
|
J:169477
|
Tbc1d4tm1.2Arte/Tbc1d4tm1.2Arte
(involves: C57BL/6 * CBA)
|
decreased skeletal muscle cell glucose uptake
|
J:194026
|
Tbc1d4tm1Lex/Tbc1d4tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J * C57BL/6N)
|
decreased skeletal muscle cell glucose uptake
|
J:191749
|
Tbc1d25Gt(IST10205D5)Tigm/Y
(involves: C57BL/6N)
|
decreased cardiac muscle contractility
|
J:295960
|
decreased heart ventricle muscle contractility
|
J:295960
|
Tbcepmn/Tbcepmn
(NMRI/Pan)
|
progressive muscle weakness
|
J:1717
|
Tbx1tm1Bld/Tbx1+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased vascular smooth muscle cell proliferation
|
J:212881
|
Tbx3tm2.1Moon/Tbx3tm2.1Moon
(involves: 129 * BALB/cJ * C57BL/6 * SJL)
|
increased cardiac muscle contractility
|
J:179977
|
Tbx20tm1.1Rph/Tbx20+
(involves: C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:98489
|
dilated cardiomyopathy
|
J:98489
|
Tbx20tm1.1Rph/Tbx20tm1.1Rph
(involves: C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:98489
|
Tbx20tm1.1Sev/Tbx20tm1.1Sev
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:98516
|
Tbx20tm1Akis/Tbx20tm1Akis
(involves: 129S1/SvImJ * NMRI)
|
abnormal fetal cardiomyocyte proliferation
|
J:98806
|
Tcaptm1Mkc/Tcaptm1Mkc
(involves: 129 * C57BL/6)
|
abnormal muscle physiology
|
J:159687
|
myopathy
|
J:159687
|
Tcaptm1Rnk/Tcaptm1Rnk
(Not Specified)
|
increased cardiomyocyte apoptosis
|
J:188832
|
Tcf7l2tm3.1(cre/ERT2)Mrc/Tcf7l2+ Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal muscle regeneration
|
J:174914
|
Tcratm1Mom/Tcratm1Mom Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
myositis
|
J:181257
|
Tecrlem1Bcgen/Tecrlem1Bcgen
(C57BL/6-Tecrlem1Bcgen)
|
decreased heart left ventricle muscle contractility
|
J:325991
|
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal cardiac muscle contractility
|
J:110900
|
abnormal cardiac muscle relaxation
|
J:110900
|
abnormal fetal cardiomyocyte proliferation
|
J:110900
|
dilated cardiomyopathy
|
J:110900
|
increased cardiomyocyte apoptosis
|
J:110900
|
Tfamtm1Lrsn/Tfamtm1Lrsn Tg(Ckmm-cre)1Lrsn/0
(involves: 129S1/Sv * 129X1/SvJ)
|
dilated cardiomyopathy
|
J:51964
|
increased cardiomyocyte apoptosis
|
J:125471
|
Tfap2bem1Fenli/Tfap2bem1Fenli
(involves: C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:278067
|
Tfap2btm1Rbu/Tfap2btm1Rbu
(129P2.129-Tfap2btm1Rbu)
|
muscle spasm
|
J:83000
|
Tg(ACTA1*D286G)#Kjno/Tg(ACTA1*D286G)#Kjno
(involves: C57BL/6 * CBA)
|
impaired skeletal muscle contractility
|
J:209273
|
muscle weakness
|
J:209273
|
Tg(ACTA1*D286G/EGFP)#Kjno/0
(involves: C57BL/6J * CBA/Ca)
|
impaired skeletal muscle contractility
|
J:182255
|
muscle weakness
|
J:182255
|
Tg(ACTA1-Ar)141Kyjo/0
(Not Specified)
|
muscle weakness
|
J:127205
|
Tg(ACTA1-cre/ERT2)97.16Mtz/0 Tg(CAG-DMPK*)1323Coop/0
(involves: FVB)
|
impaired muscle relaxation
|
J:132154
|
Tg(ACTA1-IGF1)1Rjs/0
(involves: FVB)
|
abnormal cardiac muscle contractility
|
J:58354
|
Tg(ACTA1-MYOT*T57I)71Mah/?
(involves: C57BL/6 * SJL)
|
impaired skeletal muscle contractility
|
J:110377
|
muscle weakness
|
J:110377
|
Tg(ACTA1-PABPN1*A17)1Drub/0
(involves: FVB/N)
|
muscle weakness
|
J:115642
|
progressive muscle weakness
|
J:115642
|
Tg(ACTA1-TPM3*M9R)4Hrd/0
(FVB/NJ-Tg(ACTA1-TPM3*M9R)4Hrd)
|
abnormal muscle physiology
|
J:67596
|
muscle weakness
|
J:67596
|
myopathy
|
J:67596
|
Tg(ACTB-EGFP,-Kcnj8*G343D)9Nich/0 Tg(Myh11-icre/ERT2)1Soff/0
(involves: C57BL/6 * CBA * FVB/N)
|
abnormal vascular smooth muscle physiology
|
J:202037
|
decreased vasoconstriction
|
J:202037
|
Tg(ACTB-SOD2)66Ysh/0
(involves: C3H * C57BL/6)
|
increased cardiac muscle contractility
|
J:127776
|
Tg(AGT)2-5Afu/0
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:194606
|
Tg(ANX6)2Agh/0
(FVB/N-Tg(ANX6)2Agh)
|
cardiomyopathy
|
J:92579
|
decreased cardiac muscle contractility
|
J:92579
|
Tg(APCS-Ifng)5Imeg/0
(involves: C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:135124
|
dilated cardiomyopathy
|
J:135124
|
Tg(AR*100Q)C25Als/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
muscle weakness
|
J:89772
|
Tg(CAG-APPL1)#Ymli/0
(involves: C57BL/6 * CBA)
|
abnormal vasodilation
|
J:189487
|
decreased vasoconstriction
|
J:189487
|
increased skeletal muscle cell glucose uptake
|
J:230004
|
increased vasodilation
|
J:189487
|
Tg(CAG-Calr)#Mlk/0 Tg(Myh6-cre/Esr1*)1Liao/0
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:199413
|
dilated cardiomyopathy
|
J:199413
|
Tg(CAG-cat,-Ptpn11*Q97R)1Rbns/0 Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6 * FVB/N)
|
ventricular cardiomyopathy
|
J:142212
|
Tg(CAG-dsRed2/RNAi:Tardbp)6Zxu/0
(involves: C57BL/6 * C57BL/6J * FVB/NJ * SJL)
|
progressive muscle weakness
|
J:207750
|
Tg(CAG-GLVP)#Cath/0 Tg(GAL4-PABPN1*A16)#Cath/0
(involves: C57BL/6 * FVB)
|
dilated cardiomyopathy
|
J:178541
|
myopathy
|
J:178541
|
Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis/0
(involves: C57BL/6 * DBA/2)
|
myositis
|
J:142253
|
Tg(CAG-LARGE)126Fmu/0
(involves: C57BL/10 * CBA/Ca)
|
abnormal muscle physiology
|
J:168339
|
Tg(CAG-Map3k7*K63W)1232Mds/0 Tg(Myh6-cre)2182Mds/0
(involves: FVB/N)
|
cardiomyopathy
|
J:117108
|
Tg(CAG-Ncoa6)71Hwl/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:269856
|
Tg(CAG-Ncoa6)84Hwl/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:269856
|
Tg(CAG-Ncoa6)87Hwl/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:269856
|
dilated cardiomyopathy
|
J:269856
|
Tg(CAG-Ncoa6)104Hwl/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:269856
|
Tg(CAG-NRIP1)51Row/0
(involves: FVB/N)
|
cardiomyopathy
|
J:175885
|
decreased cardiac muscle contractility
|
J:175885
|
Tg(CAG-OTC/CAT)#Wcl/0
(involves: C3H * C57BL/6)
|
abnormal muscle physiology
|
J:176731
|
Tg(CAG-VCP*A232E)93Jpat/0
(involves: C57BL/6 * SJL)
|
myopathy
|
J:158713
|
progressive muscle weakness
|
J:158713
|
Tg(CAG-VCP*R155H)55Jpat/0
(involves: C57BL/6 * SJL)
|
myopathy
|
J:158713
|
progressive muscle weakness
|
J:158713
|
Tg(CAMalpha1b)7Wjk/?
(Not Specified)
|
decreased heart left ventricle muscle contractility
|
J:134704
|
dilated cardiomyopathy
|
J:134704
|
Tg(Camk2a-tTA)1Mmay/0 Fgf14Tg(tetO-MAPT*P301L)4510Kha/Fgf14+
(involves: FVB/N)
|
dystonia
|
J:102973
|
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-HTT*94Q,-lacZ)1Rhn/0
(involves: C57BL/6 * CBA)
|
dystonia
|
J:61490
|
Tg(CD2-Ifngr2)2Pbro/?
(NOD.Cg-Tg(CD2-Ifngr2)2Pbro)
|
myositis
|
J:81981
|
Tg(Ckm-APPSw)A2Lfa/0
(involves: C57BL/6 * SJL)
|
myositis
|
J:76338
|
Tg(Ckm-APPSw)A6Lfa/0
(involves: C57BL/6 * SJL)
|
myositis
|
J:76338
|
Tg(Ckm-Cd36)1Naa/0
(involves: FVB)
|
abnormal muscle physiology
|
J:57650
|
Tg(Ckm-Chrne*L269F)5Cgz/?
(involves: FVB/NJ)
|
muscle weakness
|
J:193524
|
Tg(Ckm-DNAJB6_ib*F93L)#Ccwe/0
(B6.Cg-Tg(Ckm-DNAJB6_ib*F93L)#Ccwe)
|
myopathy
|
J:226488
|
progressive muscle weakness
|
J:226488
|
Tg(Ckm-Fstl1)#Mvdh/0
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:177416
|
Tg(Ckm-GSN*D187N)AJewe/0
(C57BL/6J-Tg(Ckm-GSN*D187N)AJewe)
|
progressive muscle weakness
|
J:150825
|
Tg(Ckm-IGF1R*K1003R)1Dlr/0
(FVB/N-Tg(Ckm-IGF1R*K1003R)1Dlr)
|
decreased muscle cell glucose uptake
|
J:71205
|
Tg(Ckm-LPL)HRze/0
(involves: C57BL/6J * CBA/J)
|
increased muscle free fatty acids level
|
J:101818
|
myopathy
|
J:101818
|
Tg(Ckm-LPL)MRze/0
(involves: C57BL/6J * CBA/J)
|
increased muscle free fatty acids level
|
J:101818
|
myopathy
|
J:101818
|
Tg(Ckm-Mkl1)1Eno/0
(Not Specified)
|
myopathy
|
J:96122
|
Tg(Ckm-Ppara)HEDpk/0
(involves: C57BL/6 * CBA)
|
decreased muscle cell glucose uptake
|
J:129848
|
Tg(Ckm-Ppard)MEDpk/0
(involves: C57BL/6 * CBA)
|
abnormal muscle cell glucose uptake
|
J:129848
|
Tg(Ckm-Ppargc1a)31Brsp/0
(C57BL/6-Tg(Ckm-Ppargc1a)31Brsp)
|
abnormal muscle physiology
|
J:78333
|
Tg(Ckm-Ppargc1b)T37Brsp/0
(FVB-Tg(Ckm-Ppargc1b)T37Brsp)
|
abnormal muscle physiology
|
J:118258
|
Tg(Ckm-Prkaa2*K45R)1Mbb/0
(involves: C57BL/6J * SJL/J)
|
abnormal muscle physiology
|
J:110092
|
decreased heart left ventricle muscle contractility
|
J:91969
|
Tg(Ckm-PTPN1)45Bbk/0
(involves: FVB)
|
decreased skeletal muscle cell glucose uptake
|
J:122895
|
Tg(Ckm-PTPN1)45Bbk/? Tg(Ckm-PTPRF)13Bbk/?
(involves: FVB)
|
decreased skeletal muscle cell glucose uptake
|
J:122895
|
Tg(Ckm-PTPRF)13Bbk/0
(involves: FVB)
|
decreased skeletal muscle cell glucose uptake
|
J:122895
|
Tg(Ckmm-Cav3)1Ysu/0
(involves: C57BL/Slc * DBA/Slc)
|
abnormal muscle physiology
|
J:67174
|
increased heart left ventricle muscle contractility
|
J:87692
|
myopathy
|
J:67174
|
Tg(CKMM-tTA)A3Rhvh/0 Tg(tetO-H2-K1)#Papl/0
(B6.Cg-Tg(CKMM-tTA)A3Rhvh Tg(tetO-H2-K1)#Papl)
|
muscle weakness
|
J:205907
|
myositis
|
J:205907
|
Tg(CMV-APPL2)1Smoc/0
(Not Specified)
|
decreased skeletal muscle cell glucose uptake
|
J:230004
|
Tg(CMV-ATXN3*135Q)CPama/0
(C57BL/6-Tg(CMV-ATXN3*135Q)CPama)
|
abnormal muscle tone
|
J:222991
|
Tg(CMV-cat,-ROCK2*)3-1Koba/0 Tg(Tagln-cre)1Her/0
(involves: C57BL/6 * C57BL/6JJcl * DBA/2 * SJL)
|
abnormal fetal cardiomyocyte proliferation
|
J:242116
|
decreased heart left ventricle muscle contractility
|
J:242116
|
ventricular cardiomyopathy
|
J:242116
|
Tg(DM15)26Bew/0
(involves: FVB)
|
abnormal muscle relaxation
|
J:93614
|
cardiomyopathy
|
J:33711,
J:93614
|
myopathy
|
J:93614
|
Tg(DMPK/tetO-EGFP/DMPK)5-313Masm/0
(involves: FVB/N)
|
impaired muscle relaxation
|
J:131302,
J:207560
|
Tg(DMWD,DMPK*,SIX5)328Ggo/0
(involves: C57BL/6 * DBA/2)
|
impaired muscle relaxation
|
J:73187
|
Tg(DMWD,DMPK*,SIX5)328Ggo/Tg(DMWD,DMPK*,SIX5)328Ggo
(involves: C57BL/6 * DBA/2)
|
impaired muscle relaxation
|
J:73187
|
Tg(DMWD,DMPK*,SIX5)1177Ggo/Tg(DMWD,DMPK*,SIX5)1177Ggo
(involves: C57BL/6 * DBA/2)
|
impaired muscle relaxation
|
J:73187
|
Tg(DUX4*)1Maar/?
(involves: C57BL/6J * CBA/J)
|
delayed skeletal muscle regeneration
|
J:195481
|
Tg(Edn1-NOS3)22Yky/0
(involves: C57BL/6 * DBA/2)
|
decreased vasodilation
|
J:81132
|
Tg(EIF1AX-Aldh2*E487K)101Oht/Tg(EIF1AX-Aldh2*E487K)101Oht
(C57BL/6-Tg(EIF1AX-Aldh2*E487K)101Oht)
|
muscle weakness
|
J:137374
|
Tg(Eno2-TOR1A*)13Shas/0
(involves: C3H * C57BL/6J)
|
dystonia
|
J:95447
|
Tg(Fabp4-LMNA*R482Q)11ACdl/0
(FVB-Tg(Fabp4-LMNA*R482Q)11ACdl)
|
decreased muscle cell glucose uptake
|
J:149858
|
Tg(Fabp4-LMNA*R482Q)17CCdl/0
(FVB/N-Tg(Fabp4-LMNA*R482Q)17CCdl)
|
abnormal muscle cell glucose uptake
|
J:149858
|
Tg(Gfap-TGFB1)64Lms/0 Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: BALB/c * C57BL/6 * DBA/2 * SJL)
|
decreased vasodilation
|
J:167619
|
Tg(Gpx1)41Dkd/0
(involves: C3H * C57BL/6)
|
increased cardiac muscle contractility
|
J:127782
|
Tg(H2-K-Fosl1)1Wag/0
(involves: C57BL/6 * CBA)
|
decreased cardiac muscle contractility
|
J:95691
|
Tg(HBx-HCV)C5Tto/0
(involves: C57BL/6 * DBA/2)
|
cardiomyopathy
|
J:105313
|
decreased cardiac muscle contractility
|
J:105313
|
Tg(HCRT-tTA)1Ahky/0 Tg(tetO-DTA)1Gfi/0
(B6.Cg-Tg(HCRT-tTA)1Ahky Tg(tetO-DTA)1Gfi)
|
abnormal muscle physiology
|
J:211045
|
Tg(HDexon1)62Gpb/0
(B6CBA-Tg(HDexon1)62Gpb/1J)
|
decreased heart left ventricle muscle contractility
|
J:116660
|
Tg(HIV)26Aln/0
(involves: FVB/N)
|
myositis
|
J:90297
|
Tg(HSA*LR)20aCath/?
(involves: FVB/N)
|
impaired muscle relaxation
|
J:64493
|
Tg(HSA*LR)20bCath/?
(involves: FVB/N)
|
abnormal muscle electrophysiology
|
J:125885
|
impaired muscle relaxation
|
J:64493
|
Tg(HSA*LR)21Cath/?
(involves: FVB/N)
|
impaired muscle relaxation
|
J:64493
|
Tg(HSA*LR)32aCath/?
(involves: FVB/N)
|
impaired muscle relaxation
|
J:64493
|
Tg(HSA*LR)32bCath/?
(involves: FVB/N)
|
impaired muscle relaxation
|
J:64493
|
Tg(HSA*LR)41Cath/?
(involves: FVB/N)
|
impaired muscle relaxation
|
J:64493
|
Tg(HTT*)AXwy/0
(involves: FVB/NJ)
|
dystonia
|
J:219890
|
Tg(HTT*)LXwy/0
(involves: FVB/NJ)
|
dystonia
|
J:219890
|
Tg(HTT*)NXwy/0
(involves: FVB/NJ)
|
dystonia
|
J:219890
|
Tg(IGFBP1)2Miel/0
(involves: C57BL * CBA)
|
decreased vasoconstriction
|
J:84652
|
Tg(Lck-Tnfsf4)1Nish/0
(B6.Cg-Tg(Lck-Tnfsf4)1Nish)
|
increased vasoconstriction
|
J:194882
|
Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf)
|
myositis
|
J:129951
|
Tg(Lmnb1)1Yfu/0
(involves: C57BL/6J)
|
muscle spasm
|
J:197168
|
Tg(Mnx1-Mfn2*T105M,-EGFP)1Dcc/Tg(Mnx1-Mfn2*T105M,-EGFP)1Dcc
(Not Specified)
|
muscle weakness
|
J:132035
|
Tg(Mpz)88.1Mfel/0
(FVB/N-Tg(Mpz)88.1Mfel)
|
muscle weakness
|
J:77658
|
Tg(Mpz)88.2Mfel/0
(FVB/N-Tg(Mpz)88.2Mfel)
|
muscle weakness
|
J:77658
|
Tg(Mpz)88.4Mfel/0
(FVB/N-Tg(Mpz)88.4Mfel)
|
muscle weakness
|
J:77658
|
Tg(MT2A-TGFBR2)#Rser/0
(involves: C57BL/6 * DBA)
|
decreased cardiac muscle contractility
|
J:158480
|
dilated cardiomyopathy
|
J:158480
|
Tg(Myh6*)1Lnwd/0
(involves: C57BL/6 * FVB/N)
|
decreased cardiac muscle relaxation
|
J:55938
|
Tg(Myh6*)140Lnwd/0
(involves: C57BL/6 * CBA)
|
decreased cardiac muscle contractility
|
J:134706
|
Tg(Myh6*)140Lnwd/0 Tg(WTbeta2)4Wjk/0
(involves: C57BL/6 * CBA)
|
abnormal cardiac muscle contractility
|
J:134706
|
Tg(Myh6*/tetO-BAG3)69Atsa/0 Tg(Myh6-tTA)55Rbns/0
(involves: C57BL/6CrSlc * FVB/NJ)
|
decreased cardiac muscle contractility
|
J:273465
|
Tg(Myh6*/tetO-Capn1)L2Gwd/0
(involves: FVB/N)
|
decreased heart ventricle muscle contractility
|
J:133797
|
Tg(Myh6*/tetO-Capn1)L3Gwd/0
(involves: FVB/N)
|
decreased heart ventricle muscle contractility
|
J:133797
|
Tg(Myh6*/tetO-FXYD1*S68E)39Jych/0 Tg(Myh6-tTA)55Rbns/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:182365
|
increased heart ventricle muscle contractility
|
J:182365
|
Tg(Myh6*/tetO-Hspb8*K141N)#Atsa/0 Tg(Myh6-tTA)55Rbns/0
(involves: C57BL/6CrSlc * FVB/NJ)
|
cardiomyopathy
|
J:197853
|
decreased cardiac muscle contractility
|
J:197853
|
Tg(Myh6*/tetO-Slc8a1)BJych/0 Tg(Myh6-tTA)55Rbns/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:151091
|
Tg(Myh6-1810058I24Rik)#Eno/0
(involves: C57BL/6)
|
cardiomyopathy
|
J:325962
|
decreased cardiac muscle contractility
|
J:325962
|
Tg(Myh6-Acsl1)J3Jesc/0
(FVB/N-Tg(Myh6-Acsl1)J3Jesc)
|
decreased heart ventricle muscle contractility
|
J:68639
|
Tg(Myh6-Acsl1)M13Jesc/0
(FVB/N-Tg(Myh6-Acsl1)M13Jesc)
|
decreased heart ventricle muscle contractility
|
J:68639
|
Tg(Myh6-Acsl1)O7Jesc/0
(FVB/N-Tg(Myh6-Acsl1)O7Jesc)
|
cardiomyopathy
|
J:68639
|
decreased heart ventricle muscle contractility
|
J:68639
|
increased cardiomyocyte apoptosis
|
J:68639
|
Tg(Myh6-ACTC1*E99K)#Sbm/0
(involves: C57BL/10 * CBA/Ca)
|
abnormal cardiac muscle relaxation
|
J:175388
|
decreased cardiac muscle contractility
|
J:175388
|
dilated cardiomyopathy
|
J:175388
|
Tg(Myh6-ACTC1*E361G)361.20Sbm/0
(Not Specified)
|
decreased cardiac muscle relaxation
|
J:242344
|
decreased heart ventricle muscle contractility
|
J:242344
|
dilated cardiomyopathy
|
J:242344
|
Tg(Myh6-Actc1*R312H)307Iko/?
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:178587
|
dilated cardiomyopathy
|
J:178587
|
increased cardiomyocyte apoptosis
|
J:178587
|
Tg(Myh6-Actc1dt)2Kwan/0
(involves: C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:297375
|
Tg(Myh6-Adra1a)A1A1Rmgr/0
(FVB/N-Tg(Myh6-Adra1a)A1A1Rmgr)
|
abnormal cardiac muscle relaxation
|
J:108879
|
increased cardiac muscle contractility
|
J:108879
|
increased heart left ventricle muscle contractility
|
J:108867
|
Tg(Myh6-Adra1a)A1A4Rmgr/0
(FVB/N-Tg(Myh6-Adra1a)A1A4Rmgr)
|
increased cardiomyocyte apoptosis
|
J:108867
|
increased heart left ventricle muscle contractility
|
J:108867,
J:108879
|
Tg(Myh6-ADRB1)4Mjlo/0
(FVB/N-Tg(Myh6-ADRB1)4Mjlo)
|
decreased cardiac muscle contractility
|
J:55719
|
decreased heart left ventricle muscle contractility
|
J:55719
|
increased cardiac muscle contractility
|
J:55719
|
Tg(Myh6-ADRBK1)27Wjk/0
(involves: C57BL/6 * SJL)
|
increased cardiac muscle contractility
|
J:134706
|
Tg(Myh6-AIP/PLN*)46Jded/0
(FVB/N-Tg(Myh6-AIP/PLN*)46Jded)
|
abnormal cardiac muscle relaxation
|
J:84333
|
Tg(Myh6-Akt1*T308D*S473D)1Siz/0
(Not Specified)
|
decreased heart left ventricle muscle contractility
|
J:75780
|
Tg(Myh6-ANKRD1)#Camm/0
(involves: FVB)
|
abnormal cardiac muscle contractility
|
J:302922
|
decreased cardiac muscle contractility
|
J:302922
|
Tg(Myh6-BAG3*P209L)#Mswi/0
(involves: C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:234278
|
decreased cardiac muscle relaxation
|
J:234278
|
Tg(Myh6-Bclaf1)#Cya/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:301260
|
increased cardiomyocyte apoptosis
|
J:301260
|
Tg(Myh6-BRUNOL4*)10Coop/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:99369
|
dilated cardiomyopathy
|
J:99369
|
Tg(Myh6-CACNA1C)M1Aschw/0
(involves: FVB/N)
|
dilated cardiomyopathy
|
J:134761
|
increased cardiac muscle contractility
|
J:129494
|
increased cardiac muscle relaxation
|
J:129494
|
increased cardiomyocyte apoptosis
|
J:134761
|
Tg(Myh6-Camk2d)1Jhb/0
(involves: C57BL/6)
|
decreased cardiac muscle contractility
|
J:73694
|
decreased cardiac muscle relaxation
|
J:73694
|
Tg(Myh6-Camk2d)1Xdfu/0
(Not Specified)
|
abnormal cardiac muscle contractility
|
J:96039
|
dilated cardiomyopathy
|
J:96039
|
Tg(Myh6-Camk2d_ic)LJhb/0
(either: (involves: Black Swiss) or (involves: C57BL/6))
|
decreased cardiac muscle contractility
|
J:130644
|
dilated cardiomyopathy
|
J:130644
|
Tg(Myh6-Camk2d_ic)MJhb/0
(either: (involves: Black Swiss) or (involves: C57BL/6))
|
decreased cardiac muscle contractility
|
J:130644
|
dilated cardiomyopathy
|
J:130644
|
Tg(Myh6-Camta2)1Eno/0
(Not Specified)
|
dilated cardiomyopathy
|
J:115868
|
Tg(Myh6-CASQ2)1Mord/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:79838
|
decreased cardiac muscle relaxation
|
J:79838
|
decreased heart left ventricle muscle contractility
|
J:79838
|
decreased heart ventricle muscle contractility
|
J:79838
|
dilated cardiomyopathy
|
J:79838
|
Tg(Myh6-CASQ2)1Mord/0 Tg(Myh6-TNNI3K)#Dmar/0 Tnni3kB/Tnni3kB
(involves: C57BL/6J * DBA/2J * SJL/J)
|
decreased cardiac muscle contractility
|
J:154116
|
dilated cardiomyopathy
|
J:154116
|
Tg(Myh6-CASQ2)1Mord/0 Tnni3kB/Tnni3kA
(involves: AKR/J * DBA/2J)
|
decreased cardiac muscle contractility
|
J:154116
|
Tg(Myh6-Cast)1Gwd/0
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:133797
|
decreased heart ventricle muscle contractility
|
J:133797
|
dilated cardiomyopathy
|
J:133797
|
Tg(Myh6-Ccna2)58Djw/0
(involves: C57BL/6 * CBA)
|
decreased cardiac muscle contractility
|
J:92551
|
Tg(Myh6-cre)TG9Pjay/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:198043
|
dilated cardiomyopathy
|
J:198043,
J:119070
|
increased cardiomyocyte apoptosis
|
J:198043
|
Tg(Myh6-CREB1*S133A)1Jml/0
(involves: CD-1)
|
abnormal cardiac muscle contractility
|
J:133881
|
decreased heart left ventricle muscle contractility
|
J:133881
|
dilated cardiomyopathy
|
J:133881
|
Tg(Myh6-Cryab*R120G)708Rbns/0
(FVB/N-Tg(Myh6-Cryab*R120G)708Rbns)
|
decreased cardiac muscle contractility
|
J:133093
|
decreased cardiac muscle relaxation
|
J:133093
|
Tg(Myh6-CRYAB*R120G)7302Ijb/0
(involves: C57BL/6)
|
cardiomyopathy
|
J:126781
|
Tg(Myh6-Des*)641Rbns/0
(involves: FVB/N)
|
abnormal cardiac muscle relaxation
|
J:108730
|
decreased heart left ventricle muscle contractility
|
J:108730
|
Tg(Myh6-Dyrk1b)#Yax/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:334531
|
decreased heart left ventricle muscle contractility
|
J:334531
|
Tg(Myh6-EGFR*)9-12Iko/0
(involves: C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:182337
|
dilated cardiomyopathy
|
J:182337
|
Tg(Myh6-EP300)21Csk/0
(C57BL/6-Tg(Myh6-EP300)21Csk)
|
decreased heart left ventricle muscle contractility
|
J:110549
|
Tg(Myh6-EP300)39Csk/0
(C57BL/6-Tg(Myh6-EP300)39Csk)
|
decreased heart left ventricle muscle contractility
|
J:110549
|
Tg(Myh6-Erbb2)6Kaga/0
(involves: C57BL/6J * SJL/J)
|
cardiomyopathy
|
J:189979
|
decreased cardiac muscle contractility
|
J:189979
|
Tg(Myh6-Gnaq)25Gwd/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:144736,
J:41949
|
decreased heart left ventricle muscle contractility
|
J:41949
|
Tg(Myh6-Gnaq)25Gwd/0 Tg(Myh6-Gnaq)40Gwd/0
(involves: FVB/N)
|
dilated cardiomyopathy
|
J:41949
|
Tg(Myh6-Gnaq)#Gwd/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:145086
|
increased cardiomyocyte apoptosis
|
J:145086
|
Tg(Myh6-Gnaq)#Gwd/0 Tg(Myh6-tTA)55Rbns/0 Tg(tetO-Bnip3l)1Gwd/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:145086
|
increased cardiomyocyte apoptosis
|
J:145086
|
Tg(Myh6-Gnaq*Q209L)44Ejne/0
(involves: FVB)
|
dilated cardiomyopathy
|
J:127756
|
Tg(Myh6-Gnaq*Q209L)44Ejne/Tg(Myh6-Gnaq*Q209L)44Ejne
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:127756
|
dilated cardiomyopathy
|
J:127756
|
Tg(Myh6-Gnaq*Q209L)52Ejne/?
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:127756
|
dilated cardiomyopathy
|
J:204274,
J:127756
|
Tg(Myh6-Gnaq*Q209L/Esr1*)7Rzl/0
(involves: C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:104100
|
decreased cardiac muscle contractility
|
J:104100
|
dilated cardiomyopathy
|
J:104100
|
Tg(Myh6-Grem2)1Akh/0
(involves: C57BL/6)
|
increased cardiac muscle contractility
|
J:250034
|
Tg(Myh6-HBEGF)#Iko/0
(involves: C57BL/6 * DBA/2)
|
decreased cardiac muscle contractility
|
J:93335
|
dilated cardiomyopathy
|
J:93335
|
Tg(Myh6-IGF1R)7Jmcm/0
(involves: FVB/N)
|
increased heart ventricle muscle contractility
|
J:87944
|
Tg(Myh6-Jund1)9Wag/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:95691
|
Tg(Myh6-Jup*)1Ajm/0
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:192719
|
Tg(Myh6-JUP*)1Dpju/0
(FVB/N-Tg(Myh6-JUP*)1Dpju)
|
increased cardiomyocyte apoptosis
|
J:235770
|
Tg(Myh6-KDM4A)BZpl/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:173908
|
Tg(Myh6-LDB3*S196L)93Mva/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:243711
|
Tg(Myh6-Lef1)2Tfo/0
(involves: C57BL/6J * FVB/N)
|
decreased heart ventricle muscle contractility
|
J:109612
|
dilated cardiomyopathy
|
J:109612
|
Tg(Myh6-LMNA*E82K)35Lizh/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:167734
|
decreased heart left ventricle muscle contractility
|
J:167734
|
dilated cardiomyopathy
|
J:167734
|
increased cardiomyocyte apoptosis
|
J:167734
|
Tg(Myh6-Map2k1*)1Jmol/?
(involves: FVB)
|
decreased cardiomyocyte apoptosis
|
J:66102
|
Tg(Myh6-Map2k1*)1Jmol/?
(involves: FVB/N)
|
decreased cardiomyocyte apoptosis
|
J:127872
|
Tg(Myh6-Map2k1*)1Jmol/0 Tg(Myh6/tetO-Tnnc1*I61Q)1Jmol/0 Tg(Myh6-tTA)55Rbns/0
(involves: FVB)
|
increased cardiac muscle contractility
|
J:234490
|
Tg(Myh6-Map2k3*)1Jmol/0
(FVB-Tg(Myh6-Map2k3*)1Jmol)
|
cardiomyopathy
|
J:83547
|
decreased cardiac muscle contractility
|
J:83547
|
decreased heart left ventricle muscle contractility
|
J:83547
|
Tg(Myh6-Map2k6*)1Jmol/0
(FVB-Tg(Myh6-Map2k6*)1Jmol)
|
decreased cardiac muscle contractility
|
J:83547
|
decreased heart ventricle muscle contractility
|
J:83547
|
Tg(Myh6-Map2k7)1Jmol/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:102152
|
decreased cardiomyocyte apoptosis
|
J:102152
|
Tg(Myh6-Mapk8*,Myh6-Mapk9*)22.4Jmol/0
(involves: FVB/N)
|
decreased cardiomyocyte apoptosis
|
J:102152
|
Tg(Myh6-Mapk14*)1Jmol/0
(FVB-Tg(Myh6-Mapk14*)1Jmol)
|
cardiomyopathy
|
J:83547
|
decreased cardiac muscle contractility
|
J:83547
|
decreased heart left ventricle muscle contractility
|
J:83547
|
decreased heart ventricle muscle contractility
|
J:83547
|
Tg(Myh6-MEF2A)1Jmol/0
(involves: FVB)
|
decreased heart ventricle muscle contractility
|
J:111573
|
Tg(Myh6-Mef2c)2Jmol/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:111573
|
dilated cardiomyopathy
|
J:111573
|
Tg(Myh6-Mef2c)2Jmol/0 Tg(Myh6-Ppp3ca)37Eno/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:111573
|
Tg(Myh6-Mef2d)2Eno/0
(Not Specified)
|
cardiomyopathy
|
J:130825
|
Tg(Myh6-Mir30c-1)AEec/0
(involves: C57BL/6JOlaHsd * FVB/N)
|
dilated cardiomyopathy
|
J:216095
|
Tg(Myh6-Mir30c-1)BEec/0
(involves: C57BL/6JOlaHsd * FVB/N)
|
decreased cardiac muscle contractility
|
J:216095
|
dilated cardiomyopathy
|
J:216095
|
Tg(Myh6-Mmp2*V107G)712Ajb/0
(involves: 129/Sv * CD-1)
|
decreased cardiac muscle contractility
|
J:105703
|
Tg(Myh6-Mtg1)3Ywxu/0
(involves: C57BL/6J)
|
increased cardiac muscle contractility
|
J:271147
|
Tg(Myh6-Mtpn)4Ssen/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:89823
|
Tg(Myh6-Myh7)102Rbns/Tg(Myh6-Myh7)102Rbns
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:166125
|
Tg(Myh6-Myh7)137Rbns/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:166125
|
Tg(Myh6-MYH7B)#Lnwd/0
(C57BL/6-Tg(Myh6-MYH7B)#Lnwd)
|
decreased cardiac muscle contractility
|
J:285433
|
Tg(Myh6-Myl2*)21Rbns/0
(Not Specified)
|
abnormal cardiac muscle contractility
|
J:114298
|
abnormal cardiac muscle relaxation
|
J:114298
|
decreased cardiac muscle contractility
|
J:110993
|
Tg(Myh6-MYL2*A13T)L1Dsc/0
(involves: C57BL/6 * SJL)
|
cardiomyopathy
|
J:181028
|
Tg(Myh6-MYL2*D94A)1Dsc/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:258888
|
dilated cardiomyopathy
|
J:258888
|
Tg(Myh6-MYL2*K104E)2Dsc/0
(involves: C57BL/6 * SJL)
|
cardiomyopathy
|
J:263776
|
decreased cardiac muscle relaxation
|
J:263776
|
increased cardiac muscle contractility
|
J:263776
|
Tg(Myh6-MYL2*R58Q)#Dsc/0
(involves: C57BL/6 * SJL)
|
abnormal cardiac muscle contractility
|
J:162200
|
decreased cardiac muscle relaxation
|
J:162200
|
Tg(Myh6-MYL3*A57G)#Dsc/0
(involves: C57BL/6 * SJL)
|
increased heart left ventricle muscle contractility
|
J:202154
|
Tg(Myh6-MYL3*E143K)2Dsc/0
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:258831
|
cardiomyopathy
|
J:258831
|
Tg(Myh6-MYPN*Y20C)#Jato/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:181871
|
decreased heart left ventricle muscle contractility
|
J:181871
|
Tg(Myh6-NEBL*A592E)#Jato/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:242962
|
dilated cardiomyopathy
|
J:242962
|
Tg(Myh6-NEBL*G202R)#Jato/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:242962
|
dilated cardiomyopathy
|
J:242962
|
Tg(Myh6-Nox4)#Jusa/0
(FVB-Tg(Myh6-Nox4)#Jusa)
|
decreased heart ventricle muscle contractility
|
J:163751,
J:164275
|
increased cardiomyocyte apoptosis
|
J:163751,
J:164275
|
Tg(Myh6-Pfkfb3)7Pne/0
(FVB-Tg(Myh6-Pfkfb3)7Pne)
|
decreased cardiac muscle cell glucose uptake
|
J:94475
|
decreased cardiac muscle contractility
|
J:94475
|
Tg(Myh6-Pkp2*/mRuby)4Rbrug/0
(involves: C57BL/6 * DBA/2)
|
cardiomyopathy
|
J:237859
|
Tg(Myh6-Pkp2*/mRuby)4Rbrug/0 Tg(Myh6-Pkp2*/mRuby)5Rbrug/0
(involves: C57BL/6 * DBA/2)
|
cardiomyopathy
|
J:237859
|
decreased heart left ventricle muscle contractility
|
J:237859
|
Tg(Myh6-Pkp2*/mRuby)5Rbrug/0
(involves: C57BL/6 * DBA/2)
|
cardiomyopathy
|
J:237859
|
Tg(Myh6-Pln)416Egk/?
(FVB/N-Tg(Myh6-Pln)416Egk)
|
abnormal cardiac muscle contractility
|
J:135899
|
Tg(Myh6-Pln*)#Egk/0
(Not Specified)
|
dilated cardiomyopathy
|
J:105976
|
Tg(Myh6-Pln*R9C)#Ces/0
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:82353
|
dilated cardiomyopathy
|
J:82353
|
Tg(Myh6-POLG*Y955C)DWcc/0
(Not Specified)
|
cardiomyopathy
|
J:122507
|
Tg(Myh6-Ppara)402-2Dpk/0
(involves: C57BL/6 * CBA/J)
|
cardiomyopathy
|
J:110580
|
decreased heart ventricle muscle contractility
|
J:110580
|
Tg(Myh6-Ppara)404-3Dpk/0
(involves: C57BL/6 * CBA/J)
|
cardiomyopathy
|
J:81834,
J:110580
|
decreased cardiac muscle cell glucose uptake
|
J:110580
|
decreased heart ventricle muscle contractility
|
J:110580
|
Tg(Myh6-Ppard)HEDpk/0
(involves: C57BL/6 * CBA)
|
decreased cardiac muscle contractility
|
J:130750
|
increased cardiac muscle cell glucose uptake
|
J:130750
|
Tg(Myh6-Prkaa2*D157A)1Rti/0 Tg(Myh6-PRKAG2*T400N)1Feah/0
(involves: FVB)
|
decreased heart ventricle muscle contractility
|
J:123005
|
Tg(Myh6-Prkaca)2Eno/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:263774
|
dilated cardiomyopathy
|
J:263774
|
Tg(Myh6-Prkaca)33Eno/0
(Not Specified)
|
dilated cardiomyopathy
|
J:263774
|
Tg(Myh6-PRKAG2)#Rro/0
(involves: FVB)
|
decreased heart ventricle muscle contractility
|
J:108102
|
Tg(Myh6-PRKAG2*N488I)4623Jse/0
(involves: FVB)
|
decreased heart left ventricle muscle contractility
|
J:128648
|
Tg(Myh6-PRKAG2*R302Q)#Rro/0
(involves: FVB)
|
decreased heart ventricle muscle contractility
|
J:108102
|
Tg(Myh6-PRKAG2*R531G)22Dca/0
(involves: C57BL/10 * CBA/Ca)
|
decreased heart left ventricle muscle contractility
|
J:108517
|
Tg(Myh6-PRKAG2*T400N)1Feah/0
(involves: FVB/N)
|
decreased heart ventricle muscle contractility
|
J:123005
|
Tg(Myh6-Prkca)1Jmk/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:88510
|
Tg(Myh6-PRKCE*A159E)344Robo/?
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:133478
|
dilated cardiomyopathy
|
J:133478
|
Tg(Myh6-PROKR1)13Cagn/0
(involves: C57BL/6 * CD-1 * DBA/2)
|
abnormal cardiac muscle contractility
|
J:149020
|
Tg(Myh6-Rab1a)highGwd/0
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:134581
|
dilated cardiomyopathy
|
J:134581
|
Tg(Myh6-Rab1a)lowGwd/0
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:134581
|
dilated cardiomyopathy
|
J:134581
|
Tg(Myh6-Rab1a)medGwd/0
(involves: FVB/N)
|
decreased heart left ventricle muscle contractility
|
J:134581
|
decreased heart ventricle muscle contractility
|
J:134581
|
dilated cardiomyopathy
|
J:134581
|
Tg(Myh6-Rest*)474Ysai/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:86837
|
decreased heart left ventricle muscle contractility
|
J:86837
|
dilated cardiomyopathy
|
J:86837
|
Tg(Myh6-rtTA)8585Jam/0 Tg(Myh6*/tetO-SCN5A*F1759A)#Marx/0
(involves: C57BL/6 * CBA * FVB/NTac)
|
cardiomyopathy
|
J:229825
|
decreased heart left ventricle muscle contractility
|
J:229825
|
Tg(Myh6-rtTA)8585Jam/0 Tg(tetO-CUGBP1)3413Coop/0
(involves: FVB * FVB/N * FVB/NTac)
|
decreased cardiac muscle contractility
|
J:157646
|
dilated cardiomyopathy
|
J:157646
|
Tg(Myh6-rtTA)8585Jam/0 Tg(tetO-Fgfr3*R248C/Fgfr1)#Dor/0
(involves: 129 * C57BL/6 * FVB/N * FVB/NTac)
|
abnormal cardiac muscle relaxation
|
J:211151
|
cardiomyopathy
|
J:211151
|
increased cardiac muscle contractility
|
J:211151
|
increased heart left ventricle muscle contractility
|
J:211151
|
Tg(Myh6-rtTA)8585Jam/0 Tg(tetO-Ppargc1a)1Dpk/0
(involves: FVB/N * FVB/NTac)
|
cardiomyopathy
|
J:96614
|
decreased cardiac muscle contractility
|
J:96614
|
Tg(Myh6-Rxra)41Pcn/0
(Not Specified)
|
dilated cardiomyopathy
|
J:60351
|
Tg(Myh6-Sgcd*S151A)5Mcn/0
(involves: 129T2/SvEms * C57BL/6J)
|
dilated cardiomyopathy
|
J:117855
|
Tg(Myh6-SLC2A1)54Rti/0
(FVB-Tg(Myh6-SLC2A1)54Rti)
|
increased cardiac muscle cell glucose uptake
|
J:106467
|
Tg(Myh6-Sln)26Peri/0
(involves: C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:108309
|
decreased cardiac muscle contractility
|
J:108309
|
Tg(Myh6-Snai1)B10Jcc/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:126850
|
dilated cardiomyopathy
|
J:126850
|
Tg(Myh6-Snai1)B10Jcc/Tg(Myh6-Snai1)B10Jcc
(Not Specified)
|
decreased cardiac muscle contractility
|
J:126850
|
dilated cardiomyopathy
|
J:126850
|
Tg(Myh6-STK4)28Jusa/0
(involves: C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:139414
|
dilated cardiomyopathy
|
J:139414
|
increased cardiomyocyte apoptosis
|
J:139414
|
Tg(Myh6-STK4*K59R)10Jusa/0
(involves: C57BL/6)
|
decreased cardiomyocyte apoptosis
|
J:139414
|
Tg(Myh6-Sumo2*)9606Jwang/0
(either: B6.FVB-Tg(Myh6-Sumo2*)9606Jwang or (involves: C57BL/6 * FVB/N))
|
cardiomyopathy
|
J:230540
|
increased cardiomyocyte apoptosis
|
J:230540
|
Tg(Myh6-Sumo2*)9608Jwang/0
(either: B6.FVB-Tg(Myh6-Sumo2*)9608Jwang or (involves: C57BL/6 * FVB/N))
|
cardiomyopathy
|
J:230540
|
Tg(Myh6-Sumo2*)9610Jwang/0
(either: B6.FVB-Tg(Myh6-Sumo2*)9610Jwang or (involves: C57BL/6 * FVB/N))
|
decreased cardiac muscle contractility
|
J:230540
|
Tg(Myh6-Tcap)#Rnk/0
(Not Specified)
|
decreased cardiomyocyte apoptosis
|
J:188832
|
Tg(Myh6-Tmod1)65Msus/Tg(Myh6-Tmod1)65Msus
(involves: FVB/N)
|
abnormal cardiac muscle relaxation
|
J:107823
|
decreased cardiac muscle contractility
|
J:107823
|
decreased heart left ventricle muscle contractility
|
J:107823
|
dilated cardiomyopathy
|
J:107823
|
Tg(Myh6-Tmod1)65Msus/Tg(Myh6-Tmod1)65Msus
(FVB/N-Tg(Myh6-Tmod1)65Msus)
|
dilated cardiomyopathy
|
J:58879
|
Tg(Myh6-Tnf)1.6Amf/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:104759
|
dilated cardiomyopathy
|
J:104759
|
Tg(Myh6-Tnf)1Brgi/?
(involves: C57BL/6J * SJL)
|
decreased heart ventricle muscle contractility
|
J:100006
|
Tg(Myh6-Tnf)2Brgi/?
(involves: C57BL/6J * SJL)
|
decreased heart ventricle muscle contractility
|
J:100006
|
Tg(Myh6-Tnni3*)1Ammu/0
(involves: A/J * C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:59433
|
decreased cardiac muscle contractility
|
J:104770,
J:59433
|
dilated cardiomyopathy
|
J:104770
|
Tg(Myh6-TNNI3*G203S)1Chs/0
(Not Specified)
|
cardiomyopathy
|
J:114537
|
Tg(Myh6-TNNI3*G203S)4Chs/0
(Not Specified)
|
cardiomyopathy
|
J:114537
|
Tg(Myh6-Tnni3*R146G)121Rbns/0
(Not Specified)
|
decreased cardiac muscle relaxation
|
J:243628
|
increased cardiac muscle contractility
|
J:243628
|
Tg(Myh6-Tnni3*R193H)42Xhu/0
(involves: C57BL/6)
|
cardiomyopathy
|
J:119991
|
decreased cardiac muscle contractility
|
J:119991
|
decreased cardiac muscle relaxation
|
J:119991
|
Tg(Myh6-Tnni3*R193H)594Jmme/0
(involves: C57BL/6 * SJL)
|
cardiomyopathy
|
J:186721
|
decreased cardiac muscle relaxation
|
J:186721
|
increased cardiac muscle contractility
|
J:186721
|
Tg(Myh6-Tnnt2)117Lnwd/0
(involves: C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:48301
|
decreased cardiac muscle contractility
|
J:48301
|
Tg(Myh6-Tnnt2)191Lnwd/0
(involves: C57BL/6)
|
abnormal cardiac muscle relaxation
|
J:48301
|
decreased cardiac muscle contractility
|
J:48301
|
Tg(Myh6-Tnnt2*)1Feah/0
(129S.FVB-Tg(Myh6-Tnnt2*)1Feah)
|
dilated cardiomyopathy
|
J:137964
|
Tg(Myh6-Tnnt2*)1Feah/0 Tnnt2tm1Feah/Tnnt2+
(involves: 129S/SvEv * 129S6/SvEvTac * FVB/N)
|
decreased cardiac muscle contractility
|
J:137964
|
dilated cardiomyopathy
|
J:137964
|
Tg(Myh6-Tnnt2*R92L)1Jcf/0
(B6.Cg-Tg(Myh6-Tnnt2*R92L)1Jcf)
|
cardiomyopathy
|
J:104369
|
decreased cardiac muscle contractility
|
J:104369
|
decreased cardiac muscle relaxation
|
J:104369
|
Tg(Myh6-Tnnt2*R92Q)2Lnwd/0
(involves: C57BL/6)
|
abnormal cardiac muscle contractility
|
J:56911
|
abnormal cardiac muscle relaxation
|
J:56911
|
increased cardiac muscle contractility
|
J:56911
|
Tg(Myh6-Tnnt2*R92W)1Jcf/0
(B6.Cg-Tg(Myh6-Tnnt2*R92W)1Jcf)
|
cardiomyopathy
|
J:104369
|
decreased cardiac muscle contractility
|
J:104369
|
decreased cardiac muscle relaxation
|
J:104369
|
Tg(Myh6-TNNT2*R141W)#Lian/0
(involves: C57BL/6J)
|
decreased cardiac muscle contractility
|
J:211769
|
dilated cardiomyopathy
|
J:211769
|
Tg(Myh6-Tpm1*D175N)#Dfw/0
(Not Specified)
|
decreased cardiac muscle contractility
|
J:57365
|
decreased cardiac muscle relaxation
|
J:57365
|
Tg(Myh6-Tpm1*D230N)HJcf/0
(B6.FVB-Tg(Myh6-Tpm1*D230N)HJcf)
|
decreased cardiac muscle contractility
|
J:243724
|
decreased heart left ventricle muscle contractility
|
J:243724
|
dilated cardiomyopathy
|
J:243724
|
Tg(Myh6-Tpm1*E54K)30Dfw/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:137813
|
decreased cardiac muscle relaxation
|
J:137813
|
decreased heart left ventricle muscle contractility
|
J:137813
|
dilated cardiomyopathy
|
J:137813
|
Tg(Myh6-Tpm1*E54K)67Dfw/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:137813
|
decreased cardiac muscle relaxation
|
J:137813
|
decreased heart left ventricle muscle contractility
|
J:137813
|
dilated cardiomyopathy
|
J:137813
|
Tg(Myh6-Tpm1*E180G)57Dfw/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:127507,
J:172340
|
abnormal cardiac muscle relaxation
|
J:127507,
J:172340
|
decreased cardiac muscle contractility
|
J:171021
|
increased cardiac muscle contractility
|
J:172340
|
Tg(Myh6-Trim72)1Rpx/0
(C57BL/6-Tg(Myh6-Trim72)1Rpx)
|
cardiomyopathy
|
J:234132
|
decreased cardiac muscle contractility
|
J:234132
|
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-DTA)1Gfi/0
(involves: C57BL/6 * CBA)
|
increased cardiomyocyte apoptosis
|
J:128617
|
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-Mir208a)#Dzw/0
(involves: C3H * C57BL/6 * CBA)
|
decreased cardiac muscle contractility
|
J:152696
|
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-Spp1)5Gad/0
(involves: C57BL/6 * CBA)
|
decreased heart left ventricle muscle contractility
|
J:194810
|
dilated cardiomyopathy
|
J:194810
|
Tg(Myh6-tTA)6Smbf/0 Tg(tetORo1-lacZ)3Conk/0
(FVB.Cg-Tg(Myh6-tTA)6Smbf Tg(tetORo1-lacZ)3Conk)
|
abnormal cardiac muscle relaxation
|
J:107363
|
decreased cardiac muscle contractility
|
J:107363
|
decreased heart left ventricle muscle contractility
|
J:107363
|
decreased heart right ventricle muscle contractility
|
J:107363
|
decreased heart ventricle muscle contractility
|
J:107363
|
dilated cardiomyopathy
|
J:107363
|
Tg(Myh6-tTA)55Rbns/? Tg(Myh6/tetO-BNIP3)1Gwd/?
(Not Specified)
|
increased cardiomyocyte apoptosis
|
J:127533
|
Tg(Myh6-tTA)55Rbns/0 Tg(Myh6/tetO-PRKAG2*N488I)1Chib/0
(Not Specified)
|
decreased heart left ventricle muscle contractility
|
J:145090
|
Tg(Myh6-tTA)55Rbns/0 Tg(Myh6/tetO-PRKCA*)1Jmk/0
(involves: FVB/N)
|
abnormal cardiac muscle contractility
|
J:132098
|
increased heart ventricle muscle contractility
|
J:132098
|
Tg(Myh6-tTA)55Rbns/0 Tg(tetO-Bnip3l)1Gwd/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:145086
|
increased cardiomyocyte apoptosis
|
J:145086
|
Tg(Myh6-tTA)55Rbns/0 Tg(tetO-Dusp6)1Jmol/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:124903
|
increased cardiomyocyte apoptosis
|
J:124903
|
Tg(Myh6-Yap1*S112A)#Eno/0
(involves: C3H * C57BL/6)
|
decreased cardiomyocyte apoptosis
|
J:200670
|
enhanced cardiac muscle regeneration
|
J:200670
|
Tg(Myh6/tetO-Mybpc3*)#Rbns/0 Tg(Myh6-tTA)55Rbns/0
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:213370
|
Tg(Myh6/tetO-Tnnc1*I61Q)1Jmol/0 Tg(Myh6-tTA)55Rbns/0
(involves: FVB)
|
decreased cardiac muscle contractility
|
J:234490
|
increased cardiac muscle relaxation
|
J:234490
|
Tg(Myh6/tetO-Tnnc1*L48Q)2Jmol/0 Tg(Myh6-tTA)55Rbns/0
(involves: FVB)
|
abnormal cardiac muscle contractility
|
J:234490
|
decreased cardiac muscle relaxation
|
J:234490
|
increased cardiac muscle contractility
|
J:234490
|
Tg(Myh7-BVp35-EGFP)#Ksa/?
(involves: C3H * C57BL/6)
|
abnormal cardiomyocyte apoptosis
|
J:102279
|
Tg(Myh7-Phc1)#Yota/0
(involves: C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:75968
|
dilated cardiomyopathy
|
J:75968
|
increased cardiomyocyte apoptosis
|
J:75968
|
Tg(Myh7-Pln)2Egk/0
(FVB/N-Tg(Myh7-Pln)2Egk)
|
abnormal muscle physiology
|
J:224766
|
impaired skeletal muscle contractility
|
J:94077
|
muscle weakness
|
J:224766
|
myopathy
|
J:224766
|
Tg(Myh7-Pln)2Egk/?
(involves: FVB/N)
|
impaired muscle relaxation
|
J:127873
|
impaired skeletal muscle contractility
|
J:127873
|
Tg(Myh7-Ptpn11*Q79R)11Rbns/0
(FVB.Cg-Tg(Myh7-Ptpn11*Q79R)11Rbns)
|
decreased cardiac muscle contractility
|
J:123963
|
ventricular cardiomyopathy
|
J:123963
|
Tg(Myh7-Ptpn11*Q510E)#Krnz/0
(FVB/N-Tg(Myh7-Ptpn11*Q510E)#Krnz)
|
cardiomyopathy
|
J:181656
|
decreased heart left ventricle muscle contractility
|
J:181656
|
increased cardiac muscle contractility
|
J:222124
|
Tg(Myh7-RARA/lacZ)30Mcco/0
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:146424
|
decreased cardiac muscle contractility
|
J:146424
|
decreased heart left ventricle muscle contractility
|
J:146424
|
dilated cardiomyopathy
|
J:146424
|
Tg(Myh7-RARA/lacZ)32Mcco/0
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:146424
|
decreased heart left ventricle muscle contractility
|
J:146424
|
Tg(Myhca-Casq2)418Egk/0
(involves: FVB/N)
|
abnormal cardiac muscle relaxation
|
J:50498
|
decreased cardiac muscle contractility
|
J:50498
|
decreased heart left ventricle muscle contractility
|
J:50498
|
Tg(Myl1-SOD1*G93A)#Amu/0
(FVB/NJ-Tg(Myl1-SOD1*G93A)#Amu)
|
abnormal muscle physiology
|
J:143747
|
Tg(Myl2SLC2A1)2Mue/0
(involves: C57BL/6 * SJL)
|
increased skeletal muscle cell glucose uptake
|
J:93868
|
Tg(Myog-Myhas)#Bcgen/0
(C57BL/6J-Tg(Myog-Myhas)#Bcgen)
|
abnormal muscle physiology
|
J:240240
|
Tg(Myog-tTA)1Eno/0 Tg(tetO-HDAC5*)1Eno/0
(involves: C3H * C57BL/6)
|
abnormal muscle physiology
|
J:127416
|
Tg(NEFH)200Jpj/0
(Not Specified)
|
progressive muscle weakness
|
J:69180
|
Tg(NEFH)200Jpj/Tg(NEFH)200Jpj
(Not Specified)
|
progressive muscle weakness
|
J:69180
|
Tg(NFH)120Jpj/0
(Not Specified)
|
progressive muscle weakness
|
J:69180
|
Tg(NFH)120Jpj/Tg(NFH)120Jpj
(Not Specified)
|
progressive muscle weakness
|
J:69180
|
Tg(Notch3*R169C)88Bbb/0
(involves: FVB/N)
|
abnormal vascular smooth muscle physiology
|
J:220006
|
decreased vasoconstriction
|
J:156682,
J:220006
|
Tg(Pkd1)6Mtru/0
(involves: C57BL/6J * CBA/J)
|
increased cardiac muscle contractility
|
J:157952
|
Tg(Prnp*)#Rgab/0
(involves: C57BL/6 * FVB/N)
|
myoclonus
|
J:183170
|
Tg(Prnp*P101L)2866Sbp/0
(involves: FVB/N)
|
myopathy
|
J:136434
|
Tg(Prnp-APPSweArc)#Rmni/0
(involves: C57BL/6 * DBA/2)
|
abnormal vasodilation
|
J:239408
|
Tg(Prnp-CCS)17Jlel/? Tg(SOD1*G93A)dl1Gur/?
(involves: C57BL/6 * SJL)
|
muscle hypertonia
|
J:120361
|
Tg(Prnp-FUS)WT3Cshw/Tg(Prnp-FUS)WT3Cshw
(involves: C57BL/6 * Crl:CD-1(ICR))
|
abnormal muscle physiology
|
J:189360
|
impaired muscle relaxation
|
J:189360
|
impaired skeletal muscle contractility
|
J:189360
|
Tg(Prnp-Immt/SOD1*G93A)7Gmnf/Tg(Prnp-Immt/SOD1*G93A)7Gmnf
(involves: C57BL/6 * CBA * SJL)
|
decreased heart left ventricle muscle contractility
|
J:177846
|
Tg(Prnp-MAPT*P301L)#Ruvi/Tg(Prnp-MAPT*P301L)#Ruvi
(involves: C3HeB/FeJ * C57BL/6)
|
dystonia
|
J:197198
|
Tg(Prnp-MAPT*P301S)PS19Vle/0
(involves: C3H * C57BL/6)
|
progressive muscle weakness
|
J:119741
|
Tg(Prnp-PFN1*C71G)22Zxu/0
(involves: FVB/N)
|
progressive muscle weakness
|
J:235427
|
Tg(Prnp-PFN1*C71G)22Zxu/0 Tg(Thy1-PFN1*C71G)67Zxu/0
(involves: FVB/N)
|
progressive muscle weakness
|
J:235427
|
Tg(Prnp-PFN1*C71G)22Zxu/0 Tg(Thy1-PFN1*C71G)67Zxu/Tg(Thy1-PFN1*C71G)67Zxu
(involves: FVB/N)
|
progressive muscle weakness
|
J:235427
|
Tg(Prnp-SNCA*A53T)25Mkle/0
(involves: C3H/HeJ * C57BL/6J)
|
dystonia
|
J:77344
|
Tg(Prnp-TARDBP)4Jlel/0
(involves: C57BL/6 * CD-1 * SJL)
|
hypotonia
|
J:165985
|
muscle weakness
|
J:165985
|
myopathy
|
J:165985
|
Tg(Prnp-TARDBP*A315T)23Jlel/0
(involves: C57BL/6 * CD-1 * SJL)
|
muscle weakness
|
J:165985
|
Tg(Prnp-TARDBP*A315T)95Balo/0
(involves: C57BL/6 * CBA)
|
abnormal muscle electrophysiology
|
J:153197
|
muscle weakness
|
J:153197
|
Tg(Prnp-TARDBP*Q331K)103Dwc/?
(involves: C57BL/6 * C3H)
|
abnormal muscle electrophysiology
|
J:191785
|
abnormal muscle physiology
|
J:191785
|
abnormal muscle regeneration
|
J:191785
|
Tg(RSV-BDKRB2)8905Chao/0
(involves: C57BL/6 * DBA/2)
|
impaired smooth muscle contractility
|
J:128651
|
Tg(SOD1)2Gur/0 Tg(Thy1-SOD1*G93A)T3Hgrd/0
(involves: C57BL/6 * CBA * FVB * SJL)
|
muscle weakness
|
J:134095
|
Tg(SOD1*)DF7Yaw/0
(C57BL/6-Tg(SOD1*)DF7Yaw)
|
abnormal muscle physiology
|
J:97932
|
Tg(SOD1*)DF7Yaw/Tg(SOD1*)DF7Yaw
(C57BL/6-Tg(SOD1*)DF7Yaw)
|
abnormal muscle physiology
|
J:97932
|
Tg(SOD1*G37R)9Dpr/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:69178
|
Tg(SOD1*G37R)29Dpr/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:69178
|
Tg(SOD1*G37R)42Dpr/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:69178
|
Tg(SOD1*G37R)106Dpr/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal muscle electrophysiology
|
J:69178
|
Tg(SOD1*G85R)74Dwc/?
(Not Specified)
|
progressive muscle weakness
|
J:77600
|
Tg(SOD1*G85R)148Dwc/?
(Not Specified)
|
progressive muscle weakness
|
J:77600
|
Tg(Sod1*G86R)M1Jwg/0
(involves: FVB/N)
|
abnormal muscle physiology
|
J:91800
|
Tg(SOD1*G93A)1Gur/0
(involves: C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:111498
|
muscle weakness
|
J:109423,
J:84843
|
Tg(SOD1*G93A)1Gur/0
(B6SJL-Tg(SOD1*G93A)1Gur/J)
|
abnormal muscle physiology
|
J:158298
|
muscle weakness
|
J:130811
|
progressive muscle weakness
|
J:103582,
J:146652
|
Tg(SOD1*G93A)1Gur/0 Vegfatm2Pec/Vegfatm2Pec
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
muscle weakness
|
J:84843
|
Tg(SOD1*G93A)2Gur/0
(involves: C57BL/6 * SJL)
|
progressive muscle weakness
|
J:32665
|
Tg(SOD1*G93A)dl1Gur/0
(involves: C57BL/6 * CBA * SJL)
|
muscle weakness
|
J:134095
|
progressive muscle weakness
|
J:134095
|
Tg(SOD1*G93A)dl1Gur/0
(involves: C57BL/6 * SJL)
|
muscle weakness
|
J:106420
|
Tg(SOD1*G93A)dl1Gur/0 Tg(Thy1-SOD1*G93A)T3Hgrd/0
(involves: C57BL/6 * CBA * FVB * SJL)
|
muscle weakness
|
J:134095
|
progressive muscle weakness
|
J:134095
|
Tg(SOD1*H46R)#Maw/0
(involves: C57BL/6 * DBA/2)
|
progressive muscle weakness
|
J:99701
|
Tg(Tagln-Ager)#Yon/?
(C57BL/6-Tg(Tagln-Ager)#Yon)
|
abnormal vascular smooth muscle physiology
|
J:82620
|
decreased vascular smooth muscle cell proliferation
|
J:82620
|
Tg(Tagln-tTA)1Mrab/0 Tg(tetO-Mcpt1)1Mrab/0
(involves: C57BL/6 * SJL)
|
abnormal vasoconstriction
|
J:70031
|
increased vasoconstriction
|
J:70031
|
Tg(Thy1-App*R609D*K612E)4Vln/0
(involves: FVB)
|
facial muscle spasm
|
J:32213
|
myoclonus
|
J:32213
|
Tg(Thy1-App*R609D*K612E)4Vln/Tg(Thy1-App*R609D*K612E)4Vln
(involves: FVB)
|
facial muscle spasm
|
J:32213
|
myoclonus
|
J:32213
|
Tg(Thy1-App*R609D*K612E)6Vln/0
(involves: FVB)
|
facial muscle spasm
|
J:32213
|
myoclonus
|
J:32213
|
Tg(Thy1-App*R609D*K612E)6Vln/Tg(Thy1-App*R609D*K612E)6Vln
(involves: FVB)
|
facial muscle spasm
|
J:32213
|
myoclonus
|
J:32213
|
Tg(Thy1-DCTN1*G59S)M2Pcw/?
(involves: C57BL/6 * SJL)
|
progressive muscle weakness
|
J:132857
|
Tg(Thy1-GLRA1*R271Q)300Wha/0
(involves: C57BL/6 * DBA/2)
|
abnormal muscle physiology
|
J:173399
|
abnormal muscle tone
|
J:173399
|
Tg(Thy1-MAPT)1Vln/Tg(Thy1-MAPT)1Vln
(involves: FVB)
|
muscle weakness
|
J:100972
|
Tg(Thy1-MAPT*)1Avil/Tg(Thy1-MAPT*)1Avil
(involves: C57BL/6 * CBA)
|
myoclonus
|
J:201700
|
Tg(Thy1-MAPT*P301S)2541Godt/Tg(Thy1-MAPT*P301S)2541Godt
(involves: C57BL/6J * CBA/Ca)
|
muscle weakness
|
J:108870
|
Tg(Thy1-PFN1*C71G)67Zxu/0
(Not Specified)
|
progressive muscle weakness
|
J:235427
|
Tg(Thy1-PFN1*C71G)67Zxu/Tg(Thy1-PFN1*C71G)67Zxu
(Not Specified)
|
progressive muscle weakness
|
J:235427
|
Tg(Thy1-SNCA*)#Ztzh/0
(involves: C57BL/6J)
|
muscle weakness
|
J:313970
|
Tg(Thy1-SNCA*A30P)18Pjk/Tg(Thy1-SNCA*A30P)18Pjk
(involves: C57BL/6)
|
progressive muscle weakness
|
J:80181
|
Tg(Thy1-SOD1*G93A)T1Hgrd/0 Tg(Thy1-SOD1*G93A)T3Hgrd/0
(involves: C57BL/6 * CBA * FVB)
|
progressive muscle weakness
|
J:134095
|
Tg(Thy1-SOD1*G93A)T3Hgrd/Tg(Thy1-SOD1*G93A)T3Hgrd
(involves: C57BL/6 * CBA * FVB)
|
progressive muscle weakness
|
J:134095
|
Tg(Thy1-TARDBP)4Singh/Tg(Thy1-TARDBP)4Singh
(involves: C57BL/6J * SJL/J)
|
facial muscle fasciculation
|
J:157550
|
facial muscle spasm
|
J:157550
|
Tg(Tuba1-MAPT)14Vle/0
(involves: C57BL/6 * SJL)
|
dystonia
|
J:78400
|
Tg(WTbeta2)4Wjk/?
(Not Specified)
|
abnormal cardiac muscle relaxation
|
J:17862
|
cardiomyopathy
|
J:128583
|
decreased cardiac muscle contractility
|
J:128583
|
increased cardiac muscle contractility
|
J:17862
|
increased heart left ventricle muscle contractility
|
J:17862
|
Tg(WTbeta2)4Wjk/0
(involves: C57BL/6)
|
abnormal cardiac muscle contractility
|
J:134706
|
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * CF-1)
|
diaphragmitis
|
J:2892
|
myositis
|
J:2892
|
Tgfb1i1tm1.1Knos/Tgfb1i1tm1.1Knos
(involves: C57BL/6)
|
abnormal vascular smooth muscle physiology
|
J:223628
|
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S/Sv * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:164749
|
dilated cardiomyopathy
|
J:164749
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased cardiac muscle contractility
|
J:164749
|
dilated cardiomyopathy
|
J:164749
|
Tgfbr2tm1Karl/Tgfbr2tm1Karl H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal vasodilation
|
J:96359
|
Tgfbr3tm1Stv/Tgfbr3tm1Stv
(involves: 129/Sv * C57BL/6)
|
abnormal fetal cardiomyocyte proliferation
|
J:83727
|
Thbs4tm1Dgen/Thbs4tm1Dgen
(B6.129P2-Thbs4tm1Dgen)
|
decreased heart ventricle muscle contractility
|
J:187437
|
Thratm1Jas/Thratm1Jas
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased heart ventricle muscle contractility
|
J:68577
|
Thratm1Syc/Thra+
(involves: 129S6/SvEvTac)
|
decreased cardiac muscle cell glucose uptake
|
J:95397
|
Thratm2Jas/Thratm2Jas
(involves: 129)
|
decreased heart ventricle muscle contractility
|
J:68577
|
Thrbtm1.1Syc/Thrbtm1.1Syc
(involves: 129S6/SvEvTac)
|
increased cardiac muscle cell glucose uptake
|
J:95397
|
Tigartm1.2Smat/Tigartm1.2Smat Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JJcl * C57BL/6NCrj)
|
decreased cardiomyocyte apoptosis
|
J:183674
|
increased cardiac muscle contractility
|
J:183674
|
Timp3tm1Osya/Timp3tm1Osya
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased vasodilation
|
J:211441
|
Timp3tm1Rkho/Timp3tm1Rkho
(involves: 129 * C57BL/6)
|
decreased cardiac muscle contractility
|
J:112033
|
dilated cardiomyopathy
|
J:112033
|
Timp3tm1Rkho/Timp3tm1Rkho
(B6.129-Timp3tm1Rkho)
|
abnormal cardiac muscle relaxation
|
J:102205
|
decreased heart ventricle muscle contractility
|
J:102205
|
dilated cardiomyopathy
|
J:102205
|
Timp3tm1Rkho/Timp3tm1Rkho Tnftm1Gkl/Tnftm1Gkl
(involves: 129 * 129S/SvEv * C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:112033
|
Tincrem1(IMPC)Ccpcz/Tincrem1(IMPC)Ccpcz
(C57BL/6NCrl-Tincrem1(IMPC)Ccpcz/Ccpcz)
|
increased cardiac muscle contractility
|
J:211773
|
Tlr3tm1Aki/Tlr3tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal vascular smooth muscle physiology
|
J:116310
|
Tlr4Lps-d/Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d)
|
abnormal skeletal muscle cell glucose uptake
|
J:126488
|
tlss/tlss
(Not Specified)
|
intestinal hypoperistalsis
|
J:169366
|
Tmem38atm1Hta/Tmem38a+ Tmem38btm1Hta/Tmem38b+
(involves: 129S4/SvJae)
|
abnormal muscle physiology
|
J:122817
|
Tmem70tm1a(KOMP)Wtsi/Tmem70+
(involves: C57BL/6N)
|
decreased heart left ventricle muscle contractility
|
J:238642
|
Tmem182em1Cya/Tmem182em1Cya
(C57BL/6J-Tmem182em1Cya)
|
abnormal myoblast migration
|
J:314094
|
enhanced skeletal muscle regeneration
|
J:314094
|
Tmod1tm1Vmf/Tmod1tm1Vmf
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal cardiac muscle contractility
|
J:87158
|
Tmprss2tm2b(EUCOMM)Hmgu/Tmprss2tm2b(EUCOMM)Hmgu
(C57BL/6N-Tmprss2tm2b(EUCOMM)Hmgu/Orl)
|
decreased cardiac muscle contractility
|
J:211773
|
Tnftm1Gkl/Tnftm1Gkl Zfp36tm1Pjb/Zfp36tm1Pjb
(involves: 129S/SvEv * C57BL/6)
|
abnormal vasodilation
|
J:214114
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6J)
|
decreased heart left ventricle muscle contractility
|
J:264147
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:104990
|
TnksGt(RRC239)Byg/TnksGt(RRC239)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased muscle cell glucose uptake
|
J:154388
|
Tnnc1tm1.1Jrpi/Tnnc1+
(involves: 129S6/SvEvTac * C57BL/6)
|
cardiomyopathy
|
J:274007
|
Tnnc1tm1.1Jrpi/Tnnc1tm1.1Jrpi
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:249978
|
abnormal cardiac muscle relaxation
|
J:249978
|
cardiomyopathy
|
J:274007
|
decreased cardiac muscle relaxation
|
J:274007
|
increased cardiac muscle contractility
|
J:274007
|
Tnni3kB/Tnni3kB
(involves: C57BL/6J * DBA/2J)
|
decreased cardiac muscle contractility
|
J:339644
|
Tnnt1tm1.2Jin/Tnnt1tm1.2Jin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal muscle contractility
|
J:219907
|
abnormal muscle physiology
|
J:219907
|
abnormal muscle relaxation
|
J:219907
|
Tnnt1tm1Jin/Tnnt1tm1Jin
(B6.129P2-Tnnt1tm1Jin)
|
abnormal muscle contractility
|
J:219907
|
abnormal muscle physiology
|
J:219907
|
abnormal muscle relaxation
|
J:219907
|
Tnnt2tm1Feah/Tnnt2tm1Feah
(involves: 129S6/SvEvTac * FVB/N)
|
decreased cardiac muscle contractility
|
J:137964
|
Tnnt2tm2.1Feah/Tnnt2+
(involves: 129S6/SvEvTac * FVB/N)
|
decreased cardiac muscle contractility
|
J:243725
|
dilated cardiomyopathy
|
J:243725
|
Tnnt2tm2Mmto/Tnnt2+
(involves: 129S/SvEv * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:137784
|
Tnnt2tm2Mmto/Tnnt2tm2Mmto
(involves: 129S/SvEv * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:137784
|
decreased heart left ventricle muscle contractility
|
J:137784
|
Tns3em1(IMPC)Bay/Tns3+
(C57BL/6N-Tns3em1(IMPC)Bay/Bay)
|
decreased cardiac muscle contractility
|
J:211773
|
Tor1atm1Calak/Tor1atm1Calak
(involves: 129 * C57BL/6)
|
dystonia
|
J:247570
|
Tor1atm1Wtd/Tor1atm3.1Wtd Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
dystonia
|
J:288753,
J:213785
|
Tor1atm2Wtd/Tor1atm3.1Wtd Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
dystonia
|
J:213785
|
Tph1tm1Mlt/Tph1tm1Mlt
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased cardiac muscle contractility
|
J:99733
|
Tpm3tm3Pgun/Tpm3tm3Pgun
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle contractility
|
J:200893
|
Tpm3tm4.1Pgun/Tpm3tm4.1Pgun
(B6JArc.Cg-Tpm3tm4.1Pgun)
|
abnormal muscle contractility
|
J:200893
|
Tpp1m1J/Tpp1m1J
(STOCK Tpp1m1J/GrsrJ)
|
myopathy
|
J:201119
|
Trak1hyrt/Trak1hyrt
(involves: AKR * C3HeB/FeJ * C57BL/6J)
|
abnormal muscle physiology
|
J:105231
|
Trdntm1.2Isma/Trdntm1.2Isma
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal muscle electrophysiology
|
J:157794
|
abnormal muscle physiology
|
J:157794
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd)
|
cardiomyopathy
|
J:92264
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6)
|
myositis
|
J:181257
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
myositis
|
J:234263
|
Trim29tm1a(EUCOMM)Wtsi/Trim29tm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
decreased fetal cardiomyocyte apoptosis
|
J:349246
|
Trim29tm1c(EUCOMM)Wtsi/Trim29tm1c(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac)
|
decreased fetal cardiomyocyte apoptosis
|
J:349246
|
Trim32Gt(BGA355)Byg/Trim32Gt(BGA355)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
myopathy
|
J:146155
|
Trim32tm1Hdin/Trim32tm1Hdin
(involves: 129S1/Sv)
|
abnormal muscle physiology
|
J:184218
|
delayed skeletal muscle regeneration
|
J:184218
|
myopathy
|
J:184218
|
Trim37Gt(RRO307)Byg/Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg)
|
cardiomyopathy
|
J:232482
|
Trim54tm1Eno/Trim54tm1Eno
(B6.Cg-Trim54tm1Eno)
|
abnormal cardiac muscle contractility
|
J:120068
|
dilated cardiomyopathy
|
J:120068
|
increased cardiomyocyte apoptosis
|
J:120068
|
Trim55tm1Cpat/Trim55tm1Cpat Trim63tm1Glas/Trim63tm1Glas
(involves: 129S1/Sv * C57BL/6)
|
decreased cardiac muscle contractility
|
J:267246
|
Trim55tm1Slbt/Trim55tm1Slbt Trim63tm1Slbt/Trim63tm1Slbt
(involves: 129 * C57BL/6)
|
decreased cardiac muscle contractility
|
J:130921
|
Trim72tm1Hta/Trim72tm1Hta
(Not Specified)
|
abnormal muscle physiology
|
J:146965
|
abnormal muscle regeneration
|
J:146965
|
impaired skeletal muscle contractility
|
J:146965
|
Trp53tm1Tyj/Trp53tm1Tyj Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NCrj)
|
decreased cardiomyocyte apoptosis
|
J:183674
|
increased cardiac muscle contractility
|
J:183674
|
Trpc4tm1Bni/Trpc4tm1Bni
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased vasodilation
|
J:68178
|
Trpc6tm1Lbi/Trpc6tm1Lbi
(involves: 129S/SvEv * C57BL/6J)
|
abnormal vascular smooth muscle physiology
|
J:106082
|
abnormal vasoconstriction
|
J:106082
|
increased vasoconstriction
|
J:106082
|
Trpm2tm1.1Jych/Trpm2tm1.1Jych
(involves: FVB/N)
|
decreased cardiac muscle contractility
|
J:196475
|
Trpv4tm1Rck/Trpv4tm1Rck
(Not Specified)
|
abnormal vasodilation
|
J:129365
|
Tshz3tm1Lafa/Tshz3tm1Lafa
(involves: 129P2/OlaHsd * CD-1)
|
impaired ureteric peristalsis
|
J:138769
|
Ttnem1Kage/Ttnem1Kage
(B6J.B6N-Ttnem1Kage)
|
decreased heart left ventricle muscle contractility
|
J:302920
|
Ttnmdm/Ttnmdm
(Not Specified)
|
myositis
|
J:14016
|
Ttnshru/Ttnshru
(B6.BTBR-Ttnshru)
|
decreased cardiac muscle contractility
|
J:92178
|
Ttntm1.1Hgra/Ttntm1.1Hgra
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal muscle contractility
|
J:206713
|
Ttntm1.1Isrd/Ttntm1.1Isrd
(involves: 129S2/SvPas * C57BL/6)
|
decreased heart ventricle muscle contractility
|
J:165576
|
dilated cardiomyopathy
|
J:165576
|
impaired skeletal muscle contractility
|
J:165576
|
myositis
|
J:165576
|
Ttntm1Brge/Ttn+
(B6.Cg-Ttntm1Brge)
|
decreased cardiac muscle contractility
|
J:152736
|
dilated cardiomyopathy
|
J:152736
|
Ttntm1Her/Ttntm1Her Tg(Ckmm-cre)5Khn/0
(Not Specified)
|
progressive muscle weakness
|
J:81993
|
Ttntm2.1Mgot/Ttn+
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal muscle physiology
|
J:169969
|
Ttntm2.1Mgot/Ttntm2.1Mgot
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal cardiac muscle contractility
|
J:169969
|
abnormal muscle physiology
|
J:169969
|
Ttpatm1Hsz/Ttpatm1Hsz
(involves: 129S7/SvEvBrd * C57BL/6J)
|
dystonia
|
J:90006
|
Tubb4aem1Avan/Tubb4aem1Avan
(involves: C57BL/6)
|
dystonia
|
J:291062
|
Tulp4tm1a(KOMP)Wtsi/Tulp4+
(involves: C57BL/6N * C57BL/6NRj)
|
telangiectasia
|
J:344151
|
Twist2tm1(cre)Dor/Twist2tm1(cre)Dor
(involves: 129/Sv * 129X1/SvJ)
|
dystonia
|
J:81485
|
Txniptm1.1Rlee/Txniptm1.1Rlee
(involves: 129S4/SvJae)
|
decreased heart left ventricle muscle contractility
|
J:141487
|
increased cardiac muscle cell glucose uptake
|
J:141487
|
Txniptm1.1Road/Txniptm1.1Road
(B6.Cg-Txniptm1.1Road)
|
increased skeletal muscle cell glucose uptake
|
J:132756
|
Txniptm1Rlee/Txniptm1Rlee A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S4/SvJae * FVB/N)
|
increased cardiac muscle cell glucose uptake
|
J:141487
|
Txnrd2tm1.1Marc/Txnrd2tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased fetal cardiomyocyte proliferation
|
J:94136
|
Ube3ctm1b(EUCOMM)Hmgu/Ube3ctm1b(EUCOMM)Hmgu
(C57BL/6NCrl-Ube3ctm1b(EUCOMM)Hmgu/Rbrc)
|
increased cardiac muscle contractility
|
J:211773
|
Ube4btm1Kei/Ube4btm1Kei
(involves: C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:103761
|
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(involves: 129 * C57BL/6 * SJL)
|
dystonia
|
J:182805
|
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(FVB.Cg-Ugt1tm1.1Afmu)
|
dystonia
|
J:216224
|
uns/uns
(involves: C57BL/6J * CD-1)
|
abnormal muscle contractility
|
J:14139
|
abnormal muscle electrophysiology
|
J:14139
|
Usp14ax-J/Usp14ax-J
(C.Cg-Usp14ax-J)
|
progressive muscle weakness
|
J:203043
|
Usp14nmf375/Usp14nmf375
(B6;CByJ-Usp14nmf375/J)
|
muscle spasm
|
J:87349
|
Usp14nmf375/Usp14nmf375
(C.B6-Usp14nmf375)
|
muscle weakness
|
J:203043
|
Uts2rtm1Djbe/Uts2rtm1Djbe
(B6.129P2-Uts2rtm1Djbe)
|
abnormal vasoconstriction
|
J:103118
|
UvragTn(pb-Act-RFP)1.100107015-HRAZhu/UvragTn(pb-Act-RFP)1.100107015-HRAZhu
(involves: FVB/NJ)
|
cardiomyopathy
|
J:219546
|
decreased cardiac muscle contractility
|
J:219546
|
increased cardiomyocyte apoptosis
|
J:219546
|
Vapbtm1.2Ics/Vapbtm1.2Ics
(B6N.129S2-Vapbtm1.2Ics)
|
hypotonia
|
J:198145
|
Vav3tm1Xrb/Vav3tm1Xrb
(Not Specified)
|
decreased heart ventricle muscle contractility
|
J:111973
|
vc/vc
(DBA/1-vc)
|
muscle weakness
|
J:297
|
Vcltm1Eda/Vcl+
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
decreased heart left ventricle muscle contractility
|
J:92398
|
Vcltm1Eda/Vcltm1Eda
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
decreased cardiac muscle contractility
|
J:45781
|
Vcptm1Itl/Vcp+
(B6.129S-Vcptm1Itl)
|
myopathy
|
J:166230
|
progressive muscle weakness
|
J:166230
|
Vcptm1Itl/Vcptm1Itl
(involves: 129S6/SvEvTac)
|
muscle weakness
|
J:191963
|
myopathy
|
J:191963
|
Vdac3tm1Wjc/Vdac3tm1Wjc
(Not Specified)
|
abnormal muscle physiology
|
J:72188
|
Vegfatm1Pec/Vegfatm1Pec
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal cardiac muscle relaxation
|
J:56003
|
decreased cardiac muscle contractility
|
J:56003
|
decreased heart left ventricle muscle contractility
|
J:56003
|
Vegfatm2Pec/Vegfatm2Pec
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal muscle physiology
|
J:69797
|
progressive muscle weakness
|
J:69797
|
Vgll4tm1b(EUCOMM)Hmgu/Vgll4tm1b(EUCOMM)Hmgu
(involves: C57BL/6N * CBA)
|
increased cardiac muscle contractility
|
J:273437
|
Vgll4tm1b(EUCOMM)Hmgu/Vgll4tm1c(EUCOMM)Hmgu Tg(Tek-cre)1Ywa/0
(involves: C57BL/6N * CBA * SJL)
|
decreased cardiac muscle contractility
|
J:273437
|
Vhltm1Jae/Vhltm1Jae Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA)
|
abnormal vasodilation
|
J:97652
|
Vhltm1Jae/Vhltm1Jae Tg(Myh6-cre)2182Mds/0
(involves: 129S4/SvJae * FVB/N)
|
cardiomyopathy
|
J:179490
|
decreased heart ventricle muscle contractility
|
J:179490
|
Vimtm1Cba/Vimtm1Cba
(involves: 129S2/SvPas)
|
abnormal vasoconstriction
|
J:43049
|
abnormal vasodilation
|
J:43049
|
Vkorc1tm1.1Jobg/Vkorc1tm1.1Jobg
(involves: 129S4/SvJae * BALB/cJ * C57BL/6)
|
muscle hemorrhage
|
J:207884
|
Vps16em1Weli/Vps16em1Weli
(C57BL/6J-Vps16em1Weli)
|
dystonia
|
J:243974
|
Vps54wr/Vps54wr
(multiple strains)
|
abnormal muscle physiology
|
J:5102
|
muscle weakness
|
J:5102
|
Vps54wr/Vps54wr
(involves: C57BL/6J * C57BL/Fa)
|
progressive muscle weakness
|
J:181019
|
Wars1tm1b(EUCOMM)Hmgu/Wars1+
(C57BL/6N-Warstm1b(EUCOMM)Hmgu/Ieg)
|
decreased cardiac muscle contractility
|
J:211773
|
Wars2mpc151H/Wars2mpc151H
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
cardiomyopathy
|
J:234901
|
Wdr1tm1.1Zzy/Wdr1tm1.1Zzy Tg(Myh6-cre)1Xya/0
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased heart left ventricle muscle contractility
|
J:211364
|
Wfikkn1tm1.1Sjl/Wfikkn1tm1.1Sjl
(involves: 129 * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:201148
|
Wfikkn1tm1.1Sjl/Wfikkn1tm1.1Sjl Wfikkn2tm1.1Sjl/Wfikkn2tm1.1Sjl
(involves: 129 * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:201148
|
Wfikkn2tm1.1Sjl/Wfikkn2tm1.1Sjl
(involves: 129 * C57BL/6)
|
impaired skeletal muscle regeneration
|
J:201148
|
Wnt1sw/Wnt1sw
(Not Specified)
|
muscle hypertonia
|
J:30722
|
Wnt10btm1Ptr/Wnt10btm1Ptr
(involves: FVB)
|
abnormal muscle regeneration
|
J:99298
|
Wsb2tm1b(EUCOMM)Hmgu/Wsb2tm1b(EUCOMM)Hmgu
(C57BL/6N-Wsb2tm1b(EUCOMM)Hmgu/Cnrm)
|
decreased cardiac muscle contractility
|
J:211773
|
Wwtr1tm1.1Eno/Wwtr1+ Yap1tm1.1Eno/Yap1tm1.1Eno Tg(Myh6-cre)2182Mds/0
(involves: 129S/SvEv * FVB/N)
|
increased cardiomyocyte apoptosis
|
J:200670
|
Wwtr1tm1.1Eno/Wwtr1tm1.1Eno Yap1tm1.1Eno/Yap1+ Tg(Myh6-cre)2182Mds/0
(involves: 129S/SvEv * FVB/N)
|
dilated cardiomyopathy
|
J:200670
|
Xiaptm1Vdr/Xiaptm1Vdr
(involves: 129S1/Sv)
|
decreased cardiac muscle contractility
|
J:182515
|
Xirp1tm1Dofr/Xirp1tm1Dofr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal cardiac muscle contractility
|
J:159352
|
decreased cardiac muscle contractility
|
J:159352
|
Xirp1tm1Jl/Xirp1+
(involves: 129)
|
cardiomyopathy
|
J:132079
|
Xirp1tm1Jl/Xirp1tm1Jl
(involves: 129)
|
cardiomyopathy
|
J:132079
|
Xirp2tm1Jl/Xirp2tm1Jl
(B6.129-Xirp2tm1Jl)
|
increased cardiomyocyte apoptosis
|
J:158491
|
Xlch/?
(C57BL/6J-Xlch)
|
increased cardiac muscle contractility
|
J:136798
|
Yap1tm1.1Eno/Yap1tm1.1Eno Tg(Myh6-cre)2182Mds/0
(involves: 129S/SvEv * FVB/N)
|
decreased cardiac muscle contractility
|
J:200670
|
dilated cardiomyopathy
|
J:200670
|
Yme1l1tm1Tlan/Yme1l1tm1Tlan Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * C57BL/6NCrl * FVB/N)
|
abnormal muscle physiology
|
J:229455
|
decreased heart left ventricle muscle contractility
|
J:229455
|
dilated cardiomyopathy
|
J:229455
|
increased cardiac muscle cell glucose uptake
|
J:229455
|
Ywhaetm1Awb/Ywhaetm1Awb
(involves: 129S6/SvEvTac)
|
decreased fetal cardiomyocyte proliferation
|
J:192860
|
YwhaqGt(RRR746)Byg/Ywhaq+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cardiomyocyte apoptosis
|
J:118280
|
Zdhhc9tm1Lex/Y
(B6.129S5-Zdhhc9tm1Lex)
|
hypotonia
|
J:268248
|
Zdhhc16tm1Goff/Zdhhc16tm1Goff
(involves: 129S1/Sv)
|
cardiomyopathy
|
J:228307
|
Zeb1tm2Yhi/Zeb1tm2Yhi
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal vascular smooth muscle physiology
|
J:110800
|
Zfp36tm1Pjb/Zfp36tm1Pjb
(B6.Cg-Zfp36tm1Pjb)
|
abnormal vasodilation
|
J:214114
|
Zfp106tm1a(KOMP)Wtsi/Zfp106tm1a(KOMP)Wtsi
(involves: C57BL/6Brd * C57BL/6Dnk * C57BL/6N)
|
abnormal muscle electrophysiology
|
J:229162
|
abnormal muscle physiology
|
J:229162
|
Zfp235tm1b(KOMP)Wtsi/Zfp235tm1b(KOMP)Wtsi
(C57BL/6N-Zfp235tm1b(KOMP)Wtsi/Bay)
|
increased cardiac muscle contractility
|
J:211773
|
Zfp280dem1(IMPC)Hmgu/Zfp280dem1(IMPC)Hmgu
(C57BL/6N-Zfp280dem1(IMPC)Hmgu/Ieg)
|
decreased cardiac muscle contractility
|
J:211773
|
Zfp422em1Mode/Zfp422em1Mode Pax7tm1(cre/ERT2)Gaka/Pax7+
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
impaired skeletal muscle regeneration
|
J:297035
|
Zfpm2tm1.1Esv/Zfpm2tm1.1Esv
(involves: 129S1/SvImJ * 129S2/SvPas * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
decreased heart left ventricle muscle contractility
|
J:216295
|
Zfpm2tm1Sho/Zfpm2tm2Sho Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:150452
|
decreased heart ventricle muscle contractility
|
J:150452
|
increased cardiomyocyte apoptosis
|
J:150452
|
Zfpm2tm1Sho/Zfpm2tm2Sho Tg(Tnnt2-rtTA,tetO-cre)1Wtp/0
(involves: 129S1/Sv * 129S7/SvEvBrd)
|
decreased cardiac muscle contractility
|
J:150452
|
increased cardiomyocyte apoptosis
|
J:150452
|
Zic1tm1Jaru/Zic1+
(B6.129S4-Zic1tm1Jaru)
|
hypotonia
|
J:72342
|
Zmpste24tm1Otin/Zmpste24tm1Otin
(involves: 129P2/Ola * C57BL/6)
|
dilated cardiomyopathy
|
J:76209
|
Zmpste24tm1Sgy/Zmpste24tm1Sgy
(involves: 129S4/SvJae * C57BL/6)
|
progressive muscle weakness
|
J:95274,
J:79501
|